{
  "doc_id": "LG149_Polmone_agg2024",
  "created_date": "2024",
  "country": "IT",
  "source_type": "clinical_guideline",
  "chunks": [
    {
      "heading": "",
      "text": "GUIDA GUIDA DELL'Sistema Sistema National",
      "start_page": 1,
      "end_page": 2
    },
    {
      "heading": "March March 2020",
      "text": "3, 3, 202",
      "start_page": 2,
      "end_page": 2
    },
    {
      "heading": "October October 2024",
      "text": "Novello Novello (Passig Passig (Bertolaccini Bertolaccini (Chirugo) Re Re (Farmacologa) Francesca Facchinetti (Onocologo Polico) Roberto Ferrara (Oncolgo Medico) Tindara Francina (oncologist Medical) Paolo Graziano (Patologo) Larici Larici (Radiologo) Umberto Malapelle (Biologist Molecular) Jessica Menis (Onconologia Medico), Antonio Passaro (Oncologia Medicalo) Sara Pilotto (Oncogologia Doctoro) co) of of Turin; Gonzaga Gonzaga (TO) Rendina (Chirurgo) Vieri Scotti (Radioterapista) Versitario Versitario . Fano Fano (PU) Sometimes Sometimes \"spinous,\" ask ask is: \"something something better?\" difference. difference.",
      "start_page": 2,
      "end_page": 5
    },
    {
      "heading": "Table of Contents",
      "text": "recommendations recommendations .................................................................................................................................................. First-line First-line treatment: immunotherapy ................. First-row First-row treatment: chemotherapy .................. lines lines ............................................. 2 2 ................................................. ari .... KRAS KRAS . LINE ET .... cancer cancer (_MEDTERM5__) ................................................................ treatment treatment ......................................................................................... treatments treatments ................................................................. cancer. cancer.....................................................",
      "start_page": 6,
      "end_page": 8
    },
    {
      "heading": "recommendations recommendations *",
      "text": "method method (see specific chapter), Recommendation Recommendation (2) tests tests (1) Recommendation (3) Patients with pN+ lymphadenectomy lymphadenectomy (<D2) radiochemotherapy radiochemotherapy (1) OF OF TESTS: process process (MOLTO MOLTO BASSA).",
      "start_page": 9,
      "end_page": 9
    },
    {
      "heading": "(2) CLINICAL RECOMMENDATION",
      "text": "an an intervention/the the PICO* question question (comparison, comparison, outcome). symbol symbol √.",
      "start_page": 9,
      "end_page": 9
    },
    {
      "heading": "FORMAL FORMAL APPROACH",
      "text": "below. below.",
      "start_page": 9,
      "end_page": 9
    },
    {
      "heading": "RECOMMENDATION:",
      "text": "the the recommendation: Reasons/comments to benefit/damage balance: been been identified: motivate motivate benefit/deal balance:",
      "start_page": 9,
      "end_page": 9
    },
    {
      "heading": "Quality of tests",
      "text": "following following reasons:",
      "start_page": 9,
      "end_page": 9
    },
    {
      "heading": "(3) CLINICAL CLINICAL RECOMMENDATION",
      "text": "four four levels: Terminology Terminology - with with (selection criteria) option option (intention intention - damage)",
      "start_page": 9,
      "end_page": 10
    },
    {
      "heading": "CONFLICT OF INTEREST",
      "text": "indicated indicated (see example below). melanoma melanoma (1 1 mm), favour favour dabrafenib+option option COI: of of interest: YY YY * site site = process process (when applied) document. document.",
      "start_page": 10,
      "end_page": 10
    },
    {
      "heading": "the the Guideline",
      "text": "Guidelines Guidelines are: and and comorbidity) 6 6 (advanced advanced disease) PLA PLA ASIE",
      "start_page": 11,
      "end_page": 18
    },
    {
      "heading": "1. Epidemiological data",
      "text": "(Source: 2023. 2023. AIOM-AIRTUM)",
      "start_page": 19,
      "end_page": 19
    },
    {
      "heading": "1.1 Incidence",
      "text": "Italy Italy (in in women): men men (15%) women women (6%). 14. 14.3% 7. 7.4% 1. 1.3% genders. genders.",
      "start_page": 19,
      "end_page": 19
    },
    {
      "heading": "1.2 Mortality",
      "text": "Italy Italy (men: 23,600; women: 12,100). 18. 18.7%. the the 2007‐of of 16%.",
      "start_page": 19,
      "end_page": 19
    },
    {
      "heading": "1.3 Survival",
      "text": "is is 16% and and 23% is is 37% and and 44% diagnosis. diagnosis.",
      "start_page": 19,
      "end_page": 20
    },
    {
      "heading": "1.4 Prevalence",
      "text": "cancer cancer (600 600 women) Italy. Italy. 34% years, years, 23% years, years, 17% only only 25% be be 8% and and 13% in women.",
      "start_page": 20,
      "end_page": 20
    },
    {
      "heading": "Risk Risk factors",
      "text": "the the 20-year-olds and 15-0% country. country. (1) factors factors including: duration duration (in years) cigarettes cigarettes (2). smokers smokers (considered as total) smokers smokers (per per day) years years (3-4). between between 20% and 50%, men men (5-6). on on nicotine: working working and/the the market; tobacco tobacco smoke; upon upon nicotine: oral oral nicotine; and and / substances substances (and and chloro- methyl ether, chloro) and and chloroat-and and other) and and others) A A 55% non-smokers non-smokers (9), etiology etiology (10).",
      "start_page": 21,
      "end_page": 22
    },
    {
      "heading": "Primary Primary prevention",
      "text": "measures measures \"MPOWER\" programme programme \"Language,\" Directive Directive 2014/40/least least 65% studies studies (n=662) e-Cig e-Cig (no nicotine) of of e- nicotine nicotine (abstention 9% vs 4%; 2. 2.29; CI95% 96 96 respectively). studies studies (observational, observational, n=1722) e e - devices devices (12). reported reported (13). compounds compounds (carbon carbon dioxide) cigarettes cigarettes (14). nicotine nicotine (containing containing Nicotine) S. S.",
      "start_page": 22,
      "end_page": 25
    },
    {
      "heading": "Secondary Secondary prevention",
      "text": "Trial Trial (NLST) CT CT (LDCT) subjects subjects (of of enrollment) a a 20% X-ray X-ray (15). with with FEV1/FVC ratio <by by 37% (16). Services Services (USPSFT) Network Network (NCCN). years years (year year old), 20 20 pakLGDI/years years earlier? RECOMMENDATION: Recommendation Recommendation Force: of of Motivazioni/comments to benefit/damage balance; screening screening (NS) radiography radiography (CXRR) 895 895 million; in in fatality; 8, 8,1050; women women (p=0.21; I2=33.6%) world world (24). of of tests: MODERATA COI: approved approved and/2. 2.1% 43. 43.5%, 0. 0.2% and 15% field field (27). Oncology Oncology (ESMO) the the EU'project, project, 4-IN-THE-LUNG-RUN (4-iTLR), cancers cancers (first first LDCT) risk. risk.",
      "start_page": 25,
      "end_page": 28
    },
    {
      "heading": "Invasive Invasive cancers",
      "text": "Organization Organization (WHO) than than 95% main main histotypes: squamous carcinoma (CS), adenocarcinoma (ADC), carcinoma carcinoma (CGC) carcinomas carcinomas (microcytoma) (29). increasing increasing (>50%), reduced reduced (29). cancers cancers (Cancer, Cancer, __MEDTERM4_) histology histology (29-32). colorations colorations (e.g. May-Grunwald-Giemsa) investigations investigations (carcinoma carcinoma (Carcinoma, Carcinoma, LCNEC) characterization characterization (Cd56), that that >50% pattern pattern (36). markers markers (and and synaptophysin) sample sample (surgical surgical resection) (42-44). Table 3.1: WHO WHO - 2021.",
      "start_page": 29,
      "end_page": 31
    },
    {
      "heading": "Variants Variants Notes",
      "text": "Palilloma - Pneumocytoma Pneumocytoma - Pattern: properties properties (cd. Adenoma - species species Bronchyolary-Grossic-Glass-Grass-Cross-glassed-Gastic-Glypian-Galiphous-Galent-Glossy-Global-Glimatic-Glue-Gulcan-Gallstone-Ghiant-Gilan-Gilitary-Militious-Golitative-Gossips-Adeno-Carcinoma-Gilet-Glorian-Geliot-Gribal-Filit-Vilitarian-Gliot-Lypyl-Grypular-Gild-Glime-Dilitable-Gliat-Golf-Gold-Gill-Gloud-El-Folit-Pilotose-Gustile-Glausive-Gilat-Hiper-Girthypious-Filkly-Gleplish-Glaebileon-Glorious-Oly-Flue, and Minimum-Gelo-Gro-Filen-Fly-Blue",
      "start_page": 31,
      "end_page": 32
    },
    {
      "heading": "molecular molecular pathology",
      "text": "the the patient'IIIB-IIIC IIIB-IIIC (locoregional locoregional treatments) MEDTERM17__ MEDTERM17__ (Factor Factor Receptor), BRAF (B-Raf proto-oncogene) and KRAS (Sarcoma Sarcoma virus), __medTERM18_ __medTERM18_ (Anaplastic Lymphoma Kinase), studies studies (kinase kinase ROS), __MEDTERMW20_ (REarranged during Transfection), _ ==See also==*Centraline==References===External links== for for PD- L1 ≥50% Score Score (TPS) (68). stage, stage, l/TPS TPS ≥1%. PQC PQC (69), __ __ MEDTERM17_; of of _MEDTERM18___; strategy strategy (Algorith. 2). of of {MEDTERMM17___; _ _ • 52_ 52_ NAS; suspected suspected and/component component (adenosquamous) procedure procedure (61): • and and / or metastasis (61); • and and non-",
      "start_page": 33,
      "end_page": 37
    },
    {
      "heading": "for for ALK",
      "text": "with with ADC",
      "start_page": 37,
      "end_page": 37
    },
    {
      "heading": "NAS NAS (75-76):",
      "text": "• tumor tumor and/or metastasis (75-76); • smokers smokers (<15 packets/year or ≤per per day) and ex-smoking (≥15 years) determination determination (75/76). FISH FISH (In In Situ-Hybridization) test test (RT-PCR RT-PCR treatment). MEDTERM20__ MEDTERM20__ ultimicenti; __medterm3_ __ ‐ ‐ - ‐- − • • - • . • * • \" • i • o ■ • a •",
      "start_page": 37,
      "end_page": 38
    },
    {
      "heading": "rearrangements rearrangements RET",
      "text": "histotype histotype (62-63): • tumor tumor and/or metastasis (62-66); • __médterm0_ __médterm0_ (62-63, 96).",
      "start_page": 39,
      "end_page": 39
    },
    {
      "heading": "rearrangements rearrangements NTRK",
      "text": "histotype histotype (67): • tumor tumor and/or metastasis (67); • NGS NGS (67, 96). 15th 15th , NAS NAS (64-65): • tumor tumor and/or metastasis (64-64); • NGS NGS (medicinal medicinal products; • 100 100 (97). 48 48 (DAKO), ULTRA ULTRA (Ventana) ULTA ULTA (Vantana) Ultra Ultra (Ventana) Score Score (TPS). Oncology Oncology (ESMO), use use programs/enlarged access and/Italy Italy (96). Cancer Cancer (98).",
      "start_page": 39,
      "end_page": 42
    },
    {
      "heading": "3 3 Diagnostic/of of malignancy",
      "text": "history history (for for malignancies) adenosis adenosis (90-100). disease disease (99-100), not not affected; about about 10% TC TC (hepatic hepatic cysts) ultrasound ultrasound and/imaging imaging (RM) adenocarcinoma adenocarcinoma __MEDTERM0_+, 6. 6.9% IA IA (0.5%) of of 55%, radiology radiology (8.1%), of of 58% metastases metastases (106-109). stagement stagement (N-parameter), cautions cautions (102) negligible negligible (up to 20% of cases) (102). methods methods (negative, negative, mediastinoscopy) and and ESTS/requirements requirements (size size >Radiology Radiology (ESR), an an SR: the the report; organisation. organisation.",
      "start_page": 42,
      "end_page": 46
    },
    {
      "heading": "of of disease",
      "text": "site site (central or peripheral) airways airways (endobronchial vs peribronchial) metastases metastases and/or remotely (114).of of 90% (112-15). has has endotracheal/with with transbronchyal/oesophagal needles (TBNA) less-used, less-used, non-between between 60% and 90% used used (119-120), TC-guided TC-guided (TTNA) effective effective (approximately approximately 90%) pneumothorax pneumothorax (10-30% sampled sampled lesions), lesions lesions <pathological pathological (size >PET-TC PET-TC positive). procedure procedure ... ..neoplasm neoplasm (125-126).",
      "start_page": 46,
      "end_page": 48
    },
    {
      "heading": "parameter parameter N",
      "text": "years years \"8\" the the aspiration/agobiopsy transbronchial (TBNA) paratracheal paratracheal (4R, 4L), subcarenal (7), 10 10 (R and L) and 11 (R &amp; L) (ilari). such such as: nod nod (Sound, Sound, EBUS) involved involved (and and 7), and the operator'Surgeons Surgeons (10th-century) tumors tumors >nodes nodes >PET PET (SUV >2) node node <with with cN0/transbronchial transbronchial (EBUS) and transesophageal (EUS); the the EBUS-TBNA/EUS of 93%, is is 97% (129-130). with with EBus/mediastinoscopy. mediastinoscopy.",
      "start_page": 48,
      "end_page": 50
    },
    {
      "heading": "NMW NMW Classification",
      "text": "tumour tumour (T factor), involvement involvement (N factor) metastases metastases (M factor). system system (see subsequent tables) 2017 2017 (133-136). new new classification",
      "start_page": 50,
      "end_page": 50
    },
    {
      "heading": "(IX edition), 2024 2024 (137) 2025. 2025.",
      "text": "Edition Edition (Clinical classification)",
      "start_page": 50,
      "end_page": 50
    },
    {
      "heading": "primitive primitive tumor",
      "text": "lobar lobar (by by disease) T1a(mi) larger larger size",
      "start_page": 50,
      "end_page": 51
    },
    {
      "heading": "Edition Edition (Clinical classification)",
      "text": "I'cm cm long; long. long. • nodule nodule (i) neoplastic (ii) separated (i), following following structures: chest wall (upper upper five-footer).",
      "start_page": 51,
      "end_page": 52
    },
    {
      "heading": "General General principles",
      "text": "activity activity (138). lung lung resections: to to 150±Stage Stage IIIA/IIIB (multi-disciplinary multi-disciplinary groups), operability operability include: operability operability (the the stage); operability operability (the the radicality); operabilità operabilità (respiratory respiratory function). therefore therefore defined: 1. operable: surgical surgical trauma; 2. repeatable: intervention. intervention.",
      "start_page": 53,
      "end_page": 54
    },
    {
      "heading": "Functional Functional operability",
      "text": "mainly mainly with: spirometry; Modified Modified by: al. al. ERS/patients patients (surgery and chemo-radiotherapy). 2013; 143:cardiological cardiological evaluation: ppoFEV1% ppoFEV1% >60% & ppoDLCO%>60% or or ppoDLCO% treatment treatment •ppoFev1% or psoDLCO %<60% pred",
      "start_page": 54,
      "end_page": 56
    },
    {
      "heading": "ppoFEV1% or ppoDLCO%<30% predicted",
      "text": "•ppoFEV1% <30% pred&",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "ppoDLCO%<30% pred",
      "text": "VO2max<35% pred. or CPET: VO2max VO1max>75% <10 ml/Kg/or or >20 ml/kg/VO VO 2max35-75% preds. or 10-20ml/K g/min SCT>or or SWT<not not recommended; to to pneumonectomy",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "Surgical Surgical options",
      "text": "tumor tumor (Tis or T1a). glass glass (Opacities, Opacities, GGO) stages stages (T T 1a). rates rates (143). bronchoplasty bronchoplasty (sleeve lobectectomy) of of disease; losses losses (p <0.71), arrhythmias (p<0.86), lungitis (p>0.09) and mortality (p=0.49).",
      "start_page": 56,
      "end_page": 58
    },
    {
      "heading": "COI: No conflict declared",
      "text": "stage stage (IA), recommended recommended (the the plebectomy)? RECOMMENDATION: phase phase (IA) the the recommendation: CONDITIONAL FOR MOtivations/comments on benefit/damage balance: The The JCOG0802/period period (III III controlled). studies studies (Ottawa Ottawa Scale), the the trials: MODERATA COI: no conflict declared",
      "start_page": 58,
      "end_page": 59
    },
    {
      "heading": "4.2 Radiotherapy",
      "text": "conventional conventional radiotherapy? radiotherapy radiotherapy (Therapy Therapy - Radiotherapy Radiotherapy - SABR) disease disease (of of PRISma). work work (SBRT 7395; RTC 10.578). survival survival (HR 0.66; CI95% 0.62-0.70; p <0,001), survival survival ( HR 0.42; IC95% 0.35-0.50; p<0,001) and __MEDTERM1_ (HR 0.34; CI95% 0.25-0.48; p (<0,001). grades grades (155). Limits: propose. propose. Benefit/damage balance: medical medical contraindications",
      "start_page": 59,
      "end_page": 60
    },
    {
      "heading": "COI: No conflict declared",
      "text": "1. 1.5%, standard standard (156).analysis analysis (157) and and toxicity; and and short- VALOR VALOR (Sureotactic Sureotactic Radiotherapy). (ClinicalTria igoventiate: survival survival (OS) survival survival (DSS), expected. expected.",
      "start_page": 60,
      "end_page": 61
    },
    {
      "heading": "adjuvant adjuvant therapy",
      "text": "approximately approximately 90% about about 60% II II (139). about about 1/operated. operated.",
      "start_page": 62,
      "end_page": 62
    },
    {
      "heading": "Adjuvant Adjuvant therapy",
      "text": "is is recommended? excluded excluded < following following reasons: studies studies (were were included). LACE LACE (Cisplatin Cisplatin Evaluation), observation observation (159). 0. 0.7%; 86 86 (IC95% 0.81-0,92; p <0,0001), of of 4% (increase from 60% to 64%) (160). arms arms (CI95% 0.64-1,08; p=0.12) (161). guidelines guidelines (163-164) stage stage (TNM TNM stage) of of >the the risk/benefit benefit (165).survival survival (p=0.01) trials trials (15.000) toxicity toxicity (34% patients patients <vs vs 41% in patients >70 years) evidence evidence (elderly elderly patients), population population ≥with with ≥clinical clinical studies; caution caution (167-68). studies studies (stage stage (T2N0) (161), IIIA, IIIA, (N2) of of 24-T3N1 T3N1 (VII edition TNM) survival survival (HR 1.01; IC95% 0.62-1.65; p=0.97) survival survival ( HR 0.96; IC95% 0.75-1,22; p=0.74). However, only 66% arms arms (170). cisplatin cisplatin + cisplatin cisplatin + vinorelbine vinorelbine (95.5%; IC95% 75. 75.4%; CI95% 63,1-85,2; p=0.001) (173). 16-2, 16-2,1; b=0.42), survival survival (0.83: CI95% 0.31-2,17; p=0.001) survival survival (HR 0.59; CI95% 0.16-2,1; p=0.42) (174). III III (JIPANG) cysplatin cysplatin + operated operated (edition edition TNM) receive receive cisplatin+precision precision (confidence confidence intervals) results results (metanalysis metanalysis [159] analysis analysis [160]). chemotherapy chemotherapy < a a >patients patients (of of age). trials trials (im lie). aged aged >pre-emptive pre-emptive half-year; five-year five-year phase; first first two-first first phase; second second stage; selected selected (post-operative post-operative recovery); IIA IIA (T >4 cm) well-selected (post-operational post-operational recovery). be be usable",
      "start_page": 62,
      "end_page": 68
    },
    {
      "heading": "COI: No conflict declared",
      "text": "years years (176) year year (177) survival survival (_MEDTERF0__: HR 0.90; IC95% 0.74-1,10; p=0.32; _MEDTERH1_; P=0.48; CI95% 0.92-1,76; p = 0.0014) survival survival (__MEDTERMM0 _: HR 1.13; IC95% 0.88-1,44; p=0.33; __medTERM1,8_ study: HR 1,24; IC95% 0.90-1,71; p=0.18) operated operated (IB-IIIA) study study (WJOG6410L) survival survival (HR 0.92; p=0.63) survival survival ( HR 1.03; p=0.0089) (181). Of Of relapse- free survival (hr 0.36; IC95% 0.24-0.55; p <0.0001), survival survival [HR 0.91; IC95% 0.42-1.94; p=0.80) (182). of of −of of •study study (see Appendix 2: of of studies). IB-IIIA IB-IIIA (of of TNM) MEDTERM25_ MEDTERM25_ (exone exone 21) II-IIIa II-IIIa (HR 0.16; IC95% 0.10-0.26), 02, 02,0; 0, 0,2; p <0,0001) therapy therapy (0, 0, 0; 26, 26, 26), and 26), with with full-2 2 (3 3 (from from five-study study (study study (1 1 (in in 23% __MEDTERM15_ __MEDTERM15_ (skin skin dryness) and 14% were were 27%, 12% and 13% (186), years years was",
      "start_page": 68,
      "end_page": 71
    },
    {
      "heading": "COI: No conflict declared",
      "text": "benefit benefit (DFS) patients patients (HR 0.24; CI95% 0.13-0.45; p <0.0001) population population (stage IB-IIIa) (HR 0,24; IC95% 0.10-3.43; p<0.0001). disease disease (HR 022; CI95% 0.08-0.58). in in 30% with with •of of 5% and 31% chemotherapy chemotherapy (188). PD-L1 PD-L1 ≥1% cells cells (SP263) (HR 0.66; CI95% 0.50-0.88) stage stage II- IIIA patients (HR 0.79; CI95% 0.64-0.96), patients patients (hr 0.81; IC95% 0.67-0.99) (189). II II - survival survival (follow-up 45 months), at at PD- to to 50% (Phase Phase I: HR 0,43; CI95% 0.24-0.78",
      "start_page": 71,
      "end_page": 73
    },
    {
      "heading": "COI: No conflict declared",
      "text": "a a PD-1/PD-L1 (_MEDTERM0_) an an anti-PD-1 inhibitor (__MEDTERM1_) study study PEARLS/stage stage (≥4 cm)-IIIA (TNM TNM stage) placebo placebo (in in 86% of cases). population population (IB-IIIa stage: HR 0,76; IC95% 0.63-0.91; p=0.0014), option option (P18-150); the the time; 5501. 5501.",
      "start_page": 73,
      "end_page": 73
    },
    {
      "heading": "Adjuvant Adjuvant radiotherapy",
      "text": "L07 L07 (L10) to simple observation? I-III I-III (1998 1998 (192) 2016 2016 (193). I-iii I-iii (this this paragraph), trials trials (to to 2011/8 July 2016) alone alone (12 12 [CId95% 1.01-1,24] 13 13 [IC95% 1,02-1,24], respectively) a a general; option option (192-193)",
      "start_page": 74,
      "end_page": 75
    },
    {
      "heading": "primary primary therapy",
      "text": "is is 60-80%, of of 40-60%, is is 20-40% (194). year year (195). between between 6% and 10% per person/and and 2% years years (196), 3. 3.5% and 15% (197). primary primary treatment's end.",
      "start_page": 76,
      "end_page": 76
    },
    {
      "heading": "5.1 Imaging",
      "text": "treatment treatment . in in unfit/lesions lesions (helpful helpful (1strous) disease disease (percentive patients <1 cm). as as \"minimal\" , up up (maximal) TC TC chest/ the the 5° the the follow- up (maximal) followup followup (n=888). I-II I-II (82% in each arm). a a Follow-up",
      "start_page": 76,
      "end_page": 77
    },
    {
      "heading": "Survival Survival care",
      "text": "radiotherapy radiotherapy and/of of 25-40% (201). frameworks frameworks (a a \"mass-like\" or \"scar-like-like\") is is available; interruption interruption (203) lifestyles lifestyles (physical physical activity) of of content/uploads/2021/01/2021_Racc_vacc_antiinfluenza_AIOM_agg.pdf).",
      "start_page": 77,
      "end_page": 78
    },
    {
      "heading": "of of follow-up",
      "text": "risks risks (false false positives). recommended. recommended.",
      "start_page": 78,
      "end_page": 79
    },
    {
      "heading": "5.4 Organisation",
      "text": "the the patient'radiotherapy radiotherapy and/are are recommended: PET/nervous nervous system; Strong Strong positive",
      "start_page": 79,
      "end_page": 80
    },
    {
      "heading": "advanced advanced disease",
      "text": "should should include: disease disease (or or IIIC), alterations alterations (III III C), prediction prediction (long long dose) and oesophageal.",
      "start_page": 81,
      "end_page": 81
    },
    {
      "heading": "Surgical Surgical therapy",
      "text": "therapeutic therapeutic terms: IIIA (T3-T4, N1; T1-T2, N2); IIIB (T3), station station (R4,5), therapies therapies (chemotherapy or chemo-radiotherapy) setting setting (204). IIIA IIIA - undergo. undergo.",
      "start_page": 81,
      "end_page": 83
    },
    {
      "heading": "Neoadjuvant Neoadjuvant chemotherapy",
      "text": "recommended recommended (surgery surgery alone)? data data (2385 patients), surgical surgical resection; of of 13%, treatment treatment (HR 0.87; IC95% 0.78-0.96; p=0.007), survival survival (HR 0.87; CI95% 0.81-0,94; p <0,001) survival survival ( HR 0.86; CI95% 0.78-0.96; p=0.005). 2 2 (RR 1.07; IC95% 1.02- 1.12; p=0.007) years years (RR 1.16; CI95% 1.06-1.27; p=0.011). enrolled enrolled ≥less less than",
      "start_page": 83,
      "end_page": 84
    },
    {
      "heading": "III. III.",
      "text": "Limits: results results (indirectness). analysis analysis (205) size size (80 80 participants), I-IIIA I-IIIA (N1), disease disease (cN2) (TNM VIII edition) the the risk/patient patient (206-207)",
      "start_page": 84,
      "end_page": 85
    },
    {
      "heading": "Neoadjuvant Neoadjuvant chemio-radiotherapy",
      "text": "response response (pathological pathological response). surgery surgery (208). significant significant (22 22 months). pneumonectomy pneumonectomy (the the patient'trimodal trimodal treatment; induction induction study; study study (disease disease (cN2), group. group.",
      "start_page": 85,
      "end_page": 86
    },
    {
      "heading": "Postoperative Postoperative radiotherapy",
      "text": "phase phase (pN2), methanalysis methanalysis (Post-Operative Radio-Therapy) III III (217).justified justified (radiotherapy radiotherapy planning), the the late-separation separation (1.8- 2 Gy/die), of of •8% (HR 0.73; CI95% 0.58- 0.92; p=0.008), survival survival (HR 0,70; CI95% 0.60-0,83; p <0.0001) relapse relapse (HR 0.37; CI95% 0.24-0.58; p<0.0001). survival survival ( HR 0.85; CI95% 0.79-0,92) and disease- free survival (hr 0.57; IC95% 0.38-0.85) involvement involvement (221). G3-G4 G3-G4 (33.7% vs 15%) 5. 5.3% 14. 14.6% IIIA IIIA (pN2). that that 18% respectively respectively 13% and 32% total. total. All/volume volume (223). for for 66% and and 47% difference difference (HR 0.46; IC95% 0.3-0.7). station station (conlaterally) setting. setting.",
      "start_page": 86,
      "end_page": 88
    },
    {
      "heading": "chest chest wall",
      "text": "about about 5% wall wall (healthy healthy margins) lymphadenectomy. lymphadenectomy.",
      "start_page": 88,
      "end_page": 88
    },
    {
      "heading": "Pancoast Pancoast cancer",
      "text": "arm arm (ulnar side), of of Claude-stagement stagement (TC, RM, PET), to to mediastinoscopy/tomia and/approaches approaches (EBUS, EUS). involvement involvement (N0-N1) chemo-radiosurgery chemo-radiosurgery (of of patients) (224-226). medicine. medicine.",
      "start_page": 89,
      "end_page": 89
    },
    {
      "heading": "pulmonary pulmonary vessels",
      "text": "hull hull and/airway airway and/ or vessels.",
      "start_page": 89,
      "end_page": 89
    },
    {
      "heading": "advanced advanced disease",
      "text": "stage stage IIIA/IIIB IIIB (N3) the the −IIIA IIIA / recommended recommended (compared to sequential)? methanalysis methanalysis (227) studies studies (1024 patients) of of 13%, al. al. (702 patients) survival survival (HR 0.84; CI95% 0.74-0.95; p=0.004), 5. 5.7% 4. 4.5% control control (HR 0.77; IC95% 95, 95, p=0.01), characteristics characteristics (histology, histology, stage) in in 4-18% of cases. Limits: analysis analysis (227) met-analysis met-analysis (228) therapy. therapy.",
      "start_page": 90,
      "end_page": 92
    },
    {
      "heading": "COI: No conflict declared",
      "text": "stage stage IIIA/with with radiotherapy? following following reasons: studies studies (4 4 RCT) stage stage IIIa/al. al. (29) studies studies (230-231) drugs drugs (paclitaxel or docetaxel) al. al., treatment treatment with: cisplatin cisplatin (n=153), carboplatin carboplatin (no=152), carbomune carbomune (n=156). survival survival (months months respectively) years years (17,5%, 17.8% and 19,8% respectively) cysplatin cysplatin (of of 31% cisplatin cisplatin -vs vs 25% carboplatin carboplatin - paclitaxel arm (p=0.50). al. al., __M5 __M5 - arms arms (_MEDTERM5_: 8 8 months; HR 0.98; CI95% 0.79-1.20; p=0.831), pemetrexed pemetrexed (64% versus 76.8%; p=0.01). Limits: outcomes. outcomes. Benefit/damage balance: stage stage IIIA/IIIA IIIA / combination combination (2-29 patients)",
      "start_page": 92,
      "end_page": 95
    },
    {
      "heading": "COI: No conflict declared",
      "text": "to to 1%, to to observation? RECOMMENDATION: of of PD- equalto equalto 1%, of of recommendation: FORTE AWELO Motivations/comments to benefit/day balance balance: III III - before before benefit/benefit/day benefit balance: balance balance (the benefit balance/day/balance balance balance/Da: The 3 days: 3 3 , with with non- __MEDTERM0_ __MEDTERM0_ (29.9% vs 26.1%) treatment treatment (15.4% vs 9.8%). MEDTERM0__ MEDTERM0__ (7 7 months; HR 0.68; IC95% 0.53-0.87; 2 2 years: 66.3% vs 55.6%; p=0.005), __medterm15_ __medterm15_ (HR 0.51; CI95% 0.41- 0.63; p=0.001). of of −status status (HRTERM0) of of 25%, about about 63% of patients: Cut-off ≥ 25% (HRTerM0_ medicinally) these these (arm arm (HR 0.71; CI95% 0.57-0.88) and 35.3% vs 19.5% with with PD- L1 ≥1%, in in 63% study study (237). 42. 42.9% 33. 33.4% of of 33% vs 19% (238).",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "Quality of tests",
      "text": "following following reasons: interest. interest.",
      "start_page": 96,
      "end_page": 97
    },
    {
      "heading": "Advanced Advanced Disease",
      "text": "__MEDTERM0_ __MEDTERM0_ (stage IIIB/stage stage IV) following following parameters: • histology (squamosa vs non-squammosa); • driver driver alterations; • PD-L1 expression level; ■ number (s) of metastatic lesions; â ¢ the the patient: status status (PS), approaches. approaches.",
      "start_page": 98,
      "end_page": 98
    },
    {
      "heading": "oligometastatic oligometastatic disease",
      "text": "disease disease (241). 20-50% disease disease (OM) treatment treatment (LAT) between between 12% and 52% (242-243). studies studies (246-249) staging staging (EBUS/mediastinoscopy), used used (in 55% OM OM disease), stereotaxic stereotaxic (SBRT) 1212 1212 articles; al. al. (250), with with ≤randomised randomised (treatment treatment (surgery or radiotherapy) months months (28,3-61,4), clinically clinically (local local treatment). analisys analisys (II II (PEMBRO-RT and MDACC) __MEDTERM0_ __MEDTERM0_ (3 3 weeks) PEMBRO PEMBRO - session session (3 3 fractions), MDACC MDACC l'treatment treatment (15 15 fractions). survival survival (5 5 months; p < 0.0001) 4 4 months; P < 0.001); Only 6% survival survival (5 5 month; p< 0.001); __MEDTERRM19__ __MEDTERRM19__ (4 4 months;p < 0.001; p < 0.0001); only 6% trials trials (HR: 0.1 - 0, - 12, - 10, - 5, - 8 - 6, - 9 - 5 - 5), - 45 -, -, 52 -, 2 - 3, - 3 - 5 and - 5 *the the evidence: LOW COI: no conflict declared",
      "start_page": 98,
      "end_page": 101
    },
    {
      "heading": "oncogene-addicted oncogene-addicted disease",
      "text": "These These include: gene gene (20-30%), __ MEDTERM0_ (10-15% to to 40% of Asian patients), BRAF (2-4%), __medTERM1_ __medTERM1_ (3-7%), ____MEDTERM2_ (1-2%), _MEDTERm3_ (1-2%), __MDTERM4_ (0.5-1%) __médterm5_ __médterm5_ (2%).",
      "start_page": 101,
      "end_page": 101
    },
    {
      "heading": "disease disease EGFR-mutated",
      "text": "of of •exone 20 (Algorithm 5) (254-263).of of −approximately approximately 85% remaining remaining 15% a a __médterm24=English 19 (Ex19desone) alterations alterations (single or complex), rare rare (10-12) 20 20 (3-6%) (264). the the recommendation: ADVANTAGE ADVANTAGE Motivations/comments to benefit/damage balance: __MEDTERM0_ __MEDTERM0_ (80 mg/day) inhibitors inhibitors (150 150 mg/250 250 mg/die) __AMTERM24_ __AMTERM24_ (Ex19dels, L858R) (263). arm arm (midian: 2 2 months; HR 0,46; CI95% 0.37-0.57; p <0,001). brain brain (subgroup subgroup analysis) __medterm0_ __medterm0_ (medial: 9 9 months; HR 0,48; IC95% 0,26-0,86; p=0,014). RR RR (66% vs 43%; OR 2,5; IC95% 1,2-5,2; p=0.011). events events (34% vs 45%).",
      "start_page": 101,
      "end_page": 102
    },
    {
      "heading": "Quality of tests",
      "text": "following following reasons: of of tests: BASS_ COI: recommended recommended (to to chemotherapy)? study study (see Appendix 2: of of studies). 1 1 (RR 71.1%; 7 7 months; 4 4 months), patients patients (RR 14,3%; 9 9 months; .9 9 month; outcomes outcomes (n=315) 7 7 months; -2 2 months). trial trial KCSG-LU15-09 (II II trials), with with non-of of •22 22 (61%) months months (272). patients patients (n=46) who received −molecule molecule (275). Limits: interest. interest. Benefit/damage balance: __medTERM20_ __medTERM20_ (changes/exons exons 18-21); of of • deute_moderations/also also , into into medically",
      "start_page": 103,
      "end_page": 105
    },
    {
      "heading": "COI: No conflict declared",
      "text": "of of •of of −recommended recommended (compared to chemotherapy)? patients patients (62 62 years), by by 37%, 13. 13.7% (276). evaluated, evaluated, 13% (n=15) years years (277). in in 13% and 4% of patients (276) Limits: results. results. Benefit/status. status.",
      "start_page": 105,
      "end_page": 107
    },
    {
      "heading": "COI: No conflict declared",
      "text": "__MEDTERFX58_ __MEDTERFX58_ (73% vs 47%) alone alone (7 7 months; HR 0.40; IC95% 0.30-0.53; p < 0.001). in in 75% combination combination (of of 69%) and in 54% chemotherapy chemotherapy (of of 36%) (278). T790M T790M mutation; randomised randomised (2:1) __medTERM6_ __medTERM6_ (80 mg/day) pemetrexed pemetrexed (500 mg/g. g. 1) cisplatin cisplatin (75 mg/ mq ed. g). MEDTERM6_ MEDTERM6_ (means: 6 6 months; HR 0.32; IC95% 0.15-0.69; p=0.004). outcomes outcomes (PRO) of of −degree degree >__médterm6_ __médterm6_ were: diarrhea (41%), rash (34%), skin xerosis (23%) and paronicia (22%). in in 4% with with •Overall Overall benefit/damage ratio: among among which: __MDTERM38_ __MDTERM38_ (e.g. C797F), microcytoma microcytoma (282). MEDTERM3_ MEDTERM3_ (285). RECIST RECIST (primary endpoint) with with −MEDTERM2_ (secondary endpoint) patients patients −__AMTERM38_ __AMTERM38_ (months months (received received radiotherapy) months months (287). respectively respectively (288-289). therapies therapies (radiology radiology techniques) today. today.",
      "start_page": 107,
      "end_page": 111
    },
    {
      "heading": "disease disease ALK-rearranged",
      "text": "__MEDTERM108_ __MEDTERM108_ (present in 3-7% pulmonary pulmonary malignancies) habit habit (292). study study \"PROFILE 1014\" 2014 2014 (293) 2018 2018 (294), 1029 1029 (and and Malaysia) inhibitor inhibitor (295). in in 78%, only only 3% 600 600 mg/750 750 mg/die in fasting; the the benefit/450 450 mg/_MEDTERN135_ _MEDTERN135_ (with with ____MEDTERMO0_; HR 0,34; IC95% 0,17-0,71; p <0,0001). __MDTERM12_ __MDTERM12_ (92% vs 79%), baseline baseline (stratification stratification factor) lesions lesions (n=122) MEDTERM0_ MEDTERM0_ (some some patients). progression progression (HR 0.18; IC95% at at baseline; HR 0.14; IC95% at at baseline) (303). the the →with with −Overall Overall benefit/damage balance: chemotherapy chemotherapy (74%) regimen regimen (26%). __medTERM56_ __medTERM56_ (180 mg/90 90 mg/die) or __MDTERM0_ (d. d.). analysis analysis (303) 2020 2020 (306) (____MEDTERM56_ ____MEDTERM56_ (6 6 months; HR 0.31; IC95% 0.17-0.56; p <0,0001). arms arms (99% vs 100% of patients), the the ›MEDTERM57_ (73% vs 610%). overall overall health/ALTA-1L ALTA-1L (307). 5 5 million; last last group: recommended recommended (compared to __medTERM0__)? of of •to to −2020 2020 (308). review review (BICR). were were 82% vs vs 23% which which 71% years years 60% MEDTERM0_ MEDTERM0_ , with 83% and and 92% __medTERM79_ __medTERM79_ (310). Limits: conduction conduction (independent independent reviewers).Background/damage: treated. treated.",
      "start_page": 111,
      "end_page": 117
    },
    {
      "heading": "COI: No conflict declared",
      "text": "recommended recommended (compared to chemotherapy)? RECOMMENDATION: Recommendation Recommendation Force: AWAREER AWAREER Motivations/the the benefit/al. al., phase phase I/of of −95. 95.3% and 48.1% degree degree (84.4% and 67.1% respectively) 4 4 (18% in both cases) Overall Overall benefit/damage balance: effects effects (brain brain activity) and undesirable (drug-specific adverse events) following following reasons: al. al., RECIST RECIST (generation generation pre-inhibitions) (Media: 9 9 months; HR 0.27; IC95% 0.17-0.42; p <0,0001), __MEDTERMI_10_ __MEDTERMI_10_ (Medium: 8 8 months; H 0.30; CI95% 0.19-0.46; p<0.0001). 5, 5, (314). progression progression (318). ALK-rearranged. ALK-rearranged.",
      "start_page": 117,
      "end_page": 119
    },
    {
      "heading": "disease disease ROS1-rearranged",
      "text": "is is recommended? grade grade were: visual disturbances (87%), diarrhoea (45%), nausea (51%), peripheral oedemas (47%), constipation (34%), vomiting (38%), transaminase increase (36%) and asthenia (21%), hypophosphataemia hypophosphataemia (15%), neutropenia (9%), transaminases transaminases (4%) and vomiting (4%). patients patients (5 5 years), female sex (64.5%) and non-smoking (67.7%). 1 1 months; trial trial (321). patients patients (324). 47. 47.2% 69. 69.4% (325). is is recommended? RECOMMENDATION: with with −with with benefit/damage adjustments: studies studies (growth growth (n=17; 8.1%), ALT rise (n=7; 3.3%) and diarrhea (n = 6; 2.9%), 7 patients (3.3%) events events (hyperuricaemia; hypertriidemia; limbic cephalitis; myocardiate; creatinine elevation. Benefit/damage balance: The risk/following following reasons: number number (improvement of estimates) studies studies (and and indirectness), phase phase I/of of 62% and and 35% in in pre‐than than 50% with with •MEDTERm22_ (64% and and 50% with with −MEDTERMM0_) (330). strategies. strategies.",
      "start_page": 119,
      "end_page": 122
    },
    {
      "heading": "BRAF-V600 BRAF-V600 disease",
      "text": "of of serine/about about 5% 15 15 (in particular V600E), is is recommended? patients patients (64%), with 2 (6%) 21 21 (58%) at at 60%. 25 25 (69%) grade grade 3-4: companies companies (11%), 3 3 (8%). al. al., 3 3 (0.8%). following following reasons: of of tests: VERY LOW COI: dabrafenib dabrafenib + chemotherapy chemotherapy (331). to to be: 68.4%, respectively. respectively.",
      "start_page": 122,
      "end_page": 124
    },
    {
      "heading": "disease disease NTRK-rearranged",
      "text": "is is recommended? included included (see Appendix 2: of of studies). studies studies (STARTRK-2, ALKA-and and STARTRK-NG) of of −study study I/STARTRk-1 STARTRk-1 (333) safety safety (332-333).al. al. (335) tumours tumours (17 histologies) of of -_MEDTERM7_.",
      "start_page": 124,
      "end_page": 125
    },
    {
      "heading": "disease disease RET-rearranged",
      "text": "trial trial (i.e., from __MDTERM10) to to platinum- Therefore, Therefore, l/mmunotherapy (with with chemotherapy) these these patients: from from •__MEDTERM10_ __MEDTERM10_ (Funded or Mutations).of of −latter, latter, 58% with with anti-PD-1/anti-PD‐0-1 0-1 (97%, n=20447) to to 33% at at enrollment; was was 85% including 27% remaining remaining 15% 0. 0.7% access access program",
      "start_page": 126,
      "end_page": 127
    },
    {
      "heading": "LIBRETTO-201 (340-341).",
      "text": "==References===External links==* http://www.interpol.int/en/notice/search/un_en/LIB__MEDTERM5_TO-001 LIB__MEDTERM5_TO-001 (340), PROs PROs (344-345). access access program/SIREN SIREN (346), these these 27% (n=10) and 35% (n=13) the the →was was 68% ( 24% disease disease stability) was was 100% emerged. emerged.",
      "start_page": 128,
      "end_page": 129
    },
    {
      "heading": "COI: No conflict declared",
      "text": "Phase Phase I/II (ARROW) of of activity/MEDTERM10_ MEDTERM10_ (347- 349). of of −of of •transcription transcription (exon skipping) of of →medterm14 of ›about about 2-4% alteration alteration are: sex sex (60-70%), smoking smoking (54-64%), metastases metastases 37% (350-351). advanced advanced (pre-treated pre-treated patients) 2 2 lines) l/o_MEDTERM22_ was 41%, the the −53. 53.8%.",
      "start_page": 129,
      "end_page": 131
    },
    {
      "heading": "COI: No conflict declared",
      "text": "of of •immunotherapy immunotherapy and/recommended recommended (compared to chemotherapy)? following following reasons: combination with −MEDTERM1_ (2), __MDTERM2_ (1) study study (1). of of {biopsy biopsy and/was was 46%, event event (67.1%); 11. 11.2%. Limits: estimates. estimates. Benefit/damage balance: skipping skipping of",
      "start_page": 131,
      "end_page": 132
    },
    {
      "heading": "of of KRAS",
      "text": "about about 10-12% immunotherapy immunotherapy and/recommended recommended (compared to chemotherapy)? 960 960 mg/day (356). grade grade ≥3 were 33% vs 40% grade grade ≥ diarrhoea diarrhoea (12%), ALT ALT (8%) and AST (5%); neutropenia neutropenia (9%), fatigue (6%) neutropaenia neutropaenia (5%). 23 23 (13%) 2 2 (1%) immunotherapy immunotherapy and/considered considered (compared to chemotherapy) (355-357)",
      "start_page": 132,
      "end_page": 135
    },
    {
      "heading": "not not oncogene-addicted",
      "text": "expression. expression.",
      "start_page": 135,
      "end_page": 135
    },
    {
      "heading": "First-line First-line treatment: immunotherapy",
      "text": "PD-L1 PD-L1 ≥50%, status status (0-1), recommended recommended (compared to chemotherapy)? RECOMMENDATION: of of −MEDTERM27_, or re‐arrangement of •the the PD- L1 ≥ 50%, with with {the the recommendation: FORTE AVOID Motivations/the the benefit/damage balance: MEDTERM40_ MEDTERM40_ (6 6 months; HR 0,50; IC95% 0,37-0,68; p <0,001). the the •of of −chemotherapy chemotherapy (HR 0,62; IC95% 0,48-0,81; p=0,001) of of •31, 31,9% with •16, 16,3% responses responses (46,1% vs 31,1%) response response (3 3 months) (370). following following reasons: open open (independent independent reviewers; provided the crossover; the the manuscript; study study (of of __MEDTERM41_). of of testing: MODERATA COI: PD-L1 PD-L1 ≥50%, of of −of of • status status (0-1), recommended recommended (based based chemotherapy)? with with high/PD-M1 PD-M1 expression; a a high-38. 38.3% HR8. HR8.6% with with −had had high- of of −SP1 SP1 -L1 ≥50% 22C3 22C3 (11 11 months; HR 0.60; CI95% 0.42-0,86) SP3 SP3 -expression expression ≥50%, status status (0-1), considered considered (platinum-based platinum-based chemotherapy) (360)",
      "start_page": 135,
      "end_page": 137
    },
    {
      "heading": "COI: No conflict declared",
      "text": "PD-L1 PD-L1 ≥50%, status status (01-1), with with −MEDTERF0_ < is recommended (based based chemotherapy)? PD-l1 PD-l1 ≥ 50% (tested with 22C3) of of I-with with , including , i-week-with with {-of of , with •-1 1 study; 1 1 trial-t-test-PD-L1 PD-L1 ≥50%, survival survival (2 2 months; HR 0.57; CI95% 0.42-0.77), progression-free survival (7 7 months; H 0.54; IC95% 0.43- 0.78) for for PD- a a 46% with with PD-L1- ≥90% longer-lasting longer-lasting responses; the the progression- months months (HR 0.28; IC95% 0.17-0.56), stage stage IIIB/PD-L1 PD-L1 >50% practices. practices. Limits: indirectness. indirectness. Benefit/damage balance: of of PD- L1 ≥50%, status status (0-1), consideration consideration (respect to platinum) (to to chemotherapy)",
      "start_page": 138,
      "end_page": 139
    },
    {
      "heading": "COI: No conflict declared",
      "text": "of of •PD-L1 PD-L1 <50% status status (0-1), and and •and and −recommended recommended (compared to chemotherapy)? RECOMMENDATION: the the →MEDTERM34_, or re‐of of {of of P-L1-50% Status Status (NO- 1). with with __MEDTERM0_==Film ==__ __ MEDTERM5==Volume 5=Further reading: __medTERM2=Firth-First-Fridays; __Mer-Ferce-Far, __Ferme 5=Hierarchy and __Metro-Front-Fracials===The median-Fifth-Serge 4=Fercent-Faith==*Ferse-Français, −Fermo-Florence, ‐Fertimes, •Ferber-Flight, 1⁄2=Emergency, versus 33=Friendwards, and −Ever-Fernth-Lenth-Cer. __All-Forpouse==References= including including PD- L1 negative (n=190; HR 0.55; IC95% 0.39-0.76) and PD-l1 1-49% (n=86; HR 0.65; CI95% 0.46-0.90). 19. 19.4% 11. 11.3% alone alone (52. 52.1% vs 42.1%), events events (27. 27.7%, 12. 12.6%) of of −Walktop Walktop (3-5. 3-5.6%). the the trials: MODERATA COI: expression expression <50% status status (0-1), with with −recommended recommended (to to chemotherapy)? RECOMMENDATION: PD PD - L1 <50%, Status Status (0-1), of of LOD/treatment treatment cycles; treatment treatment options: PD-L1 PD-L1 (PD-L1-1% vs <1%), taxan taxan (paclitaxel vs nab-paclitaxel) region region (the the world). after after l'MEDTERM0_ MEDTERM0_ (6 6 months; HR 0.71; CI95% 0.59-0.85), 18. 18.4% 9. 9.4% of of evidence: BASSA COI: PD-L1 PD-L1 <50% status status (0- 1), week week −72 72 (IC95% 0.61-0.86). 68 68 (CI95% 0.57-0.82). lesions lesions (371-372). survival survival (_MEDTERM53_), with 21% __medTERM25_ __medTERM25_ + to to 16% 000 000 [34], mutations mutations l[expression expression <50% status status (0-1), with with −option option (371)",
      "start_page": 140,
      "end_page": 143
    },
    {
      "heading": "COI: No conflict declared",
      "text": "__ __ MEDTERM4_; PD-L1 PD-L1 1-49% status status (0-1), recommended recommended (compared to chemotherapy)? of of › responses responses (22, 22,7%; p <0,0001) 56 56 (CI95% 44-0, 44-0,70). 42. 42.7% ___MEDTERM0_ ___MEDTERM0_ + 27. 27.3% 42. 42.7% 47. 47.7% with with [__MEDTHERM0_] + 2-27. 27.3% PD-L1 PD-L1 <1% (HR: 0.74; CI95%) 3-4 3-4 3-4- the the chem/3 3 /were were 3% were were anaemia3; 3; 8, 8,8% arm, arm,8%, 8.8% the the five-to- to 8% 10. 10.8% in favour,8- to 8.8%,arms, arms,8; the the last- the the two- and and seventy- mutations mutations l\"__ __ MEDTERM5__/expression expression 1-49% status status (0-1), option option (374-375).",
      "start_page": 144,
      "end_page": 145
    },
    {
      "heading": "First-line First-line treatment: chemotherapy",
      "text": "chemotherapy chemotherapy (cisplatin-based cisplatin-based schemes) MEDTERM15_ MEDTERM15_ (primary endpoint) (383). with with non- IIIB IIIB (curative curative purposes) or IV (384). randomised randomised (receive receive cisplatin/gemcitabine (cisplatin 75 mg/1250 1250 mg/ 3 3 weeks) or cysplatin/8 8 months; the the cisplatin/toxicity toxicity (neutropenia: 15% vs 27%; anaemia: 6% vs 10%; thrombocytopenia: 4% vs 13%; p <0,001) and alopecia (any grade 12% vs 21%; p=0.002), nausea nausea (7% vs 4%; p=0.000). cisplatin cisplatin / with with I-2 2 phases: phase phase (induction phase) 1-line 1-line cisplatin/pemetrexed (cisplatin 75 mg/500 500 mg/ following following reasons: of of tests: BASSA COI: non-squamosa non-squamosa › histology histology (387). __MEDTERM0_ __MEDTERM0_ (and and headache; treatment treatment (control control arm), metastatic metastatic (or or IV) (389). of of Cisplatin/gemcitabine (cisplatin 80 mg/1250 1250 mg/ grade grade ≥three three arms; Grade Grade ≥with with •MEDTERM19_ advanced",
      "start_page": 145,
      "end_page": 149
    },
    {
      "heading": "treatment treatment lines",
      "text": "vinorelbine vinorelbine (393-394). line line (395). second-line second-line (395) of of , at at [_; chemotherapy, chemotherapy, −_MEDTHERM4__ _MEDTHERM4__ (PD-L1 PD-L1 ≥ 1%) of of recommendation: FORT MOtivations/comments to benefit/damnance balance: randomized randomized (prior prior approval). MEDTERM91_ MEDTERM91_ (medial: 6 6 months; HR 0.59; IC95% 0.44-0.71; p <0,001), __medTERM96_ (mediated: 8 8 months; H 0.62; CI95% 0.47-0.81; p<0.001) and RR (20% vs 9%, p=0.008) with with −grade grade (58% vs 86%), grade 3-4 (7% vs 55%) 5 5 (0% vs 2%), selected selected (immune immune aetiology) study study were: hypothyroidism (4% with •MEDTERMI3_ vs 0% with docetaxel), diarrhoea (8% vs 20%), pneumonia (5% vs 0%), creatinine creatinine (3% vs 2%) and rash (4% vs 6%). either either PD-imediental) on on platinum; also also allowed; of of mutation; −__EDTERM77_ __EDTERM77_ (401). __Temperm3_3_ __Temperm3_3_ (3 mg/2 2 weeks); or docetaxel (75 mg/3 3 weeks). observed observed were: rash (9% vs vs 3% for docetaxel), pruritus (8% vs 1%) erythema (1% vs 4%), diarrhoea (8% versus 23%), hypothyroidism (7% versus 0%), ALT increase (3% versus 1%) and AST (3% vs 1%), infusional reactions (3% v 1%) pneumonia pneumonia (3% against < 1%). patients patients (≥1%, ≥5%, ≥ 10%). of of __MEDTERM3_; pre-specificated pre-specificated (≥10%, ≥10%) confirmed confirmed (402). phase phase II/expression expression ≥1% (antibody antibody 22C3), doubles doubles (of of −of of •MEDTERM77_) (403). About 30% randomised randomised (1:1:1) MEDTERM4_2 MEDTERM4_2 mg/10 10 mg/ kg; ==References===External links==* http://www.interpol.int/en/notice/search/un_en/represented represented by: open-label design (monitoring monitoring committee), trial trial (with with l'immunotherapy in II-line). drivers drivers (the the study) of of PD/practice practice (1-49). __MEDTERM91_ __MEDTERM91_ (intention-to-treat, ITT) PD-L1 PD-L1 (as % expressing expressing PD- L1: TC3 TC3 ≥50%, TC2 ≥5% and <50%, CT1 ≥1% and <5%, and TC0 <1%; immune cells infiltrating: CI3 ≥10%, IC2 ≥ 5% and <10%; IC1 ≥ 1% and <5 percent; and IC0 <1%) population population (7 7 months; HR 0,73; IC95% 0,53-0,99; p=0.04). represented represented by: chemotherapy chemotherapy (of of __medTERM3; ¡tv. (1200 mg/tv) or docetaxel (75 mg/mq), disease disease (n=222; HR 0.73; CI95% 0.54-0.98) and non-squamosa (n=628; 73, 73, CI95% 0.60-0.89), non-smoking patients (n=156; HR 0,71; IC95% 0.47-1.08) metastases metastases (n =85; HR 0.54; IC95% 0.31-0.94), PD-L1 PD-L1 (TC3 or IC3), __medTERM5_ __medTERM5_ (HR for −MEDTERMC96__ 0.63; IC95% 0,43-0.91). ITT ITT (l8_MEDTM5). Every 2 weeks) PD-L1 PD-L1 expression; __ MEDTERM4_ (2 2 mg/3 3 weeks) Advanced Advanced PD- therapy therapy ≥1% chemotherapy chemotherapy (receiving receiving __MDTERM4___); __méMEDTERM5_ (every every 3-week) of of PD‐L1-expression (receiving receiving ____MEDTERm5_annually).",
      "start_page": 150,
      "end_page": 153
    },
    {
      "heading": "Quality of tests",
      "text": "by by MODERATA: in in open-label; of of non- of of trials: MODERATA COI: docetaxel docetaxel alone? weeks weeks + nintedanib (d. d.) days days 2-21; i = 10,000; i= 10,000, i=10,000; I = 1,000; i: and and i=1 1 million; 5, 5,000; e = 1 1 year; i#2, 2,000; placebo placebo were: diarrhea (all grades: 42.3% vs 21.8%; grade ≥3: 6.6% vs 2.2%), transaminases transaminases (ALT, all grades: 26.8% vs 8.4%; grade >3: 7.8% vs 0.9%; AST, all degrees: 22.5% vs 6.6%; grade < 3.4% vs 0.5%), nausea (all levels: 24.2% vs 18%; grade>3: 0.8% vs 0.9%) papetite papetite (all classes: 22.2% vs 15.6%; degree ≥3 1.4% vs 1.2%). life life (410). data, data, __medterm0_% schedule schedule (HR 0,97; IC95% 0,68-1,18; p=0,8439) schedules schedules (HR 0,88; IC95% 0,48-1,61; p=0.31). the the study: lines. lines. Limits: log__ log__ MEDTERM25_; furthermore, the sponsor'study study ( range range 53-67) pathology. pathology. Benefit/damage: therapy. therapy.",
      "start_page": 154,
      "end_page": 157
    },
    {
      "heading": "status status 2",
      "text": "agent agent (vinorelbine) agents agents (gemcitabine/winorelbine), mono-hemotherapy mono-hemotherapy (411-412). patients patients (of of age) 0-2 0-2 (413). carboplatin carboplatin (4 4 weeks) + paclitaxel (90 mg/4 4 weeks). carboplatin carboplatin (HR 0.67; IC95% 0.59-0.78) cisplatin cisplatin ( HR 0.91; IC95% 0.77-1.08), compared to mono-chemotherapy; age age ≥0-1 0-1 (415). receive receive cisplatin/gemecitabine (cisplatin 60 mg/1200 1200 mg/ 2 2 (416). status2 status2 (i.e., non-amplified non-amplified efficacy) randomised randomised (with with carboplatin/paclitaxel (200 200 mg/3 3 weeks) or cisplatin/gemcitabine (cisplatin 60 mg/ 1000 1000 mg/3 3 week), arms arms (RR 25% vs 23%; 8 8 months; 9 9 months) with with −trials trials (418-420). strategy. strategy.",
      "start_page": 157,
      "end_page": 160
    },
    {
      "heading": "cancer cancer (SCLC)",
      "text": "system system (TNM edition VIII) Cancer Cancer (IASLC), a a \"Limited\" stage (as as homo- therapy therapy field) stage stage (remote remote metastasis) implications. implications.",
      "start_page": 161,
      "end_page": 161
    },
    {
      "heading": "disease disease treatment",
      "text": "disease disease (T1-T2, N0), approximately approximately 5% SCLC SCLC (421-422). the the patient'conditions, conditions, chemo‐is is recommended? included included (1 1 RCT). of of age; as as 16% approximately approximately 90% radiotherapy radiotherapy (in in others) radiation radiation (in in others), control control (L50, L50, L) and L) only only 1; 1. 1.2% (IC95% 0.6-3) years years (26% vs 16%; p=0.04) (425). 45 45 Gy: 1.8 Gy/fractions fractions (5 weeks) fractions fractions (3 weeks) years years 44% and 23% Gy Gy (BID BID fractions) doses doses (66 Gy), cycles cycles (426). The The 30-al. al. (425). chemotherapy chemotherapy (late late administration). al. al.427) first first day-used. used. Benefit/damage balance: a a −disease disease (428). Index Index (CICs) rates rates (p=0.20), survival survival (p =09) toxicity toxicity (G5).",
      "start_page": 161,
      "end_page": 166
    },
    {
      "heading": "COI: No conflict declared",
      "text": "population population (PCI); included included (see Appendix 2: of of studies). metastasis metastasis (PPI) with with −a a limited/to to PCI; chemo-radio chemo-radio (HR 0.94; CI95% 0.74-1.18; p=0.59), examination examination (HR 0.70; IC95% 0.57-0.85) (429). dose dose (430). study study (431).",
      "start_page": 166,
      "end_page": 167
    },
    {
      "heading": "BM.",
      "text": "study study (432) radiotherapy radiotherapy (WBRT) hippodampus hippodampus (HA-WBrt) radiotherapy radiotherapy (\"PCI\"). today today (433-434) months months (the the study), Netherlands Netherlands (primary study) has many similarities: CC003 CC003 (ClinicalTrials.gov: NCT02635009) plans. plans. Limits: included. included. Benefit/damage: Encephalus Encephalus (PCI) option option (430, 432-434)",
      "start_page": 167,
      "end_page": 168
    },
    {
      "heading": "extended-stage extended-stage disease",
      "text": "than than 60% platinum-based platinum-based chemotherapy? RECOMMENDATION: and and −MEDTERMM0__, and • ___MEDTERM0 ___MEDTERM0 #, a a recommendation: FOR WIT Motivations/Comed/third third year;, the the last;, three three years:: a a clinical;; three three years; studied studied 3; 56. 56.6% 56. 56.1% patient patient (PRO) life life (HRQoL) __medTERM0_ __medTERM0_ (436). EMA EMA (September 2019) MIFA MIFA (with September 2020) following following reasons: of of tests: LOWER COI: based based chemotherapy? RECOMMENDATION: 12_, 12_, multiyear: chemotherapy-__MEDTERM12_ chemotherapy-__MEDTERM12_ (5 5 months), maintaining a 25% alone alone (HR 0,75; IC95% 0.62-0.91; p=0.0032) to to etoposide-cisplatin/alone alone (5 5 months; HR 0.82; CI95% 0.68-1.00; p = 0.005). trial trial (HR 0.71; 3 3 years). following following reasons: of of tests: BASS AI: with with platinum/etoposide is recommended? following following grounds: 87 87 (CI95% 0.75-0.98; p=0.03) 80 80 (IC95% 0.69-0.93; p=0.002), studies studies (1579 patients), 4 4 phase-polychememiotherapy polychememiotherapy (and and carboplatin) 2015 2015 (443), 18 18 studies; platinum-treated platinum-treated population; at at 6-, 12- treated treated population; the the study; of of study; had had included: topic topic (444), studies studies (2027 patients), irinotecan-platin irinotecan-platin (Cyro-Family) States States (46-447), survival survival (4 4 months) countries. countries. Limits: study. study. L'rate rate (449).",
      "start_page": 168,
      "end_page": 174
    },
    {
      "heading": "COI: No conflict declared",
      "text": "the the brain'encephalum (PCI) recommended? RECOMMENDATION: brain brain (CPI) of of recommendation: CONDIED MOtiva/the the benefit/dam benefit balance: disease disease (PCI) study study (450) to to chemotherapy; benefit benefit (27. 27.1% 1. 1.3% caution caution (452). 2018 2018 (453) survival survival (HR 0.57; CI95% 0.47-0.69; p <0.01) metastases metastases (HR 0.47; IC95% 0.33-0.69); p <0.01). 93. 93.7% different different tests: survival survival (454-455). other other therapies? following following reasons: 24. 24.3% (IC95% 16,2-32,4) versus 18.3% (CI95% 10,8-25,7) CAV CAV (p=0,285). progression progression (weeks weeks respectively; p=0,552) survival survival (weeks, weeks, respectively; P=0,795), 3-4 3-4 L=arm arm (neutropenia 37.8% vs 51,4% (p <0,001); 9. 9.8% vs 1.4% (p<0,001) treatment treatment regimen; anemia 17,7% vs 7.2% (p to <0,001). comparison comparison detected: Grade 2: 14% vs 12% infections; sepsis 4% vs 1%; vomiting 3% diarrhoea diarrhoea 6% vs 0; dyspnoea 3% vs 9%, pain 3% vs 6%. al. al. (459) 4 4 (to to 2% responses responses respectively). topotecan topotecan (__MEDTERM8_: 8 8 months; HR: 0.880; CI95% 0.733-1.057; p=0.170; __MEDTERM9_: 5 5 months; HU 0.802; IC95% 0.667-0,965; p=0.018), amrubinicin amrubinicin (31% vs 16.9%; OR 2.223; p < 0.001). severe severe toxicity: neutropenia (41% vs 54%; p = 0.004), plateletopenia (21% vs 54; p=0.000), anaemia (16% vs 31%; p (= 0.001), infections (16% versus 10%; p=103), febrile neutropenias (10% vs 3%; p=2003), transfusion rate 32% vs 53% (p=0.001). study. study.",
      "start_page": 174,
      "end_page": 178
    },
    {
      "heading": "COI: No conflict declared",
      "text": "good good activity/pre-treated pre-treated (461), lurbindectin lurbindectin (with with irinotecan) the the Investigator's Choice (topotecan or iriotecan) relapsed. relapsed.",
      "start_page": 178,
      "end_page": 178
    },
    {
      "heading": "lung lung cancer",
      "text": "survival survival (462). 2009 2009 (463). survival survival (9 9 months; p=0.02) intensive intensive end-arm arm (33% compared to 54%). disease disease (to to death), simultaneous_in_Oncologia. simultaneous_in_Oncologia.pdf] oncology oncology .",
      "start_page": 179,
      "end_page": 180
    },
    {
      "heading": "Bibliography",
      "text": "long long cancer: Oncol. Oncol. 2005; 23:3175- Robotic-assisted Robotic-assisted bronchoscopy: system system functions",
      "start_page": 181,
      "end_page": 186
    },
    {
      "heading": "Diagnostics. Diagnostics. 2024; 14:399.",
      "text": "[of of print]. mortality mortality (screening screening (follow up: 35 35 years) mortality mortality - disease disease - screening screening ( Follow up: 5 5 years) rate rate - selection selection (follow up: 35 35 years; rated with: LOLK. LOLK.",
      "start_page": 194,
      "end_page": 204
    },
    {
      "heading": "Explanation",
      "text": "inprecision. inprecision.",
      "start_page": 204,
      "end_page": 204
    },
    {
      "heading": "APPLICATION 1",
      "text": "to to non-screening? POPULATION: Lung cancer INTERVENTION: LDCT screening COMPARISON: MAIN MAIN OUTCOMES: related related mortality; All-cause mortality; Early stage detection; Late stage disease; Resectability rate; Overdia",
      "start_page": 205,
      "end_page": 205
    },
    {
      "heading": "SETTING:",
      "text": "PERSPECTIVES: Population",
      "start_page": 205,
      "end_page": 205
    },
    {
      "heading": "BACKGROUND:",
      "text": "CONFLICT OF INTERESTS: TC TC chest; dose dose VALUTAZION",
      "start_page": 205,
      "end_page": 206
    },
    {
      "heading": "Problem",
      "text": "JUDIZI JUDIZI • No • Probably no •Probably yes • Yes • Varies • Don'JUDICES JUDICES • Trivial • Small • Moderate • Large • Various • NE NE rity? • cancer cancer (LC) tomography tomography (LDCT) achieved a 20% Trial Trial (NLST), radiography radiography [1], trials trials (RCT) Italy Italy (6, 10, 13) Netherlands Netherlands (14), Germany (11), and Denmark (8). perf perf and/b b . PO PO OLMONE",
      "start_page": 206,
      "end_page": 209
    },
    {
      "heading": "Undesirable effects",
      "text": "anticipated anticipated effects? follow up: rate rate - positive positive - 8635 • screening screening - 53 53 (2 RCT) follow ups: 0 0 (09 09 greater) performance performance and/among among (I-squared=65%) Falses Falses positive",
      "start_page": 210,
      "end_page": 213
    },
    {
      "heading": "Certainty of evidence",
      "text": "of of effects?",
      "start_page": 213,
      "end_page": 213
    },
    {
      "heading": "Values",
      "text": "main main outcome? inconsistentness, inconsistentness, , EVIDEN EVIDEN TESTS",
      "start_page": 213,
      "end_page": 214
    },
    {
      "heading": "Balance of effects",
      "text": "OF OF EVIDEN'S TESTS",
      "start_page": 214,
      "end_page": 214
    },
    {
      "heading": "Equity",
      "text": "health health equity?",
      "start_page": 214,
      "end_page": 215
    },
    {
      "heading": "Acceptability",
      "text": "JUDIZI JUDIZI • No ♪ Probably no ● Probable yes • Yes • Varies • Don't know",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "Feasibility",
      "text": "JUDIZI JUDIZI • No -Probably no ● Probably yes • Yes - Varieties • Don'obvious obvious implementation? • fou fou s? ADDING ADDING ONI",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "COURTS",
      "text": "the the Favor'probabilities probabilities Probally",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "TYPE OF RECOMMENDATION",
      "text": "intervention intervention Don't know Don' Don Don 't know",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "Recommendation",
      "text": "screening screening examination",
      "start_page": 217,
      "end_page": 217
    },
    {
      "heading": "QUESITE 3",
      "text": "Author: ACT Question: stage stage Setting: inpatients Bibliography: results results (follow up: median 7 years) randomized randomized important",
      "start_page": 218,
      "end_page": 218
    },
    {
      "heading": "Overall Survival",
      "text": "RCT RCT (follow up: median 7 years) randomized randomized important",
      "start_page": 218,
      "end_page": 218
    },
    {
      "heading": "Disease free Survival",
      "text": "life life - not reported",
      "start_page": 218,
      "end_page": 218
    },
    {
      "heading": "Harvested Harvested Lymphonodes",
      "text": "segmentectomy segmentectomy (95% CI) (95% CIs) 148/892 (16.6%) 182/911 (20.0%) Critical Critical (1. 1.02) per 100 (0 0 minus) ne -/0 -/CRITIC CRITIC (1. 1.28) per 100 (and and less) oc 234/892 (26.2%) 239/911 (26.2%) 0 0 less",
      "start_page": 218,
      "end_page": 219
    },
    {
      "heading": "Postoperative air leaks",
      "text": "investigations investigations observational: median 7 years) in in 171/1966 (8.7%) 185/3500 (to to (95% CI) (95% CI), - Bottom Bottom (than than below) - Bottoms Bottoms (below below greater) %) CRITIC CRITIC (2. 2.31) 100 (9 9 3%) studies studies (2 2 PORTs)",
      "start_page": 219,
      "end_page": 220
    },
    {
      "heading": "Lymph node relapse",
      "text": "important important observational",
      "start_page": 220,
      "end_page": 220
    },
    {
      "heading": "Postoperative complications RCT) (follow up: 3 3 years)",
      "text": "randomized randomized important",
      "start_page": 220,
      "end_page": 220
    },
    {
      "heading": "Postoperative complications",
      "text": "important important observational",
      "start_page": 220,
      "end_page": 220
    },
    {
      "heading": "Rehospitalization - not reported",
      "text": "CI: Confidence interval; HR: Hazard Ratio; MD: Mean difference; OR: Odds ratio; RR: segmentectomy segmentectomy (95% CI) (95% CI), 36/552 (6.5%) 21/554 (3.8%) more more per",
      "start_page": 220,
      "end_page": 220
    },
    {
      "heading": "Explanation",
      "text": "studies studies . events. events.",
      "start_page": 221,
      "end_page": 221
    },
    {
      "heading": "References",
      "text": "H. H., Okada, M., R. R., Suzuki, K., Aokage, K ., Aoki, T., Wakami, J., Yoshino, I., N. N., Mitsudomi, T ., H H .. peripheral peripheral non-cancer cancer (JCOG0802/WJOG4607L): With With Non-Cancer Cancer ≤ or or &gt; Wedge Wedge Resection: A. A., I I non-small-cell long cancer: Cardiothorac Cardiothorac Surg; A. A., S. S., S. S., A. A., B. B., D'Cunha, J.. lung lung cancer: Thorac Thorac Surg; C. C., Fang, W., Mao, T., Yao, F., Chen, w., Hu, D.. Cardiovasc Cardiovasc Surg; Y. Y., Sakai, T., Kimura, D., Tsushima, Tt., lung lung cancer: Jorrac Jorrac Dis; M. M., Ojanguren, A., Forster, V., resection resection margins--M. M., Cardiothorac Cardiothorac Surg; C. C., Yoder, G., Thorac Thorac Surg; A. A., Matsunaga, T., Takamochi, K., Oh, S., solid solid non-Cardiothorac Cardiothorac Surg; P. P., Daddi, N., L. L., Ardò, M., Ragusma, P.",
      "start_page": 221,
      "end_page": 222
    },
    {
      "heading": "APPLICATION",
      "text": "stage stage POPULATION: stage stage INTERVENTION: The segmentectomy COMPARISON: Lobectomy MAIN OUTCOMES: Overall survival RCT; Overall Survival; survival survival RTC; Diseasefree Survival; Quality of life; Harvested Harvested Lymphhonodes; Lenght hospital stay; Local Local recurrence; Postoperative air leaks; leaves leaves (RCT); Lymph node relapse; Postoperational complications RCT); Postoperative complications; Rehospitalization SETTING: Inpatients",
      "start_page": 222,
      "end_page": 222
    },
    {
      "heading": "Problem",
      "text": "a a priority?",
      "start_page": 223,
      "end_page": 223
    },
    {
      "heading": "Desirable effects",
      "text": "anticipated anticipated effects? CO CO • 121 121 ●that that • lobectomy. lobectomy. •to to • Don'Effect Effect Early* (95% CI) follow follow up: 7 7 (14 to 20) 100 100 (-- a --) Follow Follow up: 7 7 (23 to 30) 100 100 ( -- a) POLMO POLMO % parts parts (studies) CI) 1803 1803 (to to (2 RCT) 1,09 (20 studies (1803 1803 (to to (2RCT) 08 08 (bone bone (ipanti ipanti i) initial initial tests) 58 58 - 1412 • lower lower (9 observational studies) 0 0 (K. K., Aoki, T., Okami, J., Yoshino, I., Ito, H., Ukumura, N., Yamaguchi, M., Verbeda, No., Wakabayashi, Ml., S. S., Dai, C., Y. Y., Zhong, S., Zeng, H., He, J., K. K., Liang, W., Jiang, G., Yang, P., H. H., Cl. Cl., Rocco, G ., Brunelli, A., Shen, Y ., C-, He; With With Non-Small-Cell Lung ≤ or or &gt; Wedge Wedge Resection: Clin Clin Oncol; M. M., V. V., T. T.. long long cancer: Cardiothorac Cardiothorac Surg; R. R., Zurek, W., Marjanski, T., Rudzinski, P., M. M., M. M. , Polannska, J., I I non-small-cell lung cancer: Cardithorac Cardithorac Surg; A. A., Groth, S., Cardithorac Cardithorac Surg; M. M., S. S., P. P., Chin, C., Cardiovasc Cardiovasc Surg; after after robotic- J J Surg; studies studies . Noost Noost dell'eff",
      "start_page": 223,
      "end_page": 228
    },
    {
      "heading": "DFS (RCT)",
      "text": "direction. direction.",
      "start_page": 228,
      "end_page": 228
    },
    {
      "heading": "_MEDTERM0__",
      "text": "anticipated anticipated effects? 5466 5466 • 40 40 (100 100 (to to observational) segmentectomy segmentectomy (5 to 10) 2.08) 4127 4127 • 22,27 • 28 • NEOPLAS NEOPLAS (8 to 16) 1.75) leaks leaks (RCT) complicated complicated RCT) followed up: NEOPLAS NEOPLAS (16) Akada, M., J., Nakajima, R., Suzuki, K., T. T., I. I., Ikuda, H., S. S., Mitsudomi, T-, H. H.. peripheral peripheral non-cancer cancer (JCOG0802/WJOG4607L): Cardithorac Cardithorac Surg; W. W., Yoshimura, M., Maniwa, Y., Kitamura, Y ., Tane, K., Takenaka, D., Adachi, S., L. L., Pennathur, A., R. R., P. P., Daddi, N., Loizzi, D., Ampollini, L., Ardò, No., Ventura, Ll., Carbognani, P.; Potenza, R., Ardissone, F., S. S., Puma, F-, Santini, M., Ragusa, Mn.. long long cancer: elderly elderly patients?. Surg Today; SR. SR., Schuchert, Mj., Pennathur, A., Wilson, D'O., Siegfried, J., M. M., Koike, T., Higashiyama, M ., Yamato, Y., Kodama, K., Tsubota, N.. lung lung cancer: Cardiovasc Cardiovasc Surg; H. H., long long cancer: Cardiothorac Cardiothorac Surg; F. F., O. O., P. P., C. C., R. R., POLMO POLMO NEO",
      "start_page": 229,
      "end_page": 239
    },
    {
      "heading": "Certainty of evidence",
      "text": "of of effects?",
      "start_page": 239,
      "end_page": 239
    },
    {
      "heading": "Values",
      "text": "variability variability ● GIUDIZI GIUDIZI \" comparison comparison \" compare compare \" comparison comparison ● intervention intervention \" participation participation \" Varies \" Don'SEARCh SEARCh \"found. found.",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "Equity",
      "text": "JUDICES JUDICES • Reduced • Probably reduce • imp imp ● Probaby increa • Increased • Varies • Don'JUDIZI JUDIZI • No ♪ ProbaBly yes • Yes • Various • Do not know",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "Feasibility",
      "text": "JUDIZI JUDIZI • No • Probably no ● Probable yes • Yes • Varies • Don'health health equity? to to implementation? No No variables",
      "start_page": 241,
      "end_page": 242
    },
    {
      "heading": "COURTS",
      "text": "Varieses Varieses Don't know Don'Don Don 'studies studies Don' t know Don'.t know Don't Know Don'ts know Don?t know",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "TYPE OF RECOMMENDATION",
      "text": "intervention intervention interventions",
      "start_page": 243,
      "end_page": 243
    },
    {
      "heading": "CONCLUSIONS",
      "text": "on on ale",
      "start_page": 243,
      "end_page": 243
    },
    {
      "heading": "QUESITE 12",
      "text": "Author(s): MC Date: September 2019 Question: to to placebo/with with PD-L1<HR HR Setting: inpatients Bibliography: Med Med 2018; 379:2342-50; 2018 2018 EMA/CHMP/548232/Imprecision Imprecision (Q1)_MEDTER_Patients",
      "start_page": 244,
      "end_page": 244
    },
    {
      "heading": "Local control - not reported",
      "text": "NEOPLASE",
      "start_page": 245,
      "end_page": 245
    },
    {
      "heading": "Objective response",
      "text": "response response (follow up: 8 8 months) life life - pneumonia pneumonia (follow up: 5 5 months; anemia anemia (fullowup: 5 5 months; assembled with: NCI-CTCAE 4.03) months months (30.0%)",
      "start_page": 245,
      "end_page": 246
    },
    {
      "heading": "Treatment related death",
      "text": "thousand thousand thousand; thousand. thousand.",
      "start_page": 246,
      "end_page": 247
    },
    {
      "heading": "PROSPECTIVE:",
      "text": "BACKGROUND:",
      "start_page": 247,
      "end_page": 247
    },
    {
      "heading": "Problem",
      "text": "a a priority? JUDICES • No • to to 1%, with with •to to observation? Patients with −to to 1% •Overall Overall survival; disease-free survival; distance metastases; local disease control; objective response rate; duration of response; quality of life; adverse adverse events; Grade 3-4 lungitis; Grade 5 - with with {JUDIANCES JUDIANCES (THE THE MERCE) assessed assessed with: followed followed up: 100 100 (29 to 46) DELLute DELLute effects* (95% Risk withtion (Q1) 100 100 (2 to 41) 100 100 (9 to 49) 100 100 (3 to 46). JUDIZI JUDIZI - Possibdenum Possibdenum - Variant - ffetti ffetti indusibile? with with placebo/assessed assessed by: follow follow up: 100 100 with: metastasis metastasis (DELLute DELLute effects* (95% partition partition (Q1) 100 100 (22 to 41) 100 100 (2 to 49) 100 100 (25 to 46) L POLM % CILAPE) 709 709 (to to (1 RCT) 2. 2.03) (1 to 7) including including (to to (1RCT) 1. 1.51) (23 to 39) 709 709 (to to (1rCT) 4. 4.41) (0 to 6) the the survival/central central review; bias bias ) LOWa) JUDI JUDI • Bassa Bassa /the the p",
      "start_page": 247,
      "end_page": 255
    },
    {
      "heading": "Values",
      "text": "main main outcomes? JUDICIAL TEST SEARCH",
      "start_page": 256,
      "end_page": 256
    },
    {
      "heading": "Budget of effects",
      "text": "comparison comparison \" confrontation confrontation \" discussion discussion \" intervention intervention \" in in favour\" operation operation \"Varia \" I don'D D ronto? to to 1%.",
      "start_page": 256,
      "end_page": 256
    },
    {
      "heading": "Fair",
      "text": "of of equity? SEARCH SEARCH • found found • impact impact • equity equity • Improves fairness • Vary • I don't know",
      "start_page": 257,
      "end_page": 257
    },
    {
      "heading": "Acceptance",
      "text": "main main stakeholders?",
      "start_page": 257,
      "end_page": 257
    },
    {
      "heading": "Feasibility",
      "text": "do do l'impl JUDIZI • No • Probabilmen • Si Si • Varia • RIA RIA PROBLEM",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "EFFECTS",
      "text": "SIDE EFFECTS",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "LI",
      "text": "probably probably doesn'EQUITA EQUITA (no no equity) occur. occur.",
      "start_page": 258,
      "end_page": 259
    },
    {
      "heading": "Recommendation Recommendation Recommendation",
      "text": "of of intervention",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "Recommendation",
      "text": "to to 1%, MEDTERM0__ MEDTERM0__ d",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "Recommendation",
      "text": "of of euthic",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "QUESITE 13",
      "text": "Author: ACT Question: Locoregional treatment + stage stage Setting: inpatients Bibliography: considerations considerations + distortion distortion (95% CI) (95% CI), none none 0/0-0/randomised randomised (0. 0.72) 100 (0 0 less)",
      "start_page": 261,
      "end_page": 261
    },
    {
      "heading": "Progression-free survival",
      "text": "none none 74/176 (42.0%) 140/183 (76.5%) randomized randomized (0. 0.35) 100 (37 37 less) life life - not reported",
      "start_page": 261,
      "end_page": 261
    },
    {
      "heading": "_MEDTERM0__",
      "text": "none none 30/72 (41.7%) 15/76 (19.7%) more more per",
      "start_page": 261,
      "end_page": 261
    },
    {
      "heading": "treatment treatment component",
      "text": "CRITIC CRITIC ... important important randomizedb",
      "start_page": 261,
      "end_page": 262
    },
    {
      "heading": "Loco-regional progression",
      "text": "Polmonites Polmonites (follow up: 6 6 months) 11 non-relevant non- b b randomized",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "Grade 3-5 toxicity",
      "text": "randomized randomized CI: Confidence interval; HR: Hazard Ratio; RR: Risk ratio",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "Explanation",
      "text": "loco-regional loco-regional + systemic considerations (95% CI) (95% CI), no one 1/68 (1.5%) 1/65 (1.5%). per per (14. 14.97) 100 (21 21 more) none 6/68 (8.8%) 29/65 (44.6%) less less per",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "References",
      "text": "S. S., F. F., Verma, V., L. L., L. L., Zhu, Q., Liu, H., C. C., M. M., X. X., Metastatic Metastatic Non-Small-Cell Lung Cancer: JAMA JAMA Oncol; R. R., R. R., Jr., J. J., Hernandez, M., Ye, R. , D. D., C. C., Skoulidis, F., E. E., Gibbons, D",
      "start_page": 263,
      "end_page": 263
    },
    {
      "heading": "APPLICATION",
      "text": "treatment treatment + treatment treatment POPULATION: therapy therapy INTERVENTION: Loco-Regional treatment + Systemic therapy COMPARISON: MAIN MAIN OUTCOMES: Overall survival; Progression-free survival; Quality of life; ORR; treatment treatment component; Loco-regional progression; Polmonites; toxicity toxicity SETTING: Inpatients",
      "start_page": 263,
      "end_page": 263
    },
    {
      "heading": "BACKGROUND:",
      "text": "CONFLICT OF INTERESTS:",
      "start_page": 263,
      "end_page": 263
    },
    {
      "heading": "Problem",
      "text": "a a priority?",
      "start_page": 264,
      "end_page": 264
    },
    {
      "heading": "Desirable Effects",
      "text": "anticipated anticipated effects? TESTS TESTS → 202 202 • records. records. • Modernised) metastatic metastatic (3 3 lesions), systemic systemic treatment/al al . only. only. (-- a --) 359 359 • treatment treatment (to to (4 RCT) 0. 0.35) survival survival (34 to 40) life life - - -- - - 148 148 − loco loco treatment- (to to (1 RCT), 3, 3,58) rate. rate. (24 to 71) S. S., F. F., Verma, V., L. L., Tian, W., L. L., Q. Q., V. V., R. R., C. C., Skoulidis, F., E. E., W. W., L. L., A. A., D. D., S. S., G. G., Oligotastatic Oligotastatic Non-Small-Cell Lung Cancer: Clin Clin Oncol; P. P., Wardak, Z., oligomethastatic oligomethastatic (Immunotherapy + RT) al al . Cancer Cancer Inst; Comments Comments → or or loco‐regional treatment. • loco loco - regional progression. − L. L., Zhu, Q., Liu, H., Pan, X.,C. C., M. M., NEO NEO toxicity",
      "start_page": 264,
      "end_page": 271
    },
    {
      "heading": "Certainty of evidence",
      "text": "of of effects?",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "Values",
      "text": "TESTS TESTS • variableity variableity • variability variability ● variable variable • variables variables • e e mes? imprecisio one.",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "Balance of effects",
      "text": "TESTS TESTS • comparison comparison • appearance appearance • comparison comparison - intervention intervention ● participation participation • Varies • Don't know",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "Equity",
      "text": "health health equity?",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "Acceptability",
      "text": "key key stakeholders?",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "EVIDENCE EVIDENCE TESTS",
      "text": "• found. found. • Probably no ● Probable yes • Yes • Varies • Don't know",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "Feasibility",
      "text": "to to implementation?",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "EVIDENCE EVIDENCE TESTS",
      "text": "• found. found. • Probably no ● Probable yes • Yes • Varies • Don't know",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "SUMMARY OF JUDGEMENTS",
      "text": "PROBLEM No",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "DESIRABLE",
      "text": "Trivia",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "EFFECTS",
      "text": "NsideRATIONS NsideRATIONS Don't know Don'T know",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "EFFECTS",
      "text": "BALANCE BALANCE OF",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "EFFECTS",
      "text": "EQUITY ACCEPTABILITY FEASIBILITY",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "COURTS",
      "text": "Varies Varies Don'studies studies Don'T know Don' Don Don 'not not know",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "TYPE OF RECOMMENDATION",
      "text": "intervention intervention intervention",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "Recommendation",
      "text": "Loco-regional treatment + consideration. consideration.",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "Justification",
      "text": "LINES LINES GUIDE",
      "start_page": 275,
      "end_page": 276
    },
    {
      "heading": "QUESITE 14",
      "text": "Author(s): MC Date: September 2019 Question: advanced advanced non-cancer cancer Setting: inpatients Bibliography: ESMO ESMO 2019; C. C. \"__MDTERM3. __MDTERM3._- Mutated Advanced non- small-cell long cancer\", Med Med 2018; 378:113-25; Apr Apr 1;25 (7):2058-2063; Oncol Oncol 36:Absolute. Absolute.",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "Overall survival",
      "text": "none none 128/279 155/fewer fewer (45.9%) (56.0%) (0. 0.997) (0 0 feet)",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "Objective response rate",
      "text": "I'none none 223/279 211/000 000 (79.9%) (76.2%) (1, 1,90) LOW LOW (10 10 more) rate rate (assessed with: full analysis set) live live - cough (assied seriously by: QLQ-C30; Scale from: 0 to 100) alive alive - cous (assessed with: QlQ-D30; Scale from:0 to 100)",
      "start_page": 276,
      "end_page": 278
    },
    {
      "heading": "Treatment interruption",
      "text": "acne acne (assessed with: NCI-CTCAE) 247 247 - MD 0.5",
      "start_page": 278,
      "end_page": 278
    },
    {
      "heading": "213/28 28 feet",
      "text": "(76.9%) (0. 0.56) MODER MODER (21 21 feet)",
      "start_page": 278,
      "end_page": 278
    },
    {
      "heading": "19/277 (6.9%)",
      "text": "(0. 0.52) LOW LOW (3 3 feet)",
      "start_page": 278,
      "end_page": 278
    },
    {
      "heading": "25/277 (9.0%) 9 9 feet",
      "text": "(0. 0.29) LOW LOW (6 6 feet) DA • CRITICAL RATE • Critical RATE - W W • LINEE LINEE • GUIDE • elevation elevation (assessed with: NCI-CTCAE) • b b • serious c •d none • 2/279 (0.7%) • 12/277 (4.3%) RR • feet feet • trials (0. 0.73) Low Low (1 1 feet)",
      "start_page": 278,
      "end_page": 279
    },
    {
      "heading": "adverse adverse events",
      "text": "none none 89/279 (31.9%) 114/Infarce Infarce (41.2%) (0. 0.97) LOW LOW (1 1 feet) CI: months months (21 21 months) month month (1 1 month) population population (62%) events events (OIS <300) QUESITO QUESITO 14: Medevals Medevals (OS <300).",
      "start_page": 279,
      "end_page": 280
    },
    {
      "heading": "PROSPECTIVE:",
      "text": "BACKGROUND: generation generation __medTERM1__/__DEMM3_ __DEMM3_ (Dels19, L858R).",
      "start_page": 280,
      "end_page": 280
    },
    {
      "heading": "Problem",
      "text": "a a priority?",
      "start_page": 280,
      "end_page": 280
    },
    {
      "heading": "ADDITIONAL ADDITIONAL TESTS",
      "text": "I'm sorry. (forty-five forty-five thousand) (fifty-five fifty-five million) (thirty-five thirty-five years) (Don'hundred hundred thousand) D. D. (056 056 0HF) follow up: 0. 0.57) months months (40 to 54) population population (62%) events events (OIS <300) LOWA, LOWA,b",
      "start_page": 280,
      "end_page": 286
    },
    {
      "heading": "Quality of tests",
      "text": "moderated moderated - High - No studies included",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "Values",
      "text": "JUDITIONS JUDITIONS - variation variation - volatility volatility - safety safety N? main main outcomes? ADDITIONAL ADDITIONAL IONES",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "Budget of effects",
      "text": "comparison comparison - confrontation confrontation - comparison comparison - intervention intervention - Varia - not not know",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "Fair",
      "text": "of of equity?",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "Acceptance",
      "text": "R R \" No \" Probably no \" PROV PROV Olders? D D RONTO? X X Yes",
      "start_page": 288,
      "end_page": 289
    },
    {
      "heading": "Feasibility",
      "text": "case case (s) \" No ... Probably no ... probably no ... X Yes ... Vary ... to to intervention? PROBLEM PROBLEM EFFECTS",
      "start_page": 289,
      "end_page": 290
    },
    {
      "heading": "DESIDERABLES",
      "text": "EFFECTS",
      "start_page": 290,
      "end_page": 290
    },
    {
      "heading": "SIDES",
      "text": "equity equity l/I I don'Not Not know",
      "start_page": 290,
      "end_page": 290
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 291,
      "end_page": 291
    },
    {
      "heading": "Recommendation",
      "text": "MEDTERM1__ MEDTERM1__ (Ex19dels, L858R), option. option.",
      "start_page": 291,
      "end_page": 291
    },
    {
      "heading": "QUESITE 17",
      "text": "0vervall4_ _details (0vervalm4_) mutated (Ex19del, L858R) an an anti- -_MEDTERM2_ Setting: inpatients Bibliography: Med Med 2017; 376:A. A., et al",
      "start_page": 292,
      "end_page": 292
    },
    {
      "heading": "brain brain metastasis",
      "text": "anyone anyone 50/51 (98.0%) d 46/93 (49.5%) randomized randomized (0. 0.49) 100 (21 21 less)",
      "start_page": 292,
      "end_page": 292
    },
    {
      "heading": "Objective response rate",
      "text": "of of Reproducibility: life life - symptom symptom (evaluated by: QLQ-LC13; Scale from: 0 to 100) to to ,Life Life - symptom symptom (assessed with: QlQ- LC13); scale from:0 to 100) to to .sympton sympton (as assessed by: qlq-Lc13; at at all",
      "start_page": 292,
      "end_page": 294
    },
    {
      "heading": "Diarrhea grade <= 3",
      "text": "g g randomized",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "Nausea grade < 3",
      "text": "g g randomized",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "Thrombocytopenia grade <= 3",
      "text": "chemotherapy chemotherapy (95% CI) (95%CI) 228 113 - than than lower) 239 97 - than than below) 3/279 (1.1%) 1/140 (0.7%) less less per",
      "start_page": 294,
      "end_page": 295
    },
    {
      "heading": "Neutropenia grade < 3",
      "text": "nobody nobody 1/279 (0.4%) 15/140 (10.7%) randomized randomized (0. 0.25) 100 (to to LOW)",
      "start_page": 295,
      "end_page": 295
    },
    {
      "heading": "Anaemia grade <=3",
      "text": "nobody nobody 1/279 (0.4%) 13/140 (9.3%) per per ... randomized (0. 0.29) 100 (7 7 less) CI: Confidence interval; HR: Hazard Ratio; RR: Risk ratio; MD: Mean difference",
      "start_page": 295,
      "end_page": 295
    },
    {
      "heading": "Explanation",
      "text": "outcome. outcome.",
      "start_page": 295,
      "end_page": 295
    },
    {
      "heading": "References",
      "text": "S. S., Y. Y., J. J., Delmonte, A., S. S., W. W., J J ., H. H., prior. prior.",
      "start_page": 295,
      "end_page": 296
    },
    {
      "heading": "PROSPECTIVE:",
      "text": "BACKGROUND: mechanism. mechanism.",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "Problem",
      "text": "a a priority?",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "ADDITIONAL ADDITIONAL TESTS",
      "text": "• 1 1 (42 to 65)b follow up: 419 419 (_MEDTERM15_) (to to (1 RCT) follow-up: 1. 1.08) months months (8 to 20) 2. 2.90) (55 to 91) es es (GRADE) ) 1 1 (42 to 65)b follow up: 68 68 (_MEDTERM15_) (to to (1 RCT) followed up: 1. 1.08) months months (8 to 20) metastasis metastasis (to to (1RCT) 0. 0.49) (13 to 28) rate rate (from from (1 RTC) 2. 2.90) (55 to 91) evidence evidence es) (GRADE) f f ),I I ADDI) conducted. conducted.",
      "start_page": 296,
      "end_page": 303
    },
    {
      "heading": "Quality of tests",
      "text": "safety safety tests? was was judic",
      "start_page": 303,
      "end_page": 303
    },
    {
      "heading": "Values",
      "text": "main main outcomes?",
      "start_page": 303,
      "end_page": 303
    },
    {
      "heading": "Budget of effects",
      "text": "comparison. comparison.",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "Fair",
      "text": "of of equity?",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "Acceptance",
      "text": "not. not.",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "Feasibility",
      "text": "JUDENCIES JUDENCIES • No • Probably no • X Yes • Vary • I don'stakeholders stakeholders ?",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "FACTIVITY",
      "text": "Large Very low",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "Important",
      "text": "No No No",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "Moderat Irrelevant",
      "text": "probably probably not",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "LINES GUIDE",
      "text": "Augen Augen l'I I don'not not know",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 307,
      "end_page": 307
    },
    {
      "heading": "Recommendation",
      "text": "MEDTERM4__ MEDTERM4__ (Ex19dels, L858R), mutation mutation (liquid liquid biopsy) option. option.",
      "start_page": 307,
      "end_page": 307
    },
    {
      "heading": "QUESITE 18",
      "text": "Author: ACT Question 14: __medTERM4_ __medTERM4_ Setting: inpatients Bibliography: Lancet Lancet 2017; 390:29-39; Med Med 2017; 377:JTO JTO 2019; information information (95% CI) (95% CI). none none 1/103 (1.0%) 3/104 (2.9%) randomized randomized (1. 1.28) 100 (1 1 more) the the \"Critical SSA\" (criticism)",
      "start_page": 308,
      "end_page": 308
    },
    {
      "heading": "Alanine aminotransferase increase- grade 3-4",
      "text": "none none 10/380 (2.6%) 40/317 (12.6%) randomized randomized (0. 0.45) 100 (7 7 less) increase increase - nobody nobody 9/255 (3.5%) 21/255 (8.2%) randomised randomised (0. 0.91) 100 (1 1 less)",
      "start_page": 309,
      "end_page": 309
    },
    {
      "heading": "Nausea - grade 3-4",
      "text": "none none 2/381 (0.5%) 7/316 (2.2%) randomized randomized (1. 1.07) 100 (0 0 less)",
      "start_page": 309,
      "end_page": 309
    },
    {
      "heading": "Toxic deaths",
      "text": "none none 7/381 (1.8%) 10/316 (3.2%) randomized randomized (1. 1.46) 100 (1 1 more) CI: Confidence interval; HR: Hazard Ratio; RR: Risk ratio",
      "start_page": 309,
      "end_page": 309
    },
    {
      "heading": "Explanation",
      "text": "b. b. I2=44% __medTERM0__ __medTERM0__ (al. al. trials). J J -the the 36% sadness. sadness.",
      "start_page": 309,
      "end_page": 309
    },
    {
      "heading": "References",
      "text": "C. C., W. W., Reungwetwattana, T., Zhou, J., Lhang, Y., H. H., Bu, L., Xu, T-, T T -, N. N., Lu, Y; Zhang, L ... lymphoma-positive lymphoma-positive non-cancer cancer (ALESIA): Respir Respir Med; K. K., Hida, T ., Nokihara, H.",
      "start_page": 309,
      "end_page": 309
    },
    {
      "heading": "APPLICATION 18",
      "text": "meta-stage meta-stage __MEDTERM4_POPULATION: MEDTERM5_ MEDTERM5_ INTERVENTION: _MEDTERM2_ COMPARISON: __medTERM3__ MAIN OUTCOMES: __PFS; __EDTERM9_; •MEDTERM10__; progression progression - al. al., Gadgeel 2018; death death - et et at; increase increase - grade 3-4; Nausea - grade3-4; Toxic death - and and al; aminosferase aminosferase - grade; N nausea - Grade 3-4; or or death",
      "start_page": 310,
      "end_page": 310
    },
    {
      "heading": "Problem",
      "text": "a a priority? No No • Probably no → Probaby yes ● Yes • Varies • Don'ncrease-grade ncrease-grade 3-4; Trivial Trivial @ Moderate Moderate ● Large ♪ Varies - Don'anticipated anticipated effects? Advanced Advanced Comments* (95% CI) trials trials (95% (studies) (GRADE) Risk CI) 100 100 (37 to 50) 510 510 → follow-up follow-up months: (to to (2 RCT) 0. 0.79) kinase-positive kinase-positive non-small-cell cancer (ALESIA): Respir Respir Med; K. K., Hida, T., Yoshioka, H., Kumagai, T ., Hotta, K ., Watanabe, S., Goto, K",
      "start_page": 310,
      "end_page": 313
    },
    {
      "heading": "by by an",
      "text": "b. b. I2=44% alectinib alectinib (etc. etc. trials). J J -the the 36% is is rare",
      "start_page": 313,
      "end_page": 313
    },
    {
      "heading": "_MEDTERM0__",
      "text": "substant substant JUDIZI",
      "start_page": 313,
      "end_page": 314
    },
    {
      "heading": "_MEDTERM0__",
      "text": "MEDTERM1_Further MEDTERM1_Further reading: _MEDTERM5_Found_Fair_Fal_Failure_Flat_Fix_Floor_Ful_Furnish_Flan_Fund_Frank_Fro_Fros_Famila_Fat_Flag_Flexit_Freadsheet_Fruition_Fotories_Fatishing_File_Flihood_Fl_Fon_Fert_Fold_S_F _MEDTERM5_Found_Fair_Fal_Failure_Flat_Fix_Floor_Ful_Furnish_Flan_Fund_Frank_Fro_Fros_Famila_Fat_Flag_Flexit_Freadsheet_Fruition_Fotories_Fatishing_File_Flihood_Fl_Fon_Fert_Fold_S_F ==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/A. A., Seto, T., Takiguchi, Y., Nishio, M., Yoshioka, H., Kumagai, T ., Hotta, K., Watanabe, S., M M ., Kozuki, T ... __medTERM18_-positive __medTERM18_-positive non-Lung Lung Cancer; Tr. Tr., R. R., Gadgel, S",
      "start_page": 314,
      "end_page": 318
    },
    {
      "heading": "Certainty of evidence",
      "text": "of of effects?",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "Values",
      "text": "EVIDENZ EVIDENZ 'found found □ variability variability ● variables variables ► ris ris mes? ne ne (attrition attrition bias), ADDUNTIVATIVE ADDUNTIVATIVE SIDERATIONS",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "Balance of effects",
      "text": "JUDIZI JUDIZI \" comparison comparison \" compare compare \" comparison comparison ● intervene intervene \" intervention intervention \" Varies \" Don't know",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "Equity",
      "text": "h h JUDIZI",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "Acceptability",
      "text": "JUDICES JUDICES • No • Probably no • health health equity? aDDONTIVE aDDONTIVE ● Yes • Varies - Don'TO TO IMPLEMENT?",
      "start_page": 319,
      "end_page": 322
    },
    {
      "heading": "TYPE OF RECOMMENDATION",
      "text": "the the participation",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "Recommendation",
      "text": "NEOPLASI NEOPLASI option",
      "start_page": 322,
      "end_page": 323
    },
    {
      "heading": "QUESITE 19",
      "text": "Author: ACT Question: treated treated Setting: Outpatients Bibliography: R. R., et al. (2020). __MEDTERM9_ __MEDTERM9_ (follow up: 9 9 months)",
      "start_page": 323,
      "end_page": 324
    },
    {
      "heading": "spelling spelling inGHS/QoL",
      "text": "I'grade grade < 3 (follow up: 9 9 months) grade grade (follow up: 9 9 mesi) AST AST (G3 (full7 up:9 9 mi) grade grade <3 ( followup: 9 9 mei) rate rate (fogliow up; 9 9 mei).",
      "start_page": 324,
      "end_page": 325
    },
    {
      "heading": "Explanation",
      "text": "bias bias (open label study). data data (sponsor bias). 1-L 1-L 27% indirectiness indirectiness (inadequate inadequate follow-ups). imprecision imprecision (an an interim-analysis). 1-l 1-l 27% treatment. treatment.",
      "start_page": 325,
      "end_page": 325
    },
    {
      "heading": "References",
      "text": "R. R., J. J., H. H., Han, Jj., A. A., W. W., Griesinger, F., Felip, E., Califano, R. , Spira, A ., N. N., Tiseo, M ., M. M., j. j., Ni, Q., Zhang, P., Popat, S .. Cancer. Cancer.",
      "start_page": 325,
      "end_page": 325
    },
    {
      "heading": "APPLICATION 19",
      "text": "NSLC NSLC POPULATION: OSHC OSHC INTERVENTION: __medTERM2__ CONFRONENT: _MEDTERM3__ Main outcomes: Progression free survival; Overall survival; __MDTERM4__; Intracranial __MEDTERm5__; CNS __méMEDTERM4_; rate rate SETTING: Inpatients PROSPECTIVE: BACKGROUND: interest. interest.",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "Problem",
      "text": "a a priority? ==See also==*Source==References===Further reading==External links== GUIDA GUIDA (a. a. ZCT) 1 MOLTO inGHS/for for (0. 0.56) prior prior (49 to 210) chemotherapy follow up: P. P., R. R., J. J., H. H., Hochmair, MJ., H. H., Delmonte, A., W. W., Griesinger, F., Felip, E., 1-L 1-L 27% indirectiness indirectiness (inadequate inadequate follow-up). accuracy accuracy (an an interim-analysis). bias bias (open label study). data data (sponsor bias). expected undesirable? in in full-283 283 records; of of full-Phase-of Phase-of full-to-text. In Phase-_ _ . the the following: of of Precipitation* (95% CI) Relative Particip (95% (studies) Risk CI) grade grade > 19 19 (1 RCT) 99 99 (months months (97 to 100) 1.01) AST < follow follow up: 0.56 (1 RTC) per per (1, 1,60) (12 to 107) ezza ezza ADED) MEDTERM30__ MEDTERM30__ Inhibitor- Lung Lung Cancer: Clin Clin Oncol; stu stu 27% __medTERM0_ __medTERM0_ in",
      "start_page": 326,
      "end_page": 333
    },
    {
      "heading": "Certainty of evidence",
      "text": "safety safety tests?TESTS TESTS ● been been identified: Low - distortion distortion (sponsor sponsor bias); Moderate - of of generalization; High - imprecision. imprecision.",
      "start_page": 333,
      "end_page": 333
    },
    {
      "heading": "Values",
      "text": "main main outcomes? EVIDENCE EVIDENCE TESTS",
      "start_page": 333,
      "end_page": 333
    },
    {
      "heading": "Budget of effects",
      "text": "comparison. comparison. ● intervention. intervention.",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "Fair",
      "text": "JUDICES JUDICES \" Reduce equity \" equity equity ● equity equity \" Improving equity \" Vary \" or or comparison? life. life.",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "Acceptance",
      "text": "no_BAR__BAR_ no_BAR__BAR_ It'yes yes ● Yes ^I I don't know",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "Feasibility",
      "text": "DOUBLES DOUBLES (probably) found. found. ENTO? no no matter",
      "start_page": 335,
      "end_page": 337
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "Recommendation",
      "text": "option option (__ __ MEDTERM1__).",
      "start_page": 338,
      "end_page": 339
    },
    {
      "heading": "QUESITE 20",
      "text": "Author(s): MC Date: 2019 Question: __medTERM19__ __medTERM19__ Setting: inpatients Bibliography: Oncology Oncology 0: 1-8; Oncology Oncology 2017; 18: __medTERM26_ __medTERM26_ 0/1 (91.7% vs 85.7% metastasis metastasis (34.7% vs 25.7%). to to followed-up; patients patients (70% and and 59% chemotherapy chemotherapy arm) and ex-smokers (34% and and 44% in the SETTING: Ambulatorials",
      "start_page": 339,
      "end_page": 341
    },
    {
      "heading": "PROSPECTIVE:",
      "text": "BACKGROUND: inhibitors inhibitors (Ceritinib or alectinib) __MDTERM2__. __MDTERM2__.",
      "start_page": 341,
      "end_page": 341
    },
    {
      "heading": "Problem",
      "text": "a a priority?",
      "start_page": 341,
      "end_page": 341
    },
    {
      "heading": "ADDITIONAL ADDITIONAL TESTS",
      "text": "as as follows: (a) survey, survey, (b) and and (c) of of Auditors; (c); (d) 3 3 (2) of Regulation (EEC) No 1408/71; (d), (e) Member Member States; (f) carried carried out; (g) the the programmes; (h) the the programme; (i) the the projects; (ii) the the objectives; (iii) of of projects; MEDTERM9__ MEDTERM9__ 0/1 (91.7% vs 85.7% metastasis metastasis (34.7% vs 25.7% vs 24.7%). patients patients (70% and and 59% chemotherapy chemotherapy arms) and ex-smokers (34% and and 44% chemotherapy chemotherapy arm). yesterday yesterday 34% and and 44% chemothertherapy chemothertherapy arm).but but __",
      "start_page": 341,
      "end_page": 343
    },
    {
      "heading": "I2=89%",
      "text": ", , . . . , (. . .) , 1 1 , 6 6 , 8 8 , 15 15 , 14 14 , 28 28 , 30 30 , 16 16 , 27 27 , 34 34 , 37 37 , 57 57 , 74 74 , 60 60 , 43 43 , 85 85 , 95 95 , 93 93 , 96 96 , 50 50 , 68 68 , 56 56 , 48 48 , 84 84 , 87 87 , 35 35 , 94 94 , 33 33 , 102 102 , 120 120 , ___MEDTHERM9__ ___MEDTHERM9__ 0/1 (91.7% vs 85.7% metastasis metastasis (34.7% vs 25.7%). patiences patiences (70% and and 59% chemotherapy chemotherapy arm) and ex-smokers (34% and and 44% __MERTM8__to_MEDTEM11_ __MERTM8__to_MEDTEM11_ & chemotherapy. chemotherapy.",
      "start_page": 343,
      "end_page": 345
    },
    {
      "heading": "Quality of tests",
      "text": "safety safety tests? Ps Ps - estimates estimates - moderated - high - no studies included",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "Values",
      "text": "Ps Ps - variation variation - variableness variableness - been been assessed? IONSI IONSI ADDITIONAL",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "Budget of effects",
      "text": "JUDIZI JUDIZI R",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "Fair",
      "text": "of of equity?",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "Acceptance",
      "text": "R R - No - Probably no - HolderS HolderS ? PLASIE PLASIE frontale? favori favori l'ACTION. ACTION.",
      "start_page": 347,
      "end_page": 348
    },
    {
      "heading": "Feasibility",
      "text": "JUDICIAL JUDICIAL • No • Probably no • Yes Yes • Vary • Summary Summary PROBLEM",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "EFFECTS",
      "text": "Prohibitions",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "BILLS",
      "text": "THE THE SUPERVISION? I I don'EQUITA EQUITA FACTIVITY",
      "start_page": 348,
      "end_page": 349
    },
    {
      "heading": "COURTS",
      "text": "probably probably don'Aumen Aumen l/not not know",
      "start_page": 349,
      "end_page": 349
    },
    {
      "heading": "Recommendation Recommendation Recommendation",
      "text": "of of intervention",
      "start_page": 350,
      "end_page": 350
    },
    {
      "heading": "Recommendation",
      "text": "option. option.",
      "start_page": 350,
      "end_page": 350
    },
    {
      "heading": "Strong recommendation",
      "text": "__ __ MEDTERM2__",
      "start_page": 350,
      "end_page": 350
    },
    {
      "heading": "QUESITE 21",
      "text": "Author: ACT Question: __medTERM2__ __medTERM2__ Setting: inpatients Bibliography: et et al: ____MEDTERMM0__ in non-___MEDTERAM7__ ___MEDTERAM7__ rearrangement: single-arm single-arm first-Oncol Oncol 18:1590-1599, 2017; et et at: page page 18:159-1599.; etc, etc, et: Intra-centralE/the the following: About 35",
      "start_page": 351,
      "end_page": 352
    },
    {
      "heading": "grade grade 3-4",
      "text": "and and observational",
      "start_page": 352,
      "end_page": 352
    },
    {
      "heading": "nervous nervous system",
      "text": "and and observational",
      "start_page": 352,
      "end_page": 352
    },
    {
      "heading": "Hypercholesterolaemia grade 3-4",
      "text": "and and observational",
      "start_page": 352,
      "end_page": 352
    },
    {
      "heading": "Grade 3-4 hyperglycemia",
      "text": "of of AST",
      "start_page": 352,
      "end_page": 353
    },
    {
      "heading": "Explanation",
      "text": "et et al'TKI. TKI.",
      "start_page": 353,
      "end_page": 353
    },
    {
      "heading": "References",
      "text": "E. E., T. T., Bearz, AA., R. R., J. J., R. R., M. M., Peters, S., Toffalorio, F., Abbattista, A:, Thurm, H., Peltz, G., Wiltshire, R. , SS. SS., Toffalorio,F., Tabbattisista, A ., Thurm,H., Pellz,G., Wiltshire, Ru., Wilthshire, Ra., patients patients without-small-in in patient;: E E - Cancer, E/, Fel, Fel, F",
      "start_page": 353,
      "end_page": 353
    },
    {
      "heading": "APPLICATION 21",
      "text": "progress progress POPULATION: INTERVENTION: COMPARISON: MAIN EXITS: SETTING: PROSPECTIVE: BACKGROUND: CONFLICTS OF INTEREST",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "Problem",
      "text": "JUDICES JUDICES • Probably not • Yes • Varia • from from •study study • MEDTERM1_ or •Stage Stage Chemotherapy; Duration of response; Progression free survival; Objective response; the the SNC; grade grade 3-4; Hyperglycaemia Grade 3-4; al. al., months months (95%6-16. 6-16.7). F., J. J., P. P., A. A., in in non-RO_MEDTERM26_ RO_MEDTERM26_ rearrangement: single-arm single-arm first-Lancet Lancet Oncol; De. De., M. M., Peters, S., Toffalorio, F., H. H., R. R., Besse, B., MEDTERM15__-positive MEDTERM15__-positive non-Oncol. Oncol., A A .T., Felip, E., J., P. P., JUDI JUDI ● Gainor, Jr., Johnson., Dietrich., L. L., LL.",
      "start_page": 354,
      "end_page": 359
    },
    {
      "heading": "Values",
      "text": "main main outcomes? EVIDENCE EVIDENCE TESTS",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "Budget of effects",
      "text": "or or comparison? TESTS TESTS • months months (95%1-30. 1-30.3). • comparison comparison (95%6-16. 6-16.7). • months months (95%CI 6.8-NR). comparison comparison (<6 6 -16.7).",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "Fair",
      "text": "JUDIZI JUDIZI • Reduce equity • equity equity ● impact impact ■ Probably improves equity",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "Acceptance",
      "text": "JUDICIAL JUDICIAL • No • Probably no • Yes • Vary • I don't know",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "Feasibility",
      "text": "INTERVIEWS INTERVIEWS \" No \" Probably no • exist exist ● It doesn't exist? found. found. stakeholder? TESTS. TESTS. ento? No No matter",
      "start_page": 361,
      "end_page": 362
    },
    {
      "heading": "COURTS",
      "text": "Varies Varies yes",
      "start_page": 363,
      "end_page": 363
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 363,
      "end_page": 363
    },
    {
      "heading": "Recommendation",
      "text": "chemotherapy. chemotherapy.",
      "start_page": 363,
      "end_page": 364
    },
    {
      "heading": "QUESITE 22",
      "text": "Author(s): IDS Date: September 2019 Question: with with Setting: inpatients Bibliography: Med Med 2014; 371:1963-71; Oncol Oncol 2015; 33:992-9 Show A: Oncology Oncology 30: life life (L. L.) Life Life - al al - life life - al. al. - not reported Diarrhea/Nausea/Constipation grade <=3 - at at (METROS) mone mone y/50 ceation 17/retrospective retrospective - reduction. reduction.\"",
      "start_page": 364,
      "end_page": 366
    },
    {
      "heading": "Explanations",
      "text": "and and Landi; grade 3; grade 5; of of 7/b. b. 76% patients patients (89%) and and 42% sufferants sufferants (80.7%) chemotherapy chemotherapy QUE-Lifeline?",
      "start_page": 366,
      "end_page": 367
    },
    {
      "heading": "PROSPECTIVE:",
      "text": "BACKGROUND: rearrangements. rearrangements.",
      "start_page": 367,
      "end_page": 367
    },
    {
      "heading": "CONFLICTS OF INTEREST",
      "text": "VALUATION",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "Problem",
      "text": "JUDICIAL JUDICIAL • No • Probably no − Probably yes",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "X Yes",
      "text": "(Q6)1000 1000 (0 to 0) t t (METROS) - per per 1/for for 1/00 00 (0 to 0) not not ---ble ble (1 observat study) ble (observat study) ble (1 observed study) 00 00 (0 to 0) 1. 1..00 ( 00 00 (0. to 0), 000 000 (0) BLE BLE (1 observat study) ble (1 observed study) BLE (observat studies) ble (1) observato study) ble (Wabexive Wabexive study) pati pati (80.7%) LINE LINE (LOMEVAL) (LIVER) (LOVERFUL LINE IENSES) JUDITIONS JUDITIONS - Major - Modern - Irrelevant Irrelevant - Varian - erevival erevival - al al (METROS) survival survival - - all all - survivor survivor - survival survival - al al (METROS) - (METRO) - life life - et et - al - Life Life - reported reported Diarrhea/Nausea/grade grade <3 - al al (MITROS) 00 00 Diarrhea/N nausea/00 00 (0 to 0)000 000 (0to 0) 000 000 (to to 2) _ _ (reduction. reduction.\" of of 8/observat observat study) ble (1 observatt study) ble (1 observed study) blue (1observat studied) ble (observant study) observate study) of of 7/L. L.",
      "start_page": 368,
      "end_page": 375
    },
    {
      "heading": "Values",
      "text": "main main outcomes?",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "Budget of effects",
      "text": "action action • Vary • I don'PLASIE PLASIE frontale? GU GU CONSI",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "Fair",
      "text": "of of equity?",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "Acceptance",
      "text": "JUDIZI JUDIZI • No • Probably no • X Yes • Varia • I don't know • RICERC keepers?",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "Feasibility",
      "text": "intervention intervention feasible?",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "SIDES",
      "text": "I I don'FACTIVITY FACTIVITY No",
      "start_page": 378,
      "end_page": 379
    },
    {
      "heading": "TYPE OF RECOMMENDATION",
      "text": "DEL DEL POLMONE",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "COURTS",
      "text": "fairness. fairness.",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "Recommendation",
      "text": "option. option.",
      "start_page": 380,
      "end_page": 380
    },
    {
      "heading": "QUESITE 23",
      "text": "__MEDTERM2_ __MEDTERM2_ Setting: inpatients Bibliography: et et al: Fusion-Positive Fusion-Positive Non-Oncol Oncol 39:Duration Duration (follow up: 8 8 months) months months (IC95% 13.9-28.6) • observational Very low",
      "start_page": 381,
      "end_page": 382
    },
    {
      "heading": "Explanation",
      "text": "cases. cases.",
      "start_page": 382,
      "end_page": 382
    },
    {
      "heading": "References",
      "text": "R. R., G. G., F. F., Siena, S., Drilon, A., C. C., Patel, M-R., C. C., V. V., J. J., H. H., Farago, A",
      "start_page": 382,
      "end_page": 382
    },
    {
      "heading": "APPLICATION 23",
      "text": "by by POPULATION: __medterm2__ __medterm2__ INTERVENTION: __MDTERM1__ CONFRONTO: Main chemotherapy: Overall survival; Progession free survival; Objective response; c c SETTING: Inpatients PROSPECTIVE: BACKGROUND: interest. interest.",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "Problem",
      "text": "a a priority? TESTS TESTS • completed. completed. • Probably no • avanz avanz alica; • Irrelevant • Modern • Large • Variano • siderable siderable effects? • V. V., N. N., JUDITIONS JUDITIONS N:modern modern ● Small • Irrelevants Varian () Varian ? response response (1 study- months months (IC95% 13.9-28.6) observational) follow follow up: months months (1 study - follow-ups: median of 81%, observationally observationally deceased) the the follow- on on patient'b. b.",
      "start_page": 383,
      "end_page": 386
    },
    {
      "heading": "Certainty of evidence",
      "text": "safety safety tests?",
      "start_page": 386,
      "end_page": 386
    },
    {
      "heading": "Values",
      "text": "main main outcomes?",
      "start_page": 386,
      "end_page": 386
    },
    {
      "heading": "Budget of effects",
      "text": "comparison. comparison. ● intervention. intervention.",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "Fair",
      "text": "JUDIZI JUDIZI \" Reduces equity \" equity equity \"impact impact \" fairness fairness \" Improved equity \" Vary \" I don'or or comparison? months months (11-21.1), ento ento (IC95% 13.9-28.6). followed-up. followed-up. uità? from from 108/of of 8/2. 2.5% baseline baseline (both with abilities). of of 81%, co-EDELES. co-EDELES.",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "Acceptance",
      "text": "no_BAR__BAR_ no_BAR__BAR_ It'yes yes ● Yes ^I I don't know",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "Feasibility",
      "text": "Isn'JUDITIONS JUDITIONS ? not not ? Probably yes ● projects projects ? found found ? POLMONE POLMONE JUICES",
      "start_page": 388,
      "end_page": 390
    },
    {
      "heading": "COURTS",
      "text": "Don Don 'w w Don'Don Don 'w w don't kno w",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 391,
      "end_page": 391
    },
    {
      "heading": "Recommendation",
      "text": "option option (compared to chemotherapy).",
      "start_page": 391,
      "end_page": 391
    },
    {
      "heading": "QUESITO 24",
      "text": "with with −BRAF-V600 BRAF-V600 Setting: inpatients Bibliography: Lancet Oncol 2017; 18: 1307/Survival Survival (follow up: 9 9 months; assessed with: each each cause) 36 36 (47%) survival survival (follow up: 9 9 month; evaluated with: or or death) VOLLOW VOLLOW UP: 9 9 months) 25 25 (69%) events events (8 [22%)), disease disease (14 [39%)), investigator investigator (2 [6%)) patient patient (1.3%) nine nine (36%) one one (4%) two two (8%) three three (12%) ten ten (40%) 3-4 3-4 (follow-up: 9 9 months) non-occurrence non-occurrence studies",
      "start_page": 392,
      "end_page": 393
    },
    {
      "heading": "Explanations",
      "text": "been been decreased: not not achieved",
      "start_page": 393,
      "end_page": 393
    },
    {
      "heading": "References",
      "text": "M M D'untreated untreated BRAFV600E- mutant metastatic non-small-cell lung cancer: Lancet Lancet Oncol; 2017.",
      "start_page": 393,
      "end_page": 393
    },
    {
      "heading": "APPLICATION 24",
      "text": "POPULATION: mutation mutation INTERVENTION: _MEDTERM1__ _MEDTERM1__ CONFRONTO: Only primary chemotherapy: Overall Survival; Progression free survival; Response rate; Quality of life; Any discontinuation; Grade Grade 3-4; SETTING deaths: Inpatients PROSPECTIVE: Population",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "BACKGROUND:",
      "text": "the the vote: Dr. Novello",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "Problem",
      "text": "a a priority? siderabili siderabili expected? CENTRAL, CENTRAL, PubMed/months months (95% of of 7· (010 [16.16·6), being being 72% followed up: following following up: Median (8 8 (22.22.0), 27 27 (75%, 95% 25 25 (69%) episodes episodes (four [1%)), Aminotransferase Aminotransferase (four [11%), hypertension (four (11%)) and vomiting (three [8%). BA BA onal) were were sought; trial trial (thirty-five thirty-five years). included included (1) oral oral (twice twice daily) oral oral (once once daily) life life - participants participants (studies) (observed observed (at at (the the (GR onal) 1 MO BA_onal) onal onal 1) 25 25 (69%) events events (8 [22%), followed up: progression progression (14 [39%), decision decision (2 [6%)) decision decision (1.3%) nine nine (36%) treatment treatment (12 percent) two two (8%) three three (1.4%) treatment treatment (less). NE o (observed observed (Juli Juli ,c c onale) onale onale 1) bA bA onale) untreate untreate cancer: arm. arm.",
      "start_page": 394,
      "end_page": 401
    },
    {
      "heading": "Quality of tests",
      "text": "safety safety tests?",
      "start_page": 401,
      "end_page": 401
    },
    {
      "heading": "ADDITIONAL ADDITIONAL TESTS",
      "text": "arm. arm.",
      "start_page": 401,
      "end_page": 401
    },
    {
      "heading": "Values",
      "text": "main main outcomes?",
      "start_page": 401,
      "end_page": 401
    },
    {
      "heading": "ADDITIONAL ADDITIONAL TESTS",
      "text": "• found found • variable variable • or or variability",
      "start_page": 401,
      "end_page": 401
    },
    {
      "heading": "Budget of effects",
      "text": "the the comparison",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "Fair",
      "text": "JUDIZI JUDIZI • Reduce equity • impact impact • equity equity ■ Improves fairness • Vary • nto nto uità? OPLAS OPLAS onfronto? GIUNTIVE GIUNTIVE GUIDE",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "Acceptance",
      "text": "JUDICES JUDICES • No − Probably no • Yes Yes • Varia • I don't know",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "Feasibility",
      "text": "JUDICIAL JUDICIAL • No • Probably no • X Yes • Vary • DESIDERABLE DESIDERABLE EFFECTS",
      "start_page": 403,
      "end_page": 404
    },
    {
      "heading": "SIDES",
      "text": "I I don'No No yes",
      "start_page": 404,
      "end_page": 405
    },
    {
      "heading": "Recommendation Recommendation Recommendation",
      "text": "of of intervention",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "Recommendation",
      "text": "option option (benefit/damage balance vote: favor surgery 4; surgery surgery 3; I don'vote vote recommendation: positive strong 3; positive weak 5) te yes",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "Strong recommendation",
      "text": "I I don'MEDTERM1__ MEDTERM1__ alone",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "QUESITE 30",
      "text": "Author(s): MC Date: September 2019 Question: status status (0-1) Setting: inpatients Bibliography: Med Med 2016; none none 63/154 (40.9%) 126/interruption interruption reasons: Continuation Continuation reasons: CRITICAL CRITICAL CRITICAL",
      "start_page": 406,
      "end_page": 407
    },
    {
      "heading": "APPLICATION 30",
      "text": "expression expression ≥ 50%, status status (0-1), recommended recommended (to to chemotherapy)? POPULATION: PDL1 PDL1 ≥ 50% of of −of of •status status (01) INTERVENTION: __medTERM1_ CONFRONTO: MAIN MAIN RESULTS: Progression-free survival; overall survival; objective response rate; to to 3; discontinuation discontinuation rate: Ambulatorial",
      "start_page": 408,
      "end_page": 408
    },
    {
      "heading": "PROSPECTIVE:",
      "text": "BACKGROUND: expression expression ≥ 50%, status status (0-1).",
      "start_page": 408,
      "end_page": 408
    },
    {
      "heading": "CONFLICTS OF INTEREST",
      "text": "VALUTAZION",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "Problem",
      "text": "JUDICES JUDICES • No • Probably no • X Yes • Varieties • Effects Effects • JUDITION JUDITION • Irrelevant • Small • Moderate • Large • Variant • Don'how how much? • Resumes • Depth • Discovery • outcomes outcomes • Overall survive effects*: months months • NEOPLA • population population • Absolute Absolute effects* (95% CI) a a (95% first first CI) 0. 0. (0. 0.69) (29 to 50) evidence evidence (GRAD to (1 RCT) 50 50 (to to (1 RCT) 305 305 + (1 Rct) 304 304 + (to to (1RCT) 305 305 + (to to (1 RTT) JUDIZI JUDIZI • 100 • 50 • 30 • 5 • 10 • 15 • 6 • 9 • 8 • 7 • 11 • 12 • 13 • 17 • 16 • 25 • 24 • 28 • 14 • 20 • 21 • 22 • 45 • 55 • 52 • 36 • 40 • 35 • 60 • 38 • 65 • 33 • 59 • 53 • 80 • 56 • 70 • 102 • 37 • 3 • 34 • 61 • 2 • 51 • 57 • 4 • 47 • 54 • 74 • 75 • 85 • 95 • 67 • 63 • 105 • 78 • 48 • 72 • 68 • 64 • 44 • 90 • 66 • 97 • 150 • 500 • 0 • 42 • 43 • 125 • 58 • 103 • 23 • bias. bias.",
      "start_page": 409,
      "end_page": 412
    },
    {
      "heading": "Values",
      "text": "main main outcomes?",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "Budget of effects",
      "text": "action action • Vary • I don'PLASIE PLASIE frontale? GU GU CONSI",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "Fair",
      "text": "JUDICIAL JUDICIAL • Reduces equity • impact impact • fairness fairness • Improves equity - • Vary • I don't know",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "Acceptance",
      "text": "Principles Principles • No − Probably no • Yes Yes • Varia • I don't know",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "Feasibility",
      "text": "JUDICIES JUDICIES • No • Probably no • X Yes • Vary • I don'equity equity ? work work • • Ricerc or ? • P P • OF OF PROBLEM",
      "start_page": 414,
      "end_page": 415
    },
    {
      "heading": "SIDES",
      "text": "LINEE LINEE GUIDE",
      "start_page": 415,
      "end_page": 416
    },
    {
      "heading": "COURTS",
      "text": "institution institution EQUITA-L'equity equity L'No No Yes",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "Recommendation",
      "text": "expression expression ≥ 50%, option. option.",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "QUESITE 33",
      "text": "Author(s): MC Date: September 2019 Question: expression expression <50% status status (0-1) Setting: infectiouss Bibliography: Med Med 2018; 378:Oncol Oncol 2016; 17: 14977508",
      "start_page": 417,
      "end_page": 417
    },
    {
      "heading": "patients patients Effect",
      "text": "chemotherapy chemotherapy (95% CI) __ MEDTERM0/none none 112/315 (35.6%) 113/17 17 feet",
      "start_page": 417,
      "end_page": 418
    },
    {
      "heading": "Progression free survival",
      "text": "a, a,e",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "Objective response rate",
      "text": "a, a,e",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "any any AEs",
      "text": "apia apia (95% CI) (95% CI), feet feet . CRITICAL ) (0. 0.80) (7 7 feet) 25 25 more",
      "start_page": 418,
      "end_page": 419
    },
    {
      "heading": "Explanations",
      "text": "189 189 study: following following reasons: clinical clinical progression; following following reasons: monitoring monitoring reasons: clinical clinical progression; proportion proportion score",
      "start_page": 420,
      "end_page": 420
    },
    {
      "heading": "APPLICATION 33",
      "text": "expression expression <50% mutation mutation l",
      "start_page": 421,
      "end_page": 421
    },
    {
      "heading": "Problem",
      "text": "a a priority?",
      "start_page": 421,
      "end_page": 421
    },
    {
      "heading": "ADDITIONAL ADDITIONAL CONSIDERATIONS",
      "text": "\"1 1 (PD-1) metastatic metastatic non-smal-cell - cancer cancer (__MEDTERM12_) __MEDTERF0__ __MEDTERF0__ (Keytruda, Merck), __MEDTHERM1__ • Probably yes (Opdivo, Bristol-Myers Squibb), and_MEDTRAM2__ (Tecentriq, Genentech) therapy. therapy. [...] your your password?Anticipating effects? absolute absolute effects* (95% CI) at at (95% (Studies) (GRADE) and and CI) 499 499 (to to (2 RCTs) 0. 0.83) (35 to 55) rate rate (to to (2RCTs), MODERATEa,c;0. 0.80) (56 to 73) the the 95% g. g. I2=53% j. j. KYNOTE/following following reasons: in in the",
      "start_page": 421,
      "end_page": 424
    },
    {
      "heading": "_MEDTERM0__:",
      "text": "Objective response rate: grade grade 3-5: Discussation rate: JUDGEMENT JUDGEMENT • Large • absolute absolute effects* (95% CI) treatment treatment (95% (studies) (GRADES) and and CI) 189 189 study: following following reasons: clinical clinical progression; following following reasons: Following Following factors: clinical clinical progression; For For Plot",
      "start_page": 424,
      "end_page": 428
    },
    {
      "heading": "_MEDTERM0__:",
      "text": "Objective response rate: grade grade 3-5: Continuation rate: DEL DEL POL",
      "start_page": 428,
      "end_page": 430
    },
    {
      "heading": "Certainty of evidence",
      "text": "of of effects?",
      "start_page": 430,
      "end_page": 430
    },
    {
      "heading": "Values",
      "text": "main main outcome?",
      "start_page": 430,
      "end_page": 430
    },
    {
      "heading": "Balance of effects",
      "text": "RESEAR RESEAR • comparison comparison • compare compare • appearance appearance • intervention intervention • Varies • Don't know",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "Equity",
      "text": "health health equity?",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "Acceptability",
      "text": "JUDGEMENT JUDGEMENT RESEAR",
      "start_page": 431,
      "end_page": 432
    },
    {
      "heading": "Feasibility",
      "text": "No No - Probably no - Yes Yes - Varieces → Don'to to implement? NS NS Don' t know Don'i i Favorn't known don't rever",
      "start_page": 432,
      "end_page": 434
    },
    {
      "heading": "Recommendation",
      "text": "expression expression <50% mutation mutation l",
      "start_page": 435,
      "end_page": 435
    },
    {
      "heading": "QUESITE 34",
      "text": "Author: ACT Question: status status (0-1) Setting: inpatients Bibliography: patients patients + Paclitaxel Paclitaxel + none none 181/338 (53.6%) 211/344 (61.3%) randomized",
      "start_page": 436,
      "end_page": 436
    },
    {
      "heading": "Progression free survival",
      "text": "none none 240/338 (71.0%) 285/344 (82.8%) rate rate (answers answers + partial answers) none none 207/338 (61.2) 126/344 (36%) life life (follow up: 9 weeks; rated with: Life Life Questionnaire- Core 30 (global health status/life life score); Scale from: 0 to 100) living living (follow up: 18 weeks; evaluated with:Life Life Questionaire- Core30 (global healthy status/life life scores); Scales from:0 to 100) Assoluto Assoluto (95% CI) (95% CI), less less for",
      "start_page": 436,
      "end_page": 437
    },
    {
      "heading": "Any breakdown",
      "text": "death death (treatment related deaths) serious serious randomized",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "adverse adverse events: Anaemia",
      "text": "and and randomized",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "adverse adverse events: Neutropenia",
      "text": "and and randomized",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "adverse adverse events: Thrombocytopenia",
      "text": "and and randomized",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "Immunotherapy-related adverse events",
      "text": "CBDCA CBDCA + or or Nab- Beta Beta + (95% CI) (95% CI), for for ... (0. 0.85) 100 (11 11 less) none 32/337 (9.5%) 21/342 (6.1%) 100 100 • (2. 2.64) (10 10 more) none none 51/337 (15.1%) 67/342 (19.6%) CRI CRI (1. 1.07) 100 (1 1 more) none 66/337 (19.6%), 70/342 (20.5%) CRIA CRIA (1. 1.77) 100 (plus plus BASS335L)",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "patients patients Effect",
      "text": "CBDCA CBDCA + Paclitaxel Paclitaxel + (95%CI) (95% CI) none none 111/337 (32.9%) 32/342 (9.4%) randomized randomized (5. 5.96) 100 (BASSA BASSA plus) CI: Confidence interval; HR: Hazard Ratio; RR: Risk ratio; MD: Mean difference",
      "start_page": 438,
      "end_page": 438
    },
    {
      "heading": "Explanation",
      "text": "distortion distortion (sponsor sponsor bias: Merck Merck & the the sponsor; Sharp Sharp & data data analysis). population population (or or IV; RTC RTC KEYNOTE-407: stage stage IV). biases biases (trial trial & Ohme.",
      "start_page": 438,
      "end_page": 438
    },
    {
      "heading": "References",
      "text": "J. J., Kowalski, D., Luft, A., M. M., Laktionov, K., Hermes, B., Cicin, I., T. T., Paz-Ares, L.. Squamous Squamous Non-Clin Clin Oncol; Borghaek. Borghaek.",
      "start_page": 438,
      "end_page": 439
    },
    {
      "heading": "Problem",
      "text": "a a priority? chemotherapy chemotherapy + of of chemotherapy+ platinum platinum + Platinum Platinum + absolute absolute effect* (95% of of CI) relative participation (95% (studies) Risk with CI) chemotherapy CBDCA + Nab-Paclitaxel Nab-Paclitaxel + 72 72 (2 RCT) 100 100 (a a (43 to 57) 0.88) major major - 386 life (the the (to to (1 RCT) 3, QLQ-C30) greater greater with: Life Life Questionnaire- Core 30 (global health status/life life score) Scale from: follow follow up: life life Questionnaire- core 30 (Global Health Status/Life Life score) scale from:follows follows up: J. J., M. M., Borghaei, H., F. F., D. D., L. L., Piperdi, B., Li, X., Burke, T., Squamous Squamous Non-Jlin Jlin Oncol; distortion distortion (Sponsor bias survey: Merck Merck & The The study'the the sponsor; Sharp Sharp & RCT RCT MED14",
      "start_page": 439,
      "end_page": 443
    },
    {
      "heading": "_MEDTERM0__",
      "text": "JUDICES JUDICES - Varies Varies Don'the the undesir",
      "start_page": 443,
      "end_page": 444
    },
    {
      "heading": "_MEDTERM0__",
      "text": "anticipated anticipated effects? carboplatin carboplatin + paclitaxel/PDL-1 PDL-1 <50% status status (0-1), absolute absolute anticipated* of of (95% CI) relative participated (95% (studies) with with CI) chemotherapy CBDCA + nab-paclitaxel nab-paclitaxel + 76 76 (2 RCT) 100 100 (a a (50 a 62) 0.85) 679 679 (55 55 (2 Rct) 1.3 treatment) 100 100 (a a (6 a 16) 2.64) grade grade 3-4: 0.77 (2 RTC) 100 100 (+a a (11 a 21) 1.07) tests tests (Commenti Commenti E) , or or Nab- Pacilitaxel + B. == Demographic evolution ====References== Paz-Ares, L., Luft, A., Vicente, D., M. M., Mazières, J., Hermes, B., F. F., Csőszi, T., Fülzep, S., Rodríguez-Cid, X., M. M., D D .Squamous Squamous Non-J J Med; for for inaccuracy: eneity eneity (I2= 55%) legato legato all'PO PO OLMONE",
      "start_page": 444,
      "end_page": 449
    },
    {
      "heading": "Certainty of evidence",
      "text": "of of effects?",
      "start_page": 450,
      "end_page": 450
    },
    {
      "heading": "Values",
      "text": "main main outcomes?",
      "start_page": 450,
      "end_page": 450
    },
    {
      "heading": "Balance of effects",
      "text": "Varies Varies Don't know",
      "start_page": 451,
      "end_page": 451
    },
    {
      "heading": "Equity",
      "text": "Varies Varies Don'the the comparison? CBDCA CBDCA + Nab-Paclitaxel Nab-Paclitaxel + CBDCa CBDCa + Nab-Paclitaxel Nab-Paclitaxel + A A + nab-Paclitaxel nab-Paclitaxel + CBDCO CBDCO + Beta Beta + 3-4. 3-4.",
      "start_page": 451,
      "end_page": 451
    },
    {
      "heading": "Acceptability",
      "text": "JUDIZI JUDIZI • No ♪ Probably no • Probabilly yes ● Yes • Varies • Don't know",
      "start_page": 452,
      "end_page": 452
    },
    {
      "heading": "Feasibility",
      "text": "JUDIZI JUDIZI \" no no \" Probabyly yes ● Yes - Varieties Don'key key stakeholders? SEARCH OF EVIDENZ'to to implement? SEVERATION OF EVIDENZ'GTS GTS JUBLY",
      "start_page": 452,
      "end_page": 453
    },
    {
      "heading": "COURTS",
      "text": "Vari Vari 'kno kno w",
      "start_page": 454,
      "end_page": 454
    },
    {
      "heading": "TYPE OF RECOMMENDATION",
      "text": "intervention intervention intervention",
      "start_page": 454,
      "end_page": 454
    },
    {
      "heading": "Recommendation",
      "text": "status status (0-1).",
      "start_page": 454,
      "end_page": 454
    },
    {
      "heading": "QUESITE 37",
      "text": "I'm sorry. Author(s): IM Date: 2021 Question: NSCLC1 NSCLC1 Settings: Pemetrexed Pemetrexed Bibliography: Oncol Oncol 2012;13:2012, 2012,7:1713-1721 Paz - JCO JCO 2013;Survival Survival (5 5 months; appointed with: not detected) non non 255/359 inaccience",
      "start_page": 455,
      "end_page": 456
    },
    {
      "heading": "transfusion (5 5 months)",
      "text": "none none 48/359 9/67 67 (100 100 (imprecision imprecision (13.4%) (5%) 22 22 more) HIGH G-CSF (5 5 months; appointed with: G-GF OR GM-CSF) none none 20/359 1/03 03 (10 10 (indirectness8 indirectness8 (5.6%) 15 (0.56) 74. 74.13) 41 41 more) HIGHenzagrade 3-4 (5 5 months; assigned with: grade grade 3-4) available available 88% Investigator Investigator -> months months (3,2-4.6), 8 8 (2,6-3,1); Indipendent -> months months (3- 4,2) , 6 6 (2.2-2,9) Wide Wide 95% (2,6-3,1); confidence confidence 9",
      "start_page": 456,
      "end_page": 457
    },
    {
      "heading": "APPLICATION 37",
      "text": "used used POPULATION: Advanced NSCLC INTERVENTION: Pemetrexed Pemetrexed COMPARISON: Main Placement: Overall Survival; Progression free survival; Objective response rate; life life -EQ-5D; Qual grade 3-4; Neutropenia Neutropenia SETTING: PERSPECTIVE: BACKGROUND: INTEREST CONFLICTS",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "Problem",
      "text": "a a priority? TESTS TESTS - No ... probably no - probably not - Probably yes ● Yes • life life -VAS; Toxicity Toxicity (CONSIDE CONSIDE ratory); Fatigue grade 3-4; trans- ADDENTIONAL HERATIONS disfusion; G-CSF ; Consid Consid JUDICICITI: three three weeks) + placebo placebo + Comments Comments * (95% CI) participants participants (95% (Studies) (GRADE) Risk with CI) 539 539 = Survival (__MEDTERM2_) 0.78 (1 RCT) ALTA evaluated with: 100 100 (100 100 (62 a 76) 0.96) follow up: 100 100 (_MEDTERM3_) assessed with: 0 0 follow-up: rate rate (_medTERM4_) the the following: 0 0 follow-ups: median",
      "start_page": 458,
      "end_page": 461
    },
    {
      "heading": "38 38 - 134",
      "text": "-VAS (_MEDTERM0__) lower average (1 RCT) BASSAd,f",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "SEA - life life - a 0.01",
      "text": "was was greater) available available 88% Wide Wide 95% e. e. 95% and and lower",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "difference difference (MID= 0.08",
      "text": "index index score); f. f. 95% difference difference (MID= 7 VAS) expected? Advanced Advanced Comments* (95% CI) trials trials (95% (studies) (GRADE) CI CI (luxury) 539 539 • Toxicity (51 51 (1 RCT) ALTA laboratory) 100 100 (a a (ST) 100 (4 a 20) 5.91) evaluated by: N° follow follow up: 100 100 (1 to 20) assessed by: follow follow up; follow-up follow-up study: 100 100 (7 to 27) evaluated evaluated with: G- 100 100 (1 a 41) followed up: 12 12 months",
      "start_page": 461,
      "end_page": 464
    },
    {
      "heading": "Certainty of evidence",
      "text": "safety safety tests?EVIDENCE EVIDENCE TESTS",
      "start_page": 464,
      "end_page": 464
    },
    {
      "heading": "Values",
      "text": "main main outcomes?",
      "start_page": 464,
      "end_page": 464
    },
    {
      "heading": "Budget of effects",
      "text": "comparison. comparison. ● intervention. intervention.",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "Fair",
      "text": "equ equ JUDIZI",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "Acceptance",
      "text": "JUDICES JUDICES • No • Probably no ● Probably yes • Yes • Vary • I don't know",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "Feasibility",
      "text": "NEOPLAS NEOPLAS stakeholders? found. found. ento? found. found.",
      "start_page": 466,
      "end_page": 468
    },
    {
      "heading": "ABILITY",
      "text": "I I don'yes yes Yes",
      "start_page": 468,
      "end_page": 468
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 468,
      "end_page": 468
    },
    {
      "heading": "Recommendation",
      "text": "status status (0-1), considered. considered.",
      "start_page": 468,
      "end_page": 469
    },
    {
      "heading": "QUESITE 38",
      "text": "Author: MC Question: the the Setting: Inpatients Bibliography: Open Open 2017; 2:e000236; Lancet Lancet 2016; 387: 1837-46 ; none none randomized",
      "start_page": 469,
      "end_page": 469
    },
    {
      "heading": "Progression free survival",
      "text": "nobody nobody randomized",
      "start_page": 469,
      "end_page": 469
    },
    {
      "heading": "Overall response rate",
      "text": "AE AE (or or 4) nobody nobody randomized",
      "start_page": 469,
      "end_page": 469
    },
    {
      "heading": "Continuation rate",
      "text": "Oncology Oncology 29: 959 • 965, 2018; al. al. / 107 107 (2019) 124e132; 510; or or (95% CI) (95% CI), __medTERM2__ 1384/1874 (73.9%) 1316/1525 (86.3%) less less for",
      "start_page": 469,
      "end_page": 470
    },
    {
      "heading": "Explanation",
      "text": "studies studies (POPLAR POPLAR studies) c. c. I2=61% found found (I2=82%), of of effects",
      "start_page": 470,
      "end_page": 470
    },
    {
      "heading": "References",
      "text": "J. J., Rittmeyer, A., Gadgeel, S., Hida, T., L. L., F. F., Yu, W., Matheny, C., Ballinger, M., __ __ MEDTERM9_: Thorac Thorac Oncol; S. S. , Baas, P., Kim, D-W., Fellip, E., M QUESITE 38: recommended recommended (second-line second-line chemotherapy)? POPULATION: chemotherapy. chemotherapy. INTERVENTION: _MEDTERM5__ _MEDTERM5__ CONFRONTO: Main EXIT Chemotherapy: Progression-free Survival; Overall Survival; Objective Response Rate; to to 3; adverse adverse events: Ambulatorial",
      "start_page": 470,
      "end_page": 471
    },
    {
      "heading": "PROSPECTIVE:",
      "text": "BACKGROUND: chemotherapy. chemotherapy.",
      "start_page": 471,
      "end_page": 471
    },
    {
      "heading": "Problem",
      "text": "a a priority?",
      "start_page": 471,
      "end_page": 471
    },
    {
      "heading": "ADDITIONAL ADDITIONAL TESTS",
      "text": "It'not. not.",
      "start_page": 471,
      "end_page": 471
    },
    {
      "heading": "X Yes",
      "text": "(61 to 67) 037 037 (studies) (with with CI) _ _ [Studies] (with with CI). with with Q10: (95% (studies) (with with CI), __ __ -0 0 77) (61/ 67) to to 67* 3024 3024 077) survival (to to (4 CCTs) years years (to to 57) progressive) 0 0 0; 0 0 98) 0 0, 85) to to 66) 0 0 0) 0) 5 5 ( ( ( to 59) surve) 0 0 - 0 0 ( (69 69 ( (to to ( (79) to (0 0 79) to (to to (4 to (79 79 ( (44 to (to to (4 74, 79) studies) to to (45, 45, 60) 100 100 64) 3 3 ( ( 3 3 ( 100 100 64",
      "start_page": 472,
      "end_page": 473
    },
    {
      "heading": "I2=61%",
      "text": "found found (I2=82%), conside conside GIUDIZI",
      "start_page": 473,
      "end_page": 477
    },
    {
      "heading": "I2=61%",
      "text": "studies studies (POPLAR POPLAR studies) found found (I2=82%), compless compless JUDIZIONI",
      "start_page": 477,
      "end_page": 480
    },
    {
      "heading": "Values",
      "text": "main main outcomes? JUDICIAL TEST SEARCH",
      "start_page": 480,
      "end_page": 480
    },
    {
      "heading": "Budget of effects",
      "text": "comparison comparison \" confrontation confrontation \" discussion discussion \" It'intervention intervention \" in in favour\" operation operation \"Varia \"I don'D D onto?\" participation participation \"vole. vole.",
      "start_page": 480,
      "end_page": 480
    },
    {
      "heading": "Fair",
      "text": "of of equity?",
      "start_page": 481,
      "end_page": 481
    },
    {
      "heading": "Acceptance",
      "text": "JUDIZI JUDIZI • No • Probably no • X Yes • Varia • I don't know • RICERC keepers?",
      "start_page": 481,
      "end_page": 481
    },
    {
      "heading": "Feasibility",
      "text": "of of intervention? I I don'Confr. Confr.",
      "start_page": 482,
      "end_page": 483
    },
    {
      "heading": "COURTS",
      "text": "I I don'LINE LINE GUID",
      "start_page": 483,
      "end_page": 484
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 484,
      "end_page": 484
    },
    {
      "heading": "Recommendation",
      "text": "option. option.",
      "start_page": 484,
      "end_page": 484
    },
    {
      "heading": "QUESITE 42",
      "text": "Author: MGL,MC Question: cancer cancer Setting: inpatients Bibliography: 1) Annane. Annane. 2018;379(23) 2220- 9. 2) treatment treatment (Fifth Non-Important treatment) with with (95%CI) (95% CI) survival survival (follow up: 9 9 months) none none 104/201 (51.7%) 134/202 (66.3%) randomised randomised (0. 0.91) 100 (MODERATA MODERATA less) studies studies 13/none none 171/201 (85.1) 189/202 (93.6%) above above 80% 34 34 (8%) arm arm (mostly <10 points) none none 124/201 (61.7%) 142/202 (70.3%) 100 100 (1. 1.01) (1 1 plus) MODERAT none 21/155 (13.5%) 5/163 (3.1%) for for 100",
      "start_page": 485,
      "end_page": 486
    },
    {
      "heading": "patients patients Effect",
      "text": "with with (95% CI) (95% CI), 3-4 3-4 - none none 45/198 (22.7%) 48/196 (24.5%) randomized randomized (1. 1.32) (8 8 more) events events - anyone anyone 28/198 (14.1%) 24/196 (12.2%) randomised randomised (1. 1.92) (11 11 more) 3-4 3-4 - neutrophils neutrophils 1-10%) studies studies (to to 12",
      "start_page": 487,
      "end_page": 487
    },
    {
      "heading": "Explanation",
      "text": "distortion distortion (sponsor sponsor bias: Hoffmann Hoffmann - La Roche / of of data). for for imprecision: RR RR calculation: stage. stage.",
      "start_page": 487,
      "end_page": 488
    },
    {
      "heading": "References",
      "text": "L. L., S. S., Szörksna, A ., Havel, L ., Krzakowski, M., J. J., Huemer, F., Losonczy, G., Reck, Reck, M; Lin, W., V. V., J J Med; Mansfields, Mansfields, A: Każarnowicz, A! Au. Au.",
      "start_page": 488,
      "end_page": 488
    },
    {
      "heading": "APPLICATION 42",
      "text": "lung lung cancer? POPULATION: stage stage INTERVENTION: A first- CONFRONTO CONFRONTO Treatment: Main ESITI chemotherapy: Overall survival; Progression free survival; Response rate (partial partial responses) ; life life (_MEDTERM4_); Any discontinuion (of of treatment).",
      "start_page": 489,
      "end_page": 489
    },
    {
      "heading": "BACKGROUND:",
      "text": "CONFLICTS OF INTEREST",
      "start_page": 489,
      "end_page": 489
    },
    {
      "heading": "Problem",
      "text": "a a priority? JUDICES • No • Probably no • X Yes • Vary • Effects Effects (Fifth Century Centuries) • Fifty-Fifteenth Centennials (Fixth Census) {Fifteen Centorals] • follow follow up: effect effect early* of of (95% CI) relative participation (95% (studies) CI) than than 80% hundred-grade hundred-grade (Menth to 12-population) 34 34 (8%) of of RCT)1 RCT 1) interruption interruption (of of treatment) Any discontinuion (to to discontinuation) - 100 100 (53 to 71) arm arm (to to 528) 403 403 (to to (1 RCT). Horn, L., S. S., J. J., Huemer, F., Losonczy, G., 99 99 (a a (1 RCT) 394 394 (a a (1RCT) A A ., Havel, L ., L. L., M. M., Ho k., air, air, , T., RR RR calculation: by by imprecision: as as follows: (i) and and (ii) following following languages: (ii), (iii), (iv), (v), (vi), (vii), (viii), (e) and (vi); (iv) the the results; (v) the the studies; (vi) the the survey; (iii) the the findings; (iv). 1 1 RCT) discontinuation discontinuation (of of treatment) Any interruption (of of treatment). - arm arm (mostly <10 points) 403 403 (a a (1 RCT), 100 100 (53 a 71) 318 318 (a a (1RCT) 100 100 (5 a 35) 318 318 (a a (1 RTT) 100 100 (1 a 24) 100 100 mg/ J. J., Huemer, F., Losonczy, G., 99, 99, (to to (1 RCT) 394 394 (to to (1RCT)394 394 (to to (1rCT) (1) 334, 334, (to to (1 rCT) 1) 318 318 (to to (1 rect) A. A., Havel, L., Mio, Mio, M-, Reck M., m. m., T. T., S. S., two two levels: and and safety? ADDITIONAL ADDITIONAL HERATIONS",
      "start_page": 490,
      "end_page": 501
    },
    {
      "heading": "Values",
      "text": "C) JUDICES JUDICES • variation variation • variable variable • or or variability",
      "start_page": 501,
      "end_page": 501
    },
    {
      "heading": "Budget of effects",
      "text": "main main outcomes? or or comparison? SELLING THE POLMONE'ADDING ADDING HERATIONS",
      "start_page": 501,
      "end_page": 502
    },
    {
      "heading": "Fair",
      "text": "JUDIZI JUDIZI - Reduces equity - impact impact - fairness fairness - Improves equity",
      "start_page": 502,
      "end_page": 502
    },
    {
      "heading": "Acceptance",
      "text": "JUDICIAL JUDICIAL • No • Probably no • and and •with with •with with −treatment treatment . low low . uity?",
      "start_page": 502,
      "end_page": 503
    },
    {
      "heading": "Feasibility",
      "text": "JUDICES JUDICES • No • Probably no • Yes Yes • Vary • I don'do do this? • ADDITIONAL ADDITIONAL HERATIONS",
      "start_page": 503,
      "end_page": 503
    },
    {
      "heading": "SUMMARY OF COURTS",
      "text": "FACTIVITY FACTIVITY No",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "COURTS",
      "text": "Probably Probably doesn'I I don'not not know",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "in in favour",
      "text": "the the intervention",
      "start_page": 505,
      "end_page": 505
    },
    {
      "heading": "Recommendation",
      "text": "cancer. cancer. (benefit/damage balance vote: favors intervention 8; weak weak 5; Strong positive 6)",
      "start_page": 505,
      "end_page": 505
    },
    {
      "heading": "QUESITE 43",
      "text": "1DER/i: ACT Question: __MEDTERM0_ + etoposide etoposide (disease disease Setting: Inpatients Bibliography: W. W., et al., Lung Cancer 149: 46-52, 2020; et et al",
      "start_page": 506,
      "end_page": 506
    },
    {
      "heading": "patients patients Effect",
      "text": "Durvalumab Durvalumab + and and (95% CI) (95% CI), none none 171/265 (64.5%) 173/266 (65.0%) randomized randomized (1. 1.12) 100 (8 8 more) interruption interruption (follow up: 1 1 months) None None 27/265 (10.2%) 25/266 (9.4%) randomized randomized (1. 1.82) (8 8 plus) MODERATA CI: Confidence interval; HR: Hazard Ratio; RR: Risk ratio",
      "start_page": 507,
      "end_page": 507
    },
    {
      "heading": "Explanation",
      "text": "investigator investigator unmasked",
      "start_page": 507,
      "end_page": 507
    },
    {
      "heading": "References",
      "text": "W. W., Dvorkin, M., Chen, Y., Reinmuth, N., Hotta, K., Trukhin, D., Statsenko, G., O. O., Poltoratskiy, A., Ponce, S., Verderame, F., Havel, L., Bondarenko, I., Każarnowicz, A",
      "start_page": 507,
      "end_page": 508
    },
    {
      "heading": "Problem",
      "text": "JUDICES JUDICES • Probably no • probably probably • Varia • Non-Varie_of patients • __MEDTERM0_ __MEDTERM0_ + disease disease • PlatterM1_ + Overall Overall survival; survival survival study; •MEDTERM22_; AE any grade; AE grade<3; ACTION ACTION • p p n; effect effect anticipated* Comments Comments (95% CI) trials trials (95% (studies) (GRADE) with with CI) Sola __Medterm1_ + 537 537 • Nruvelz • survival. survival. • 547 547 • • median median (70 to 83) • GCT. ■ 100 100 (follow follow up: (79 to 89) 0.96) __MEDTERM24_seems. __MEDTERM24_seems. ♪ JUDICES JUDICES • Large Moderates ●Small • Irrelevant • Variano • effects effects expected? age age > treatment treatment arms: effect effect anticipated* Comments Comments (95% CI) participants participants (95% (studies) (GRADE) chemotherapy chemotherapy + 531 531 ›MEDTERM1_ follow up: 1.01 (1 RCT) 1 + 100 100 (months months (95 to 100) 1.04) grade grade <RR RR 531",
      "start_page": 508,
      "end_page": 513
    },
    {
      "heading": "Certainty of evidence",
      "text": "safety safety tests?TESTS TESTS • Low Low (detection detection bias). ● Moderate • High • No studies included",
      "start_page": 513,
      "end_page": 513
    },
    {
      "heading": "Values",
      "text": "main main outcomes?",
      "start_page": 513,
      "end_page": 513
    },
    {
      "heading": "Budget of effects",
      "text": "JUDICES JUDICES RICE",
      "start_page": 514,
      "end_page": 514
    },
    {
      "heading": "Fair",
      "text": "of of equity?",
      "start_page": 514,
      "end_page": 514
    },
    {
      "heading": "Acceptance",
      "text": "no_BAR__BAR_ no_BAR__BAR_ It'yes yes ● Yes ^I I don't know",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "Feasibility",
      "text": "JUDITIONS JUDITIONS • No • Probably no • does does • Vary • main main stakeholders' ella ella intervento? • NEO DERS? ■ EVIDENTS. EVIDENTS. • EQUITACY EQUITACY • ACCEPTABILITY ♪ Various Various interventions",
      "start_page": 515,
      "end_page": 516
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 517,
      "end_page": 517
    },
    {
      "heading": "Recommendation",
      "text": "__Durvalumab __Durvalumab + option option (only only chemotherapy).",
      "start_page": 517,
      "end_page": 517
    },
    {
      "heading": "QUESITE 45",
      "text": "Author(s): MC Date: September 2019 Question: L'radiazione prostitutiva dell'encephalo (PCI) chemotherapy chemotherapy Setting: inpatients Bibliography: No. No.: Oncology Oncology (2018) 13:Effect Effect l'irradiation irradiation (95% CI) (PCI) - Brazil not - free - Brain reports",
      "start_page": 518,
      "end_page": 518
    },
    {
      "heading": "Overall survival",
      "text": "none none 748/1859 644/feder feder ? a a (40.2%) f (11.6%) f (0. 0.66) LOW LOW (4 4 feet)",
      "start_page": 518,
      "end_page": 518
    },
    {
      "heading": "Progression free survival",
      "text": "261 261 (0.0%) 0/406 (0.0%) 76 76 -- per 100 • g g (0. 0.89) (from -- to VERY LOW",
      "start_page": 518,
      "end_page": 518
    },
    {
      "heading": "Quality of life",
      "text": "that that \"the the quality-of-life \" 93. 93.7% 46. 46.3% groups groups (P = 0.00)\" Function Function (neurological damage) - not reported - - -",
      "start_page": 518,
      "end_page": 519
    },
    {
      "heading": "lethargy lethargy (any grade)",
      "text": "none none 52/386 (13.5%) 16/570 (2.8%) more more ...l l (8. 8.44) LOW LOW (209 209 more) CI: Confidence interval; HR: Hazard Ratio; RR: Risk ratio",
      "start_page": 519,
      "end_page": 519
    },
    {
      "heading": "Explanations",
      "text": "d. d. I2=84% treatment. treatment.",
      "start_page": 519,
      "end_page": 520
    },
    {
      "heading": "PROSPECTIVE:",
      "text": "BACKGROUND:",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "CONFLICTS OF INTEREST",
      "text": "VALUE",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "Problem",
      "text": "priority priority JUDICITIS: \" No ... no no . \" Yes Yes ? Varia → brain brain (PCI) of of progression; overall survival; to to 3; cerebral cerebral testes; q alo (PCI) groups groups (P = Impered - - - evidence evidence (GRADE) Function Function (neurological damage) - 3-5 3-5 - - AES - afthargy afthargy (any (to to (2 grade) 8. 8.44) observational (80 to 237) studies)Forest Forest plot: OS:",
      "start_page": 520,
      "end_page": 523
    },
    {
      "heading": "_MEDTERM0__:",
      "text": "Grandi Grandi ...Moderati (21 0.66) effects effects expected? metastases metastases - free survival - solute solute effects* (95% CI) with with l'encefa encefa (PCI) 100 100 (7 to 8) 100 100 (N to NaN) ne ne (95% (studies) alo CI) 7395 7395 (to to (21 0.76) CEAN, CEAN, B/N) studies",
      "start_page": 523,
      "end_page": 525
    },
    {
      "heading": "Mr VERY",
      "text": "that that \"with with - (1 RCT)j = the quality-93. 93.7% 46. 46.3% groups groups (P = Impered - - -- - - Cognitive Function (neurological damage) - 3-5 3-5 - -",
      "start_page": 525,
      "end_page": 525
    },
    {
      "heading": "(80 to 237) studies",
      "text": "d. d. I2=84% the the Newcastle- Ottawa scale.",
      "start_page": 525,
      "end_page": 527
    },
    {
      "heading": "_MEDTERM0__:",
      "text": "Fatigue or lethargy: and and safety? ADDANTIVE ADDANTIVE N",
      "start_page": 527,
      "end_page": 528
    },
    {
      "heading": "Values",
      "text": "main main outcomes? JUDICIAL TEST SEARCH",
      "start_page": 528,
      "end_page": 528
    },
    {
      "heading": "Budget of effects",
      "text": "TESTS TESTS • comparison comparison • confrontation confrontation • intervention intervention •operation operation • Varia • D D onto?",
      "start_page": 528,
      "end_page": 528
    },
    {
      "heading": "Fair",
      "text": "JUDICIAL JUDICIAL • Reduces equity • impact impact • fairness fairness • Improves equity - • Vary • I don'Judici Judici • No • Possibly no • X X • Other • Not so",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "Feasibility",
      "text": "judicatures judicatures or? RICERC keholders ? RICEREC o? intervention. intervention.",
      "start_page": 529,
      "end_page": 530
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 531,
      "end_page": 531
    },
    {
      "heading": "Recommendation",
      "text": "brain brain (PCI) ice ice 2: POLMONE POLMONE Q1: years years before? MEDLINE (PubMed) (August August 2023) ((((!(( (( (...) (() \"Lung Neoplasms\"[Mesh] OR \"Clinoma,\" Non-Small-Cell Lung\"[Ash] Or",
      "start_page": 531,
      "end_page": 533
    },
    {
      "heading": "Selected 1 Record",
      "text": "Q2: approach approach (VATS or robotics) or toracotomy? MEDLINE (PubMed) ((((·c(\"Carcinoma, Non-Small-Cell Lung/Surgery\"[Mesh]) OR \"Lung Neoplasms/Surgiry\"[Mesh] OR ((\"lung cancer\"[Title/Abstract] OR \"lung lung cancer\" [Titler/Attract])",
      "start_page": 533,
      "end_page": 533
    },
    {
      "heading": "Records: 197",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'long long cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'lung lung cancer' Or 'lung lung cancer') OR nsclc:ti,ab #3 #1 OR #2 #4 'grade ia' OR'stage ia':b b #5 #3 AND #POLMONE POLMONE #6 'vats lobectomy' OR OR 'thoracic surgeries, video-assisted' OR -video surgery (vats) lobectomy' OR",
      "start_page": 533,
      "end_page": 534
    },
    {
      "heading": "Selected 3 records",
      "text": "Q3 GRADE: stage stage (IA), segment segment (compared to lobectomy)? MEDLINE (PubMed) (August August 2023) ((\"Lung Neoplasms\"[Mesh]) OR \"Carcinoma, Non-Small-Cell Lun Neoplasmas\"[Mesh]) Or \"lung cancer\"[Title/Abstract] OR \"lung neoplasms' tumor\"[Title/Attract] or \"Non-small-cell long cancer\" [Title/abstract]. OR cancer\"[1Title/ Abstract] OR NSCLC_[Title /abstraction]",
      "start_page": 534,
      "end_page": 534
    },
    {
      "heading": "Records:70",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'lung neoplasms' OR \"long tumor\" OR 'not-long long cancer' or nsclc:ti,ab",
      "start_page": 534,
      "end_page": 534
    },
    {
      "heading": "Selected 2 records",
      "text": "Q4: MEDLINE MEDLINE (PubMed) radio station ((((āb(\"Carcinoma, Non-Small-Cell Lung/surgery\"[Mesh]) OR \"Lung Neoplasm ((\"lung cancer\"[Title/Abstract] OR \"lung neoplasms\"[Title/Attract] Or \"long t \"Non-small-cell lung cancer\" [Titler/Aptract] or \"Don'lung lung cancer\"\"[T_MEDTERF0_[Tittel/App]",
      "start_page": 534,
      "end_page": 534
    },
    {
      "heading": "Selected 3 records",
      "text": "entec entec ng\"[M \"[Title R \"oterap oterap ms/sur tumor Title/A 0\" (thoracic thoracic ctomy' è è Mesh]) OR \"Lung e/Abstract] OR \"lung lung er' OR 'pia pia conventionale? rhey\"[Mesh] OR (\"[Title/Ambs] OR Abstract])))",
      "start_page": 534,
      "end_page": 535
    },
    {
      "heading": "Records: 116",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-small-cell long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 #1 OR #2 #4 'adjuvant chemotherapy'/esp/mj #5 #3 AND #4",
      "start_page": 535,
      "end_page": 535
    },
    {
      "heading": "Selected 19 records",
      "text": "Q6: is is recommended? MEDLINE (PubMed) (August August 2023) ((((·(( \"Carcinoma, Non-Small-Cell therapy\"[Mesh] OR \"Carcinoma, Not-Small-Cello Lung/pathology\"[Mesh]) OR ((\"Lung Neoplasms/Drug therapy\"[ Mesh] Or ((\"\"lung-cell cancer\" [Title/Abs] or \"Lung neoplasms\"[Titler/Aabs] OR (\"Lung tumor\")",
      "start_page": 535,
      "end_page": 535
    },
    {
      "heading": "Records: 107",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-small-cell long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 'grade iii' OR'stage iii 'OR OR 'advanced disease' NEAR/7 (egfr OR '_MEDTHERM2___ mutated') #4 (#1 OR #2) AND #3 #5 '_medTERM0__'/Exp #6 osimertinib_:POLMNONE POLMNONE #8 #4 AND #5 OR6",
      "start_page": 535,
      "end_page": 536
    },
    {
      "heading": "Selected 1 Record",
      "text": "Q7: L1 L1 ≥50% is is recommended? MEDLINE (PubMed) (August August 2023) (((([(( [(( -(( (( _ [( [ (( [ [( (0] [( \" (( - [ [ [ ... [ [ ] [ [ \" \" Carcinoma, Non-Small-Cell Lung/drug therapy\"[Mesh] OR \"Carcino Long/pathology\"[Mesh]))) OR (( ([Mesh] Or \"Lung Neoplasms/drug therapy\"[ Mesh]]) OR [(\"lung lung cancer]]] [Title/Ab] OR or \"lung neoplasms\"[Titgle/Ang Neoplasplasms][Tile/A abstract] OR\"Lung neoplasm][Notle/Or \"lung tumor\"[Title/Atle]] /Ab/ab] OR, [Tat] OR non-ab] or \"Non-) or \"non-ill/ab/ab [ ( ( (;]] OR,\" Non-health/ab]. OR \"Non, or \"Dat]] or\" (Non-health-cell-cell,)) or or \"N,) or ( ()) ( (L))]] ( (or)) [ (non-rel) or,) (Lan))), or \"not)) as, or (no-health) or not) or\" or \" (Lat)) / (L,) [or ( (a)) nor,)]) () or))). ( (n,) if ( (G or \"F)) =)) ] or \"L) or (\" ( (. ( (!))",
      "start_page": 536,
      "end_page": 536
    },
    {
      "heading": "Records: 98",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-lung lung Cancer' OR nsclc:ti,ab #3 'grade iii' iii iii 'OR OR 'advanced disease' NEAR/7 (__MEDTERM2_) #4 (#1 OR #2) AND #3 #5 '_MEDTERM0__/exp/mj #6 __MEDterm0_:i,ab#7 #4 AND (#5 OR #6)",
      "start_page": 536,
      "end_page": 536
    },
    {
      "heading": "Selected 1 Record",
      "text": "Q8: simple simple observation? MEDLINE (PubMed) (August August 2023) (((([(( [(( ((·(( -((\"Carcinoma, Non-Small-Cell Lung/radiotherapy\"[Majrra/Abstr neoplasm]) OR ((!(( (...) (( (.(() \"Carcinomas, Not-Smalle) Lung tumor*[Madle/Abrative] OR lung tumour*[Title/abstr neoplast]] long long cancer*[Tritle/Abbsto] lu lu cancer]*[Title/abstral]] [Titler/Agr]] ] lung lung cancer**[title/ab] OR __MED/ab].",
      "start_page": 536,
      "end_page": 536
    },
    {
      "heading": "Records: 238",
      "text": "oma, oma, Non-Small- long long pt]) OR cer' OR 'postoperat postoperat ((((?lung ract]) ung ung C*[Title/Abstract] Title/Ambs] OR)) AND \"radical cal Trial\" [Publica OR sh]) AND l PD- or la -Embase Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR #limterM1_su_lung neoplasms' OR'lung tumor' OR \"non-small-cell lung cancer'.",
      "start_page": 536,
      "end_page": 537
    },
    {
      "heading": "Selected 2 records",
      "text": "OR9: recommended recommended (only only Fields)? ((\"neoadjuvant therapy\"[MeSH Terms] OR (\"neoadiuvant\"[All Fields] AND \"neoaddjuvants\"[all Fields]] OR \"neodjuvations\"[ All Fields=] OR \"newfield\"[All Fields].",
      "start_page": 537,
      "end_page": 537
    },
    {
      "heading": "Selected 2 records",
      "text": "Q10: stage stage IIIA/recommended recommended (compared to sequential)? MEDLINE (PubMed) (August August 2023) ((((with Carcinoma, Non-Small-Cell Lung/radiotherapy\"[Majr:noexp]) OR ((áz((õlung cancer*[Title/Abstract]) Or long tumor*[Title/Ambstract]] lung lung cancer* [Titler/Abbs])",
      "start_page": 537,
      "end_page": 537
    },
    {
      "heading": "Records: 171",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/POLMONE POLMONE #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR \"non-small-cell lung cancer\" OR 'long long cancer' or nsclc:ti,ab #3 #31 OR #32 #4 ('grade iii' OR'stage iii') OR OR 'locally-advanced disease') NEAR/5 ('inoperable' Or 'surgically unreectable') #5 #33 AND #34 #6 'radiotherapy'/esp/mj OR 'chemotherapy'/Exp/mJ #7 'radiotherapeuticly unresectable'",
      "start_page": 537,
      "end_page": 538
    },
    {
      "heading": "Selected 3 records",
      "text": "Q11: stage stage IIIA/with with radiotherapy? MEDLINE (PubMed) (August August 2023) ((((⁄((\"Carcinoma, Non-Small-Cell Lung/radiotherapy\"[Majr:noexp]) OR ((áz((õlung cancer*[Title/Abstract]) Or long tumor*[Title/Approach]) lung lung cancer* [Title/abstract]] lung lung Cancer*[Tritle/Attract]",
      "start_page": 538,
      "end_page": 538
    },
    {
      "heading": "Records: 261",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-small-cell long cancer' Or 'lung lung disease' OR nsclc:ti,ab #3 #31 OR #32 #4 ('grade iii' OR'stage III' OR OR 'locally-advanced disease') NEAR/5 ('inoperable' OR surgically unresponsive') #5 #3 AND #4 #Protocols Protocols #7 #5 AND #6",
      "start_page": 538,
      "end_page": 538
    },
    {
      "heading": "Selected 6 records",
      "text": "Q12: to to 1%, with with −to to observation? MEDLINE (Pubžežalm) (August August 2023) ((((!((\" Carcinoma, Non-Small-Cell Lung/Drug therapy\"[Mesh] OR \"L Neoplasms-Clung-Cathology\"[Mesh]) OR ((\"Tung Cancer\"[Title/Abs] OR",
      "start_page": 538,
      "end_page": 539
    },
    {
      "heading": "Records: 21",
      "text": "Embase (Embase.com) (2018) 2023 2023 #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-small-cell long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 #31 OR #32 #4 durvalumab #5 #3 AND #4 AND ([cochrane review]/lim OR [systemic review] / lim OR [meta analysis]/lem OR [ranmed controlled trial]/LIM OR 'controlled clinical trial'/de)",
      "start_page": 539,
      "end_page": 539
    },
    {
      "heading": "Selected 3 records",
      "text": "Q13 GRADE: recommended recommended (therapy therapy only)? MEDLINE (PubMed) (March March 2021) ((\"Lung Neoplasms\"[Mesh]) OR \"Carcinoma, Non-Small-Cell Lung\"[Mesh]) Or \"Lung neoplasms'[Mesh] OR \"lung cancer\"[Title/Abstract] OR (\"lung neoplasmas\"[Title/Attract] or \"lung tumor\"[Textle/abstract]. OR \"Non-small-cell lung cancer\" [Title/ abstract] OR 'lung lung cancer'[Tittle/ Abstract] OR NSCLC[Title/Att.]",
      "start_page": 539,
      "end_page": 539
    },
    {
      "heading": "Records:38",
      "text": "Embase (Embase.com) (March March 2021) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'long long cancer' or 'lung lung Cancer' OR nsclc:ti,ab",
      "start_page": 539,
      "end_page": 539
    },
    {
      "heading": "Selected 4 Record",
      "text": "Q14: MEDTERM5_ MEDTERM5_ (Ex19dels and L858R), __medterm5_ __medterm5_ __MEDTERMO) recommended recommended (__DETERM1_ __DETERM1_ and/or __EDTERM2_)? MEDLINE (PubMed) (August August 2023) ((((·((!((\" Carcinoma, Non-Small-Cell Lung/drug therapy\"[Mesh] OR \"Lung Neoplasms/pathology\"[Mesh] OR",
      "start_page": 539,
      "end_page": 540
    },
    {
      "heading": "Records: 69",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-small-cell long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 'grade iii' OR'stage iii 'OR OR 'advanced disease' NEAR/7 (egfr OR '_MEDTHERM2___ mutated') #4 (#1 OR #2 AND #3 #5 '_medTERM0_'/Exp #6 '__MEDTERMO0__':OR6 OR6 #8 #4 AND #7 AND ([corangema] review] [medterm]",
      "start_page": 540,
      "end_page": 540
    },
    {
      "heading": "Selected 3 records",
      "text": "Q15: MEDTERM2_ MEDTERM2_ (of of •exone 20), of of {recommended recommended (compared to chemotherapy)? MEDLINE (PubMed) (December December 2023) ((((\"Carcinoma, Non-Small-Cell Lung\"[Majr]) AND \"__MEDTERM 2_, uncommon\"[Mayr]\") OR ((!((lung cancer*[Title/Abstract]) OR lung tumor*[Title/Ambral]",
      "start_page": 540,
      "end_page": 540
    },
    {
      "heading": "Records: 203",
      "text": "Embase (Embase.com) (December December 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'long long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 #1 OR #2 #4 '_MEDTERM0___ uncommon': ti,ab#5 #3 AND #4",
      "start_page": 540,
      "end_page": 540
    },
    {
      "heading": "Selected 1 Record",
      "text": "POLMONE POLMONE Q16: of of •with with __MEDTERMO]recommended recommended (compared to chemotherapy)? MEDLINE (PubMed) (August August 2023) (((( (...) \"Carcinoma, Non-Small-Cell Lung/Drug Therapy\"[Mesh] OR \"Lung Neoplasms/Pathology\"[Mesh] OR (\"Tung cancer\"[Title/Abstract] OR\"lung neoplasms\"[tell] or \"Long Neoplasm-Patology\"",
      "start_page": 541,
      "end_page": 541
    },
    {
      "heading": "Records: 69",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-small-cell long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 'grade iii' OR'stage iii 'OR OR 'advanced disease' NEAR/7 (egfr OR '_MEDTHERM2___ mutated') #4 (#1 OR #2 AND #3 #5 '_medTERM0_'/Exp #6 '__MEDTERMO0__':OR6 OR6 #8 #4 AND #7 AND ([corangema] review] [medterm]",
      "start_page": 541,
      "end_page": 541
    },
    {
      "heading": "Selected 1 Record",
      "text": "OR17 GRADE: MEDTERM7_ MEDTERM7_ (Ex19dels, L858F) identified identified (liquid liquid biopsy) with with −recommended recommended (compared to chemotherapy)? MEDLINE (PubMed) (August August 2023) ((((!((\" Carcinoma, Non-Small-Cell Lung/Drug therapy\"[Mesh] OR \"Lung Neoplasms/pathology\" (Non-Small-Lung Lung-Long/Pathology)",
      "start_page": 541,
      "end_page": 542
    },
    {
      "heading": "Records: 69",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-small-cell long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 'grade iii' OR'stage iii 'OR OR 'advanced disease' NEAR/7 (egfr OR '_MEDTHERM2___ mutated') #4 (#1 OR #2 AND #3 #5 '_medTERM0_'/Exp #6 '__MEDTERMO0__':OR6 OR6 #8 #4 AND #7 AND ([corangema] review] [medterm]",
      "start_page": 542,
      "end_page": 542
    },
    {
      "heading": "Selected 1 Record",
      "text": "MEDTERM8_ MEDTERM8_ () ===Further readings===;;;:;;*;; being recommended (compared to __medTERM1_)? MEDLINE (PubMed) (August August 2023) ((((Mesh] OR \"Carcinoma, Non-Small-Cell therapy\"[Mesh];;# \"Lung Neoplasms/Drung-Lumpy][Mech] Or \"Long Neoplasm/Pathology\"[Non-Th]) OR ((\"lung cancer\"[Title/Abs] OR\"Lung neoplasms\"[Mesh].",
      "start_page": 542,
      "end_page": 542
    },
    {
      "heading": "Records: 117",
      "text": "Embase Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'long long cancer'/exp #2 'long cancer' OR 'lung neoplasms' OR \"lung tumore' OR or 'non-lung lung cancer' Or 'cancer cancer ' OR nsclc:ti,ab #3 'grade iii 'lung tumor ' OR 'lung lung cancer'Or 'longer longer cancer'OR 'long long cancer\" bi, bi,ab#3 'degree iii' OR'r 'stage III 'stage 3' OR OR ('advanced disease' NEAR/7 ('advanced disease' NAAR/rearrangeme rearrangeme #4 (#1 OR] AND #2) AND 3 #3 #5 '5 '_5 ' '__5 __ [__[__*__^__",
      "start_page": 543,
      "end_page": 543
    },
    {
      "heading": "Selected 3 records",
      "text": "Q19: recommended recommended (respect __MDTERM1_)? MEDLINE (PubMed) (August August 2023) ((0(arCarcinoma, Non-Small-Cell Lung/drug therapy\"[Mesh] OR \"Carcinomas, Not-Small-Chell Long/pathology\"[Mesh] Or \"lung neoplasms\"[Title/Abstract] \"lung tumor\"[Title/abs] OR (\"non-small-cell cancer\"[Triple/Ambs]",
      "start_page": 543,
      "end_page": 543
    },
    {
      "heading": "Records: 40",
      "text": "Embase_ (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'lung neoplasms' OR \"lung tumor\" OR 'long tumor 'non-cancer cancer ' OR 'don' long long cancer' Or nsclc_:ti,ab #3 'gene rearrangement'/esp/mj/mJ #OR OR '_MEDTHERM4_ OR'__MEDTERMM4___ reactionment':ti",
      "start_page": 543,
      "end_page": 544
    },
    {
      "heading": "MEDLINE (PubMed) (September September 2024)",
      "text": "((_TER_Terz] [Mesh] OR \"Carcinoma, Non-Small-Cell Lung/Drug Therapy\"[Mesh) OR \"Lung Neoplasms/pathology\"[Mesh]) OR ((\"lung cancer\"[Title/Abstract] Or \"lung neoplasms\"[Title/Attract] OR (\"Lung neoplasmas\") [Titles/Aptract] or \"Non-small-cell cancer\"[1Titler/Autsume] OR\"Non-small cung carcinoma\"[English]",
      "start_page": 544,
      "end_page": 544
    },
    {
      "heading": "Embase (Embase.com) (September September 2024)",
      "text": "#1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'lung cancer' OR 'lung neoplasms' OR \"long tumor\" OR 'not-small-cell lung cancer') OR 'don'lung lung Cancer' OR _MEDTERM9__:ti,ab #3 'grade iii' iii iii 'OR OR 'advanced disease' NEAR/7 (RET) #4 (#1 OR #2) AND #3 #5 '__medTERM0__'/Exp/mj OR '_MEDTHERM1__'/esp/mJ OR 'capmatinib___OR_OR_DETERM2___MEDTERS2__EXTEM2_FRIEN_FRlG",
      "start_page": 544,
      "end_page": 544
    },
    {
      "heading": "Selected 3 records",
      "text": "Q21 GRADE: recommended recommended (compared to chemotherapy)? MEDLINE (PubMed) (August August 2023) ((((\"Carcinoma, Non-Small-Cell Lung/Drug therapy\"[Mesh] OR \"Lung Neoplasms/Pathology\"[Mesh] Or \"Long cancer\"[Title/Abstrac] OR",
      "start_page": 544,
      "end_page": 544
    },
    {
      "heading": "Records: 28",
      "text": "Embase (Embase.com) (August August 2023) chin mall- ment ment ct] POLMONE POLMONE #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'lung neoplasms' OR \"long tumor\" OR 'not-or or 'long long cancer' Or _ nsclc:ti,ab #3 'gene rearrangement'/xp/mj #OR OR '_ _ response':ti",
      "start_page": 544,
      "end_page": 545
    },
    {
      "heading": "Selected 1 Record",
      "text": "==References===External links==*http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 545,
      "end_page": 545
    },
    {
      "heading": "Records: 9",
      "text": "THE POLM'S EOPLASIE",
      "start_page": 546,
      "end_page": 546
    },
    {
      "heading": "Selected 1 Record",
      "text": "I'm sorry. OR: is is recommended? MEDLINE (PubMed) (August August 2023) ((((l. l.)",
      "start_page": 546,
      "end_page": 547
    },
    {
      "heading": "Records: 17",
      "text": "==References===External links==* Official website",
      "start_page": 547,
      "end_page": 548
    },
    {
      "heading": "Records: 50",
      "text": "Embase/Embase.com (August August 2023) #35 'lung lung cancer'/exp/mj (36 'lung cancer' / exp/ mj #37 'long cancer' OR 'lung neoplasms' OR \"lung tumor' OR - n-small-cell cancer' or 'non-small metals' OR __MEDTERM11_:ti,ab #38 #35 OR - lung tumors - OR #37 #39 'metastasis'/expaly_mj_e_i_g_b_f_d_ed_en_v_o_de_t_ad_er_n_e",
      "start_page": 548,
      "end_page": 548
    },
    {
      "heading": "Records:82",
      "text": "Embaseter (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'lung cancer' OR 'lung neoplasms' OR \"lung tumor' OR' meta 'stage iii' OR OR 'advanced disease' NEAR/7 (_MEDTERM14_) #4 (#1 OR #2) AND #3 #5 '_MEDTERMI0__an advanced OR' stage ̈/exp/mj OR'_MEDTERM1___/Exp/QJ #6 __MEDTHERM1____:ti,ab #7 &amp; OP_4 AND/mJ OR (#5 OR_M)",
      "start_page": 548,
      "end_page": 549
    },
    {
      "heading": "Records: 326",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'lung neoplasms' OR \"long tumor\" OR 'long long cancer' Or 'lung lung Cancer' OR RET) #4 (#1 OR #2) AND #3 #5 '_MEDTERM0____/exp/mj OR '__MEDTHERM1___EXP/MOR_M_DEMM2____MEDTERS2____MOR lorlatinibExp_MER_M5_MEDTEM6_M",
      "start_page": 549,
      "end_page": 549
    },
    {
      "heading": "Selected 5 records",
      "text": "GRADE Q30: PDL1 PDL1 ≥ 50%, of of {status status (0- 1), recommended recommended (compared to chemotherapy)? MEDLINE (PubMed) August August 2023) (((( (...)((!(([((\"Lung Neoplasms\"[Mesh]) OR \"Carcinoma, Non-Small-Cell Lung\"[Mesh] OR (\"Lung Cancer\"[Title/Abstract] OR \"Lung neoplasms\"\"[Tytle/Ambs]",
      "start_page": 549,
      "end_page": 550
    },
    {
      "heading": "Records: 245",
      "text": "ORbase (Embase.com) (2018) #1 'lung tumor'/exp OR 'long long cancer'/exp #2 'lung cancer' OR 'lung neoplasms' OR \"long tumor\" OR 'not-small-cell lung cancer' or \"lung lung cancer\" OR nsclc:ti,ab #3 'stage 4' OR'stage iv' OR OR recurrence* OR relapse*: ti,ab#4 'recurrent disease'/Exp/mj #5 (#1 OR #2) AND (#3 OR #4) #9 'tumor marker'/esp/mmj #7 ('pd-l1' OR pd l1') NEAR/5 (OR OR diagnostic* OR75 testing_8 #8_EXP/MJ #10'",
      "start_page": 550,
      "end_page": 550
    },
    {
      "heading": "Selected 2 records",
      "text": "Q31: PDL1 PDL1 ≥50%, recommended recommended (platinum platinum chemotherap)? MEDLINE (PubMed) (August August 2023) (((( (...)((!(([((0] \"Carcinoma, Non-Small-Cell Lung/Drug therapy\"[Mesh] OR \"Lung Lung /pathology\"[Mesh]) OR (\"Lung Neoplasm/Drug therapy] OR (\"Ang lung-Lung neoplasm\"[ Mesh] Or \"Long Neoplasms/Pathology\" [Tm]",
      "start_page": 550,
      "end_page": 550
    },
    {
      "heading": "Records: 98",
      "text": "Embase (Embase.com) (August August 2023) stretch] OR a- a Trial\" on small s]/s s (0-1), POLMONE POLMONE #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'lung cancer' OR 'lung neoplasms' OR \"long tumor\" OR 'long long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 'grade iii' iii iii 'OR OR 'advanced disease' NEAR/7 (__MEDTERM2_) #4 (#1 OR #2) AND #3 #5 '__medTERM0___/exp/j #6_MEDTERD_7_6_8",
      "start_page": 550,
      "end_page": 551
    },
    {
      "heading": "Records: 118",
      "text": "Q32: PDL1 PDL1 ≥50%, status status (0- 1), recommended recommended (on on platinum)? MEDLINE (PubMed) (August August 2023) (((( (...)((!((·((¡((Í((0]((\" \"Carcinoma, Non-Small-Cell Lung/Drug therapy\"[Mesh] OR \"Lung Neoplasms/pathology\"[Mesh]) OR ((lung-lung l) cancer\"[Tung Neoplasmas/Tugtherapy]",
      "start_page": 551,
      "end_page": 551
    },
    {
      "heading": "Records: 528",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'lung neoplasms' OR \"long tumor\" OR 'long long cancer' Or 'lung lung Cancer' OR RET) #4 (#1 OR #2) AND #3 #5 (atezolizumab__/exp/mj OR",
      "start_page": 551,
      "end_page": 551
    },
    {
      "heading": "Records: 220",
      "text": "OR33 (A) PD-L1 PD-L1 <50% status status (0-1), MEDLINE MEDLINE (PubMed) (August August 2023) ((((?((!((¡(( lung-cancer\" (( (...)(( (()((\"Lung Neoplasms/Abstract] Or \"Carcinoma, Non-Small-Cell Lung\"[10]",
      "start_page": 551,
      "end_page": 552
    },
    {
      "heading": "Records:21",
      "text": "Embase (Embase.com) 2023 2023 #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-small-cell long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 'non‐squamous' OR'non squamous';ti,b #4 (#1 OR #2) AND #3 #5 ('_MEDTERM0__'/Exp/mj AND 'pemetrexed trial]/exp/mJ) OR ('__MEDTM0__' AND 'petetrexed': ti,ab) #6 #4 AND #5 AND ([randomized controlled trial]/lim OR 'contested clinical trial'/de)",
      "start_page": 552,
      "end_page": 552
    },
    {
      "heading": "Selected 1 Record",
      "text": "I'Q34 Q34 GRADE: expression expression <50% status status (0-1), with with −recommended recommended (compared to chemotherapy)? MEDLINE (PubMed) (August August 2023) ((((!(([((0] [(( _((Í((\"((·\"Lung Neoplasms\"[Mesh]) OR \"lung tumor\" (non-Small) cell] Lung (Mesh) OR (\"Lung Cancer\"[Title/A abstract] OR \"Lung neoplasms\"\"",
      "start_page": 552,
      "end_page": 553
    },
    {
      "heading": "Records: 4",
      "text": "ORz-diflyus ORz-diflyus ORj-diz-ož-eštím oštápía (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'non-small-ell lung cancer'/exp #2 'long cancer' OR 'lung neoplasms' OR \"lung tumor' OR'n-cell carcinoma'/Exp/mj #4 'cell cell cancer' or 'lung lung carcinoma':ti,ab #5 (#1 OR_PH)",
      "start_page": 553,
      "end_page": 553
    },
    {
      "heading": "Selected 2 records",
      "text": "Q35: PD-L1 PD-L1 <50% status status (0-1), recommended recommended (compared to chemotherapy)? Q36: of of .recommended recommended (1-49% compared to chemotherapy)?",
      "start_page": 553,
      "end_page": 554
    },
    {
      "heading": "Records: 528",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'lung neoplasms' OR \"long tumor\" OR 'long long cancer' Or 'lung lung Cancer' OR RET) #4 (#1 OR #2) AND #3 #5 (atezolizumab__/exp/mj OR",
      "start_page": 554,
      "end_page": 554
    },
    {
      "heading": "Records: 220",
      "text": "(OR) ==References===External links==* Official website* http://www.interpol.int/en/notice/search/en_en/index_en.htm",
      "start_page": 554,
      "end_page": 554
    },
    {
      "heading": "Records:21",
      "text": "Embase (Embase.com) (2018) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-small-cell long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 'nonsquamous' OR'non squamous';POLMONE POLMONE #4 (#1 OR #2) AND #3 #5 ('_MEDTERMM0___/exp/mj AND 'pemetrexed'/Exp/mJ) OR ('pembrolizumab' AND 'permetrexed':ti",
      "start_page": 554,
      "end_page": 555
    },
    {
      "heading": "Selected 2 records",
      "text": "I'Q38 Q38 GRADE: line line chemotherapy? MEDLINE (Pubplated) (August August 2023) ((((!((·(([((0](( CH((Í((¡((\"Lung Neoplasms\"[Mesh]) OR \"Carcinoma, Non-Small-Cell Lung\"[Mesh] OR (\"lung cancer\"[Title/Abstract] OR \"Lung neoplasms]\"[Title/Azro]",
      "start_page": 555,
      "end_page": 555
    },
    {
      "heading": "Records: 4",
      "text": "Olypea Olypea (Embase.com) (August August 2023) #1 'lung tumor'/exp OR'non-small-cell cancer' OR 'n' small-cell lung cancer' Or __MEDTERM3_:ti,ab #3 'lung lung carcinoma' OR \"lung squamous cacinoma' #5 (#cell cell cancer' or 'squamous cell carcinoma' or \"epidermoid carcinoma'",
      "start_page": 556,
      "end_page": 556
    },
    {
      "heading": "Records: 15",
      "text": "OR39: stage stage (or) \"Applece\" or \"Application\" by by itself? MEDLINE (PubMed) (August August 2023) ((((···Cell Lung/Cell Therapy] OR \"Lung Neoplasms/Pathology\"[Mesh] Or \"Long Neoplasm/Patology\" [Mesh].",
      "start_page": 556,
      "end_page": 556
    },
    {
      "heading": "Records: 27",
      "text": "==References===External links==*http://www.interpol.int/en/notice/search/en_en/index_en.htm",
      "start_page": 556,
      "end_page": 557
    },
    {
      "heading": "Records: 47",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung lung cancer'/exp/mj #2 'non-small-cell long cancer' OR 'lung lung Cancer' OR nsclc:ti,ab #3 #50 OR #51 #4 'chemoradiotherapy'/exp/mJ #5 'chemosradiotherapy';ti,b #6 #53 OR #54 #7 #3 AND #6 AND ([cochrane review]/lim OR [systemic review] /lim OR (meta analysis]/im OR [controlled clinical trial]/rim OR [controlled controlled trial]",
      "start_page": 557,
      "end_page": 557
    },
    {
      "heading": "Selected 4 records",
      "text": "OR41: brain brain (PCI) is recommended? MEDLINE (PubMed) (August August 2023) (((\"Lung Lung Carcinoma\"[Mess]) OR (",
      "start_page": 557,
      "end_page": 558
    },
    {
      "heading": "Records: 86",
      "text": "I'Ombase Ombase (Embase.com) (August August 2023) #1 'lung lung cancer'/exp/mj [\"long long cancer\" OR 'long long Cancer' OR 'the the lung' OR \"lung lung \" OR \"of of lung\":ti,ab #3 #1 OR #2 #4 'skull irradiated'/exp/mJ #5 \"skull ion\" OR \"grain cell ion\": ti,b #4 OR #5 #3 AND #6 AND ([cochrane review]/lim OR [systemic first report]/lem OR [meta analysis]/Lim OR [trial trial cells]/LIM OR [randomized controlled trial]/limi]",
      "start_page": 558,
      "end_page": 559
    },
    {
      "heading": "Records: 88",
      "text": "I'oastomorphomorphus oastomorphomorphus (or phoenix)",
      "start_page": 559,
      "end_page": 560
    },
    {
      "heading": "Records: 65",
      "text": "Q43: platinum-based platinum-based chemotherapy? MEDLINE (PubMed) (2018) ((((!((\"Lung Lung Carcinoma\"[Mesh]) OR (\"Long Long Cancer\"[Title/Abstract] OR",
      "start_page": 560,
      "end_page": 560
    },
    {
      "heading": "Records: 16",
      "text": "Embase (Embase.com) (2018) (August 2023) #1 'lung lung cancer'/exp/mj #2 'long long cancer' OR 'lung lung Cancer' OR \"of of theung' OR'cell cell lung' Or 'of of lung':ti,ab #3 #50 OR #51 #4 ('etoposide'/exp/mJ OR ethoposide) AND AND ('durvalumab'/esp/mg OR durvalumab: ti,ab) #5 #4 AND #6",
      "start_page": 560,
      "end_page": 560
    },
    {
      "heading": "Records: 9",
      "text": "Q44: with with platinum/ethoposis] recommended? MEDLINE (PubMed) (August August 2023) (((([(( [(( ((\"Lung Lung Carcinoma\"[Mesh]) OR (.[Mesh] [Long Long Cancer[Title/Abs] OR",
      "start_page": 560,
      "end_page": 560
    },
    {
      "heading": "Records: 83",
      "text": "Embase (Embase.com) (August August 2023) #1 'long long cancer'/exp/mj (T) 'non-small-cell lung cancer' OR 'lung lung cancer'. OR __MEDTERM0_:ti,ab #3 #50 OR #51 #4 'etoposide'/exp/mJ OR ethoposide:ti;ab #5 platinum: DEL DEL POLMONE#6 #4 AND #6 #3 AND ([cochrane review]/lim OR [meta analysis]/lem OR [controlled clinical trial]/Lim OR [randominated controlled trial]",
      "start_page": 560,
      "end_page": 561
    },
    {
      "heading": "Records: 68",
      "text": "Embase (Embase.com) (May May 2019) #1 'lung lung cancer' OR nsclc:ti,ab #3 #50 OR #51 #4 'skull irradiated'/exp/mj #5 'skulll furan' OR 'cranial ovulation': ti,ab#6 #4 OR #5 #7 #3 AND #6 AND ([cochrane review]/lim OR [systemic review] /lim OR (meta analysis]/lem OR [controlled clinical trial]/limi OR [randomized controlled trial]",
      "start_page": 561,
      "end_page": 561
    },
    {
      "heading": "Selected 4 records",
      "text": "Q46: tera tera (PubMed) (June June 2018) ((((?((\"Lung Lung Carcinoma\"[Mesh]) OR (",
      "start_page": 561,
      "end_page": 561
    },
    {
      "heading": "Records: 89",
      "text": "Embase (Embase.com) (June June 2018) #1 'lung lung cancer' OR nsclc:ti,ab #3 #50 OR #51 #4 'topotecan'/exp/action, action, pe]) a, un apie? Cell #5 'toombacan': ti,ab#6 #4 OR #5 #7 #3 AND #6 AND [emba #9 #3 And #6 and [embah analysis]/lim OR [controlles]",
      "start_page": 561,
      "end_page": 562
    },
    {
      "heading": "Selected 4 records",
      "text": "E ase]]/lim ase]/lim AND ([clinical clinical trial]/lim OR [random w]/limi OR [controlled controlled trial] /lim) A view]/OR OR [n n e",
      "start_page": 562,
      "end_page": 563
    },
    {
      "heading": "I",
      "text": "r r c",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "S",
      "text": "i i lE",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "LASIE DE",
      "text": "PR",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "do",
      "text": "EL EL PO",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "ANSWER",
      "text": "ovreb mato giornima? 15 15 cigars",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "search database",
      "text": "(n = 172) Reco",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "records records id",
      "text": "sou sou (n = 0)",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "duplicates duplicates removed",
      "text": "(n = 137)",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "Records screened",
      "text": "(n = 137)",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "Full-text articles assigned",
      "text": "for eligibility (n = 1)",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "UIDA",
      "text": "10 10 cigarettes",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "dentified",
      "text": "urces",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "Records excluded",
      "text": "(n = 136) n n e",
      "start_page": 563,
      "end_page": 564
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "PRIS",
      "text": "L L POLMONE",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "rectomy shouldb",
      "text": "otico) or thoracot",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "in in t",
      "text": "previous version (n = 2)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "w Diag",
      "text": "tomic tomic the",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "a a mini-approach",
      "text": "Co?",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "search database",
      "text": "(n = 13)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 13)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "Records screened",
      "text": "(n = 13)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 2)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 2)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "n stad",
      "text": "-invas",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "d",
      "text": "FROM",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "god clin",
      "text": "sivo (V)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "S o",
      "text": "R",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "Record",
      "text": "(n)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "ds excluded",
      "text": "n = 13) e e d",
      "start_page": 564,
      "end_page": 565
    },
    {
      "heading": "I",
      "text": "lc lc n",
      "start_page": 565,
      "end_page": 565
    },
    {
      "heading": "LASIE",
      "text": "EL EL PO",
      "start_page": 565,
      "end_page": 565
    },
    {
      "heading": "ANSWER",
      "text": "s s (n = am am Q3: recommended recommended (remov remov (n= 121) Records screened (n=0 121) eligibility eligibility (n=12)",
      "start_page": 565,
      "end_page": 565
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 2)",
      "start_page": 565,
      "end_page": 565
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 2)",
      "start_page": 565,
      "end_page": 565
    },
    {
      "heading": "LINES GUI",
      "text": "sou sou (n = 0) see",
      "start_page": 565,
      "end_page": 565
    },
    {
      "heading": "IDA",
      "text": "Record Record (n nizial a)? n n = 119",
      "start_page": 565,
      "end_page": 565
    },
    {
      "heading": "le (IA),",
      "text": "n n e",
      "start_page": 565,
      "end_page": 566
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "PRIS",
      "text": "L L POLMON",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "SMA 2009",
      "text": "2N0 inoper",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "ords includes",
      "text": "previous ve (n = 3) or or resp",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "and t",
      "text": "ersion",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "w Diag",
      "text": "a a the",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "search database",
      "text": "(n = 8)",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n =8)",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "Records screened",
      "text": "(n =8)",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 3)",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 3)",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "GUID",
      "text": "oplasia ament",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "d",
      "text": "assico assico Re",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "_MEDTERM0__",
      "text": "or is",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "ecords",
      "text": "(n° C)",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "s excluded",
      "text": "n = 8) n n e",
      "start_page": 566,
      "end_page": 567
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "LASIE",
      "text": "AND THE",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "PRIS",
      "text": "L L POL",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "SMA",
      "text": "mutes",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "ords in",
      "text": "previous (n LMON erapia",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "nclude",
      "text": "n n = 9 9 Flow",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "and t",
      "text": "ersion",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "w Diag",
      "text": "uvent the",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "search database",
      "text": "(n = 10)",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n =10)",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "Records screened",
      "text": "(n =10)",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 19)",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 19)",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "adical",
      "text": "atine",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "d",
      "text": "o o rac",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "d",
      "text": "ccom ccom erato",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "send",
      "text": "an an ata?",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "Record",
      "text": "(n)",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "ds excluded",
      "text": "n = 10) n n e",
      "start_page": 567,
      "end_page": 568
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "stad",
      "text": "L L POLMONE",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "and and mutation",
      "text": "is is rac",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "in in the",
      "text": "previous version (n = 0)",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "search database",
      "text": "(n = 153)",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n =138)",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "Records screened",
      "text": "(n =138) Full-text articles boarded",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "for eligibility",
      "text": "(n = 1)",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 1)",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "adical",
      "text": "R, a",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "IDA",
      "text": "lmen na tera",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "d",
      "text": "a a perate",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "adjuv",
      "text": "vantage vantage point",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "Record",
      "text": "(n)",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "ds excluded",
      "text": "n = 137) n n e",
      "start_page": 568,
      "end_page": 569
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "EXP {MM/ YY}",
      "text": "L L POLMONE",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "in in the",
      "text": "previous version (n = 0)",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "gram:",
      "text": "Expree atezo or?",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "search database",
      "text": "(n = 216)",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n =165)",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "Records screened",
      "text": "(n =165) Full-text articles boarded",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "for eligibility",
      "text": "(n = 1)",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 1)",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "tudies included in",
      "text": "visual synthesis (n = 1)",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "tudies included in",
      "text": "antitative synthesis (n = 1)",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "root",
      "text": "ttame",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "IDA",
      "text": "almen ento",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "d",
      "text": "in in erapic",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "Record",
      "text": "(a)",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "ds excluded",
      "text": "n = 164) n n e",
      "start_page": 569,
      "end_page": 570
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "PRIS",
      "text": "L L POLMON",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "SMA 2009",
      "text": "r r ervation?",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "ords includes",
      "text": "previous ve (n = 1) NE 9 Flow",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "and t",
      "text": "ersion",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "w Diag",
      "text": "terap the",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "search database",
      "text": "(n = 17)",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n =17)",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "Records screened",
      "text": "(n =17)",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "n stad",
      "text": "rip",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "d",
      "text": "FROM",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "god I-II",
      "text": "hecto a",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "Roots",
      "text": "entre entre ce",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "Record",
      "text": "(n)",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "ds excluded",
      "text": "n = 17) n n e",
      "start_page": 570,
      "end_page": 571
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "PRIS",
      "text": "yield (L L POLMONE)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "SMA 2009 Flow",
      "text": "only only who",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "in in t",
      "text": "previous version (n = 2)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "w Diag",
      "text": "emiot",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "Surgery",
      "text": "the",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "by by who",
      "text": "(a)?",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "search database",
      "text": "(n = 87)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 87)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "Records screened",
      "text": "(n = 87)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 2)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 2)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "d",
      "text": "FROM",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "god II-I",
      "text": "ia è ra",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "III",
      "text": "common",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "mand",
      "text": "R",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "Record",
      "text": "(n)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "ds excluded",
      "text": "n = 87) n n e",
      "start_page": 571,
      "end_page": 572
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "PRIS",
      "text": "L L POL",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "SMA",
      "text": "ecabil ncomi",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "ords in",
      "text": "Before LMONE",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "a a trat",
      "text": "itante è raccom",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "ncluded in the",
      "text": "ous version (n = 3)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "gram",
      "text": "ttame",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "at at doses",
      "text": "uth (compared to sequential?)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "search database",
      "text": "(n = 234)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "duplicates duplicates removed",
      "text": "(n = 187)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "Records screened",
      "text": "(n = 187)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "tudies included in",
      "text": "visual synthesis (n = 3)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "tudies included in",
      "text": "antitative synthesis (n = 3)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "IIA/II",
      "text": "decrease",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "IIB no",
      "text": "R on",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "Record",
      "text": "(n)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "ds excluded",
      "text": "n = 187) n n e",
      "start_page": 572,
      "end_page": 573
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "PRIS",
      "text": "L L POL",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "SMA",
      "text": "ecabil ociazi",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "ords in",
      "text": "previous (Flow Flow Dia",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "ncluded in the",
      "text": "n n = 6)",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "chemotherapy chemotherapy regimen",
      "text": "Therapy?",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "search database",
      "text": "(n = 102)",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 87)",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "Records screened",
      "text": "(n = 87)",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 6)",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 6)",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "AND GUID",
      "text": "CLC in human",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "d",
      "text": "FROM",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "esegu",
      "text": "R",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "IB not",
      "text": "uire in",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "Records excluded",
      "text": "(n = 87) e e d",
      "start_page": 573,
      "end_page": 574
    },
    {
      "heading": "I",
      "text": "r r c",
      "start_page": 574,
      "end_page": 574
    },
    {
      "heading": "S",
      "text": "lc lc n",
      "start_page": 574,
      "end_page": 574
    },
    {
      "heading": "PRISMA",
      "text": "previous previous (n = 1- version version -3 records)",
      "start_page": 574,
      "end_page": 574
    },
    {
      "heading": "LINES",
      "text": "Q12 GRADE: with with PD-1% consolidation consolidation therapy? searching searching (n = 29) rem rem (n=29) Records screened (n=18) eligibility eligibility (n=21) included included (n=01).",
      "start_page": 574,
      "end_page": 574
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 4)",
      "start_page": 574,
      "end_page": 574
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 4)",
      "start_page": 574,
      "end_page": 574
    },
    {
      "heading": "AND GUID",
      "text": "• t t h",
      "start_page": 574,
      "end_page": 574
    },
    {
      "heading": "from NS",
      "text": "with with d",
      "start_page": 574,
      "end_page": 574
    },
    {
      "heading": "_MEDTERM0__",
      "text": "rvalum rvalum R",
      "start_page": 574,
      "end_page": 574
    },
    {
      "heading": "adio III",
      "text": "hemio- excluded excluded (n = 28) n n e",
      "start_page": 574,
      "end_page": 575
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "PRIS",
      "text": "L L POLMON",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "Nthrate oligo",
      "text": "emica è ra",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "ords includes",
      "text": "previous ve (n =0) NE 9 Flow",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "and t",
      "text": "Dia Dia tastat",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "send",
      "text": "the",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "tico, locoregional treatment",
      "text": "uth (therapy therapy alone)",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "search database",
      "text": "(n = 34)",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n =27)",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "Records screened",
      "text": "(n =27)",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "for eligibility",
      "text": "(n = 4)",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 4)",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 4)",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 4)",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "AND GUID",
      "text": "ass ass mica)?",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "d",
      "text": "FROM",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "gives you",
      "text": "socioz",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "NSCL",
      "text": "t t R",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "stages",
      "text": "terapi",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "Record",
      "text": "(a)",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "ds excluded",
      "text": "n = 23) n n e",
      "start_page": 575,
      "end_page": 576
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "PRISMA 2009",
      "text": "locally av",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "(Ex19dels and L8)",
      "text": "EGFR osimert and/or __ MEDTERM0__)",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "Records includ",
      "text": "previus ve (n =o o 858R), is is rac",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "ded in the",
      "text": "ersion",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "agram Q14 GRADE: In patients with",
      "text": "active active mutations",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "search database",
      "text": "(n = 157)",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 145)",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "Records screened",
      "text": "(n = 145) Full-text articles boarded",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "AND GUI",
      "text": "bitore bitore tiros",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "gives you",
      "text": "assich and spin-c",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "he de",
      "text": "osino- quinas",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "Records excluded",
      "text": "(n = 145) e e d",
      "start_page": 576,
      "end_page": 577
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "ig",
      "text": "lc lc n",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "PRIS",
      "text": "mut (L L POLMONE",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "Flow Flow Diag",
      "text": "previous previous version",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "gram Q15: with with NSCLC",
      "text": "EGFR (Ex19dels, L858R), and with change",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "Ida or liquid) of of prog",
      "text": "is is recomm",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "search database",
      "text": "(n = 157) removed removed (n=145) Records screened (n=145) Full-text articles assigned",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0) included included (n= 0)",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "IDA",
      "text": "in in T7",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "entries",
      "text": "ato ato (M M dimo",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "ge",
      "text": "excluded excluded (n = 145) n n e",
      "start_page": 577,
      "end_page": 578
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "PRIS",
      "text": "L L POL",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "SMA",
      "text": "erz ttame coma",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "ords in",
      "text": "2009 2009 Flow",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "6 6 mm",
      "text": "ento chem",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "ncluded in",
      "text": "ous version (n = 1) vetto vetto the",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "a a treatem",
      "text": "or chemotherapy)?",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "search database",
      "text": "(n = 157)",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 145)",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "Records screened",
      "text": "(n = 145) Full-text articles boarded",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "from NS",
      "text": "expon ment",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "I don't.",
      "text": "or with",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "d",
      "text": "co, co, with",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "transferor",
      "text": "amab is",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "Records excluded",
      "text": "(n = 145) n n e",
      "start_page": 578,
      "end_page": 579
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "PRIS",
      "text": "ava",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "gefi",
      "text": "L L POLMONE",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "SMA 2009 Flow",
      "text": "anzato with mute",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "ntified (medium",
      "text": "itinib, __ MEDTERM1__",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "ords included in",
      "text": "previous version (n = 0)",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "a a tratam",
      "text": "compared to chemotherapy)?",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "search database",
      "text": "(n = 157)",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 145)",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "Records screened",
      "text": "(n =145) Full-text articles boarded",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "for eligibility",
      "text": "(n = 1)",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 1)",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "AND GUI",
      "text": "(R) and",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "gives you",
      "text": "with m",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "of the",
      "text": "or",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "NSCL",
      "text": "LC LC inction",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "ogress",
      "text": "simert R",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "n stage",
      "text": "tinib tinib is",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "Records excluded",
      "text": "(n = 144) n n e",
      "start_page": 579,
      "end_page": 580
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "PRIS",
      "text": "L L POLMONE",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "SMA 2009 Flow",
      "text": "with with ale",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "ords included in",
      "text": "previous version (n = 3) ectini ectini the",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "search database",
      "text": "(n = 109)",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 106)",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "Records screened",
      "text": "(n = 106) Full-text articles boarded",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 3)",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 3)",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "AND GUI",
      "text": "afett",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "of AL",
      "text": "_MEDTERM0__",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "gives you",
      "text": "LK, a b)?",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "NSCL",
      "text": "ttame ttame R",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "Records excluded",
      "text": "(n = 106) n n e",
      "start_page": 580,
      "end_page": 581
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "PRIS",
      "text": "L L POLMONE",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "SMA 2009 Flow",
      "text": "with with br",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "ords included in",
      "text": "previous version (n = 1) ato ato o",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "ridatin",
      "text": "the",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "search database",
      "text": "(n = 109)",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 106)",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "Records screened",
      "text": "(n = 106) Full-text articles boarded",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "AND GUI",
      "text": "afett",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "of AL",
      "text": "zotini",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "gives you",
      "text": "LK, an ib)?",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "NSCL",
      "text": "ttame ttame R",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "Records excluded",
      "text": "(n = 106) n n e",
      "start_page": 581,
      "end_page": 582
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "PRIS",
      "text": "riar (L L POLMON",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "rrangiamen",
      "text": "chest to cr",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "ords includ",
      "text": "previous ve (n = 1) Flow Flow Dia",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "nti of Jan",
      "text": "rizotinib)?",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "ded in the",
      "text": "ersion",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "search database",
      "text": "(n = 386)",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "duplicates duplicates removed",
      "text": "(n = 356)",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "Records screened",
      "text": "(n = 356)",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "for eligibility",
      "text": "(n = 2)",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 2)",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 3)",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 3)",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "SCLC m",
      "text": "_MEDTERM0__",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "d",
      "text": "co, co, with",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "Records excluded",
      "text": "(n = 352) n n e",
      "start_page": 582,
      "end_page": 583
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "PRIS",
      "text": "Loca tera (L L POLMONE)",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "SMA 2009 Flow",
      "text": "the the chem",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "ords included in",
      "text": "previous version (n = 1)",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "w Diagram",
      "text": "cer cer myotherapy) the",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "LINES GUI",
      "text": "Q21 GRADE: In patients affected",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "of of ALK",
      "text": "with with lorlat",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "search database",
      "text": "(n = 48)",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "duplicates duplicates removed",
      "text": "(n = 39)",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "Records screened",
      "text": "(n = 39)",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "tudies included in",
      "text": "visual synthesis (n = 1)",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "tudies included in",
      "text": "antitative synthesis (n = 1)",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "gives you",
      "text": "pr pr tinib",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "rogres",
      "text": "ccoma ccoma R",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "n stage",
      "text": "in one",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "Records excluded",
      "text": "(n = 396) n n e",
      "start_page": 583,
      "end_page": 584
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "PRIS",
      "text": "L L POLMONE",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "SMA 2009 Flow",
      "text": "with with cri",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "ords included in",
      "text": "previous version",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "(n = 6; 7 records)",
      "text": "the the L",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "Searc database",
      "text": "(n = 214)",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "Records after duplicate",
      "text": "(n = 179)",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "Records screen",
      "text": "(n = 179) Full-text articles as",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "for eligibility",
      "text": "(n = 1)",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "incl. incl.",
      "text": "(n = 1)",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 7)",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 7)",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "LINES GUI",
      "text": "Affected entities",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "sssed",
      "text": "y",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "NSCL",
      "text": "Ttame Ttame R",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "Records excluded",
      "text": "(n = 178) n n e",
      "start_page": 584,
      "end_page": 585
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "PRIS",
      "text": "L L POLMONE",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "SMA 2009 Flow",
      "text": "with with en",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "in in t",
      "text": "previous version (n = 1) ntrect ntrect the",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "search database",
      "text": "(n = 43)",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 42)",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "Records screened",
      "text": "(n = 43)",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "AND GUID",
      "text": "afett",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "d",
      "text": "FROM",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "NSCL",
      "text": "ttame ttame R",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "Records excluded",
      "text": "(n = 43) n n e",
      "start_page": 585,
      "end_page": 586
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "PRISM",
      "text": "L L POLMONE",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "009 Flow Diagram",
      "text": "con con tramet",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "in in t",
      "text": "previous version (n = 1) is is the",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "search database",
      "text": "(n = 17)",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 17)",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "Records screened",
      "text": "(n = 17)",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "for eligibility",
      "text": "(n = 1)",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 1)",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "tadio",
      "text": "but lin",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "d",
      "text": "nea nea co",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "d",
      "text": "lment",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "no",
      "text": "enib enib in",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "Records excluded",
      "text": "(n = 17) n n e",
      "start_page": 586,
      "end_page": 587
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "PRI",
      "text": "E E DEL",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "ISMA",
      "text": "osino- metast metast -kinase",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "ords includ",
      "text": "previous ve (n = 4) NE",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "ow Diagram",
      "text": "tatico, with",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "ded in the",
      "text": "fusion fusion entrec",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "search database",
      "text": "(n = 207)",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "duplicates duplicates removed",
      "text": "(n = 156)",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "Records screened",
      "text": "(n = 156)",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "tudies included in",
      "text": "visual synthesis (n = 4)",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "tudies included in",
      "text": "antitative synthesis (n = 4)",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "IDA",
      "text": "lin lin ato?",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "tadio",
      "text": "almen almen nibito",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "Record",
      "text": "(nt hours)",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "ds excluded",
      "text": "n = 156) n n e",
      "start_page": 587,
      "end_page": 588
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "PRISM",
      "text": "MA MA 20",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "of p",
      "text": "L L POLMONE",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "in in prog",
      "text": "treated treated apia)?",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "in in the",
      "text": "previous version (n = 3) Q26:",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "entries",
      "text": "chin",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "previous previous treatment",
      "text": "is is racc",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "search database",
      "text": "(n = 302)",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 256)",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "Records screened",
      "text": "(n = 256) Full-text articles boarded",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "tudies included in",
      "text": "visual synthesis (n = 3)",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "tudies included in",
      "text": "antitative synthesis (n = 3)",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "AND GUI",
      "text": "chin chin coma",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "stad",
      "text": "or with",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "god av",
      "text": "chem o (to to alla",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "Records excluded",
      "text": "(n = 256) n n e",
      "start_page": 588,
      "end_page": 589
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "PRISM",
      "text": "L L POL",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "ords in",
      "text": "9 9 Flow",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "nclud",
      "text": "ous ve (n = 5) NE w Dia",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "ded in",
      "text": "ersion",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "agram",
      "text": "the m: Q",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "St",
      "text": "Q27-29. Q27-29.",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "Searc database",
      "text": "(n = 386)",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "Records after duplicate",
      "text": "(n = 276)",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "Records screen",
      "text": "(n = 276) Full-text articles as",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "incl. incl.",
      "text": "(n = 0)",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "tudies included in",
      "text": "visual synthesis (n = 5)",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "tudies included in",
      "text": "antitative synthesis (n = 5)",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "LINES",
      "text": "throu",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "chin",
      "text": "e.g. rem",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "ned",
      "text": "sisse y",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "d",
      "text": "R",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "Record",
      "text": "(n)",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "ds excluded",
      "text": "n = 276) n n e",
      "start_page": 589,
      "end_page": 590
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "PRIS",
      "text": "AND AND POLMONE",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "PDL1 output ≥50",
      "text": ", is is raccom",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "Records included in",
      "text": "previous version",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "gram",
      "text": "0% if rform",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "mand",
      "text": "L Q30 GRADE: In patients",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "the the gen",
      "text": "mance status (0-1), a trat",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "Searc database",
      "text": "(n = 294)",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "Records after duplicate",
      "text": "(n = 256)",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "Records screen",
      "text": "(n = 256) Full-text articles as",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "incl. incl.",
      "text": "(n = 0)",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 2)",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 2)",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "or _MEDTERM0__",
      "text": "What's the plan?",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "sssed",
      "text": "y",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "SCLC m",
      "text": "R o r",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "d",
      "text": "first first astatic",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "ngiam",
      "text": "co, co, with",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "States. States.",
      "text": "ea with",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "Records excluded",
      "text": "(n = 256)",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "PRIS",
      "text": "n n e",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "I",
      "text": "AND THE",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "SMA",
      "text": "2009 2009 Flow",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "one of PD-L",
      "text": "n good for",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "ords includ",
      "text": "previous ve (n = 0) L1 L1 ≥50 rform spett",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "ded in",
      "text": "ersion",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "iagram",
      "text": "0%, alla alla the",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "search database",
      "text": "(n = 578)",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "duplicates duplicates removed",
      "text": "(n = 366)",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "Records screened",
      "text": "(n = 366)",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "for eligibility",
      "text": "(n = 1)",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 1)",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "IDA",
      "text": "inea inea c",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "d",
      "text": "at at static",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "ngiam",
      "text": "co, co, with",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "States. States.",
      "text": "_MEDTERM0__",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "Records excluded",
      "text": "(n = 365) n n e",
      "start_page": 591,
      "end_page": 592
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "PRISM",
      "text": "Flow Flow D",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "PD-L1",
      "text": "good good perf",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "Records includ",
      "text": "previous ve (n = 0) NE",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "Diagr",
      "text": "Hector shape",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "ded in",
      "text": "ersion",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "search database",
      "text": "(n = 578)",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "duplicates duplicates removed",
      "text": "(n = 366)",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "Records screened",
      "text": "(n = 366)",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "for eligibility",
      "text": "(n = 1)",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 1)",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "stage",
      "text": "e e c",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "or IIIB-",
      "text": "ce ce -C and",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "ngiam",
      "text": "emipl R",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "States. States.",
      "text": "limab is",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "Records excluded",
      "text": "(n = 365)",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "PRISM",
      "text": "L1 stage <pembri pembri (e e d",
      "start_page": 593,
      "end_page": 593
    },
    {
      "heading": "I",
      "text": "r r c",
      "start_page": 593,
      "end_page": 593
    },
    {
      "heading": "S",
      "text": "lc lc n",
      "start_page": 593,
      "end_page": 593
    },
    {
      "heading": "I",
      "text": "suit suit 0% version version (n = 1)",
      "start_page": 593,
      "end_page": 593
    },
    {
      "heading": "Q33 GRADE: a a isto",
      "text": "status status (0-1), treatment treatment (a)? searching searching (n = 28) removed removed (n= 26) Records screened (n=16) for for eligibility",
      "start_page": 593,
      "end_page": 593
    },
    {
      "heading": "(n = 0)",
      "text": "NEW studies included",
      "start_page": 593,
      "end_page": 593
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 593,
      "end_page": 593
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 593,
      "end_page": 593
    },
    {
      "heading": "IDA",
      "text": "ologia non-, d d -excluded excluded (n = 26)",
      "start_page": 593,
      "end_page": 593
    },
    {
      "heading": "PRISM",
      "text": "e e d",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "ig",
      "text": "lc lc n",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "LINES GUIDE",
      "text": "AND THE POLMONE",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "Q34 Q34 GRADE: with with NSCLC",
      "text": "expression expression <50% based, based, paclitaxel",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "maintenance maintenance therapy",
      "text": "it it therapy)?",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "database database searching",
      "text": "(n = 1; 2 records) (2019-2023) (n= 19) removed removed (n=18) Records screened (n=01) Full-text articles assigned",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0) included included (n= 0)",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1) manda manda d",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "ologia",
      "text": "ato ato (tus tus (uamosa uamosa 0-1), excluded excluded (n = 19) n n e",
      "start_page": 594,
      "end_page": 595
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "PRISM",
      "text": "009 009 Fl",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "cords i",
      "text": "low low D",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "includ",
      "text": "ous ve (n = 0) NE",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "ded in",
      "text": "ersion am: L L Q35-36",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "Searc database",
      "text": "(to-2023) (n = 748)",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "Records after duplicate",
      "text": "(n = 676)",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "Records screen",
      "text": "(n = 676) Full-text articles as",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "for eligibility",
      "text": "(n = 3)",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "NEW studies inc",
      "text": "(n = 3)",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 3)",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (Q 35: 1; Q36: 2)",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "chin",
      "text": "tes rem",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "ned",
      "text": "sisse ty",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "cluded",
      "text": "E OJ",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "ugh",
      "text": "Move",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "and",
      "text": "R",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "Record",
      "text": "(n)",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "ds excluded",
      "text": "n = 673)",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "Stadium squamous",
      "text": "a a tratam",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "Records includes",
      "text": "it it (n = 1 -n n e",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "I",
      "text": "NE",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "Diagram Q",
      "text": "ment ment imm",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "ed in the",
      "text": "ersion",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "Q37 GRADE: with with NSC",
      "text": "with with contrain",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "one one tera",
      "text": "Ata (observation observation only)?",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "search database",
      "text": "(n = 28)",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "duplicates duplicates removed",
      "text": "(n = 26)",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "Records screened",
      "text": "(n = 26)",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1) DA",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "ologia",
      "text": "a a non-olute; or",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "I'later. later.",
      "text": "imento",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "Records excluded",
      "text": "(n = 26) n n e",
      "start_page": 596,
      "end_page": 597
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "PRISM",
      "text": "è è racc",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "Records includes",
      "text": "previous ve (n = 1 -3 rec NE",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "Diagr",
      "text": "atico immu coma",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "and t",
      "text": "ersion",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "(cords)",
      "text": "in in prunite",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "gone",
      "text": "the Q38 G",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "rogres",
      "text": "erapia a risp",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "first first line",
      "text": "nivol nivol treatment",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "search database",
      "text": "(n = 19)",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 19)",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "Records screened",
      "text": "(n = 19)",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "tudies included in",
      "text": "visual synthesis (n = 1)",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "tudies included in",
      "text": "antitative synthesis (n = 1)",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "of ch",
      "text": "_MEDTERM0__",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "d",
      "text": "b, b, pe",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "tadio",
      "text": "oterap embro nea? mab mab o",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "Records excluded",
      "text": "(n = 19)",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "doceta",
      "text": "n n e",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "I",
      "text": "Flow Flow D",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "Records includ",
      "text": "previous ve (n = 2) NE",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "Diagra",
      "text": "and avant-garde,",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "ded in",
      "text": "the the L",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "Searc database",
      "text": "(n = 261)",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "Records after duplicate",
      "text": "(n = 247)",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "Records screen",
      "text": "(n = 247) Full-text articles as",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "incl. incl.",
      "text": "(n = 0)",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 2)",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 2)",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "one of mal",
      "text": "Axel is racc",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "sssed",
      "text": "y",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "log",
      "text": "milk coma",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "gone",
      "text": "to to the",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "Records excluded",
      "text": "(n = 247) n n e",
      "start_page": 598,
      "end_page": 599
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "cond",
      "text": "AND THE",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "•",
      "text": "2009 2009 F",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "ords in",
      "text": "neural, neural,",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "nclud",
      "text": "ous ve (n = 4) NE",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "Diagr",
      "text": ", the",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "ded in",
      "text": "attam attam the",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "search database",
      "text": "(n = 697)",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 577)",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "Records screened",
      "text": "(n = 577) Full-text articles boarded",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 4)",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 4)",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "n stad",
      "text": "oman",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "d",
      "text": "Mimito o? n n buono",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "Record",
      "text": "(n/o)",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "ds excluded",
      "text": "n = 577) n n e",
      "start_page": 599,
      "end_page": 600
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "PRIS",
      "text": "L L POLMON",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "ords includ",
      "text": "previous ve (n = 4) chem chem a?",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "ded in",
      "text": "ersion",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "w Diag",
      "text": "mio-r the",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "Stu",
      "text": "here",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "search database",
      "text": "(n = 358)",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 269)",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "Records screened",
      "text": "(n = 269) Full-text articles boarded",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "hearings included in",
      "text": "alitative synthesis (n = 4)",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "tudies included in",
      "text": "antitative synthesis (n = 4)",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "_MEDTERM0__",
      "text": "lactic",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "IDA",
      "text": "in sta",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "adio l",
      "text": "L'and and in",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "Records excluded",
      "text": "(n = 269) e e d",
      "start_page": 600,
      "end_page": 601
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "y",
      "text": "t ib",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "ig",
      "text": "lc lc n",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "PRIS",
      "text": "Reco Reco p",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "LINES",
      "text": "L POLMONE",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "Q42 Q42 GRADE: In patients",
      "text": "of of prim",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "by by therapy",
      "text": "identified identified throu",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "(n = 1) (2019-2023)",
      "text": "(n = 153) rem rem (n= 139) Records screened (n=0 139) Full-text articles assembled",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0) included included (n= 0)",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "AND GUIDE",
      "text": "D D tino?",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "ugh",
      "text": "(n = 139) e e d",
      "start_page": 601,
      "end_page": 602
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "ig",
      "text": "lc lc n",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "PRIS",
      "text": "L L POLMONE",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "Flow Flow Diag",
      "text": "version version (n = 3)",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "gram Q43 GRADE: In affect patients",
      "text": "of of prim",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "mante mante therapy",
      "text": "trat trat eropia?",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "search database",
      "text": "(n = 25) rem rem (n= 25) Recorded (n=15) Full-text articles assigned",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0) included included (n= 0)",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 3)",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 3)",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "AND GUID",
      "text": "enime enime ttame",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "g",
      "text": "e e d",
      "start_page": 602,
      "end_page": 603
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "y",
      "text": "t ib",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "ig",
      "text": "lc lc n",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "PRISM",
      "text": "oindic oindic o/prior prior (n LMONE",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "Flow Diag",
      "text": "n n = 8)",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "gram",
      "text": "the the Q44: oterap dabile",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": ": with with SCL",
      "text": "sistam sistam e? Records identified throu",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "search database",
      "text": "(n = 157) rem rem (n= 155) Records screened (n=155) Full-text articles assembled",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0) included included (n= 0) colleges included in",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "visual synthesis",
      "text": "(n = 8) tudies included in",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "antitative synthesis",
      "text": "(n = 8)",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "AND GUI",
      "text": "LC comico",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "ugh",
      "text": "Moved and",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "IDA",
      "text": "excluded excluded (n = 155) e e d",
      "start_page": 603,
      "end_page": 604
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "y",
      "text": "t ib",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "ig",
      "text": "lc lc n",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "PRISM",
      "text": "previous previous (n = 4) NE",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "Diagra",
      "text": "a, a, l'irr",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "RADE: with with S",
      "text": "identified identified throu",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "search database",
      "text": "(n = 283) rem rem (n= 268) Records screened (n=1 268) Full-text articles assembled",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0) included included (n= 0) colleges included in",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "visual synthesis",
      "text": "(n = 4) tudies included in",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "antitative synthesis",
      "text": "(n = 4)",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "_MEDTERM0__",
      "text": "cephalus",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "ugh",
      "text": "Moved and",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "IDA",
      "text": "with m",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "or (PCI)",
      "text": "d malat ) excluded excluded (n = 268) e e d",
      "start_page": 604,
      "end_page": 605
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "y",
      "text": "t ib",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "ig",
      "text": "lc lc n",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "PRISM",
      "text": "previous previous (n n = 4) NE",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "Diagr",
      "text": "the the Q46: attem",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "with with SCLC",
      "text": "identified identified throu",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "search database",
      "text": "(n = 144) rem rem (n=121) Records screened (n=0121) Full-text articles assembled",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0) included included (n= 0) colleges included in",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "(n = 4)",
      "text": "tudies included in",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "n prog",
      "text": "send",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "ugh",
      "text": "Moved and",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "entries",
      "text": "apt? Record Record (n n = 121) 3 3 : da da AIOM",
      "start_page": 605,
      "end_page": 607
    },
    {
      "heading": "Table of Contents",
      "text": "AIOM AIOM 2021: FEATURES FEATURES ..................................................................................................... ..................................... .............................................. ...",
      "start_page": 608,
      "end_page": 608
    },
    {
      "heading": "AIOM AIOM 2021: PURPOSES AND CHARACTERISTICS",
      "text": "Guidelines Guidelines (LG) based based medicine; consideration. consideration.",
      "start_page": 609,
      "end_page": 609
    },
    {
      "heading": "TARGET TARGET USERS",
      "text": "Guidelines Guidelines are: practice practice • of of • best care • and and •payers • patients. patients.",
      "start_page": 609,
      "end_page": 609
    },
    {
      "heading": "A. ORGANISATIONAL STRUCTURE",
      "text": "LG. LG.",
      "start_page": 609,
      "end_page": 609
    },
    {
      "heading": "LG LG SINGLES",
      "text": "alone alone (the the patient). WHO WHO (al. al., 2006), figures figures (health health economists) rights. rights.",
      "start_page": 609,
      "end_page": 610
    },
    {
      "heading": "C. METHODOLOGY",
      "text": "methodology methodology (only only diagnostic/moment moment concerning: ✓ clarified clarified definitively; ✓ drugs/finally finally clarified; diversamente medicinal products/efficacy efficacy and/O. O. (P=population; I=intervention; C=confront; O=Outcome), questions questions (e.g.: of of ...... this this way: P: with with (etc. etc.) I: treatment with (the the question) C: to to (under under consideration) the the recommendations: O: outcomes outcomes (considered considered essential/therapeutic therapeutic proposal) • Group Group (multidisciplinary group) clinic clinic proposal; • databases databases (database database area-specific) literature literature (paho, paho, etc). • dimensions dimensions (publication publication bias), levels levels (very very low), Framework Framework (EtD) etc. etc. •the the benefit/question question (vote) further further discussion/followed. followed. • a a \"good practice statement\" been been met: − care care situation; − of of resources; ‐ such such \"good practices statement\" the the issue; - recommendations recommendations (current current recommendations) • reported. reported. • an an intervention/levels levels (Table 1). Clinical Clinical ..with with (selection criteria) xxx xxx (selected criteria) proposed proposed (on on damages), intention intention (selective criteria) xxxx xxxx shouldn't be intended; patient patient (on on benefits) • threshold threshold (for for benefit) outcome outcome (benefit or damage), correct correct cost/effectiveness analysis (treatment treatment alternatives) (Guyatt GH, 2008; al, al, 2013) aspects aspects (the the studies). • CNN CNN (non-negotiated C band), text. text. • tests tests \"low\" or \"very low\" ... damage damage (intervention intervention High) intervention intervention (the the harmful/costy intervention) costs costs (of of resources) cost cost (or or resources) if if harmful/increases increases (of of resources), lower lower (or moderated).",
      "start_page": 610,
      "end_page": 613
    },
    {
      "heading": "OF OF DOCUMENTS",
      "text": "any any revision/modifications/addition/trials. trials.",
      "start_page": 614,
      "end_page": 614
    },
    {
      "heading": "OF OF INTEREST",
      "text": "following following cases: ✓ recommendation recommendation ✓ be be \"declared. declared.\"",
      "start_page": 614,
      "end_page": 614
    },
    {
      "heading": "F. PERIODIAL UPDATE",
      "text": "practice. practice.",
      "start_page": 614,
      "end_page": 614
    },
    {
      "heading": "AIOM AIOM SITE",
      "text": "mobility. mobility.",
      "start_page": 614,
      "end_page": 614
    },
    {
      "heading": "OF OF IMPLEMENTATION",
      "text": "practice practice (RIGHT Projects), practice. practice.",
      "start_page": 614,
      "end_page": 615
    },
    {
      "heading": "AIOM Guidelines",
      "text": "Oncology Oncology Association",
      "start_page": 615,
      "end_page": 615
    },
    {
      "heading": "RIGHT-1 RIGHT-2 RIGHT-3",
      "text": "RIGHT RIGHT Projects",
      "start_page": 615,
      "end_page": 615
    },
    {
      "heading": "INTERNATIONAL INTERNATIONAL GUIDES",
      "text": "alone alone (NCCN NCCN - standard version) heterogeneity heterogeneity (see Lines ESMO) data data (extrapolation of evidence) revision revision - still ongoing - literature literature (GRAde GRAde method) target target (etc. etc.) Users Users (other other √ stakeholder, etc). LG) \"Target Target population: oncologist (different different figures) target target populations: oncologian (various various figures) question question (PICO); appropriate appropriate engines; bibliographical bibliographical entries; methodological quality assessment; evidence evidence (tables of evidence) questions questions (GRADE GRADE Questions) expressed expressed √ defined defined √ √ 3 Population (etc. etc.) clearly clearly √ figures figures √ & population population (patient, doctors; etc. etc.). √& users users (etc etc .) LG LG √ available available √ evidence evidence √ standards standards (quality of evidence) recommendation recommendation √ support support √experts experts √ document document √",
      "start_page": 615,
      "end_page": 617
    },
    {
      "heading": "4. BIBLIOGRAPHY",
      "text": "==References===External links==* Official website",
      "start_page": 617,
      "end_page": 617
    },
    {
      "heading": "AIOM AIOM GUIDES",
      "text": "Giovanni Giovanni Pappagallo",
      "start_page": 618,
      "end_page": 618
    },
    {
      "heading": "AND AND SCOPE",
      "text": "Groups Groups (WG) Guidelines Guidelines (LG) SIGN SIGN (Guidelines Guidelines Network) GRADE GRADE (and and Evaluation) two two parts: editing. editing.",
      "start_page": 618,
      "end_page": 618
    },
    {
      "heading": "Clinical Clinical Quesito",
      "text": "generic generic (condition condition Y) of of application; to to PIC(O) and and (Outcome). of of PIC( O: − with with (etc. etc.) • treatment with (the the question) − to to (under under consideration) ? − (or or damage) (therapeutic therapeutic proposal)) group group (trial trial (the group, and/Tab. Tab. 1: studies studies (RCTs) revisions revisions (RS) etc. etc., average, average, it'successful successful (presence presence (and traceability) tools tools (checklists) search search (and and reducible) databases databases (area-specific area-specific databases) g. g., search search (increase increase sensitivity), search search (etc. etc.) (Strategy Strategy Manual).",
      "start_page": 618,
      "end_page": 619
    },
    {
      "heading": "of of studies",
      "text": "results results (damage damage observed) outcomes outcomes (damages damages observed).error error (bias) less less credible/questions questions (with SIGN evaluation), evidence evidence (3, 3,4) bias bias (++,+++, +,-) sufficiently sufficiently near/subdivided. subdivided. − text. text. − strength. strength. Important: study study (indicated by: 1 or 2), negative negative (-) negative negative (should should not/be be administered), sign sign (-) non-reliable non-reliable results; sense sense (for example: intervention should/be be given), sign sign (+) sign sign (-) study. study. 3) letters letters (C, C, D) terms terms (HR, RR, OR) or absolutes (etc. etc.). summary summary the",
      "start_page": 619,
      "end_page": 621
    },
    {
      "heading": "opinion. opinion.",
      "text": "Tab. 3: Evidence Evidence - of of evidence-",
      "start_page": 621,
      "end_page": 622
    },
    {
      "heading": "assessed assessed 1++ and directly",
      "text": "target target population; or",
      "start_page": 622,
      "end_page": 622
    },
    {
      "heading": "A",
      "text": "assessed assessed 1+ evaluated evaluated 2++ evaluated evaluated 1++ or 1+ includes includes 2+ assessed assessed 2+ + or or 4",
      "start_page": 622,
      "end_page": 622
    },
    {
      "heading": "D",
      "text": "evaluated evaluated 2+",
      "start_page": 622,
      "end_page": 622
    },
    {
      "heading": "of of evidence",
      "text": "following following characteristics: patients patients -> etc. etc.",
      "start_page": 622,
      "end_page": 622
    },
    {
      "heading": "1 1 (randomized study) bias bias (++), event event of",
      "text": "overall overall quality",
      "start_page": 622,
      "end_page": 622
    },
    {
      "heading": "a a critic",
      "text": "evidences evidences (body of evidence), given given below: ✓ Study design - the the study: adverse adverse effects; type type are: − control control (location conceptualment). patients patients (allocation) 2 2 RCT- produced. produced. − positive positive (statistically significant). verification. verification. ✓ Precision ✓ same same objective: single single study; explanation explanation (studied studied populations) intervention intervention (systematic systematic revision). ▪ the the data: results. results. ▪ a a case-quality quality (very very high).",
      "start_page": 622,
      "end_page": 624
    },
    {
      "heading": "Meaning Meaning Consequences",
      "text": "is is limited: very very limited: outcomes outcomes (critical) of of behaviour: ✓ directions directions (undesirable undesirable effects), quality quality (as critical) same same (i.",
      "start_page": 624,
      "end_page": 625
    },
    {
      "heading": "and and damages",
      "text": "given given intervention/drug/treatment/positive positive (benefit) and negative (harmful effects) following following elements: ✓ importance of outcomes: therapeutic therapeutic proposal; ✓ to to reduce; significant significant impact; effect effect (clinical-epidemiological relevance): effects effects (the clinical/treatment).",
      "start_page": 625,
      "end_page": 625
    },
    {
      "heading": "Framework Framework (EtD)",
      "text": "question question (comparison, comparison, outcome). levels levels (Table 6): Tab. Tab. 6: Meaning Meaning - with with (be be selection) favor favor (on on damage) be be − benefit. benefit. ✓ the the benefit/Recommendation. Recommendation. − effects effects (negative negative recommendations) uncertainty. uncertainty. • considered. considered.",
      "start_page": 625,
      "end_page": 626
    },
    {
      "heading": "clinical clinical recommendations",
      "text": "green green (Table 7). GRADE GRADE (outcomes, outcomes, benefit/the the recommendation) orange orange (Table 8). Tab. 7: effects. effects. (3)5 Tab. 8: Paracetamol. Paracetamol.",
      "start_page": 626,
      "end_page": 627
    },
    {
      "heading": "RECOMMENDATION:",
      "text": "Strength of recommendation:",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "Reasons/sheet sheet Benefit/Danno:",
      "text": "been been identified: the the benefit/damage balance:",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "Certainty of evidence",
      "text": "judged judged ...... following following reasons: of of evidence: ........ COI: reference reference (s) recommendation. recommendation.",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "3.2. GRADE-Adolopment",
      "text": "Health Health (GRADE-ADOLOPMENT GRADE-ADOLOPMENT (EtD) framework. framework.",
      "start_page": 628,
      "end_page": 628
    },
    {
      "heading": "LINES LINES GUIDE",
      "text": "Guidelines Guidelines (SNLG), Law Law 24/Care Care (CNEC) social. social.",
      "start_page": 628,
      "end_page": 628
    },
    {
      "heading": "5. CRITICAL APPRAISAL",
      "text": "Tab. Tab. 10: Critical apraisal RCT/Systematic Reviews (meta-analysis) RECLUTATION: population population (recommended recommended methods)? ALLOCATION: randomization randomization sequence? (first two) was was hidden? STUDIES STUDIES INCLUSI: properly properly assessed? OF OF RESULTS: results results (plot. plot...) light. light.",
      "start_page": 628,
      "end_page": 630
    },
    {
      "heading": "CORTE STUDY CASE-CONTROL",
      "text": "population population (recommendation recommendation refers)? method method section",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "RECLUTION",
      "text": "populations populations (only difference = factor factor studied) and and controls",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "KEEPING",
      "text": "parties parties / eligible eligible subjects",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "MEASURING",
      "text": "detection detection (to to (exposure exposure factor) risk factor)",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "FOLLOW-UP",
      "text": "Drop-out content",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "CONFUNDMENT",
      "text": "observed observed effect",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "ASSOCIATION",
      "text": "formal formal checklists: AMSSTAR: review. review. PRISMA: and and Meta-Analyses: CONSORT CONSORT 2010: Explanation and Elaboring: Al. Al. It'studies. studies.",
      "start_page": 630,
      "end_page": 631
    },
    {
      "heading": "6. Bibliographical entries",
      "text": "chapter chapter (after algorithms). way way (example: 1 to N).) numbering numbering (Chapter Chapter 1: to to 22; etc. etc.) method method \"Vancouver\" (by by Pubmed) below. below. Link:",
      "start_page": 631,
      "end_page": 631
    },
    {
      "heading": "Example",
      "text": "C. C., metastatialcell metastatialcell carcinoma? 2a 2a (RAPSODY). 2013 2013 Feb;63(2):254-61. doi: 10.1016/PubMed PubMed SMED: and and 4: the the panel'following following amendments:",
      "start_page": 631,
      "end_page": 634
    },
    {
      "heading": "heading heading <October October 2024> (from previous page)",
      "text": "Row 1: Row Row 2: Boston, Boston, Massachusetts",
      "start_page": 3,
      "end_page": 3
    },
    {
      "heading": "heading heading <October October 2024> (from previous page)",
      "text": "Row 1: Martino-Minas, Martino-Minas, Messina; Row 2: Row Row 3: Evolutionary G. Barresi/of of Messina",
      "start_page": 3,
      "end_page": 3
    },
    {
      "heading": "heading heading <October October 2024> (from previous page)",
      "text": "Row 1: Polyclinic Polyclinic AOU; Row 2: Row Row 3: of of Rome",
      "start_page": 3,
      "end_page": 3
    },
    {
      "heading": "heading heading <October October 2024> (from previous page)",
      "text": "Row 1: Hospitaller Hospitaller Company- Row 2: of of Verona",
      "start_page": 3,
      "end_page": 3
    },
    {
      "heading": "heading heading <(3) CLINIC RECOMMENDATION FORCE>",
      "text": "Row 1: • Overall quality •Clinical recommendation (2) •Row 2: •Test strength (1) •Recommendation (3) • Row 3: • ALTA •PN+ lymphadenectomy lymphadenectomy (<D2) radiochemotherapy radiochemotherapy (68.73) •of of •",
      "start_page": 9,
      "end_page": 9
    },
    {
      "heading": "heading heading <(3) CLINIC RECOMMENDATION FORCE>",
      "text": "Row 1: \"Quesito xx: .......................\" Row 2: RECOMMENDATION:\" Row 3: Strength of recommendation:\"Row 4: Reasons/comments to benefit/damage balance: been been identified: motivate motivate benefit/ damage balance: \"Row 5: future future research: \" Row 6: judged judged ....... following following reasons: \"Now 7: of of tests: .......\"",
      "start_page": 9,
      "end_page": 9
    },
    {
      "heading": "heading heading <CONFLICT OF INTEREST>",
      "text": "Row 1: \"Clinical\" Row 4: Strong in favor\"with with (selection criteria) option option (on on damage) Row 5: favour favour (selected criteria) to to Yyy'alternatives alternatives (harm harm benefits) Row 6: have have (selective criteria) to to yy'y'consideration consideration shouldn't be considered; benefit benefit (s) use use (the the non-perspective)",
      "start_page": 10,
      "end_page": 10
    },
    {
      "heading": "heading heading <CONFLICT OF INTEREST>",
      "text": "Row 1: force force \"Row 2\" the the \"Raw 3\" recommendation:",
      "start_page": 10,
      "end_page": 10
    },
    {
      "heading": "heading heading <1.3 Survival>",
      "text": "Row 1: Row Row 2: 14.3% Row Row 3: 7. 7.4% Row Row 4: age. age.",
      "start_page": 19,
      "end_page": 19
    },
    {
      "heading": "heading heading <1.3 Survival>",
      "text": "Row 1: Row Row 2: 18. 18.7%. Row Row 3: the the 2007‐Row Row 4: of of 16%.",
      "start_page": 19,
      "end_page": 19
    },
    {
      "heading": "heading heading <1.4 Prevalence>",
      "text": "Row 1: Row Row 2: lung cancer (600 600 women) Italy. Italy. 34% Row Row 3: 23% years, years, 17% only only 25% Row Row 4: lung lung cancer: be be 8% and and 13% Row Row 6:",
      "start_page": 20,
      "end_page": 20
    },
    {
      "heading": "heading heading <Secondary Secondary prevention> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: Row Row 4: before? Row 5: RECOMMENDATION: Row Row 6: Strength of recommendation: Row Row 7: Motivations/comments to benefit/damage balance: screening screening (NS) radiography radiography (CXR) associated associated with: mortality mortality (0. 0.87; CI95% 0.78-0.98; 0, 0,80; CI95% 0.69-0.92); diagnosis diagnosis (2. 2.84; CI95% 1.76-4.58; 3. 3.33; IC95% 2.27-4.89; 1. 1.52; CI95% 1.04-2.23); diagnosis diagnosis (0. 0.75; IC95% 0.68-0.83; 0. 0.67; IC95% 0.56-0.80); rate rate (2. 2.57; 76-3. 76-3.74); mortality mortality (0. 0.99; CI95% 0.94-1.85); rate rate (NS 38%; CI95% 14-63).",
      "start_page": 26,
      "end_page": 26
    },
    {
      "heading": "heading heading <Variants Variants Notes>",
      "text": "==References===External links==* Official website",
      "start_page": 31,
      "end_page": 31
    },
    {
      "heading": "heading heading <Variants Variants Notes> (column 1)",
      "text": "Row1: Row Row 3: Sclerosis pneumocytoma (so-called sclerosing hemangioma) • • Patterns: bleeding bleeding (of of patterns) ♪ Row 4: Adenoma- • AdenocarcinomaAdenomatosa atypical (AAH); situ situ (AIS) invasive invasive (MIA) glands glands • solid solid Mucino-Mucino; • Carcinoso-Faculous (Basso/Alto-Cheese)",
      "start_page": 31,
      "end_page": 31
    },
    {
      "heading": "heading heading <Variants Variants Notes> (from previous page)",
      "text": "Row-Low-Centro-Cinto-Pleomorphic Pleomorphic (cells cells and/or giants) Carcinosarcoma (presence of _MEDTERma) Meso-Cyno-with with sarcoma: osteo/condro/leiomio/radbdo/angio-sarcoma) Blastoma-Row 2: Other epithelial tumors",
      "start_page": 32,
      "end_page": 32
    },
    {
      "heading": "heading heading <T • primitive tumor>",
      "text": "Row 1: Edition Edition (Clinical Classification)",
      "start_page": 50,
      "end_page": 50
    },
    {
      "heading": "heading heading <Edition Edition (Clinical classification)>",
      "text": "I'm sorry. == Demographic evolution ====References==",
      "start_page": 51,
      "end_page": 51
    },
    {
      "heading": "heading heading <Edition Edition (Clinical classification)> (column 1)",
      "text": "Row 1: Row 2:",
      "start_page": 51,
      "end_page": 51
    },
    {
      "heading": "heading heading <Edition Edition (Clinical classification)> (column 2)",
      "text": "Row 1: Edition Edition (Clinical Classification) Row 2:",
      "start_page": 51,
      "end_page": 51
    },
    {
      "heading": "heading heading <Edition Edition (Clinical classification)> (column 2)",
      "text": "Row 1: Row Row 2: Row Row 3: peribronchial peribronchial and/Row Row 4: nodes nodes and/ Row Row 5: supraclavear supraclavear ipsis- or contralaterals",
      "start_page": 51,
      "end_page": 51
    },
    {
      "heading": "heading heading <Edition Edition (Clinical classification)> (column 2)",
      "text": "Row 1: Row Row 2: primitive primitive tumor; cancer with pleural/Row Row 3: Row Row 4: more more organs",
      "start_page": 51,
      "end_page": 51
    },
    {
      "heading": "heading heading <Edition Edition (clinical classification)> (from previous page)",
      "text": "Row 1: Stadium N0M0Row 4: M0M7Row M0M7Row 5: S0MRow S0MRow 6: R0ORow R0ORow 7: M0RW M0RW 8: M02Row M02Row 10: m0Raw m0Raw 10: N0 N0 - you you doing?",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "heading heading <Edition Edition (clinical classification)> (column column 12)",
      "text": "Row 1: ... M. M.",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "heading heading <Surgical Surgical options>",
      "text": "Row 1: SCT>or or SWT<Row Row 2:",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: • Overall quality •Clinical recommendation •Row 2: •Recommendation • Row 3: Moderate •with with •thoracotomy thoracotomy (148-150) •Condicted for •row 4: • COI: declared declared •",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: stage stage (IA), Row Row 2: recommended (compared to lobectomy)? Row 3: RECOMMENDATION: phase phase (IA) Row Row 4: Strength of recommendation: Row Row 5: Motivations/comments to benefit/damage balance: segmentectomia segmentectomia (cell cell cells).",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "heading heading <4.2 Radiotherapy>",
      "text": "Row 1: Overall Overall benefit/damage balance: stage stage (IA), complications complications (aerial aerial losses). Row 2: studies studies (Ottawa Ottawa Scale), Row Row 3: of of tests: MODERATE Row 4: COI: no conflict declared",
      "start_page": 59,
      "end_page": 59
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: \"Clinical recommendation\" = Row 2: Overall quality \"Row 3 strength\": \"Raw 4: \"Rown 5: \"therapy therapy (153, 155) \"Row Row 6: Moderate Row 7: \" Row 8: \" Row 9: COI: no declared conflict\"",
      "start_page": 60,
      "end_page": 60
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "==References===External links==* usable usable (171-175)",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "heading heading <COI: no conflict declared> (column 1)",
      "text": "Row 1: \"Row 2: \"",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "heading heading <COI: no conflict declared> (column 2)",
      "text": "Row 1: Row 2: Quality of",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "heading heading <COI: no conflict declared> (column 3)",
      "text": "Row 1: Row Row 2: prov",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "heading heading <COI: no conflict declared> (column 4)",
      "text": "Row 1: Bale Row 2: ve",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "heading heading <COI: no conflict declared> (column 5)",
      "text": "Row 1: well-selected well-selected (postoperative postoperative recovery) option option (161) Row 5: usable usable (171-175).",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "heading heading <COI: no conflict declared> (column 6)",
      "text": "Row 1: Row Row 2: Recommendation",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: trials trials (Clinical recommendation) •Row Row 2: Moderate (Del19/L858R), chemotherapy chemotherapy (if indicated) (185-187) • Row Row 3: COI: declared declared • account. account.",
      "start_page": 71,
      "end_page": 71
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row 2: of of Tests",
      "start_page": 71,
      "end_page": 71
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row Force 2: Recommendation",
      "start_page": 71,
      "end_page": 71
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: tests tests (Clinical recommendation) •Row Row 2: Moderate • __ __ MEDTERM1__/PD-L1 PD-L1 ≥50% treatment with −chemotherapy chemotherapy (189) ■ Row Row 3: COI: declared declared •",
      "start_page": 73,
      "end_page": 73
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row 2: of of Tests",
      "start_page": 73,
      "end_page": 73
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row Force 2: Recommendation",
      "start_page": 73,
      "end_page": 73
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: tests tests (i) Clinical recommendation (ii) Row Row 2: Moderate (iii) option option (192-193)",
      "start_page": 75,
      "end_page": 75
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row 2: of of Tests",
      "start_page": 75,
      "end_page": 75
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row Force 2: Recommendation",
      "start_page": 75,
      "end_page": 75
    },
    {
      "heading": "heading heading <5.4 Organisation>",
      "text": "Row 1: treatment treatment (s) Row Row 4: radiotherapy radiotherapy and/Row Row 5: ...Row Row 6: .. Row Row 7: . . .thereafter. thereafter. ... Row 8: Row Row 9: ..\"Row Row 10:",
      "start_page": 79,
      "end_page": 79
    },
    {
      "heading": "heading heading <5.4 Organisation> (from previous page)",
      "text": "Row 1: treatment. treatment.",
      "start_page": 80,
      "end_page": 80
    },
    {
      "heading": "heading heading <5.4 Organization> (column column 1)",
      "text": "Row 1: Proceed Row 2: Row 3: Spirom Row 4: compl Row 5: currency Row 6: popular Row 7: Surviv Row 8: Row 9: Proceed row 10: confam Row 11:",
      "start_page": 80,
      "end_page": 80
    },
    {
      "heading": "heading heading <5.4 Organization> (column column 2)",
      "text": "Row 1: dura Row 2: Row 3: Row 4: Row Row 5: Row Row 6: Row Row 7: Row Row 8: Row 9: Row Row 10: send Row 11:",
      "start_page": 80,
      "end_page": 80
    },
    {
      "heading": "heading heading <5.4 Organization> (column column 3)",
      "text": "Row 1: \"Row Row 2: \"Row 3\" to \"treatment. treatment.\" .Row 4: \"Rop 5\": \"to to favour\" 1 Row 6: \"of of lifestyles\" 7: \"Salutari.\" Row 8: \" and and vaccination\" Row 9: \"anti-pneumococca.\" Row 10: \"L\" Row Row 11: \"routinely.\" a a \"Raw 12\" should be performed: \"T\" mdc. mdc.",
      "start_page": 80,
      "end_page": 80
    },
    {
      "heading": "heading heading <5.4 Organization> (column column 4)",
      "text": "Row 1: Row Row 2: recommendation Row 3: Row Row 4: Row 5: Row Row 6: Row 7: Row Row 8:",
      "start_page": 80,
      "end_page": 80
    },
    {
      "heading": "heading heading <Chemio-radiotherapy Chemio-radiotherapy neoadjuvant>",
      "text": "Row 1: Overall Quality (Clinical Recommendation) *Row 2: Trial Strength (Row 3: Low Recommending) the the risk/patient patient (206-207)",
      "start_page": 85,
      "end_page": 85
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: \"Clinical recommendation\" = \"Row 2: Overall quality\" *Row 3: Row Row 4: \"Rop 5: Moderate\" *stage stage IIIA/conditions conditions (__MEDTERM1_ 0-1) option option (226-228) *Row Row 6: \"COI\": no conflict declared",
      "start_page": 92,
      "end_page": 92
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: \"Clinical recommendation\" = \"Row 2: Overall quality\" = Row 3: testing strength = \"Recommendation Row 4: \" Row 5: Moderata\" = ...\"stage stage IIIA/therapy therapy (229-234) \"Row Row 6: COI: no declared conflict\"",
      "start_page": 95,
      "end_page": 95
    },
    {
      "heading": "heading heading <Quality of tests>",
      "text": "Row 1: Row Row 2: Row Row 3: to to 1%, Row Row 4: to to observation? Row 5: RECOMMENDATION: with with chemo‐as as 1%, Row Row 6: Strength of recommendation: RIGHT RIGHT 7: Motivations/comments to benefit/danno balance: placebo placebo (6 6 months; HR 0.52; IC95% 0.42-0.65; p=0.001). __MDTERM01_29. __MDTERM01_29.9% vs 26.1%), discontinuation discontinuation (15.4% vs 9.8%; HR 0.68; IC95% 0.53-0.87; 2 2 years: 66.3% vs 55.6%. EMA EMA (September 2018) AIFA AIFA (December December 2018) expression expression ≥1%. arm arm (HR 0.71; CI95% 0.57-0.88) 35. 35.3% vs 19.5% the the PD- with with PD-L1- ≥1%, in in 63% study study (237). trial. trial.",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "heading heading <Quality of tests> (from previous page)",
      "text": "Row 1: of of evidence: LOW Row 2: COI: No conflict declared",
      "start_page": 97,
      "end_page": 97
    },
    {
      "heading": "heading heading <oligometastatic oligometastatic disease> (from previous page)",
      "text": "Row 1: ROW ROW 3: recommended recommended (Row Row 4: systemic therapy only)? Row 5: Row 6: RECOMMENDATION: Row Row 7: Strength of recommendation: Row Row 8: Motivations/comments to benefit/damage balance: _12 _12 articles; al. al. (250), with with .to to ≤al. al. (251) and and non-day day 15; analisys analisys (252) studies studies (PEMBRO-RT and MDACC) trial trial (3 3 weeks) __MEDTERM0_ __MEDTERM0_ (0,67; CI95% 0.54-0,84; p=0.0004). al. al. (253), TKi TKi (TKI TKI (adult adult population). mode mode (20-12) lesions lesions (of of lesions).",
      "start_page": 100,
      "end_page": 100
    },
    {
      "heading": "heading heading <disease disease EGFR-mutated>",
      "text": "Row 1: rate rate (1. 1.36; CI95% 0.52-3.51), lung rate (1. 1.59; IC95% 0.96-2.61) interruptions interruptions (0. 0.95; IC95% 0.06-14.97). Row Row 2: estimates. estimates. *Row Row 3: of of testing: BASSa Row 4: COI: no conflict declared: considered. considered.",
      "start_page": 101,
      "end_page": 101
    },
    {
      "heading": "heading heading <disease disease EGFR-mutated> (from previous page)",
      "text": "Row 1: Row Row 2: MEDTERM24_ MEDTERM24_ (Ex19dels and L858R), Row Row 3: recommended recommended (__Medterm1_ __Medterm1_ and/or _MEDTERM2_===the the trial: Row 5: Recommendation: of of −of of •endpoints endpoints (266), __MEDTERM34_ __MEDTERM34_ (e.g., of of treatment), MEDTERM0__ MEDTERM0__ _Media: 0, 0,58; IC95% 0,44-0,78; p=0.0004). a a •MEDTERm34_ cerebral (subgroup subgroup analysis) profile profile (than than 3) favourable.",
      "start_page": 102,
      "end_page": 102
    },
    {
      "heading": "heading heading <Quality of tests>",
      "text": "Row 1: following following reasons: Row Row 2: of of tests: LOW Row 3: COI: no conflict declared",
      "start_page": 103,
      "end_page": 103
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: • Overall quality • Clinical recommendation •Row 2: •Test strength •Recommendation • Row 3: • Very low •__MEDTERM3_ __MEDTERM3_ (changes/of of • Exon 20), of of ♪MEDTERM3__ •option option •Row 4: • __DETERM3. __DETERM3. • (275) Row 5: COI: no declared conflict",
      "start_page": 105,
      "end_page": 105
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: tests tests (Clinical recommendation): considered considered (276)",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row 2: of of Tests",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row Force 2: Recommendation",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "heading heading <COI: no conflict declared> (from previous page)",
      "text": "Row Row 2: (Ex19dels, L858R) T790M T790M (liquid liquid biopsy) Row Row 3: of of •Row Row 4: recommended (compared to chemotherapy)? Row 5: RECOMMENDED: mutation mutation (fluid fluid biopsy). __MEDTERM32_ __MEDTERM32_ (chemotherapy chemotherapy respectively; HR 0,87; IC95% 0.67-1,12; p=0.277). 73% of of −disease disease (brain brain disease: 70% vs 31% [OR 5,13; IC95% 1,44-20,64; p = 0.0015], cerebral cerebral metastases: 40% 17% [OR 3,24; CI95% 1,33-8,81; p=0.014] 44 44 - 20,64 - 50; P=References= Row 8: following following reasons: bias bias (of of results), Row Row 9: Overall test quality: Row Row 10: COI: no conflict declared",
      "start_page": 108,
      "end_page": 108
    },
    {
      "heading": "heading heading <disease disease ALK-re-arranged> (from previous page)",
      "text": "Row 1: Row Row 2: recommended recommended (compared to __MDTERM1_)? Row 3: RECOMMENDED: with with −with with •Row Row 4: Strength of recommendation: Row Row 5: Motivations/the the benefit/day balance: ›__MDTERM1_ __MDTERM1_ (2 2 months; HR 0.37; IC95% 0.26-0.52), over-reachable over-reachable (medium not reached; HR 1.03; IC95% 0.67-1.58), considering that 79% 0-2 0-2 (299) status performance.",
      "start_page": 113,
      "end_page": 113
    },
    {
      "heading": "heading heading <disease disease ALK-re-arranged> (from previous page)",
      "text": "Row 1: + 0.60; CI95% 0.37-0.99) Row Row 2: l/of of • Row 3: __medterm1_. __medterm1_.",
      "start_page": 113,
      "end_page": 113
    },
    {
      "heading": "heading heading <disease disease ALK-re-arranged> (from previous page)",
      "text": "Row 1: Overall benefit/damage balance: survival survival (ALEX ALEX study) profile profile (than than 3). Row 2: following following reasons: Row Row 3: of of tests: MODERATA Row 4: COI: no conflict declared",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "heading heading <disease disease ALK-re-arranged> (from previous page)",
      "text": "Row 1: Row Row 3: recommended recommended (compared to __MDTERM1_)? Row 4: Row 5: RECOMMENDATION: of of ____MEDTERM19_; Motivations/comments on benefit/damn balance: with with •progression, progression, 1⁄arms arms (two two arm; HR 0,92; CI95% 0.57-1,47; p=0.771). baseline baseline (e.g. n=41, 78% vs 26%; OR 11,67; CI95% 2,15-6,27; p = 0.0014); treatment treatment (n=98, 66% vs. 11,75; L95% 4,19-32,91; p <0,0001).",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "heading heading <disease disease ALK-re-arranged> (from previous page)",
      "text": "Row 1: Overall benefit/damage balance: Row Row 2: following following reasons: distortion distortion (sponsor sponsor bias), Row Row 3: of of evidence: Row Row 4: COI: no conflict declared",
      "start_page": 115,
      "end_page": 115
    },
    {
      "heading": "heading heading <disease disease ALK-re-arranged> (from previous page)",
      "text": "Row 1: Row Row 2: recommended recommended (compared to __MDTERM1__)?",
      "start_page": 115,
      "end_page": 115
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: tests tests ...Clinical recommendation: \"Row Row 2: Moderate\" considered considered (compared to __MDTERM1_) (308-310).\"Row Row 3: COI: no declared conflict\"",
      "start_page": 117,
      "end_page": 117
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row 2: of of Tests",
      "start_page": 117,
      "end_page": 117
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row Force 2: Recommendation",
      "start_page": 117,
      "end_page": 117
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row Row 2: Row Row 3: recommended recommended (compared to chemotherapy)? Row 4: RECOMMENDING: Row Row 5: the the recommendation: RIGHT RIGHT 6: Motivations/comments to benefit/damn balance: al. al., Phase Phase I/of of −95. 95.3% and 48.1% degree degree (84.4% and 67.1% respectively) 4 4 (18% in both cases) Overall Overall benefit/damage balance: effects effects (brain brain activity) and undesirable (drug-specific adverse events) Row Row 7: following following reasons: imprecision. imprecision.",
      "start_page": 117,
      "end_page": 117
    },
    {
      "heading": "heading heading <disease disease ROS1-rearranged>",
      "text": "==References===External links==* patients patients (5 5 years), female (64.5%) and non-smoker (67.7%). approximately approximately 80%, 1 1 months; identified identified (321).",
      "start_page": 119,
      "end_page": 119
    },
    {
      "heading": "heading heading <disease disease ROS1-re-arranged> (from previous page)",
      "text": "rate rate (the the study) was 71.7%. __ROS1. __ROS1. Benefit/damage balance: The risk/of of •Row Row 2: following following reasons: number number (improvement of estimates) studies studies (and and indirectness), Row Row 3: of of testing: Row Row 4: COI: no declared conflict: reported. reported.",
      "start_page": 120,
      "end_page": 120
    },
    {
      "heading": "heading heading <disease disease ROS1-re-arranged> (from previous page)",
      "text": "Row Row 2: is is recommended? Row 3: RECOMMENDED: with with •with with −Row Row 4: Strength of recommendation: RIGHT RIGHT 5: Motivations/comments to benefit/damage: studies studies (and and STARTRK-NG) dysgeusia dysgeusia (n=90; 42.9%), malaise (n = 72; 34.3%); constipation (n=166; 31.4%). growth growth (n=27; 8.1%), ALT rise (n=0; 3.3%) and diarrhoea (n (=6; 2.9%); 7 patients (3.3%) events events (hyperuricaemia; hypertridemia; limbic cephalitis; myocardial infarction; creatinine elevation). Benefit/damage balance: The benefit/Row Row 6: following following reasons: number number (improportion of estimates) studies studies (and and indirectness), overall overall trials:",
      "start_page": 121,
      "end_page": 121
    },
    {
      "heading": "heading heading <disease disease mutated> (from previous page)",
      "text": "==References===External links==* patients patients (22%), 25 25 (69%) adverse adverse event: cases cases (11%), 3 3 (8%). al. al., 63. 63.9%, respectively respectively (332), was was 22%. the the trial: patients patients (n=36). with with chemo(immuno) results. results.",
      "start_page": 123,
      "end_page": 123
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: tests tests (Clinical recommendation): Very low (Row 2: Very low) option option (333-336)",
      "start_page": 125,
      "end_page": 125
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row 2: of of Tests",
      "start_page": 125,
      "end_page": 125
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row Force 2: Recommendation",
      "start_page": 125,
      "end_page": 125
    },
    {
      "heading": "heading heading <disease disease RET-re-arranged>",
      "text": "Row 1: Row Row 2: Row Row 3: recommended recommended (compared to chemotherapy)?",
      "start_page": 126,
      "end_page": 126
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: tests tests (Clinical recommendation): considered considered (338-339, 343, 346)",
      "start_page": 129,
      "end_page": 129
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row 2: of of Tests",
      "start_page": 129,
      "end_page": 129
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row Force 2: Recommendation",
      "start_page": 129,
      "end_page": 129
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: tests tests (Clinical recommendation): immunotherapy immunotherapy and/considered considered (350)",
      "start_page": 131,
      "end_page": 131
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row 2: of of Tests",
      "start_page": 131,
      "end_page": 131
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row Force 2: Recommendation",
      "start_page": 131,
      "end_page": 131
    },
    {
      "heading": "heading heading < p. p.G12C>",
      "text": "Row 1: tests tests (Clinical recommendation): immunotherapy immunotherapy and/considered considered (351)",
      "start_page": 132,
      "end_page": 132
    },
    {
      "heading": "heading heading < p. p.G12C>",
      "text": "Row 1: Row 2: of of Tests",
      "start_page": 132,
      "end_page": 132
    },
    {
      "heading": "heading heading < p. p.G12C>",
      "text": "Row 1: Row Force 2: Recommendation",
      "start_page": 132,
      "end_page": 132
    },
    {
      "heading": "heading heading < p. p.G12C>",
      "text": "Row 1: Row Row 2: immunotherapy immunotherapy and/or Row 3: recommended recommended (compared to chemotherapy)?",
      "start_page": 132,
      "end_page": 132
    },
    {
      "heading": "heading heading <First-line First-line treatment: immunotherapy>",
      "text": "Row 1: Clinical recommendation: \"Row Row 2: immunotherapy immunotherapy and/considered considered (compared to chemotherapy) (355-357).\"",
      "start_page": 135,
      "end_page": 135
    },
    {
      "heading": "heading heading <First-line First-line treatment: immunotherapy>",
      "text": "Row 1: Row 2: of of Tests",
      "start_page": 135,
      "end_page": 135
    },
    {
      "heading": "heading heading <First-line First-line treatment: immunotherapy>",
      "text": "Row 1: PD-L1 PD-L1 ≥50%, Row Row 2: status status (0-1), a Row 3: recommended recommended (compared to chemotherapy)? Row 4: RECOMMENDING: of of −MEDTERMO7_, or re‐arrangement of •Row Row 5: the the recommendation: RIGHT RIGHT 6: Motivations/the the benefit/danno balance: multi-year multi-year trial: __médterm16_ __médterm16_ (6 6 months; HR 0.50; IC95% 0.37-0.68; p <0,001) (369). at at •of of −with with •chemotherapy chemotherapy (HR 0.62; CI95% 0.48-0.81; p=0.001) of of {31. 31.9% 16. 16.3% responses responses (46.1% vs 31.9% at 31.0% with @MEDTERMA6_",
      "start_page": 135,
      "end_page": 135
    },
    {
      "heading": "heading heading <First-line First-line treatment: immunotherapy> (from previous page)",
      "text": "==See also==*Topology==References===External links==",
      "start_page": 136,
      "end_page": 136
    },
    {
      "heading": "heading heading <First-line First-line treatment: immunotherapy> (from previous page)",
      "text": "Row 1: expression expression ≥50%, without Row 2: Row Row 3: (0-1), recommended recommended (Row Row 4: platinum based)?",
      "start_page": 136,
      "end_page": 136
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: tests tests (clinical clinical recommendation): \"Row Row 2: Moderate\" (ii) expression expression ≥50%, status status (iii)), considered considered (platinum platinum chemotherapy) (360) \"Row Row 3: COI: No conflict declared\" (iii.",
      "start_page": 137,
      "end_page": 137
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row 2: of of Tests",
      "start_page": 137,
      "end_page": 137
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row Force 2: Recommendation",
      "start_page": 137,
      "end_page": 137
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: trials trials (Clinical recommendation) •Row Row 2: Moderate • IV IV • PD-L1 PD-L1 ≥50% • __MEDTERM1 __MEDTERM1 • of of •MEDTERM2_ • status status (0-1) • considered considered (platinum platinum chemotherapy) (362) • Row Row 3: COI: declared declared •",
      "start_page": 139,
      "end_page": 139
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row 2: of of Tests",
      "start_page": 139,
      "end_page": 139
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row Force 2: Recommendation",
      "start_page": 139,
      "end_page": 139
    },
    {
      "heading": "heading heading <COI: no conflict declared> (from previous page)",
      "text": "without without Row: PD-L1 PD-L1 <50% Row Row 3: performance status (0-1), Row Row 4: Row Row 5: recommended recommended (compared to chemotherapy)? Row 6: RECOMMENDATION: least least 50% of of −MEDTERME14__, using PD- L150; with with __MEDTERM0_==Film ==__medTERM24_ __medTERM24_ (58% vs 33%) MEDTERM25_ MEDTERM25_ (9 9 months; HR 0.54; IC95% 0.35-0.83) and __MDTERM26_ (1 1 months; HR 0.71; IC95% 0.45-1.12), despite a 70% was was 39% versus versus 31% chemotherapy chemotherapy (365). study study (including including PD- patients patients (n=190; HR 0.55; IC95% 0.39-0.76) and PD-l1 1-49% (n=86; HR 0.65; CI95% 0.46-0.90). 19. 19.4% 11. 11.3% alone alone (52. 52.1% vs 42.1%), events events (any 27.7%, 12. 12.6%) of of −Milanese Milanese (16.2%, grade 12.2%) placebo_M2. placebo_M2.",
      "start_page": 140,
      "end_page": 140
    },
    {
      "heading": "heading heading <COI: no conflict declared> (from previous page)",
      "text": "Row Row 2: PD-L1 expression <50% status status (0-1), Row Row 3: _ _ 0; Row Row 4: is is recommended: (compared with chemotherapy)? Row 6: RECOMMENDATION: with with PD- L1 expression<50% status status (0.-1), of of carbo-Row Row 5: (with with chemotherapy)? PD-L1 PD-L1 (PD-L1-1% vs <1%), events events (paclitaxel vs nab-paclitaxel) region region (the the world). after after l'__medTERM0_ __medTERM0_ (6 6 months; HR 0.71; CI95% 0.59-0.85), 18. 18.4% 9. 9.4% Row Row 10: of of evidence: LOW Row 11: COI: no conflict declared",
      "start_page": 141,
      "end_page": 141
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: tests tests ...Clinical recommendation: \"Row Row 2: Modernised\"mutations mutations l[expression expression <50% status status (0-1), with with {option option (371) for Row 3: COI: whatsoever. whatsoever.",
      "start_page": 143,
      "end_page": 143
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row 2: of of Tests",
      "start_page": 143,
      "end_page": 143
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row Force 2: Recommendation",
      "start_page": 143,
      "end_page": 143
    },
    {
      "heading": "heading heading <First-line First-line treatment: chemotherapy>",
      "text": "Row 1: • Overall quality •Clinical recommendation •Row 2: •Test strength •Recommendation • Row 3: Moderate •__MEDTERM4_ __MEDTERM4_ • mutations mutations •of of •MEDTERM2_/PD-L1 PD-L1 1-49% status status (0-1), with with • option option (374-375) •Row Row 4: • COI: declared declared •",
      "start_page": 145,
      "end_page": 145
    },
    {
      "heading": "heading heading <First-line First-line treatment: chemotherapy> (from previous page)",
      "text": "Rowult 1: Row Row 2: Row Row 3: Row Row 4: recommended recommended (5 5 alone: observation)? Row 6: RECOMMENDATION: status status (0-1), Row Row 7: the the recommendation: ROW ROW 8: Motivations/comments to benefit/danno balance: Phase Phase III/patient. patient.",
      "start_page": 147,
      "end_page": 147
    },
    {
      "heading": "heading heading <First-line First-line treatment: chemotherapy> (from previous page)",
      "text": "Row 1: weeks) phase phase (maintenance phase), induction induction (n=539) pemetrexed pemetrexed (500 mg/3 3 weeks) + placebo placebo + placebo placebo (8 8 months; HR 0.62; IC95% 0.49-0.79; p <0,0001) committee committee (6 6 months); HR 0.64; CI95% 0.51-0.81; p=0.0002).",
      "start_page": 148,
      "end_page": 148
    },
    {
      "heading": "heading heading <treatment treatment lines>",
      "text": "Rowter 1: __Row __Row 2: a a • Row 3: MEDTERM0_, MEDTERM0_, •MEDTERM1_ or •a a ♪ Row 4: II-line Chemotherapy? •ROW 5: RECOMMENDATION: with with •_MEDTERN0__ (PD-L1 PD-L1 ≥ 1%) should Row 7: Row Row 8: Strength of recommendation: Plus Plus • RIGHT 9: Motivations/the the −year: of of ‐therapy. therapy.",
      "start_page": 150,
      "end_page": 150
    },
    {
      "heading": "heading heading <Quality of tests>",
      "text": "Row 1: following following reasons: open-label open-label design; nor nor non- inferiority. Row 2: Overall test quality: MODERATA Row 3: COI: no conflict declared",
      "start_page": 154,
      "end_page": 154
    },
    {
      "heading": "heading heading <status status 2>",
      "text": "Row 1: tests tests (Clinical recommendation): Very low: therapy therapy (408-409) •Row Row 3: COI: no declared conflict",
      "start_page": 157,
      "end_page": 157
    },
    {
      "heading": "heading heading <status status 2>",
      "text": "Row 1: Row 2: of of Tests",
      "start_page": 157,
      "end_page": 157
    },
    {
      "heading": "heading heading <status status 2>",
      "text": "Row 1: Row Force 2: Recommendation",
      "start_page": 157,
      "end_page": 157
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: \"Clinical recommendation\" = \"Row 2: Overall quality\" = Row 3: evidence \"Recommendation Row 4: \" Row 5: \"option option (423-426) \"Row Row 6: Moderate Row 7: \" Row 8: \"Raw 9: COI: no declared conflict\"",
      "start_page": 166,
      "end_page": 166
    },
    {
      "heading": "heading heading <stage stage disease>",
      "text": "Row 1: \"Clinical recommendation\" = Row 2: Overall quality \"Row 3 strength\": \"Raw 4: \"Rown 5: \"chemo-radiotherapy, chemo-radiotherapy,\" brain brain (PCI) option option (430, 432-434) \"Strong in favor\" Row 6: \"Moderata\" Row 7: \" Row 8: \"Row 9: COI: no declared conflict\"",
      "start_page": 168,
      "end_page": 168
    },
    {
      "heading": "heading heading <stage stage disease> (from previous page)",
      "text": "Row Row 2: Row Row 3: Row Row 4: platinum-based platinum-based chemotherapy? Row 5: RECOMMENDATION: Row Row 6: Strength of recommendation: were were 7: Motivations/comments to benefit/danno: 56. 56.6% 56. 56.1% patient patient (PRO) life life (HRQoL) __medTERM0_ __medTERM0_ (436). EMA EMA (September 2019) MIFA MIFA (with September 2020) Row Row 8: following following reasons: Row Row 9: Overall test quality: LOW Row 10: COI: no conflict declared",
      "start_page": 169,
      "end_page": 169
    },
    {
      "heading": "heading heading <stage stage disease> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: Row Row 4: platinum-based platinum-based chemotherapy? Row 5: RECOMMENDATION: Row Row 6: Strength of recommendation: Row Row 7: Motivations/comments to benefit/damn: beta-cells beta-cells treatment; chemotherapy-_MEDTERM0_ chemotherapy-_MEDTERM0_ (5 5 months), maintaining a 25% alone alone (HR 0,75; IC95% 0.62-0.91; p=0.0032) with with etoposide-cisplatin/alone alone (5 5 months; HR 0.82; CI95% 0.68-1.00; p = 0.005). Row Row 8: following following reasons: Row Row 9: Overall test quality: LOW Row 10: COI: no conflict declared",
      "start_page": 170,
      "end_page": 170
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: \"Clinical recommendation\" \"Row 2: Overall quality\" \"Row 3: strength\" \"Recommendation Row 4: \"Raw 5: \"I-line I-line platinum/option option (441- 442, 444-449) \"Row Row 6: Moderate Row 7: \" Row 8: \"Rop 9: COI: no declared conflict\"",
      "start_page": 174,
      "end_page": 174
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: Row Row 2: brain brain (PCI) is recommended? Row 3: RECOMMENDATION: radiation radiation (CPI) Row Row 4: Strength of recommendation: Row Row 5: Motivations/comments to benefit/damage balance: study study (450) benefit benefit (27, 27,1% 1. 1.3% the the results",
      "start_page": 174,
      "end_page": 174
    },
    {
      "heading": "heading heading <COI: no conflict declared> (from previous page)",
      "text": "Row 1: moment moment (452). half-analysis half-analysis (453) survival survival (HR 0.57; CI95% 0.47-0.69; p < 0.001) metastases metastases (HR 0.47; IC95% p p <0.01). 93. 93.7% 46. 46.3% groups groups (p=0.10). 92 92 (RASS RASS tests: the the BowT: as as follows:",
      "start_page": 175,
      "end_page": 175
    },
    {
      "heading": "heading heading <COI: no conflict declared>",
      "text": "Row 1: •Clinical recommendation • Row 2: Overall quality •Row 3: evidence strength •Recommendation Row 4: • Row 5: Moderate • with with •option option (457- 460) •Row Row 6: COI: declared declared •",
      "start_page": 178,
      "end_page": 178
    },
    {
      "heading": "heading heading <Bibliography>",
      "text": "Row 1: long long cancer: RowFolkLowLightLowWildLoverLowSwimmedLowRow RowFolkLowLightLowWildLoverLowSwimmedLowRow 2: 85.FollowRow 3: Med. Med. 2014; 370(1):60-8.Row 6: lung lung cancer: a • Row 7: Cancer. Cancer. 2000; 27:long long cancer: Row Row 42: Med. Med. 2015; 191(10):1166-75.Row 43: Row Row 44: trial trial (DLCST). Lung Cancer 2015; 87(1):65-72.",
      "start_page": 181,
      "end_page": 181
    },
    {
      "heading": "heading heading <Bibliography> (from previous page)",
      "text": "Row 1: v1. v1.1: negative Row 2: Radiol. Radiol. 2021; 31(4):1956-68. Row 3: Row Row 4: Row Row 20: Row Row 21: Res. 2016; 22:3618-29. Row 22: Row Row 25: Cancer. Cancer. 2012; 76:1-18. Row 26: Rw Rw 25: sample. Row 40: lung lung cancer: Row Row 41: cytological cytological species: Series Series ›driver driver alterations: Row 44: OH OH (CCO) Oncol. Oncol. 2021; 39:1040-91. Row 45: underling. underling.",
      "start_page": 182,
      "end_page": 182
    },
    {
      "heading": "heading heading <Bibliography> (from previous page)",
      "text": "Row 1: advanced advanced non-Row Row 2: Med. Med. 2018; 378:113-25. Row 3: Row Row 4: non non - and and _MEDTERM23__‐Row Row 5: 2018; 36 (22):2244-50. Row 6: Med. Med. 2014; Row 23: 371:1963-71. Row 24: Row Row 25: fusion-positive fusion-positive non-Oncol. Oncol. 2021; 39:1253-63. Row 26: Row Row 27: BRAFV600E-mutant metastatic non-small-cell Lung Cancer: Incol. Incol. 2017; Row 28: 18(10) from from DESTINY-Lung01: Row Row 44: (T-DXd) in patients (Pts) with HER2-mutated (HER2m) cancer cancer (__MEDTERM39_). Ann Row 45: Oncol. 2021; 32(suppl_5):S1283-S1346. Row 46: Row Row 47: Res. Res. 2012; 18:6658-67. Row 48: NV-Bulg. NV-Bulg.",
      "start_page": 183,
      "end_page": 183
    },
    {
      "heading": "heading heading <Bibliography> (from previous page)",
      "text": "Row 1: Roche Roche cobas® Row Row 2: Diagn. Diagn. 2017; 17:209-15. Row 3: easy easy RT-Row Row 4: long long adenocarcinomas: Row Row 5: Cancer. Cancer. 2016; 99:11-6. Row 6: non-Row non-Row 18: small-cell lung cancer: Row Row 19: Oncol. Oncol. 2013; 8:352-8. Row 20: Row Row 21: advanced non-Cancer. Cancer. 2019; 131:62-8. row 22: Row Row 37: Row Row 38: Cancer. Cancer. 2015; 6:413-20. Row 39: Row Row 40: Pathol. Pathol. 2013; 37:1441-9. Row 41: clone clone (m.",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "heading heading <Bibliography> (from previous page)",
      "text": "Row 1: sequencing sequencing (NGS) Row Row 2: with metastatic cancers: Oncol. Oncol. 2020; Row 3: 31(11):1491-505. Row 4: long long cancer: Row 5: Pathol. Pathol. 2019; 72:412-7. Row 6: advanced advanced __MEDTERM0_: Row Row 7: Row Row 20: Clin. Clin. 2016; 11:243-59. Row 21: of of 18F-Row Row 22: Res. Res. 2000; 20:2189-92. Row 23: Row Row 24: Med. 2004; 45:2058-62. Row 25: all. all. 2018: 54:134-40. Row 40: cancer cancer staging; Row Row 41: 2021; 11:1569. Row 42: AG. AG. Up-of of non- Row 43: Available Available from: http://shc.amegroups.com/articles/view/3933/4711 Row 44: Cancer. Cancer.",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.>",
      "text": "Row 1: Robotic-assisted Robotic-assisted bronchoscopy: Row Row 2: Diagnostics. Diagnostics. 2024; 14:399. Row 3: Row Row 4: lesions: Roentgenol. Roentgenol. 2015; 204(1):29-34. Row 5: Row Row 6: node node sampling: Row Row 20: Row Row 21: Surg. Surg. 2011; 142:1393-400. Row 22: cancer cancer (Score Study). Row Row 23: 2019; 53:1800. Row 24: Row Row 40: Staging Staging Project: Row Row 41: Row Row 42: Oncol. 2017; 12:1109-21. Row 43: Low Low 44: Cancer Stagging Project: forthcoming forthcoming (ninth) Row Row 45: cancer. cancer.",
      "start_page": 186,
      "end_page": 186
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (from previous page)",
      "text": "Row 1: Row Row 2: cancer cancer surgery: Surg. Surg. 2020; 58(1):70-7. Row 3: Row Row 4: Row Row 5: 2015; 7:2003-9. Row 6: staging staging Row: 7-lung lung cancer: Row Row 21: ed. ed.: Row Row 22: guides. Chest. 2013; 143:e278S-e313S. Row 23: peripheral peripheral non-Row Row 24: cancer (JCOG0802/WJOG4607L): Row Row 25: Lancet. 2022; 399:1607-17. Row 26: long long cancer: a Row 40: Phys. Phys. 2018; 101(1):186-94. Row 41: cisplatin cisplatin evaluation: Row Row 42: Oncol. Oncol. 2008; 26:3552-9. Row 43: Row Row 44: Rev. Rev. 2015; 3:CD011430. Row 45: Madulg. Madulg.",
      "start_page": 187,
      "end_page": 187
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (from previous page)",
      "text": "Row 1: Row Row 2: Oncol. Oncol. 2017; 3:610-9. Row 3: Azzoli Azzoli non-Row Row 5: Onco. Onco. 2007; 25:5506-18. Row 6: Row Row 7: resected resected non-small-of of early-stage: _MEDTERM7__ Row 20: and and vinorelbine: Row Row 21: Oncol. 2013; 24(4):986-92. Row 22: Row Row 23: Nquelbine Nquelbine (the Row 24: stage stage II- Row 40: IIIA (N1-N2) __ MEDTERM5__-mutant __medTERM7__: Row Row 41: 2021; 39(7):713-22",
      "start_page": 188,
      "end_page": 188
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (from previous page)",
      "text": "Row 1: \"Row Row 2: II-IIIA II-IIIA non-mutation mutation (IMPACT). J Clin\" Row 3: Oncol. 2022; 40(3):231-41.",
      "start_page": 188,
      "end_page": 188
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (from previous page)",
      "text": "Row 1: Row Row 2: MEDTERM3__ MEDTERM3__ mutations: Row Row 3: 2014; 21(6):2091-6 Row 4: Row Row 5: One. One. 2015; 10(10):e0140794. Row 6: rest. rest.",
      "start_page": 188,
      "end_page": 188
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (from previous page)",
      "text": "==Filmography===References== non-Row non-Row 21: Oncol. Oncol. 2015; 26:902-7. Row 22: for for non-small-cell lung cancer: Row Row 23: oncol. oncol. 2012; 7:723-30. Row 24: Row Row 25: Surg. Surg. 2013; 145(1):75-81. Row 26: internship internship non- Row 38: small-cell lung cancer: Oncol. Oncol. 2015; 10(8):1195-200. Row 39: Row Row 40: 3rd 3rd Ed: Row Row 41: Chest. Chest. 2013; 143(Suppl):e437-54. Row 42: radiotherapy. radiotherapy.",
      "start_page": 189,
      "end_page": 189
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (from previous page)",
      "text": "Row 1: SAKK SAKK 16/00 Trial: Row Row 2: stage stage IIIA/N2 non-Oncol. Oncol. 2014; Row 3: 25(Suppl. 4):1v417. Row 4: Row Row 5: Thorac Surg. 2005; 80(4):1224-30. Row 6: Row Row 22: non-small-cell lung cancers: Row Row 23: Oncol. 2014; 15(1):e42-50. Row 24: Llact. Llact. 1998; 352:257-63. Row 26: post-Loc. post-Loc. 2018; Row Row 27: Row Row 40: radiotherapy (PORT) cancer cancer (_MEDTERM0_) and Row 41: mediastinal N2 involvement: ART ART (NCRI, NCRI, SAKK). Ann Row 42: Oncol. 2021; 32(Suppl 5): S939. Row 43: Row Row 44: Row Row 45: 2000; 48:34-54. Row 46: Kappers comb.",
      "start_page": 190,
      "end_page": 190
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (from previous page)",
      "text": "Row 1: comparing comparing second- Row Row 2: III III non-small-cell lung cancer: Row Row 3: Oncol. Oncol. 2010: 28(23):3739-45. Row 4: Row Row 5: Row Row 6: avanced non-small-cell long cancer: Row Row 21: __ MEDTERM10_: Oncol. Oncol. 2021; 16(5):860-7. Row 22: Spigel Row. 2019; Row 41: 393(10185):2051-8. Row 42: Row Row 43: Row Row 44: 2018; 13(9:1383-92. Row 45: Row Row 46: disease disease (NCCTG N107C/CEC·3).",
      "start_page": 191,
      "end_page": 191
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (from previous page)",
      "text": "Row 1: metastatic metastatic non-small- Row 2: cell long cancer: Med. Med. 2021; 9(5):467-75. Row 3: Row Row 4: Inst. Inst. 2023; Row 5: 115(742-8. Erratum in: Row Row 6: Row Row 21: Row Row 22: Oncol. Oncol. 2013; 31:3327-34. Row 23: Row Row 24: with advanced non-mutations mutations (LUX-Lung 6): Row Row 25: Oncol Oncol . 2014; 15:213-22. Row 26: Wul-Long Wul-Long 6): advanced advanced non-Row Row 41: MEDTERM18_ MEDTERM18_ mutations: LUX LUX -Row Row 42: LUX/Oncol. Oncol. 2015; 16:830-8. Row 43: EGFR EGFR changes: a Row 44: oncol. oncol. 2020; 15(803-15. Row 45: Popat Popat S",
      "start_page": 192,
      "end_page": 192
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (from previous page)",
      "text": "Row 1: Row Row 2: MEDTERM20__ MEDTERM20__ changes: Oncol. Oncol. 2024; 10(1):43- Row 3: 51. Row 4: Row Row 5: Lung Lung Cancer- 2020; 141:9-13. Row 6: Row Row 21: Commun. Commun. 2023; 14(1):1070. Row 22: Row Row 23: progressive disease: Row Row 24: 2012; 7(11):1722-7. Row 25: with with 41: Row Row 42: metastatic non-Row Row 43: inhibitors: Oncol. Oncol. 2024; 42(11):1252-64. Row 44: with with non-small-cell low 45: Oncol Oncol 2009; 27(26):4247-53. Row 46: the. the. MEDM_Mline",
      "start_page": 193,
      "end_page": 193
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (from previous page)",
      "text": "Row 1: __MEDTERM0_ __MEDTERM0_ (450 mg/600 600 mg/de) Row Row 2: 750-mg/Oncol. Oncol. 2019; 14(7):__MEDTERM1_ __MEDTERM1_ (ALC) vs __MEDTERM2_ (CRZ) patients patients (pts) with treatment- 2017; 18(12):1590-9.?Row 40: Row Row 41: non-Oncol. Oncol. 2021; 32(5):620-30.",
      "start_page": 194,
      "end_page": 194
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (from previous page)",
      "text": "Row 1: ROS1-rearranged ROS1-rearranged non-Med. Med. 2014; Row 2: 371(21):1963-71. Row 3: Oncol. Oncol. 2019; 30(7):1121-6. Row 5: Row Row 21: Row Row 22: fusion-positive fusion-positive non-Oncol. Oncol. 2021; 39:1253-63. Row 23: positive positive non- Row Row 24: Med. 2024; 390(2):118-31. Row 25: __MEDTERR27_-positive __MEDTERR27_-positive not-fusion-positive fusion-positive tumours: Row Row 40: phase phase 1/Oncol. Oncol. 2020; 21(4):531-40. Row 41: fusion-Row fusion-Row 42: Med. Med. 2023; 389(20):1839-50. Row 43: Al. Al.",
      "start_page": 195,
      "end_page": 195
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (from previous page)",
      "text": "Row 1: MEDTERM20_ MEDTERM20_ fusion- Row 2: positive non-small-cell cancer: trial trial (LIB___MEDTERM20_TO-321). Oncol. Oncol. 2022; Row 3: 14:17588359221105020. Row 4: of of •__medTERM2__ __medTERM2__ Fuss- Row 5: positive not-trial. trial. == References ==== External links ==* Med. Med. 2020; 383(14):1328-39. Row 43: from from IMpower110: Row Row 44: Row Row 45: 2021; 16(11):1872-82. Row 46: advanced advanced non-small-cell Row 47: least least 50%: trial. trial.",
      "start_page": 196,
      "end_page": 196
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (from previous page)",
      "text": "Row 1: cohort cohort G: pemetrexed Row 2: Row Row 3: Oncol. 2021; 16(1):162-8. Row 4: metastatic metastatic non-small-cell Row 5: Med. Med. 2018; 378 (22):078-92. stuw 6: from from KLEY-NOTSma89: _MED First-line (L) _MEDTERM6_ (N) + _MEDTERM7_ (I) + chemotherapy (C) Row 23: patients patients (pts) __MEDTERM14_ __MEDTERM14_ (m_medTERM14_) from CheckMate 9LA: Row Row 24: subtype subtype (THS). Oncol. Oncol. 2023; 41(17_suppl.): Row Row 25: Row Row 42: advanced advanced non-small-cell lung cancer: Row Row 43: 08975. 08975.",
      "start_page": 197,
      "end_page": 197
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (from previous page)",
      "text": "Row 1: al. al. PARAMOUNT: Row Row 21: patients with non-Oncol. Oncol. 2000; Row 22: 18:2095-103. Row 23: Row Row 24: advanced advanced non- small-Row Row 25: Row Row 41: nonsquamous nonsquamous non-Row Row 42: Med. Med. 2015; 373:1627-39. Row 43: Row Row 44: checkMate 017/057: 2019. 2019. [Internet]. Row 45: Available from: https://.jto.org/article/S1556-0864(19)31169-4/abstract Row 46: 47. 47.",
      "start_page": 198,
      "end_page": 198
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (from previous page)",
      "text": "Row 1: treated treated non- Row 2: cancer cancer (OAK): et et 389:255- Row 3: 65. Row 4: advanced advanced non-Row Row 5: verse verse Docetaxel: Cancer. Cancer. 2019; Row 6: 107:124-32. Row 7: Row Row 21: advanced advanced non-small-cell lung cancer: Row Row 22: Lancet. 2011; 378:1079-88. Row 23: non non - Row Row 24: Rev. Rev. 2015; (10):CD010463. Row 25: advanced advanced non- Row 26: small-cell long cancer: MILE-4 MILE-4 (C) Row 40: Row Row 41: Oncol. Oncol. 2010; 5(2):215-9. Row 42: low low 43: cancer: be be re-evaluated? Cancer. 2010); 116(5):1350-7. Row 44: Med. Med. 1992; Row 45: 327 (23):16-24.",
      "start_page": 199,
      "end_page": 199
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (from previous page)",
      "text": "== References ==== External links ==* Med. Med. 2018; 379:2220-9. Row 20: Row Row 21: cancer cancer (IMpower133): Row Row 22: Ann Oncol. 2020; 31(2):310-7. Row 23: Row Row 24: etoposide etoposide (IMpower133). Row Row 25: Oncol ==References===External links==* Official website",
      "start_page": 200,
      "end_page": 200
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (from previous page)",
      "text": "Row 1: Row Row 2: Oncol. Oncol. 2009; Row 3: 27(28:4787-92. Row 4: extende extende small- Now Now 5: Med. Med. 2007; 357:664-72. Row 6: ex ex cul: trigranal trigranal furan: Row Row 7: lung lung cancer: Oncol. Oncol. 1999; 17(2):658-67. Row 21: Row Row 22: oncol. oncol. 2006; 24(34): 5441-7. Row 23: Row Row 24: cancer. cancer.",
      "start_page": 201,
      "end_page": 201
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (column column 1)",
      "text": "Row 1: ... ...the the results: ..... Row Row 6: - \" Row 7: mortality mortality - screening screening (follow up: 35 35 years) Row 8: • Row 9: non-important non-important [non important] not important [non-important] Not important\" Row Row 10: All-case mortality -no no screening: year year old) Row 12: Row Row 13: serious serious - screening screening (follow up: 35 35 age) Row 14:",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (column column 2)",
      "text": "Row 1: • Row 2: •patients patients •Effect •Certain Row 3: •Row 4: Other considerations •LDCT screening •LDCT screening −Relative (95% CI) •Absolute (95% CI), •row 5: • row 6: ♪ Row 7: ■Row 7:",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (column column 2)",
      "text": "Row 1: 346/15917 (2.2%) •416/15189 (2.7%) •80 80 (0. 0.92) •000 000 (2 2 less)",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (column column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (column column 2)",
      "text": "Row 1: 1548/15917 (9.7%) •1515/15189 (10.0%) •98 98 (1. 1.07) •000 000 (7 7 more)",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (column column 2)",
      "text": "Row 1: 375/15917 (2.4%)",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (column column 2)",
      "text": "Row 1: 194/15917 (1.2%) • 276/15189 (1.8%) ♪ 67 67 (0. 0.80) • 000 000 (4 4 less)",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (column column 2)",
      "text": "Row 1: ng cancer) Row 2:",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (column column 2)",
      "text": "Row 1: 224/7305 (3.1%) •74/6554 (1.1%) •57 57 (3. 3.74) •000 000 (31 31 plus)",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading <Diagnostics. Diagnostics. 2024; 14:399.> (column column 3)",
      "text": "Row 1: \"Row 2: \"Importation Row 3: \" Row 4: \" Row 5: \" Row 6: \"CRITIC Row 7: \" Row 8: \" \" Row 9: \" CRITIC Row 10: \" row 11: \" ' Row 12: \" CRITIC Row 13: \" Route 14: \" - \" Row 15: \" Criticic Row 16: \"\" Row 17: \" Now 18: \"",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading <Explanations>",
      "text": "Row 1: ... . . . ... . ..\" . .\" . . .\" . . \" . .",
      "start_page": 204,
      "end_page": 204
    },
    {
      "heading": "heading heading <Explanations> (column 1)",
      "text": "Row 1: • Row 2: Certainty assessment •patients patients •Effect •Certo Row 3: •Row 4: studies studies •study study •Disruption risk •Sustainability loss •Improvement •More considerations •LDCT screening •LDCT screening ■Related (95% CI) •Absolute (95% CI), •row 5: • Overdiagnosis - screening screening (follow up: 5 5 years; •screen-detected screen-detected cancers).",
      "start_page": 204,
      "end_page": 204
    },
    {
      "heading": "heading heading <Explanations> (column 2)",
      "text": "Row 1: Row 2: Importance Row 3: Row Row 4: Row 5: CRITIC Row 6: Row 7: Row 8: IMPORTANT",
      "start_page": 204,
      "end_page": 204
    },
    {
      "heading": "heading heading <BACKGROUND:>",
      "text": "Row 1: day. day.",
      "start_page": 205,
      "end_page": 205
    },
    {
      "heading": "heading heading <BACKGROUND:> (column 1)",
      "text": "Row 1: Row Row 3: \"annual\" to to non-screening? Row 4: \"Row 5: \"POPULATION\": \"Raw 6: \"ROW 7: \"INTERVENTION\":",
      "start_page": 205,
      "end_page": 205
    },
    {
      "heading": "heading heading <BACKGROUND:> (column 2)",
      "text": "Row 1: Row Row 2: Row Row 3: Row 4:",
      "start_page": 205,
      "end_page": 205
    },
    {
      "heading": "heading heading <BACKGROUND:> (column 3)",
      "text": "Row 1: day day ... Row 2: ale ale ... Row 3: \"Row 4: \"",
      "start_page": 205,
      "end_page": 205
    },
    {
      "heading": "heading heading <Problem>",
      "text": "136, 136, - NS NS (13, 13, 14) 2021 2021 (15). Italy Italy (6, 10, 13) Netherlands Netherlands (14), Germany (11), and Denmark (8).",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: • Row 2: • Problem Row 3: • Row Row 4: •",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Row 2: Row 3: Rity? Row 4:",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Row 2: ects Row 3: Row Row 4:",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "heading heading <Problem> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "heading heading <Problem> (column 3)",
      "text": "Row 1: \"EVIDENCE EVIDENCE TESTS\": \"Row 2: Lung Cancer (LC) computing computing (LDCT) achieved a 20% Trial Trial (NLST), radiography radiography [1], trials trials (RCT) RCTs RCTs [1",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "heading heading <Problem> (column 3)",
      "text": "Row 1: Row Row 2: Reviews Reviews (CENTRAL), controlled controlled trials; population population (n.3) or intervention (n.2) CXR CXR (populating populating (n.3) or participation (interest interest & CxR CxR (3: population population (peer peer education) population population (no) (3. 3.",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "heading heading <Problem> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "(CCI) trials trials (95% CI) (studies) (GRADE) 31106 31106 - no no (a a (6 RCT) 0. 0.992) follow up: years years (19 to 25) All-case mortality - 998 998 31106",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website* European European Union: http://europa.eu.int/comm/index_en.htm",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row 2: Relative Row 3: (95% CI)",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: participants (studies)",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row confidence 2: Row 3: (GRADE)",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "== Demographic evolution ====References==",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: • Row 2: •Certez tests (GRAD) • Certez Row 3: panti •Test Row 4: •GRAD",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: Row 3: and Row 4: DE) Row 5:",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: \"Row\" 2: \"Coco Row\" 3: \"Rown\" 4: \"Raw\"",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row 2: ommen Row 3:",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: Row 2: nti",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: •Resectability rate - 13859 13859 • screening screening (a a (4 RCT) MODERATAb evaluated with: surgery 3.74) 000 000 follow-up: interval 3 (20 to 42) performance performance and/specific specific survival",
      "start_page": 208,
      "end_page": 208
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Resectability rate - evaluated evaluated with: cancer cancer follow-up: 35 35 years",
      "start_page": 208,
      "end_page": 208
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (20 to 42)",
      "start_page": 208,
      "end_page": 208
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: Resectability rate - evaluated evaluated with: follow follow up: 57 57 (3. 3.74)",
      "start_page": 208,
      "end_page": 208
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: \"Early Early detection\"",
      "start_page": 209,
      "end_page": 209
    },
    {
      "heading": "heading heading <Undesirable effects>",
      "text": "Row 1: \"Resectability Resectability rate\" Row 2: \"Row\" 3: \"Undesirable effects\" Row 4: \"anticipated anticipated effects?",
      "start_page": 210,
      "end_page": 210
    },
    {
      "heading": "heading heading <Undesirable effects> (column 1)",
      "text": "Row 1: • Row 2: • Row Row 3: • Row Row 4: •",
      "start_page": 210,
      "end_page": 210
    },
    {
      "heading": "heading heading <Undesirable effects> (column 2)",
      "text": "Row 1: \"Row 2: s\" Row 3: rable anticipated effects?",
      "start_page": 210,
      "end_page": 210
    },
    {
      "heading": "heading heading <Undesirable effects> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 210,
      "end_page": 210
    },
    {
      "heading": "heading heading <Undesirable effects> (column 10)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \"",
      "start_page": 210,
      "end_page": 210
    },
    {
      "heading": "heading heading <Undesirable effects> (from previous page)",
      "text": "Row 1: FALLOWING FALLOWING (FULLY FALSEING) FOLZING FON'FALKING FALKING - FALCING FILES) FUR, FUR, F/F. F.",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading <Undesirable effects> (from previous page)",
      "text": "Row 1: \"Row 2: Esiti\" Precipitated absolute effect* (95%) = relative effect (95% CI) = participants participants (studies) = [tests tests (GRADE) ] = [Comments Row 3: \"CI\") = Row 4: \" Row 5: \" Row 6: \"LDCT LDCT screening\" = \"Richness with \" Row 7: \"LDCT\" = row 8: \"Screening Row\" = 9: \" Row 10: Overdiagnosis - evaluated evaluated by: number number of",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading <Undesirable effects> (from previous page)",
      "text": "Row 1: Row 2: Relative Row 3: (95% CI)",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading <Undesirable effects> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: participants (studies)",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading <Undesirable effects> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: (GRADE)",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading <Undesirable effects> (from previous page)",
      "text": "Row 1: Row Row 2: LDCT screening",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading <Undesirable effects> (from previous page)",
      "text": "Row 1: Average Row 2: overdiagnosis - Row 3: Row Row 4: screening was 0",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading <Undesirable effects> (from previous page)",
      "text": "Row 1: overdiagnosis Row 2: Row Row 3: (Row Row 4: Row Row 5: Row Row 6: greater)",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading <Undesirable effects> (column column 4)",
      "text": "Row 1: \"Row 2: Esiti\" Precipitated absolute effect* (95%-) = relative effect (95% CI) = participants participants (studies) = [tests tests (GRADE) ] = [Comments]: Row 3: \"Ci\") = Row 4: \" Row 5: \" Row 6: \"LDCT LDCT screening\" = \"Richness with \"Raw 7\": \"LDCT\" = 8: \"Screening\" = 9: \" Row 10: Overdiagnosis - \"LDCT\" vs \"no screening\" evaluated by: of of \"-\"28656 (5 RCT) = \"BASSAa,b\" = 11: \"overdiagnoses overdiagnoses - major major (12. 12.63).",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading <Undesirable effects> (column column 5)",
      "text": "Row 1: Row 2: i",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading <Undesirable effects> (from previous page)",
      "text": "Row 1: \"follow follow up: rate rate - positive positive - 8635 = rate rate - 53 53 (2 RCT) is followed up: 0 0 (09 09 greater) performance performance and/studies studies (I-squared=65%) studies. studies.",
      "start_page": 212,
      "end_page": 212
    },
    {
      "heading": "heading heading <Undesirable effects> (from previous page)",
      "text": "Row 1: follow follow up: 5 5 years",
      "start_page": 212,
      "end_page": 212
    },
    {
      "heading": "heading heading <Undesirable effects> (from previous page)",
      "text": "Row 1: Row Row 2: positive rate - Row 3: Row Row 4: screening was 0",
      "start_page": 212,
      "end_page": 212
    },
    {
      "heading": "heading heading <Undesirable effects> (column column 1)",
      "text": "Row 1: follow follow up: 5 5 years",
      "start_page": 212,
      "end_page": 212
    },
    {
      "heading": "heading heading <Values>",
      "text": "Row 1: \"False positive\" = \"Row 3\": \"Certainty of evidence\" = . \"of of effects?\" = .",
      "start_page": 213,
      "end_page": 213
    },
    {
      "heading": "heading heading <Values> (column 1)",
      "text": "Row 1: \"Row 2: \" Row 3: \"Certainty of evidence\" Row 4: \"of of effects? \" Row 5: \" Row 6: \"JUDIZI\" Row 7: \"Very low \" Low ● \"Moderate \"High \" No included studies\" Row 8: \"Raw 9: \"Values\" Row 10: \"people people value\" Row 11: \"",
      "start_page": 213,
      "end_page": 213
    },
    {
      "heading": "heading heading <Values> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 213,
      "end_page": 213
    },
    {
      "heading": "heading heading <Values> (column 2)",
      "text": "Row 1: Row 2: Row 3: main main outcomes? Row 4:",
      "start_page": 213,
      "end_page": 213
    },
    {
      "heading": "heading heading <Values> (column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 213,
      "end_page": 213
    },
    {
      "heading": "heading heading <Equity>",
      "text": "Row 8: the the appearance?",
      "start_page": 214,
      "end_page": 214
    },
    {
      "heading": "heading heading <Equity> (column 1)",
      "text": "Row 1: health health capital: Row 2: \"or or variableity\" = \"or or variability\" = ● variable, variable, \"or or variables\" = row 3: \"Row 4: \"Balance of effects\" = Row 5: \"the the interv\" = rule 6: \" Row 7: JUIDIZI\" = Rule 8: \" Favors the comparison\" = * \"the the compare\" = comparison comparison \"the the intervention\" ==References===External links==* Official website",
      "start_page": 214,
      "end_page": 214
    },
    {
      "heading": "heading heading <Equity> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 214,
      "end_page": 214
    },
    {
      "heading": "heading heading <Equity> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 214,
      "end_page": 214
    },
    {
      "heading": "heading heading <Equity> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 214,
      "end_page": 214
    },
    {
      "heading": "heading heading <Equity> (column 4)",
      "text": "Row 1: Row 2: Row 3: mparison? Row 4:",
      "start_page": 214,
      "end_page": 214
    },
    {
      "heading": "heading heading <Equity> (column 11)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 214,
      "end_page": 214
    },
    {
      "heading": "heading heading <Feasibility>",
      "text": "Row 1: \"Reduced \" Probably reduced \" ● impact impact \" Probably increased \" Varies \" Don't know \"found found \" Row 2: \" Row 3: \"Acceptability \" Row 4: \"key key stakeholders? \" Row 5: \" Yes \" Diverses \" know know \" No evidence found\" Row 8: \" Row 9: \"Feasibility\" No ● \"Row 10: \"to to implementation\"?",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading <Feasibility> (column 1)",
      "text": "Row 1: \"Row 2: \"Acceptability Row 3: \"Row Row 4: \"",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading <Feasibility> (column 1)",
      "text": "Row 1: \"Row 2: \"Feasibility Row 3: \"Row Row 4: \"",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading <Feasibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading <Feasibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading <Feasibility> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: stakeholders stakeholders \" Row 4: \"",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading <Feasibility> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: implementation? \" Row 4: \"",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading <Feasibility> (column 4)",
      "text": "Row 1: Row 2: Row 3: s? Row 4:",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading <Feasibility> (column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading <Feasibility> (column 16)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading <TIP OF RECOMMENDATION>",
      "text": "Row 1; Row 2; GIUDIZI 5; Row 4; No 5; Probably: Proba bly; ProBably; Vols. Vols.",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "heading heading <TIP OF RECOMMENDATION>",
      "text": "Row 1: the the intervention",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "heading heading <TIP OF RECOMMENDATION> (column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "heading heading <TIP OF RECOMMENDATION> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: Don't know\" Row 5: \"Don't knowing\" Row 6: \"Don't known\" Row 7: \"No included studies\" Row 8: \"Raw 9: \"Row\" 10: \"Wow\" 11: \"T\" Know\" Row 12: \"N't knows\" Row 13: \"Not know\" row 14: \"don't really know\"",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: • Row 2: • Recommendation • row 3: •",
      "start_page": 217,
      "end_page": 217
    },
    {
      "heading": "heading heading <harvested harvested lymphonodes>",
      "text": "== Demographic evolution ====References==",
      "start_page": 218,
      "end_page": 218
    },
    {
      "heading": "heading heading <Harvested Harvested Lymphhonodes> (column 1)",
      "text": "Row 1: ... -Low 1: -10:study study (s) \"of of distortion\"Disruption risk (iflow up: median 7 years) \"Row 8: • Row 9: 21,2'Studies randomizability\" \"Impered\"No important\" (not important) \"no important\" \"non important\" Not important\" Row 10: Overall Survival RCT: Follow up up: years years old) \" Row 8: \"Raw 9: 2,2\" studs randomized \"non-important\" (non important) ] \" Row 10: RCT RCT (follow 9:21,2: Ooverall Survival RCT): \"Overall survival RCT\" (no important): \"Nor not important\": Ow 12: 1 1 - major observational: - major: 2 2 - 5 - 13 - 6 - not important - not significant - 12 - not major - non - not so - major - not huge - not relevant - major [ major - including important - 15 - 15, - 14 - 15; - 25 - 16 - 12, 12 - major",
      "start_page": 218,
      "end_page": 218
    },
    {
      "heading": "heading heading <Harvested Harvested Lymphhonodes> (column 2)",
      "text": "Row 1: ... .. . . . ... . ..\" . . .\" . .\" . . \" . .",
      "start_page": 218,
      "end_page": 218
    },
    {
      "heading": "heading heading <Postoperative air leaks>",
      "text": "== Demographic evolution ====References==",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading <Postoperative air leaks> (column 1)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row Row 6:",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading <Postoperative air leaks> (column 1)",
      "text": "Row 1: Row Row 2:",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading <Postoperative air leaks> (column 1)",
      "text": "Row 1: RCT RCT (follow up: Row 2:",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading <Postoperative air leaks> (column 1)",
      "text": "Row 1: Row Row 2:",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading <Postoperative air leaks> (column 1)",
      "text": "Row 1: Row Row 2:",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading <Postoperative air leaks> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row Row 6: \"",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading <Postoperative air leaks> (column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading <Postoperative air leaks> (column 2)",
      "text": "Row 1: : median 7 years) Row 2:",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading <Postoperative air leaks> (column 3)",
      "text": "Row 1: \"Row 2: Certainty assessment\" Row 3: \"Raw 4: \" Row 5: Risk of distortion\" results results \"Made of generalization\" precision precision \"More considerations\" Row 6: \" Row 7: not not important\" non-important \"Not important\" Row 8: \"Rop 9: \"Row 10: serious\" non important \"No important\" row 11: \"row 12: \" Row 13: serious \"not important\" \"Seriog\" Row 14: \"Wow 15: \"How 16: serious or serious\" not important \"Way 17: \" Now 18: \"Now 19: serious not important\"\" Not important\"",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading <Postoperative air leaks> (column 4)",
      "text": "Row 1: • Row 2: •patients patients • row 3: •Row 4: •row 5: oniřla segmentectomy •lobectomy",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading <Postoperative air leaves> (column 5)",
      "text": "Row 1: \"Row\" (95% CI) \"Absolute (95% CI), \"Certo-Row 5: \"Rop\" 6: \"Middle\" (0. 0.74) \"Very low\" [Row 7: \"ROW 8: \"Row 9: \"‐Md\" less less (0. 0.46) ] \" Very low\" (Row 10: \"Rule 11: \" Row 12: \"RR 1.61\" (2. 2.31) \"100 100 (9 9 more) \"Row Row 13: \"Now 14: \" Row 15: \"Or 1.40\" (2. 2.08) \"100 100 (5 5 more) ...\" Very low \"Raw 16\": \"Short 17: \"row 18: \"Last\" (2. 2.08) \"2 + 100 (5 5 more).",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading <Rehospitalization - not reported>",
      "text": "==References===External links==* Official website",
      "start_page": 220,
      "end_page": 220
    },
    {
      "heading": "heading heading <Rehospitalization - not reported> (column 1)",
      "text": "Row 1: ..............................................................................................",
      "start_page": 220,
      "end_page": 220
    },
    {
      "heading": "heading heading <Rehospitalization - not reported> (column 2)",
      "text": "Row 1: • \"Row\" 1: \"No\": \"No of patients\" \"Import Row 3: • Row 4: \"Oni\" the segmentectomy\" \"Lobectomy\") \"Relative (95% CI) \"Absolute (95%CI) \"Certo\" Row 5: \"Ru\" 6: \"Wow\" 7: • Row 8: \"36/552 (6.5%) \"Ra\" 21/554 (3.8%) \"72 72 (2. 2.90) \"100 100 (7 7 more) \"Bassa\" CRITICO Row 9: \"Row 10: ♪ Row 11: \"1/38\" (2.6%) \"R\"8/289 (2.8%) \"95 95 (7. 7.81) \"100 100 (15 15 more) ] \"Very low\" RW: \"CRITICo Row 12: \" Row 13: \"-Row 148/552 (26.8%) =142/554 (25.6%).\"",
      "start_page": 220,
      "end_page": 220
    },
    {
      "heading": "heading heading <DOMANDA>",
      "text": "Row 1: Recidental hospital stay; Local recurrence; Postoperative air leaks; Post-operative airleaks (Row)",
      "start_page": 222,
      "end_page": 222
    },
    {
      "heading": "heading heading <Desirable effects>",
      "text": "Row 1: \"Row 2: PERSPECTIVE: \" Row 3: \" Row 4: BACKGROUND: \" row 5: \" Row 6: \" CONFLICT OF INTERESTS: \"row 7: \"",
      "start_page": 223,
      "end_page": 223
    },
    {
      "heading": "heading heading <Desirable effects>",
      "text": "Row 1: = = ==Demographics==a a priority? ==References=_==External links==* Official website",
      "start_page": 223,
      "end_page": 223
    },
    {
      "heading": "heading heading <Desirable effects> (column 1)",
      "text": "Row 1: \"Row 2: PERSPECTIVE: \" Row 3: \" Row 4: BACKGROUND: \" row 5: \" Row 6: \" CONFLICT OF INTERESTS: \"row 7: \"",
      "start_page": 223,
      "end_page": 223
    },
    {
      "heading": "heading heading <Desirable effects> (column 1)",
      "text": "October October 2023: from from Don'October October 2023; records. records.",
      "start_page": 223,
      "end_page": 223
    },
    {
      "heading": "heading heading <Desirable effects> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 223,
      "end_page": 223
    },
    {
      "heading": "heading heading <Desirable effects> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 223,
      "end_page": 223
    },
    {
      "heading": "heading heading <Desirable effects> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading <Desirable effects> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading <Desirable effects> (from previous page)",
      "text": "Row 1: Row 2: Relative Row 3: (95% Row 4: CI)",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading <Desirable effects> (from previous page)",
      "text": "Row 1: Row Row 2: participants (studies)",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading <Desirable effects> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: (GRADE)",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading <Desirable effects> (from previous page)",
      "text": "Row 1: Row Row 2: (14 to 20)",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading <Desirable effects> (from previous page)",
      "text": "Row 1: Row Row 2: (-- a --)",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading <Desirable effects> (from previous page)",
      "text": "Row 1: Row Row 2: (23 to 30)",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading <Desirable effects> (from previous page)",
      "text": "Row 1: Row Row 2: (-- a --)",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading <Desirable effects> (column column 1)",
      "text": "==See also==*Row==References===External links==",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading <Desirable effects> (column column 2)",
      "text": "Row 1: ?Studies' No Row 3: \"Row\" 4: \"Raw\" 5: \"Rown\" 6: \"Row\" 7: \"My Row\" 8: \"The Row\" 9: \"HR\" 0.82 (1. 1.02) \" Row 10: \"Wow\" 11: \"How\" 12: \" Row\" 13: \"Now\" 14: \"row\" 15: \" Row\" 16: \"hr\" 1.09 (1. 1.28) \" Row 17: \"Heavy\" 18: \"Dow\" 19: \"raw\" 20: \" Now\" 21: \" Roll\" 22: \"- Row\" 23: \"H\" 1.00 (1. 1.18) \"Rlow\" 24: \"Ow\" 25: \"Cow\" 26: \"===References==Further reading==",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading <Desirable effects> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading <Desirable effects> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading <Desirable effects> (column column 7)",
      "text": "Row 1: \"Row\" 2: \"the the tests\" (GRADE) \"Creative Row 3: \"The Row\" 4: \"Test Row\" 5: \"GRADE\"",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading <Desirable effects> (column column 8)",
      "text": "Row 1: \" Row 2: a\"Comments Row 3: \" Row 4: \" Row 5: ) \" Row 6: \"Row Row 7: \" Row Row 8: \"probably probably doesn'row row 9: \"cause cause any",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading <Desirable effects> (from previous page)",
      "text": "07 07 - 792 • inferior inferior (5 observational studies) 58 58 - 1412 • 0 0 (0. 0.46) 0 0 (0. 0.66) H. H.",
      "start_page": 225,
      "end_page": 225
    },
    {
      "heading": "heading heading <Desirable effects> (from previous page)",
      "text": "Row 1: \"Row Row 2: \" Row 3: \" Row 4: life life - not reported\" - \"-\"-\" Row 5: \"-\"\"-\" row 6: \"Row 7: harvested harvested lymphonodes-\"\"792 (5 observational studies) 23, 23,24\" Very lowe,f\"Row Row 8: \"was was 0'lower lower (44 44 below) Row 9: \" Row 10: Lenght hospital stay-\"1412 (9 observational trials)28 28 • and, and,f",
      "start_page": 225,
      "end_page": 225
    },
    {
      "heading": "heading heading <Desirable effects> (from previous page)",
      "text": "Row 1: Average Row 2: Row Row 3: Harvested Row 4: Lymphonodes Row 5: was 0",
      "start_page": 225,
      "end_page": 225
    },
    {
      "heading": "heading heading <Desirable effects> (from previous page)",
      "text": "Row 1: Row Row 2: Lower Row 3: (Row Row 4: 0.74 lower)",
      "start_page": 225,
      "end_page": 225
    },
    {
      "heading": "heading heading <Desirable effects> (from previous page)",
      "text": "Row 1: Average Row 2: Row Row 3: Stay was 0",
      "start_page": 225,
      "end_page": 225
    },
    {
      "heading": "heading heading <Desirable effects> (from previous page)",
      "text": "Row 1: Row Row 2: Lower Row 3: (Row Row 4: 0.46)",
      "start_page": 225,
      "end_page": 225
    },
    {
      "heading": "heading heading <Desirable effects> (from previous page)",
      "text": "==References===External links==* Cardiovasc Cardiovasc Surg; J. J., P. P., A. A., Awais, O., J. J., Abbas, G., M. M., Weksler, B., Luketich, J",
      "start_page": 226,
      "end_page": 226
    },
    {
      "heading": "heading heading <Desirable effects> (from previous page)",
      "text": "==References===External links==* Thorac Thorac Cancer; T. T., M. M., D., F. F., G. G., J J Surg; X. X., Q. Q., Surg. Surg.",
      "start_page": 227,
      "end_page": 227
    },
    {
      "heading": "heading heading <DFS (RCT)>",
      "text": "Row 1: DFS DFS (RCT)",
      "start_page": 228,
      "end_page": 228
    },
    {
      "heading": "heading heading <OS>",
      "text": "Row 1: \"DFS\" OS RCT __MEDTERM0_=--",
      "start_page": 229,
      "end_page": 229
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "Row 1: \"Harvested Harvested Lymphonodes\"",
      "start_page": 230,
      "end_page": 230
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "Row 1: \"hospital hospital stay\" Row 2: \"Row 3: \"Undesirable effects\" Row 4: \"anticipated anticipated effects?\" Row 5: \"Raw 6: \"JUDICIAL EVIDENCE TESTS\"",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "heading heading <OS_> (column column 1)",
      "text": "Row 1: \"Row 2: \"Undesirab Row 3: \"Row Row 4: \"",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "heading heading <OS_> (column column 2)",
      "text": "Row 1: \"Row 2: ble effects\" Row 3: anticipated anticipated effects?",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "heading heading <OS_> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "heading heading <OS_> (column column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" ADDITIONAL CONSIDERATIONS \"",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "==Demographic evolution===References==*figures figures 2006<br>==External links==",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "Row 1: Row 2: Relative Row 3: (95% Row 4: CI)",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "Row 1: Row Row 2: participants (studies)",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: (GRADE)",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "Row 1: Row Row 2: (8 to 17)",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "Row 1: Row Row 2: (5 to 10)",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "heading heading <OS_> (column column 2)",
      "text": "Row 1: __MEDTERM0_ __MEDTERM0_ (T1aN0) Effect Effect Early* Certifications Certifications (95% CI) relative (studies) of the (95% Neiviral Neiviral disease) (GRADE) Lobctomy. Lobctomy.",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "Row 1: \"leads leads (RCT) (to to (1 RCT)2. 2.90) (4 to 11) OR OR 327",
      "start_page": 233,
      "end_page": 233
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 233,
      "end_page": 233
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "Row 1: Row Row 2: (0 to 18)",
      "start_page": 233,
      "end_page": 233
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "Row 1: Row Row 2: (22 to 33)",
      "start_page": 233,
      "end_page": 233
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "Row 1: Row Row 2: (19 to 30)",
      "start_page": 233,
      "end_page": 233
    },
    {
      "heading": "heading heading <OS_> (column column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"RR 1.72\" (2. 2.90) Row 5: \"Study population\" = 6: \" Row 7\": \"Raw 8: \"10\" = 9: \"4 to 11\") \" Row 10: \"Row 11: \"OR 0.95\" (7. 7.81) \" Row 12: \" Studio population\" * Row 13: \" row 14: \" Row 15: \"3 for 100\" = 100 (0 to 18) \" Row 16: \"ROW 17: \"04 04 (1. 1.27) \" Row 18: \"Population in study\" = 19: \" Now 20: \"",
      "start_page": 233,
      "end_page": 233
    },
    {
      "heading": "heading heading <OS> (column column 9)",
      "text": "Row 1: Row Row 2: Row 3: Row Row 4: Row Row 5: complications. complications.",
      "start_page": 233,
      "end_page": 233
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "Row 1: \"Rehospitalization - - -- - H. H., Okada, M., Tsuboi, M:, Nakajima, R., Suzuki, K., Aokage, K; Aokaki, T., Nakami, J., Yoshino, I., Ito, H ., Okaumura, N., I. I. , Asamura, H ... peripheral, peripheral, non-ferill-cell cancer (JCOG0802/WJOG4607L): E. E., Nakas, A., E. E. , J. J., Cardiothorac Cardiothorac Surg; W. W., Yoshimura, M., Maniwa, Y., Kitamura, Y ., Tane, K ., Takenaka, D ., Adachi, S.. Thorac Thorac Surg; A A ... Schuchert, MJ., L. L., P. P., Daddi, N., Loizzi, D., Ampollini, L., Ardò, N ., Ventura, L ..., Carbognani, P. , Potenza, R., Ardissone, F., Sollitto, F ., Mattioli, S., M. M., Ragusa, M .. long long cancer: elderly elderly patients?. Surg Today; Dec 2016.",
      "start_page": 234,
      "end_page": 234
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "Row 1: Rehospitalization - not reported",
      "start_page": 234,
      "end_page": 234
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "Rowhang 1: R. R., J. J., Pennathur, A., O. O., Siegfried; J. M., D. D., J J == References ==== External links ==* J J Surg; K. K., Saji, H., I. I., Okada, M., Mizusawa, J., Nakajima, R., Tsuboi, M ., Nakamura, S",
      "start_page": 235,
      "end_page": 235
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "Row 1: \"Misumi,\" K., Hanaki, H., Hida, E., Okada, M.. J J Surg; rhythmic rhythmic (Y. Y., Miyata, Y",
      "start_page": 236,
      "end_page": 236
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "Row 1: \"Postoperative air leaks\"",
      "start_page": 237,
      "end_page": 237
    },
    {
      "heading": "heading heading <OS> (from previous page)",
      "text": "Row 1: \"Postoperative complications\"",
      "start_page": 238,
      "end_page": 238
    },
    {
      "heading": "heading heading <Certainty of evidence>",
      "text": "Row 1: 'Row 2: ' Row 3: 'Certainty of evidence' Row 4: 'of of effects? ' Row 5: ' Row 6: 'JUDICES' EVIDENCE EVIDENCE TESTS'.",
      "start_page": 239,
      "end_page": 239
    },
    {
      "heading": "heading heading <Certainty of evidence> (column 1)",
      "text": "Row 1: \"Row 2: \" Row 3: \"Certainty of evidence\" \" Row 4: \"of of effects?\" \" Row 5: \" Row 6: \"JUDIZI\" Row 7: \"Very low \"Low ● Moderate \"High \" No included studies\"",
      "start_page": 239,
      "end_page": 239
    },
    {
      "heading": "heading heading <Certainty of evidence> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 239,
      "end_page": 239
    },
    {
      "heading": "heading heading <Certainty of evidence> (column 6)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 239,
      "end_page": 239
    },
    {
      "heading": "heading heading <Values>",
      "text": "Row 1: \"main main outcomes? \" Row 3: \"main main outcome?\" \" Row 4: \"Row 5: \"Judizi\"\" \"di di evidenza\" \"additional additional evidence\" \" Row 6: \"or or variable\" ● \"variability variability \"variables variables \"variation variation \"found. found.\" \"considerations considerations \" Row 7: \" Row 8: \"effects effects \" Row 9: \"the the companion\" \"Row 10: \"Company Row 11: interventions interventions \"",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 1)",
      "text": "Row 1: 'Row 2: 'Values Row 3: 'Row Row 4: ' Row 5: JUDICES' Row 6: 'or or variable' Row 7: 'Raw 8: 'Row Row 9: 'Row Row 10: ' Row 11: JUDIZI' Row 12: 'appearance appearance 'comparison comparison ' comparison comparison ● intervention intervention ' participation participation '",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 2)",
      "text": "Row 1: Row 2: Row 3: ncertaint Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 2)",
      "text": "Row 1: Row 2: cts Row 3: Row Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 4)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 4)",
      "text": "Row 1: Row 2: Row 3: desirable Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 5)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 5)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 6)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 6)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 7)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 7)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 8)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 8)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 9)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 9)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 10)",
      "text": "Row 1: Row 2: Row 3: mes? Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 10)",
      "text": "Row 1: Row 2: Row 3: mparison? Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 11)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 11)",
      "text": "Row 1: Row 2: Row 3: ? Row 4:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Values> (column 16)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading <Feasibility>",
      "text": "Rowlng 1: \"Rowlng: \"Raw\": \"Equity\": row 3: \"health health equity?\": \"Now 5: \"JUDITIONS\": ...\"TESTS, TESTS,\" \"ADDITIVE TESTING\":\"\"Row 6: \"Reduced \"Probably reduced \"impact impact ● Probably increased \"Varies \"Don't know\":found. found. \"Ruy 7: \"Row 8: \"Acceptability\"\" = 9: \"key key stakeholders?",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading <Feasibility> (column 1)",
      "text": "Row 1: \"Row 2: \"Equity Row 3: \"Row Row 4: \"",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading <Feasibility> (column 1)",
      "text": "Row 1: \"Row 2: \"Acceptab Row 3: \"Row Row 4: \"",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading <Feasibility> (column 1)",
      "text": "Row 1: \"Row 2: \"Feasibility Row 3: \"Row Row 4: \"",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading <Feasibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: health health equity? Row 4:",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading <Feasibility> (column 2)",
      "text": "Row 1: \"Row 2: balance\" Row 3: key key stakeho\" Row 4: \"Raw\"",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading <Feasibility> (column 2)",
      "text": "Row 1: \"Row 2: y\" Row 3: \"to to implementation?\" \"Rop 4: \"Raw\"",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading <Feasibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading <Feasibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: Olders? Row 4:",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading <Feasibility> (column 15)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading <JUDIZI>",
      "text": "Row 1; Row 2; GIUDIZI 5; Row 4; No 5; Probably: Proba bly; ProBably; Vols. Vols.",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "heading heading <JUDIZI> (column 1)",
      "text": "Row 1: Row 2: PROBLEM Row 3: Row 4: Row 5: Row Row 6: Row 7: Row 8: Row Row 9: Row 10: Row 11: Row Row 12: Row 13: Row 14: VALUES Row 15: Row 16: Row 17: Row Row 18: Row 19: Row 20: EQUITY Row 21: Row 22: Row 23: ACCEPTABILITY Row 24: Row 25: Row 26: FEASIBILITY Row 27:",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "heading heading <JUDIZI> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" row 7: \" \" Row 8: \" TS \" Row 9: \" Row 10: \" ' Row 11: \" ECTS \" Row 12: \" Now 13: \" Route 14: \" ENCE\" Row 15: \"Raw 16: \" Right 17: \" - \" Row 18: \" [ Row 19: \"] Row 20: \" CTS \" row 21: \" # Row 22: \") \" Row 23: \" * Row 24: \" = Row 25: \" Roll 26: \" ] Row 27: \" . \" Row 28: \" Rot 29: \" . \" Row 30: \"",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "heading heading <JUDIZI> (column 3)",
      "text": "Row 1: Row 2: JUDICES Row 3:",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "heading heading <JUDIZI> (column 3)",
      "text": "Row 1: Probably no\"Row Row 2: Small\"Moderate Row 3: Moderate\"Small Row 4: Low\"Miderate Row 5: or or variableity\"Row Row 6: the the comparison\"Row Row 7: PROBABLY REDUCED",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "heading heading <JUDIZI> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\" Row 17: \" Raw 18: \"",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "heading heading <JUDIZI> (column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6:",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "heading heading <JUDIZI> (column 6)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Don't know\" Row 5: \"Done't known\" Row 6: \"Do't knows\" Row 7: \"No included studies\" Row 8: \"Raw 9: \"Now\" 10: \"Row 11: \" Row 12: \"Wow\" 13: \" Don't Know\" Row 14: \"don't really know\" row 15: \" don't knowing\" Row 16: \"Soon't knowledge\"",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "heading heading <CONCLUSIONS>",
      "text": "Row 1: the the intervention",
      "start_page": 243,
      "end_page": 243
    },
    {
      "heading": "heading heading <CONCLUSIONS>",
      "text": "Row 1: • Row 2: • Recommendation • row 3: •",
      "start_page": 243,
      "end_page": 243
    },
    {
      "heading": "heading heading <CONCLUSIONS> (column 1)",
      "text": "Row 1: the the intervention",
      "start_page": 243,
      "end_page": 243
    },
    {
      "heading": "heading heading <CONCLUSIONS> (column 1)",
      "text": "Row 1: \"Row 2: \"Recommendation Row 3: \"",
      "start_page": 243,
      "end_page": 243
    },
    {
      "heading": "heading heading <CONCLUSIONS> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \"",
      "start_page": 243,
      "end_page": 243
    },
    {
      "heading": "heading heading <Local control - not reported>",
      "text": "==References===External links==* Official website",
      "start_page": 244,
      "end_page": 244
    },
    {
      "heading": "heading heading <Objective response>",
      "text": "== References ==== External links ==* Official website",
      "start_page": 245,
      "end_page": 245
    },
    {
      "heading": "heading heading <Objective response> (column 1)",
      "text": "Row 1: ....\"Row 2: the the \"Row 3: today's response (follow up: 8 8 months) Russ 6: \"Raw 7: 1\" \"randomised trials\" serious: \"serious b ...Row Row 5: response response (folkup up: 8 8 metres) Row 6: ): \" Row 7:1 \"ranomissed trials \"row row 5: row row 8: life life - not reportedd",
      "start_page": 245,
      "end_page": 245
    },
    {
      "heading": "heading heading <Objective response> (column 2)",
      "text": "== References ==== External links ==* Official website",
      "start_page": 245,
      "end_page": 245
    },
    {
      "heading": "heading heading <Treatment related death>",
      "text": "Row 1: \"Row\" 2: events events (follow up: 5 5 months; assigned with: NCI-CTCAE 4.03) * Row 3: \"Rown\" 4: \"Raw\" 4: 1 \"randomised trials\" \"not serious\" a \"not silky\" b \"serious\" f \"none\"145/475 (30.5%) \"61/234\" (26.1%) \"17 17 (1. 1.51) \"100 100 (13 13 more) \"LOW\" CRITICAL\" Row 5: Treatment related death\" Row 6: \"Rw\" 7: 1 \"ranked trials\" (\"not serious\") \"not seriously\" (4 4 more)",
      "start_page": 246,
      "end_page": 246
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: to to 1% Row 4: • Row 5: INTERVENTION: • _MEDTERM0__ Row 6: ♪ Row 7: CONFRONT: @Row 8: ■ Row 9: Main outcomes: − Overall survival; disease-free survival; remote metastasis; local disease control; objective response rate; duration of responses; quality of life; adverse adverse events; Grade 3-4 lunges; Row 10: ‐ Row 11: SETTING: ^Ambulatorial Row 12:",
      "start_page": 247,
      "end_page": 247
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: \"Row 2: a a priority? \" Row 3: \" Row 4: JUDICES\" \"Row Row 5: \"No\" \"Probably no\" \"No.\"",
      "start_page": 247,
      "end_page": 247
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: Row 2: Row 3: POPULATION: Row 4: Row 5: Row 6: INTERVENTION: Row 7: Row 8: CONFRONTO: Row 9: Row 10: MAIN RESULTS: Row 11: Row 12: Row 13: SETTING: Row 14: Row 15: PROSPECT: Row 16: Row 17: BACKGROUND: Row 18: Row 19: Row 20: Row Row 21:",
      "start_page": 247,
      "end_page": 247
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: Row 2: a a priority? Row 3:",
      "start_page": 247,
      "end_page": 247
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \"to to 1% Row 4: \" Row 5: \" \"_MEDTERM0__ Row 6: \" Row 7: \"Overview Row 8: \" row 9: \" Global survival; disease-free survival; distance metastasis; local disease control; objective response rate; response duration; quality of response; adverse adverse events; grade 3 - 4 lung; 10 10 treatment: \" Rot 11: \" Ambulatorial Row 12: \" Right 13: \" Rule 14: \" ' Row 15: \" with with \"Raw 11 \" after 18TERM1_Disturban patients: \"",
      "start_page": 247,
      "end_page": 247
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: \"Row 2: ?\"\" Row 3: \"Raw 4: \"THE THE TESTS\" Row Row 5: \"",
      "start_page": 247,
      "end_page": 247
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: \"X X \" Yes \" No \" Row 2: \" Row 3: \" Desirable effects \" Row 4: \"effects effects expected? \" Row 5: \" Row 6: \" JUDICES\" \"TESTS TESTS \"CONSIDERATIONS \" Row 7: \" Irrelevant \" Small \" Major \" X \" Varian\" \" Non \"Outcomes\" Anticipated Absolute Effects* (95% CI) with with (95% (study) (GRADE) placebo/Observation (Q1)_MEDTERM0_ CI) 53 53 303",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Relative Row 2: effect Row 3: (95% Row 4: CI)",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: participants Row 3: (studies)",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (GRADE)",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (29 to 49)",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (29 to 46)",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: Desired Row 3: Row Row 4:",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: Erabi Row 3: Row Row 4:",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: \"Row 2: ili\" Row 3: desirable fakes expected?",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: \"Row\" 1: \"Observat Row 7: \"Raw 8: Overall Survival\" Row 9: \"Row Row 10: \"Row 11: \" Row 12: \"Crow 12: 100\" \"Cow 13: \" Row 14: assigned assigned with: follow follow up: 5 5 months\" Row 15: \"row row 16: \"Now 17: \"Wow 18: \"65 for 100\" Row 19: \" Now 20: \"Distant metastasis\" assessed with: or or \"Rown 21: \" Row Row 22: \"-Row 23: \"",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: \"Row 2: lute effects\"* (95%: \" Row 3: \" Row 4: \" Row 5: \" Row Row 6: \"tion\"(Q1) \"Durval Row 7: \"Raw 8: \" \" Row 9: \" row 10: \" ' Row 11: \" Row 12: \" Row Row 13: \"\"22 to 41) \" Row 14: \"",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: \"Row 2: % CI) \"Relative effect (95% CI) 'particip particip (studies) ' Row Row 3: \"Raw 5: \"Rop 5: 'Row 6: lumab\" Row 7: \" Row 8: \"53 53 (0. 0.77) ' Row 9: \" Row 10: \" row 11: \" \" Row 12: \" - Row 13: \" Now 14: \" Right 15: \" 46 46 (0. 0.64) \" Row 16: \"row 17: \"",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (column column 7)",
      "text": "Row 1: \"Row\" 2: \"Certainty the eviden\" (GRADE) \"Certainty Row 3: pants\" Row Row 4: \"s\" (GRADE)",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (column column 8)",
      "text": "Row 1: \"Row 2: of \"C\" C Row 3: \"Nce\" Row 4: \"",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (column column 9)",
      "text": "Row 1: Row 2: Comments Row 3:",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (column column 10)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (column column 10)",
      "text": "Row 1: Row 2: s",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: \"distant metastasis\" (central central review) Local - - -- - control - 656 656 • response (to to (1 RCT) 2. 2.32) (22 to 41) 160 160 ■ response (1 1 RCT),follow follow up: 0. 0.84) 8 8 (9 to 31)of of -e -life life - 15 15 709",
      "start_page": 249,
      "end_page": 249
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "== References ==== External links ==* Official website",
      "start_page": 249,
      "end_page": 249
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (9 to 31)c",
      "start_page": 249,
      "end_page": 249
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (2 to 10)",
      "start_page": 249,
      "end_page": 249
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: distant metastasis (central central review) ==Row ===Rown===report report \"Row 5\": 'Row 7: Objective response\" = \" Row 8\": \"row row 9: \"N\" 10: \"Raw 11: \"Wild 18\" Row Row 12: \" Row 13: follow follow up: 8 8 months\" Row 14: \"Row Row 15: \" Row 16: \"Row 17: \"35\" for \"100c\"Row Row 18: \"How 19: life life - Row Row 20: \"-\"- \"Rlow 21:",
      "start_page": 249,
      "end_page": 249
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" - \" Row 6: \" Row 7: \" ' Row 8: \" row 9: \" \" Row 10: \"",
      "start_page": 249,
      "end_page": 249
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" \" Row 7: \" 68 68 (2. 2.32) Row 8: \" Row 9: \" row 10: \" ' Row 11: \" - Row 12: \" Route 13: \" Right 14: \" 43 43 (0. 0.84) Row 15: \" Roll 16: \" # Row 17: \" [ Row 18: \"] Row 19: \" Now 20: \" = Row 21: \"-e Row 22: \" * Row 23: \"\" Row 24: \" 15 15 (2. 2.47) Row 25: \" .",
      "start_page": 249,
      "end_page": 249
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: \"709 709 \" pneumonitis (to to (1 RCT) 3. 3.31) pneumonitis (1 to 8) assessed with: NCI- follow follow up: 709 709 'anemia (to to (1RCT) per per 100% 2. 2.03) with: (NCI- (1 to 7) follow follow up; 709 709 - opposite (to to (1 rCT) 1. 1.51) assessed (23 to 39) with the: NI- follow follow up",
      "start_page": 250,
      "end_page": 250
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "== References ==== External links ==* Official website",
      "start_page": 250,
      "end_page": 250
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (1 to 8)",
      "start_page": 250,
      "end_page": 250
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (1 to 7)",
      "start_page": 250,
      "end_page": 250
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (23 to 39)",
      "start_page": 250,
      "end_page": 250
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: asssessed asssessed with: NCI- follow follow up: 5 5 monthsg/Row 2:",
      "start_page": 250,
      "end_page": 250
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: \"Row\" 2: \"N\" Row 3: \"Rop\" 4: \"Raw\" 5: \"Ro\" 100 100 (1 to 8) \"Row Row 6: \"10\" (to 8) row 7: \"Row\" 8: \"N' Row 9: \"n\" Row 10: \"Wow\" 11: \" Row 12: \"1 for 100\" (1 to 7) \"row row 13: \"P\" (To 7) Row 14: \"T\" Row 15: \"C\" Row 16: \"No\" Row 17: \"D\" Row 18: \"I\" Row 19: \"F\" 19:",
      "start_page": 250,
      "end_page": 250
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "31 31 (3. 3.31) Row 2: \"Row 3: \" Row\" 4: \" Row 5: \" Row 6: \"Raw 7: \" Row 8: \" ROW 0.86\" (2. 2.03) Row 9: \"ROW 10: \"Roow 11: \" \" Row 12: \"- Row 13: \" - \" Row 14: \" 'Row 15: \"17 17 (1. 1.51) Row 16: \" row 17: \" Now 18: \" Route 19: \" Roll 20: \" .. Row 21: \") Row 22: \" = \"15 15 \" (4. 4.41) Row 23: \" [Row 24: \"] Row 25: \"",
      "start_page": 250,
      "end_page": 250
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: \"free free survival/central central review; the the 80% communication communication (.ppt) variation variation < +-The The 95% age. age.",
      "start_page": 251,
      "end_page": 251
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"free free survival/central central review; the the 80% communication communication (.ppt) variation variation < +-f. f. 95% benefitibilit. benefitibilit.",
      "start_page": 251,
      "end_page": 251
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: \"Row 2: \"Indesirable effects\" \"Raw 3: \"effects effects expected? \" Row 4: \" Row 5: \"JUDICI\" \"CONSIDERATIONS ADDANT TESTS\" \" Row 6: \"X X \"Important\" \"X\" \"Varianous\" \"Do not know\" \"absolute absolute effects\" * (95% CI) with with (95% (studies) (GRADE) placebo/Observation (Q1)_MEDTERM0__CI) 303 303 = Survival (to to (1 RCT) 0. 0.77) (22 to 41) 46 46 303",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Relative Row 2: effect Row 3: (95% Row 4: CI)",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: participants Row 3: (studies)",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (GRADE)",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (29 to 49)",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (29 to 46)",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: ndesi Row 3: Row Row 4:",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: idera Row 3: Row Row 4:",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: Skillful Row 3: Unwanted Ffects Expected? Row 4:",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: \"Row\": \"Raw\" 2: \"Observat Row\" 7: \"Row\" 8: \"Overall Survival\" Row 9: \"Row Row 10: \"Now\" 11: \"Wow\" 12: \"Town/Observed Row\" 12, \"100 Row 13: \"How to survive\" 14: \"Stood population Row\" follow follow up: 5 5 months\" Row 15: \"Distant metastasis\" row 16: \"Row Row 17: \"Row Row 18: \"65\" Row Row 19: \"Immediately\" 20: \"Distant metastases\" assigned with: \"distant distant metastasis\"",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: \"Row 2: lute effects\"* (95%: \" Row 3: \" Row 4: \" Row 5: \" Row Row 6: \"tion\"(Q1) \"Durval Row 7: \"Raw 8: \" \" Row 9: \" row 10: \" ' Row 11: \" Row 12: \" Row Row 13: \"\"22 to 41) \" Row 14: \"",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: \"Row 2: % CI) \"Relative effect (95% CI) 'particip particip (studies) ' Row Row 3: \"Raw 5: \"Rop 5: 'Row 6: lumab\" Row 7: \" Row 8: \"53 53 (0. 0.77) ' Row 9: \" Row 10: \" row 11: \" \" Row 12: \" - Row 13: \" Now 14: \" Right 15: \" 46 46 (0. 0.64) \" Row 16: \"row 17: \"",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (column column 7)",
      "text": "Row 1: \"Row\" 2: \"Certainty the eviden\" (GRADE) \"Certainty Row 3: pants\" Row Row 4: \"s\" (GRADE)",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (column column 8)",
      "text": "Row 1: \"Row 2: of \"C\" C Row 3: \"Nce\" Row 4: \"",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (column column 9)",
      "text": "Row 1: Row 2: Comments Row 3:",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (column column 10)",
      "text": "Row 1: Row 2: s",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (column column 11)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: \"independent central review\" Local - - - control - response response (to to (1 RCT) 2. 2.32) (22 to 41) response response (1 1 RCT),follow follow up: 0. 0.84) 8 8 (9 to 31) of of -e -life life - 15 15 709",
      "start_page": 253,
      "end_page": 253
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 253,
      "end_page": 253
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (9 to 31)c",
      "start_page": 253,
      "end_page": 253
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (2 to 10)",
      "start_page": 253,
      "end_page": 253
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (1 to 8)",
      "start_page": 253,
      "end_page": 253
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: independent central review) ==References===External links==* Official website",
      "start_page": 253,
      "end_page": 253
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: \"Row 7: \" Row 8: \" # Row 9: \" ' Row 10: \" \" Row 11: \"\" \" \" \" Row Row 12: \" - \" 22 to 41) Row 13: \" row 14: \" . \" Row 15: \" No Row 16: \" * \" Row 17: \" Row 18: \" 00 (9 to 31) \" and \" \" row row 19: \" [ 9 to 31]c Row 20: \" ( \" Row 20): \" Row 21: \" ♪ Row 22: \"- \" \" and Row 23: \" ] Row 24: \" Now 25: \" no Row 26: \" = \" Row 27: \" To Row 28: \" + 100 (2 to 10) \"Row Row 29: \" (\" \" 2 to 10) Row 30: \"",
      "start_page": 253,
      "end_page": 253
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: \"Row\" 1: \" Row\" 2: \"Rop\" 3: \"Raw\" 4: \"Rown\" 5: \"Right\" 6: \" Row 7: \"ROW\" 1,68 (2. 2.32) Row 8: \"Row\" 9: \"Now\" 10: \" Row\" 11: \"row\" 12: \"Dow\" 13: \"Sow\" 14: \"HR\" 0.43 (0. 0.84) Row 15: \"How\" 16: \"Jow\" 17: \"The Row\" 18: \"Wow\" 19: \" row\" 20: \"He Row\" 21: \"E Row\" 22: \"We\" 23: \"I\" Row 24: \"Turn\" 1.15 (2. 2.47) Row 25: \"Noah\" 26: \"Fow\" 27: \"Cow\" 28: \"New\" 29: \"Oow\" 30: \"-Row 31: \"RR\" (3. 3.31) Row 32: \"Rew\" 33: \"35: \"Mow\" 34: \"Uow\" 35: \"",
      "start_page": 253,
      "end_page": 253
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: •with: NCI- follow follow up: 709 709 •backup: 709 709 (to to (1 RCT) 1. 1.51) assessed (23 to 39) with: NI- followed followed up: 15 15 709",
      "start_page": 254,
      "end_page": 254
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: with: NCI- follow follow up: monthsg. monthsg.",
      "start_page": 254,
      "end_page": 254
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (1 to 7)",
      "start_page": 254,
      "end_page": 254
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (23 to 39)",
      "start_page": 254,
      "end_page": 254
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: with: NCI- follow follow up: monthsg. monthsg.",
      "start_page": 254,
      "end_page": 254
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"86 86 (2. 2.03) Row 5: \" row 6: \" Row 7: \" ' Row 8: \" \" Row 14: \" Row 14:\" \" \" \" 10: \" 17 17 (1. 1.51) Row 11: \" # Row 12: \" - \" Row 13: \" [100 100 (23 to 39) ] Row 15: \" Route 16: \"15 15 (4. 4.41) Row 17: \" n \" Row 18: \" Now 19: \" . \" Row 20: \" = \"Row Row 21: \" ((0 to 6) \" Row 22: \"",
      "start_page": 254,
      "end_page": 254
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "the the 80% communication communication (.ppt) variation variation <= +-The The 95% g. g.",
      "start_page": 255,
      "end_page": 255
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2\": \"Row Row 3: \"Row Row 4: \"Row Row 3\"",
      "start_page": 255,
      "end_page": 255
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 255,
      "end_page": 255
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: \"the the 80% communication communication (.ppt) variation variation <= +-The The 95% g. g.",
      "start_page": 255,
      "end_page": 255
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row Row 2: of of interest",
      "start_page": 255,
      "end_page": 255
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 255,
      "end_page": 255
    },
    {
      "heading": "heading heading <Effect balance>",
      "text": "Row 1: \"Row\": \"Raw\" 2: \"Right\" 3: \"C\" main main outcomes? \"Rop\" 4: \"Rown\" 5: \"JUDIZI\" ADDATIVE ADDATIVE TESTS\" \"RW 6: \"or or variation\" \"variability variability \"and and variability\" \"No significant variability\" [Row] 7: \"Row 8: \"Bilance of effects\" \"row 9: \"or or comparison?\" \"Rough 10: \"ROW 11: JUDICES\" \"THE THE ADVANCES\" (Row 12): \"comparison comparison \"Ru\" confrontation confrontation \"R.\"",
      "start_page": 256,
      "end_page": 256
    },
    {
      "heading": "heading heading <Budget of effects> (column 1)",
      "text": "Row 1: \"Row 2: \"Valori\" Row 3: \"C\" main main outcomes? \"Rop 4: \"Raw 5: \"JUDIZI\" Row 6: \"or or variation\"",
      "start_page": 256,
      "end_page": 256
    },
    {
      "heading": "heading heading <Budget of effects> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 256,
      "end_page": 256
    },
    {
      "heading": "heading heading <Budget of effects> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 256,
      "end_page": 256
    },
    {
      "heading": "heading heading <Budget of effects> (column 3)",
      "text": "Row 1: Row 2: Row 3: Ronto? Row 4:",
      "start_page": 256,
      "end_page": 256
    },
    {
      "heading": "heading heading <Budget of effects> (Column 10)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" ADDITIONAL CONSIDERATIONS \" Row 6: \" Row 7: \" row 8: \" \" Row 9: \" Row 10: \" ' Row 11: \" Additional CONSIDERATIONS\" Row 12: \"to to 1%.",
      "start_page": 256,
      "end_page": 256
    },
    {
      "heading": "heading heading <Acceptability>",
      "text": "Row 1: \"Row\" 2: \"Equity\" \"Rop 3: \"of of equity?\" : \"Raw\" 4: \"Right\" 5: \"Judizi\" (Judici) \"Rice\": \"Reduces equity\" x \"x x \"No impact\" equity equity \"Improves equity,\" \"Varia\" 10: \"None test found\" Row 7: \"Wow\" 8: \"Acceptability\" Row 9: \"main main stakeholders\"?",
      "start_page": 257,
      "end_page": 257
    },
    {
      "heading": "heading heading <Acceptability> (column 1)",
      "text": "Row 1: \"Row\" 2: \"Equity\" \"Raw 3: \"of of equity?\" : \" Row 5: \"JUDIZI\" Row 6: \"Reduces equity,\" \"Possibly reduces equity\" x \"Probably no impact\" equity equity \"Improves equity \"Varia\" = \"Non so\" Row 7: \"Rop\" 8: \"Acceptability\" = ...\"Row 9: \"main main stakeholders\"?",
      "start_page": 257,
      "end_page": 257
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 257,
      "end_page": 257
    },
    {
      "heading": "heading heading <Acceptability> (column 12)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 257,
      "end_page": 257
    },
    {
      "heading": "heading heading <LI>",
      "text": "Row 1: \"Row 2: intervention intervention feasible? \" Row 3: \" Row 4: JUDIZI\" \"ADDITIVE ADDITIVE TESTS\" \"Now 5: \"No\" \" Probably no \"Yeah\" x \"Yes\" \"No test found\"",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading <LI>",
      "text": "Row 1: \"Row\" 2: \"JUDIZI\" Row 3: \"Rop\" 4: \"No\"Probably not \"Probabilmente no\" - \"Si\" - ...\"Variety\" - 5: \"PROBLEM\" - 6: \"Rw\" - 7: \"Ignorant\" - Small \"Moderates\" -\"Various \"Don't know\" - 8: \"Now\" - 9: \"Desiderabili\" - 10: \"Way\" - 11: \"Great\" - Modern \"Small\"\" -\"Irrrelevant \"Varia\" - 12: Sides\" - Row 13: \"Bi\" Row 14: \"Li\" Row 15: \"",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading <LI> (column 1)",
      "text": "Row 1: Row 2: Feasibility L'is is feasible:",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading <LI> (column 1)",
      "text": "Row 1: Row 2: PROBLEM Row 3: Row 4: Row 5: SIDES Row 6: DESIDERABLE Row 7: Row 8: Row 9: EFFECTS Row 10:RIDBI Row 11: LI Row 12:",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading <LI> (column 2)",
      "text": "Row 1: Row 2: à Row 3: Lementation of intervention? Row 4:",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading <LI> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" row 7: \" Row 8: \" ' Row 9: \" \" Row 10: \" - Row 11: \" Now 12: \" Route 13: \"\" Row 14: \" Right 15: \"",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading <LI> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading <LI> (column 3)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading <LI> (column 5)",
      "text": "Row 1: Row 2: JUD Row 3:",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading <LI> (column 6)",
      "text": "Row 1: Row 2: TIZI Row 3:",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading <LI> (column 9)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" ' Row 8: \" row 9: \" \" Row 10: \"\" Row 11: \" Now 12: \"",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading <LI> (column 10)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12:",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading <LI> (column 12)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading <LI> (column 12)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Not so\" Row 5: \"Not so\" row 6: \"I don't know\"",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading <LI> (from previous page)",
      "text": "Row 1: ... ..Row Row 5: QUALITA DELL'Row 6: PROSTIVAL Row 7: ... ... very low - ... very Low - ... Very low -- moderate -- High --not included -- row row 5: ROW ROW 6: Testes -- Row 7: -- ...variability variability -- variation variation --variable variable -- intervention intervention -- \"Row 9:\" --\"Row 10:-\" Row 11: \"By comparison\"---probably doesn'intervention intervention --\"equity equity --equity equity --\"equity equity -‐-- --? --- _--_-- /--/--",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading <LI> (from previous page)",
      "text": "Row 1: Row Row 2: EFFECTS",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading <LI> (column column 1)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Very low\" Row 5: \"quality\" Row 6: \"tests\" Row 7: \"Raw 8: \"or or variability\" Row 9: \"value\" Row 10: \"right\" Row 11: \"of of comparison\" Row 12: \"of of effects\" Row 13: \"row 14: \"Row Row 15: EQUITA\" Row 16: \"No Row 17: \"no Row 18: acceptance\" Row 19: \"Now 20: \"NO Row 21: FACTIVITY\" Row 22: \"Wow\"",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading <LI> (column column 2)",
      "text": "Row 1: Row 2: JUDIZ Row 3:",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading <LI> (column column 3)",
      "text": "Row 1: \"Row 2: I\" Row 3: \"Raw 4: High\" Row 5: \"Rop 6: \" Row 7: or or variability\" Row 8: \"Si\" Row 9: \"Row 10: the the intervention\" *Row 11: \"the the equity\" Row 12: \"Yes\" Row 13: \"Now 14: \"Wow 15: \"No\" Row 16: \"I\" Row 17: \"You\"",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading <LI> (column column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" row 8: \" \" Row 9: \"",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading <LI> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6:",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading <LI> (column column 5)",
      "text": "Row 1: \"Row 2: \" Row 3: \"",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading <LI> (column column 5)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading <LI> (column column 5)",
      "text": "Row 1: \"Varia\" doesn'Row Row 2: \"Via\" Row Row 3: \"Row\" 4: \"Rop\" 5: \"Varia\" Row Row 6: \"Raw\" 7: \"Now\"",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: intervention intervention -++ operation operation -+-+ intervention intervention --++intervention intervention X",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: • Row 2: • Recommendation • row 3: •",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "heading heading <Recommendation> (column 1)",
      "text": "Row 1: intervention intervention • • operation operation •",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "heading heading <Recommendation> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Recommendation",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "heading heading <Recommendation> (column 2)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "heading heading <Recommendation> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \"",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "heading heading <treatment treatment component>",
      "text": "==References===External links==* Official website",
      "start_page": 261,
      "end_page": 261
    },
    {
      "heading": "heading heading <treatment treatment component> (column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 261,
      "end_page": 261
    },
    {
      "heading": "heading heading <treatment treatment component> (column 2)",
      "text": "Row 1: \"Row 2: \"Importance Row 3: \" Row 4: \" Row 5: \" Row 6: \" CRITIC Row 7: \" row 8: \" \" Row 9: \"CRITIC Row 10: \" Row 11: \" Route 12: \" CRITIC Row 13: \" - \" Row 14: \" ' Row 15: \" IMMPORTANT Row 16: \"\" Row 17: \"",
      "start_page": 261,
      "end_page": 261
    },
    {
      "heading": "heading heading <Explanations>",
      "text": "==References===External links==* Official website",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "heading heading <Explanations> (column 1)",
      "text": "Row 1: • Row 2: Certainty assessment •row 3: • row 4: • rows 5: no studies •study study • distortion distortion • results results • generalization generalization • depth row 6: • route 7: 11 •studies randomized • serious • not important •seriob Row 8: Loco-regional progression • right 9: ♪ row 10: 11 (studys randomized) •serious •non important ■seriob Row 11: Polmonites (follow up: 6 6 months) ♪ Row 12: â Row 13: 11 = Row Row 14: row row 15: Â Row 16: studies studies randomised",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "heading heading <Explanations> (column 2)",
      "text": "Row 1: • Row 2: •patients patients • No effect •Certain Row 3: • row 4: Other considerations •Loco-regional treatment + systemic therapy •alone alone •Relational (95% CI) • Absolute (95% CI), •row 5: •Row 6: ♪1/68 (1.5%) −1/65 (1.5%), •95 95 (14. 14.97) ■100 100 (21 21 plus)",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "heading heading <Explanations> (column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "heading heading <Explanations> (column 2)",
      "text": "Row 1: 6/68 (8.8%) - 29/65 (44.6%) - 20 20 (0. 0.44) - 100 100 (25 25 less)",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "heading heading <Explanations> (column 2)",
      "text": "Row 1: 27/65 (41.5%) •17/65 (26.2%) ♪59 59 (2. 2.61) •100 100 (42 42 more)",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "heading heading <Explanations> (column 2)",
      "text": "Row 1: 8/39 (20.5%) = 6 / 39 (15.4%) = 1,36 (3. 3.51) = 100 (39 39 more)",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "heading heading <Explanations> (column 3)",
      "text": "Row 1: \"Row 2: \"Important Row 3: \" Row 4: \"CRITIC Row 5: \" Row 6: \" \" Row 7: \" IMPORTANT Row 8: \" ' Row 9: \" Row 10: \"IMPORTANT Row 11: \" row 12: \" - \" Row 13: \"",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "heading heading <BACKGROUND:>",
      "text": "Row 1: treatment treatment + with with NSCLC",
      "start_page": 263,
      "end_page": 263
    },
    {
      "heading": "heading heading <Desirable Effects>",
      "text": "were were obtained: Row 1: Judizi \"Row 5: JUDIZI \"EVIDENCE EVIDENCE TESTS\" CON'T KNOW 3: \"a a priority?\" Row 6: \" No",
      "start_page": 264,
      "end_page": 264
    },
    {
      "heading": "heading heading <Desirable Effects> (column 1)",
      "text": "Row 1: 'Row 2: 'Problem' Row 3: 'a a priority? ' Row 4: 'Don'Row Row 7: 'Raw 8: 'Desirable Effects' Row 9: 'anticipated anticipated effects?' ' Row 10: 'Row 11: 'JUDIZI' Row 12: 'Trivial' Small 'Moderate ● Large 'Varies 'Dong't known'.",
      "start_page": 264,
      "end_page": 264
    },
    {
      "heading": "heading heading <Desirable Effects> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 264,
      "end_page": 264
    },
    {
      "heading": "heading heading <Desirable Effects> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 264,
      "end_page": 264
    },
    {
      "heading": "heading heading <Desirable Effects> (from previous page)",
      "text": "treatment treatment (Immunotherapy + RT) therapy therapy (immunotherapy). Precipital Precipital effect* (95% CI) a a (95% CI), (study) (GRADE) 51 51 (3 RCT) 3 3 • Adding a local- (survival. survival.",
      "start_page": 265,
      "end_page": 265
    },
    {
      "heading": "heading heading <Desirable Effects> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 265,
      "end_page": 265
    },
    {
      "heading": "heading heading <Desirable Effects> (from previous page)",
      "text": "Row 1: Row 2: Relative Row 3: (95% CI)",
      "start_page": 265,
      "end_page": 265
    },
    {
      "heading": "heading heading <Desirable Effects> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: participants (studies)",
      "start_page": 265,
      "end_page": 265
    },
    {
      "heading": "heading heading <Desirable Effects> (from previous page)",
      "text": "Row 1: Row confidence 2: Row 3: (GRADE)",
      "start_page": 265,
      "end_page": 265
    },
    {
      "heading": "heading heading <Desirable Effects> (from previous page)",
      "text": "== References ==== External links ==* bias. bias.",
      "start_page": 266,
      "end_page": 266
    },
    {
      "heading": "heading heading <Desirable Effects> (from previous page)",
      "text": "Row 1: • Progression-free survival •",
      "start_page": 267,
      "end_page": 267
    },
    {
      "heading": "heading heading <Desirable Effects> (from previous page)",
      "text": "were were included: 2022 2022 . study study design; been been included: treatment treatment (3 3 lesions). only only systemic/treatments treatments (3 3 injuries).",
      "start_page": 268,
      "end_page": 268
    },
    {
      "heading": "heading heading <Desirable Effects> (column column 1)",
      "text": "Row 1: \"Row 2: \"Undesirab Row 3: \"Row Row 4: \"",
      "start_page": 268,
      "end_page": 268
    },
    {
      "heading": "heading heading <Desirable Effects> (column column 2)",
      "text": "Row 1: Row 2: Row Row 3: anticipated anticipated effects? Row 4:",
      "start_page": 268,
      "end_page": 268
    },
    {
      "heading": "heading heading <Desirable Effects> (column column 2)",
      "text": "Row 1: Row Row 2: were were included: metastatic metastatic (3 3 lesions), to to systemic/treatment treatment (Immunotherapy + RT) alone alone (2 2 rts).",
      "start_page": 268,
      "end_page": 268
    },
    {
      "heading": "heading heading <Desirable Effects> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 268,
      "end_page": 268
    },
    {
      "heading": "heading heading <Desirable Effects> (column column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 268,
      "end_page": 268
    },
    {
      "heading": "heading heading <Desirable Effects> (from previous page)",
      "text": "Row 1: effect effect anticipated* (95% Comments Comments CI) participants participants (95% (studies) (GRADE) an an CI) 133 133 • treatment treatment (to to (1 RCT) 14. 14.97) of of (0 to 23) loco loco - 133 133 − treatment treatment (to to (1RCT) 0. 0.44) Y. Y., Feng, G., Xie, K., Lu, y., Zeng, M.. Cancer Cancer Inst; 2022. 2022.",
      "start_page": 269,
      "end_page": 269
    },
    {
      "heading": "heading heading <Desirable Effects> (from previous page)",
      "text": "== Demographic evolution ====References==",
      "start_page": 269,
      "end_page": 269
    },
    {
      "heading": "heading heading <Desirable Effects> (from previous page)",
      "text": "Row 1: Row 2: Relative Row 3: (95% Row 4: CI)",
      "start_page": 269,
      "end_page": 269
    },
    {
      "heading": "heading heading <Desirable Effects> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: participants (studies)",
      "start_page": 269,
      "end_page": 269
    },
    {
      "heading": "heading heading <Desirable Effects> (from previous page)",
      "text": "Row 1: Certainty Row 2: of Row 3: (GRADE)",
      "start_page": 269,
      "end_page": 269
    },
    {
      "heading": "heading heading <Desirable Effects> (from previous page)",
      "text": "Row 1: Row Row 2: (0 to 23)",
      "start_page": 269,
      "end_page": 269
    },
    {
      "heading": "heading heading <Desirable Effects> (column column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 269,
      "end_page": 269
    },
    {
      "heading": "heading heading <Desirable Effects> (column column 2)",
      "text": "Row 1: • Row 2: •Row 3: •row 4: • row 5: •Row Row 6: ♪Adding loco‐loco loco - Row Row 7: − Row Row 8: ►rate. rate.",
      "start_page": 269,
      "end_page": 269
    },
    {
      "heading": "heading heading <Desirable Effects> (from previous page)",
      "text": "Row 1: S. S., E. E., Cheedella, N., D. E., C. C., H., S., G.D., Metastatic Metastatic Non-Small-Cell Lung Cancer: JAMA JAMA Oncol; Gomez, Gomez, D",
      "start_page": 270,
      "end_page": 270
    },
    {
      "heading": "heading heading <Values>",
      "text": "Row 1: \"Row\" 1: \"Certainty of evidence\" = \"Rop\" = : \"of of effects?\" = \"Row 5: \"JUDICES\" = EVIDENCY EVIDENCY TESTS\" = [Row 6: \"Very low ● \"Low Featured \" - No included studies] performance. performance.\" = \" Row 7: \" Row 8: \"Values\" = 9: \"main main outcomes?",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "heading heading <Values> (column 1)",
      "text": "Row 1: 'Row 2: 'Certainty of evidence' Row 3: 'of of effects? ' Row 4: 'Raw 5: 'JUDICES' Row 6: 'Very low' ● 'Low' Moderate 'High 'No included studies' Row 7: 'Rop 8: 'Values' Row 9: 'how how mu' Row 10: ' Row 11: JUDIZI' Row 12: 'or or variableity'",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "heading heading <Values> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "heading heading <Values> (column 2)",
      "text": "Row 1: Row 2: Row 3:Row Row 4:",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "heading heading <Values> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "heading heading <Values> (column 4)",
      "text": "Row 1: Row 2: Row 3: mes? Row 4:",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "heading heading <Values> (column 10)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "heading heading <Equity>",
      "text": "Row 1: \"Row\" 2: \"Balance of effects\" = row 3: \"the the comparison?\" = \"Raw 5: JUDICES\" = \"EVIDENCE EVIDENCE TESTS\" = Additional CONSIDATIONS + \"RW 6: \"Favors the comparison\" * \"comparison comparison \" appearance appearance \"intervention intervention \" ● participation participation \" Varies\" = Don't know \" Row 7: \"Right 8: \"Equity\" = Row 9: \"health health equity?",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading <Equity> (column 1)",
      "text": "Row 1: 'Row 2: 'Balance of effects' Row 3: 'undesirable undesirable ' Row 4: ' Row 5: JUDICES ' Row 6: ' comparison comparison ' compare compare ' appearance appearance ' intervention intervention ' ● participation participation ' Varies ' Don'Row Row 7: 'Raw 8: 'Equity' Row 9: 'health health equity? ' Row 10: ' Row 11: JUDIZI' Row 12: 'Reduced 'Probably reduced ● impact impact 'Probaby increased 'Increated 'Miscellaneous 'Don't known'.",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading <Equity> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading <Equity> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading <Equity> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading <Equity> (column 4)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading <Equity> (column 5)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading <Equity> (column 6)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading <Equity> (column 7)",
      "text": "Row 1: Row 2: Row 3: mparison Row 4:",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading <Equity> (column 8)",
      "text": "Row 1: Row 2: Row 3: n? Row 4:",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading <Equity> (column 13)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading <EFFECTS>",
      "text": "Row 1: \"Row 2: key key stakeholders?",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading <EFFECTS>",
      "text": "Row 1: \"Row\" 2: \"JUDIZI\" Row 3: \"Rop\" 4: \"No\"Probably no\" \"Probabilly yes\" \"Yes\" \"Varies\" \"Don't know\" Row 5: \"PROBLEM\" Row 6: \"Raw\" 7: \"Trivial\" Small\" \"Moderate\" \"Large\" \"Ways\" Don't Know\" Row 8: \"DESIRABLE\" Row 9: EFFECTS\" Row 10: \"Do\"",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading <EFFECTS> (column 1)",
      "text": "Row 1: \"Row 2: key key stakeholders?",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading <EFFECTS> (column 1)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"No\" Row 5: \"PROBLEM\" Row 6: \"Raw 7: \"Trivial\" Row 8: \"DESIRABLE\" Row 9: \"EFFECTS\" Row 10: \"Read more\"",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading <EFFECTS> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading <EFFECTS> (column 2)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading <EFFECTS> (column 7)",
      "text": "Row 1: Row 2: JUDIZ Row 3:",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading <EFFECTS> (column 8)",
      "text": "Row 1: Row 2: ZI Row 3:",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading <EFFECTS> (column 10)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" row 8: \" \" Row 9: \"",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading <EFFECTS> (column 11)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9:",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading <EFFECTS> (column 12)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading <EFFECTS> (column 13)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Don't know\" Row 5: \"Don't Know\"",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading <JUDIZI>",
      "text": "==References===External links==* Official website",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "heading heading <JUDIZI> (column 1)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: Row 5: Row Row 6: Row 7: Row 8: VALUES Row 9: Row 10: Row 11: Row Row 12: Row 13: Row 14: EQUITY Row 15: Row 16: Row 17: ACCEPTABILITY Row 18: Row 19: Row 20: FEASIBILITY Row 21:",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "heading heading <JUDIZI> (column 2)",
      "text": "Row 1: \"Small Row 5: \"Row 6: \" \" Row 7: \" Very low\" \"Low\" \"Moderate Row 9: \" Row 10: \" Row 11: \" row 12: \"or or variability\" \"or or variable\" \"Row Row 13: \" Now 14: \" Right 15: \"Favors the comparison\" \"comparison comparison \"Row Row 16: \"",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "heading heading <JUDIZI> (column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "heading heading <JUDIZI> (column 3)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "heading heading <JUDIZI> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" row 7: \" Row 8: \" \" Row 9: \" ' Row 10: \" intervention intervention \" Row 11: \" Increased \" Row 12: \" Now 13: \" Route 14: \" - \" Row 15: \" Roll 16: \"\" Row 17: \"",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "heading heading <JUDIZI> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Don't know\" Row 5: \"No included studies\" Row 6: \"Raw 7: \" Row 8: \"Now 9: \" Row 10: \" Don't Know\" Row 12: \"Dun't known\" Row 13: \"Do't knowing\" Row 14: \"don't knows\"",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "heading heading <Justification>",
      "text": "Row 1: the the intervention",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "heading heading <Justification>",
      "text": "Row 1: • Row 2: • Recommendation • row 3: •",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "heading heading <Justification>",
      "text": "Row 1: \"Row 2: \"Justification\" Row 3: \"",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "heading heading <Justification> (column 1)",
      "text": "Row 1: the the intervention",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "heading heading <Justification> (column 1)",
      "text": "Row 1: \"Row 2: \"Recommendation Row 3: \"",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "heading heading <Justification> (column 1)",
      "text": "Row 1: \"Row 2: \"Justification Row 3: \"",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "heading heading <Justification> (column 2)",
      "text": "Row 1: Row 2: Row Row 3: Row Row 4: Row 5: ● Row 6:",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "heading heading <Justification> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \"",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "heading heading <Objective response rate>",
      "text": "Row 1: 5; 5: 5 - 5 - 35 - 15 - 50 - 35: 1 - 5 5 - 10 - 13 - 5: 9 - 6 - 14 - 17 - 11 - 17: 15 - 5 , 15 - 15 , 5 - 17 17 , 100 100 , 57 57 , , 45 45 , 27 27 , 18 18 , 21 21 , 24 , 11 , 7: survival survival (follow up: 0 0 months) a \"-TKI\" Relative (95% CI)",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "heading heading <Objective response rate> (column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "heading heading <Objective response rate> (column 2)",
      "text": "Row 1: \"Row 2: \"Importance Row 3: \" Row 4: \" Row 5: \" Row 6: \" CRITICAL Row 7: \" Row 8: \" \" Row 9: \" Critical Row 10: \" row 11: \" ' Row 12: \"IMPORTANT Row 13: \" - \" Row 14: \"",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "heading heading <Objective response rate> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 277,
      "end_page": 277
    },
    {
      "heading": "heading heading <Objective response rate> (column column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 277,
      "end_page": 277
    },
    {
      "heading": "heading heading <Objective response rate> (column column 2)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 277,
      "end_page": 277
    },
    {
      "heading": "heading heading <Objective response rate> (column column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 277,
      "end_page": 277
    },
    {
      "heading": "heading heading <Objective response rate> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: 30/67 (44.8%) Row 5: Row 6: Row 7: 29/67 (43.3%) Row 8: Row 9: Row 10: 252 Row 11: Row 12: Row 13: 252 Route 14: Row 15: Row 16: 252 row 17: Row 18:",
      "start_page": 277,
      "end_page": 277
    },
    {
      "heading": "heading heading <Objective response rate> (column column 6)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" CRITICAL\" Row 5: \" Row 6: \"Raw 7: \"CRITICAL\" Row 8: \" Row 9: \"Row 10: \"CRITICAL\" Row 11: \" row 12: \"ROW 13: \"critical\" Row 14: \"Now 15: \"I\" Row 16: \"critical\" Row 17: \"row 18: \"D\"",
      "start_page": 277,
      "end_page": 277
    },
    {
      "heading": "heading heading <25/277 (9.0%) 9 9 feet",
      "text": "== Demographic evolution ====References==",
      "start_page": 278,
      "end_page": 278
    },
    {
      "heading": "heading heading <25/277 (9.0%) feet feet (column 1)",
      "text": "Row 1: 1\"randomised trials\" not seriousus\" \"not seriousus,\" \"serious\" but \"serious\" Row 2: life life - Fatigue (assessed with: QLQ-C30; Scale from: 0 to 100) \"Row\" 3: \"Raw\" 4: \"randomized trials\" \"Not serious\" (\"not serious\") \"serious\" b\"not serious\" Row 5: \"Treatment discontinuion\" Row 6: \"Rown\" 7: \"Now\" 9: \"Row\" 10: \"ranomised trials\" serious \"not silky\" d Row 8: \"or or acne\" (assessed with: NCI-CTCAE) \"Right 9:",
      "start_page": 278,
      "end_page": 278
    },
    {
      "heading": "heading heading <25/277 (9.0%) feet feet (column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 278,
      "end_page": 278
    },
    {
      "heading": "heading heading <25/277 (9.0%) feet feet (column 4)",
      "text": "Row 1: 247 (0.19) - lower lower (7 7 higher) Row 2: \" Row\" 3: \"Row\" 4: 247 (0, 0,56) \"100 100 (21 21 feder) Row 8: \"Raw\" 9: \" Row 10: 19/277 (6.9%) \"16 16 (0, 0,52) \"100 100 (3 3 feder). Row 11: \" row 12: \" Row 13: 25/277 (9.0%) \"04 04 (0. 0.29) \"100 100 (3 3 feet) Row 11, \" Row 12: * Row 13: 2/257 (9.0%) \"04 04 (0. 0.20) \"100 100 [6 6 feet]",
      "start_page": 278,
      "end_page": 278
    },
    {
      "heading": "heading heading <25/277 (9.0%) feet feet + (column 5)",
      "text": "Row 1: \"CRITICAL\" Row 2: \"Row\" Row 3: \"Rop\" Row 4: \"Critical\" Row 5: \"Raw\" Row 6: \"Row\" 7: \"Critical\" Row 8: \"Now\" row 9: \"Short\" Row 10: \"CRITICAL\" Row 11: \"Wow\" 12: \"How\" 13: \"Characteristic\"",
      "start_page": 278,
      "end_page": 278
    },
    {
      "heading": "heading heading <adverse adverse events>",
      "text": "Row 1: \"Row 8: elevation elevation (assessed with: NCI-CTCAE) Row 9: \"Raw 10\": \"ranked trials\" seriously \"not serious\" (\"not serious\") b \"serious\" c, \"d\"none\" / \"2/279 (0.7%) \"12/277\" (4.3%) \"17 17 (0. 0.73) \"100 100 (1 1 feet) \"LOW\" \"CRITICAL\" Row 11: \"adverse adverse events\" Row 12: \" Row 13: \"randomised trials\" [not serious] \"not silky\" b \"serious\" = \"none\" 89/279 (31.9%) \"114/277\" (17): \"RWow 13: 1.\"",
      "start_page": 279,
      "end_page": 279
    },
    {
      "heading": "heading heading <adverse adverse events> (column 1)",
      "text": "Row 1: \"Row 8: elevation elevation (assessed with: NCI-CTCAE) Row 9: \"Raw 10\": \"Row 10\" (\"ranked trials\") \"not seriousus\" (\"not serious\"), \"serious\" \"c,\" \"d\"none\" \"2/279 (0.7%) \"12/277\" (4.3%) \"17 17 (0. 0.73) \"4 fewer\" per 100 (1 1 feder) Row 11: \"adverse adverse events\" Row 12: \" Row 13\" (41.2%) \"randomised trials\" (\"not serious\") \"not serious\" (1 1 Fewer)",
      "start_page": 279,
      "end_page": 279
    },
    {
      "heading": "heading heading <adverse adverse events> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9:",
      "start_page": 279,
      "end_page": 279
    },
    {
      "heading": "heading heading <adverse adverse events> (column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 279,
      "end_page": 279
    },
    {
      "heading": "heading heading <adverse adverse events> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" row 8: \" \" Row 9: \"",
      "start_page": 279,
      "end_page": 279
    },
    {
      "heading": "heading heading <adverse adverse events> (column 3)",
      "text": "Row 1: \"Row 2: \"",
      "start_page": 279,
      "end_page": 279
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS>",
      "text": "Row: 000, 000,000_enthusiasts: 000 000 _enthrones_enhances_enchant_enghts_enfants_en; _enhancing_enhanced_encommodation_enphrasers_english_enkling_encamp_enx_en. _enhancing_enhanced_encommodation_enphrasers_english_enkling_encamp_enx_en.html_end_enj_env_ent_enz_enp_enb_enst_enw_en_eni_enco_en@eng_en/eng=enhash_en-enhum_engen_ene_engel_eny_engl_enq_en &gt_en,enh_entr_enge_enit_enig_enu_en!n_enl_enad_enr_en gab_ened_engo_endi_engle_enact_enze_enget_engument_enthe_enquall_enquiry_en__en_eng_en _en_em_entro_enname_enter_envi_enct_enject_enex_ento_enfr_entre_ende_encr_en3_enno_en4_en5_en6_enFran_encent_en0_entech_ence_enach_en",
      "start_page": 280,
      "end_page": 280
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS>",
      "text": "Row 1: \"Row 2: a a priority? \" Row 3: \" Row 4: JUDICES\" \"ADDITIVE TESTS\" \"RW 5: \"No\" \"Probably no\" \"No.\"",
      "start_page": 280,
      "end_page": 280
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: \"Probably yes\" X \"Varie\" - \"Non so\" Row 2: \"Row\" 3: \"Advantible effects\" - row 4: \"effects effects expected?\" - \"Rown 5: \"Raw 6: \"Judizi\" -\"Ricerca dei testi\" -\"\"effects effects -\" Row 7: \"Important\" -- \"Moderate X\" --\"Variano -\" Not known\" - ...\"absolute absolute effects* \"Comments Comments (95% CI) evidence evidence (95% (studies) (GRADES) with with CI) Survival Survival (to to (1 RCT) MODERATEa follow up: 15, 15,0pully]",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "== References ==== External links ==* Official website",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Relative Row 2: effect Row 3: (95% Row 4: CI)",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: participants Row 3: (studies)",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: evidence Row 3: (GRADE)",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Osimertinib",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 2)",
      "text": "Row 1: Row 2: Desired Row 3: Row Row 4:",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 3)",
      "text": "Row 1: Row 2: Erabil Row 3: Row Row 4:",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 4)",
      "text": "Row 1: Row 2: li Row 3: Row Row 4:",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 5)",
      "text": "Row 1: \"Row 2: \" Row 3: expected derables? \" Row 4: \"",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 5)",
      "text": "Row: 30: 35: - Outcomes: - Anticipated absolute effects* - \"Relative effect (95% CI) -particip particip (studies/Row Row 3: - ...95% CI) ] -particip Row 4: - - -Studies Row 5: - --Row 6: -\" Risk with Osimertinib_? _ _ - - \"Particip row 7: - \"standard\" Row 8: --\"EGFR-TKI",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 6)",
      "text": "Row 1: \"Row\" 2: \"Certainty\" or evidence (GRADE) \"Certainty\" and \"Raw\" 3: pants\" \"evidence Row 4: \"s\" (GRADE)",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 7)",
      "text": "Row 1: \"Row\" 2: of the \"C Row\" 3: \"Rown\" 4: \"Raw\"",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 8)",
      "text": "Row 1: Row 2: Comment Row 3:",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 9)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 9)",
      "text": "Row 1: Row 2: ts",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": ";;;:::...:: (a):: -:: =::-::_:: .:: /:: _:: +:: 0::?:: \"::\":: ...::,:: a::i:: i::*:: [::]::",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: (14 to 40)",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: - Row Row 4: 0 score",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: higher Row 3: (Row Row 4: 3.2 higher)",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: - Dyspnoea Row 4: was 0",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: higher Row 3: (Row Row 4: 2.4 higher)",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: - Row Row 4: was 0",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: (Row Row 3: 2.1 higher)",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: - Appetite Row 4: Loss was 0",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: (Row Row 3: 2.7 higher)",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: quality of life",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: - - Scale Scale from: 556 556 - - - Scale Scale (5556 5556 - - discontinuion (to to (1 RCT) MODERATEa,c (0. 0.56) discontinuous) (43 to 56) 16 16 556",
      "start_page": 283,
      "end_page": 283
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 283,
      "end_page": 283
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: - Row Row 2: 0",
      "start_page": 283,
      "end_page": 283
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: (0 to 3)",
      "start_page": 283,
      "end_page": 283
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 1)",
      "text": "1, assessed with: QLQ- C30 Scale from: 100. 100.",
      "start_page": 283,
      "end_page": 283
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Relative Row 2: effect Row 3: (95% Row 4: CI)",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: participants Row 3: (studies)",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: evidence Row 3: (GRADE)",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Osimertinib",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 2)",
      "text": "Row 1: Row 2: ndesid Row 3: Row Row 4:",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 3)",
      "text": "Row 1: Row 2: derab Row 3: Row Row 4:",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Siderable Expected? Row 4:",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 5)",
      "text": "==References===External links==* Official website",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 6)",
      "text": "Row 1: \"Row\" 2: \"Certainty evidence\" (GRADE) \"Certainty Row 3: pants\" \"Evidence Row 4: s) \"(GRADE)",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 7)",
      "text": "Row 1: \"Row\" 2: of the \"C Row\" 3: \"Raw\" 4: \") \"",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 8)",
      "text": "Row 1: Row 2: Comment Row 3:",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 9)",
      "text": "Row 1: Row 2: ts",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 11)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: \"live live - score score - 500 Sugh (_MEDTERM0__ - higher higher (1 RCT) MODERATEa Cough) - 0 0 (assembled assembled with: QLQ- 2 2 higher) C30 Scale from: 1 1 - 500",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: - Row Row 4: score",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: higher Row 3: (Row Row 4: 3.2 higher)",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: - Dyspnoea Row 4: was 0",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: higher Row 3: (Row Row 4: 2.4 higher)",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: - Row Row 4: was 0",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: (Row Row 3: 2.1 higher)",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: life life - Row 3: Row Row 4: was 0",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: (Row Row 3: 2.7 higher)",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: life life - Row 3: Fatigue was 0",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: (Row Row 3: 2.1 higher)",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 1)",
      "text": "Row 1: live live - Cough (_QOL _ - Cow) assigned with: QLQ- C30 Scale from: 100. 100.",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: (discontinuation discontinuation (43 to 56) 556 (to to (treatment (1 RCT) 0. 0.56) discontinuous) 556 556 -- assessed with: NCI- (to to (1 RTC) 0. 0.52) (0 to 4) 04 04 556",
      "start_page": 286,
      "end_page": 286
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "== Demographic evolution ====References==",
      "start_page": 286,
      "end_page": 286
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: (43 to 56)",
      "start_page": 286,
      "end_page": 286
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: (0 to 3)",
      "start_page": 286,
      "end_page": 286
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 286,
      "end_page": 286
    },
    {
      "heading": "heading heading <Valori>",
      "text": "Row 1: \"Row\" 2: \"the the tests\" = \"Raw 3: \"safety safety tests?\" = \" Row 5\": \"JUDIZI\" + \"RW 5\" / \"THE THE TESTS\" =",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "heading heading <Valori> (column 1)",
      "text": "Row 1: \"Row\" 2: \"Row Row 3: \"Row Row 4: \"Row Row tests\"",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "heading heading <Valori> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •C: Row Row 4: •",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "heading heading <Valori> (column 2)",
      "text": "Row 1: Row 2: Row 3: efficacy and safety? Row 4:",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "heading heading <Valori> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: risultati risultati principali? \" Row 4: \"",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "heading heading <Valori> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "heading heading <Valori> (column 13)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "heading heading <Acceptability>",
      "text": "or or comparison?",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "heading heading <Acceptability> (column 1)",
      "text": "Row 1: \"Row\" 2: \"Budget of effects\" = \"Raw 3: \"undesirable undesirable effects\" intervention intervention \"Varia\": \"I don't know,\" Row 7: \"Right 8: \"Equity\" = row 9: \"equity equity be? \"Rw\" 10: \"Row\" 11: \"JUDIZI\" = Row 12: \"Reduce equity\" = X X \"improves improves equity\" - \"Improve equity\" + \"Vary\" =",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: Row 2: Row 3: Olders? Row 4:",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "heading heading <Acceptability> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "heading heading <Acceptability> (column 4)",
      "text": "Row 1: Row 2: Row 3: Ronto? Row 4:",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "heading heading <Acceptability> (column 11)",
      "text": "Row 1: 'Row 2: ' Row 3: ' Row 4: ' Row 5: 'ADDENTIONS' Row 6: 'profile. profile.",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "heading heading <Fatsibility>",
      "text": "Row 1: X Si • Varia • Non so • Row 2: • Row 3: •Fatsibility •Row 4: •the the intervention? • row 5: •row 6: JUDICES •TESTS TESTS • NOW 7: ♪ No • Probably no • Yes X •Varia ■ I don't know •",
      "start_page": 289,
      "end_page": 289
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •",
      "start_page": 289,
      "end_page": 289
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 289,
      "end_page": 289
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: l'intervent Row 4:",
      "start_page": 289,
      "end_page": 289
    },
    {
      "heading": "heading heading <Fatsibility> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: to? \" Row 4: \"",
      "start_page": 289,
      "end_page": 289
    },
    {
      "heading": "heading heading <Fatsibility> (column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 289,
      "end_page": 289
    },
    {
      "heading": "heading heading <Fatsibility> (column 17)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 289,
      "end_page": 289
    },
    {
      "heading": "heading heading <DESIDABLE>",
      "text": "== Demographic evolution ====References==",
      "start_page": 290,
      "end_page": 290
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 1)",
      "text": "Row 1: Row 2: PROBLEM Row 3: Row 4: Row 5: Row Row 6: Row 7: Row 8: Row Row 9: Row 10: Row 11: Row Row 12: Row 13: Row 14: VALUES Row 15: Row 16: Row 17: Row Row 18: Row 19: Row 20: EQUITA Row 21: Row 22: Row 23: ACCEPTABILITY Row 24: Row 25: Row 26: Row Row 27:",
      "start_page": 290,
      "end_page": 290
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 2)",
      "text": "Row 1: \"Row 2: \"JUDIZI\" Row 3: \"Raw 4: \"Probably no\" , \"Rop 5\" probably: \"Relevances\" or \"Moderates\" Row 6: \"Moded\" and \"Small\" Row 7: \"Very low\" Featured Row 8: \"or or variability\" or or \"variability\" or or \"revariable\" Row 9: \"of of comparison\" comparison comparison , or or \"intervention\" .",
      "start_page": 290,
      "end_page": 290
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\" Row 17: \" Raw 18: \"",
      "start_page": 290,
      "end_page": 290
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6:",
      "start_page": 290,
      "end_page": 290
    },
    {
      "heading": "heading heading <DESIDABLE> (column 5)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Don't So\" Row 5: \"Do Not So\" row 6: \"Dn't Know\" Row 7: \"No Study Included\" Row 8: \"Raw 9: \"Now\" 10: \"Wow\" 11: \"How\" 12: \"Not So\" Row 13: \"Non So So\" Right 14: \"I don't know\" Row 15: \"You Don't Do So\" 16: \"We Don'T Know\"",
      "start_page": 290,
      "end_page": 290
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: intervention intervention -++ operation operation -+-+ intervention intervention --++intervention intervention X",
      "start_page": 291,
      "end_page": 291
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: • Row 2: • Recommendation • row 3: •",
      "start_page": 291,
      "end_page": 291
    },
    {
      "heading": "heading heading <Recommendation> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Recommendation",
      "start_page": 291,
      "end_page": 291
    },
    {
      "heading": "heading heading <Recommendation> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \"",
      "start_page": 291,
      "end_page": 291
    },
    {
      "heading": "heading heading <Objective response rate>",
      "text": "==References===External links==* Official website",
      "start_page": 292,
      "end_page": 292
    },
    {
      "heading": "heading heading <Objective response rate> (column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 292,
      "end_page": 292
    },
    {
      "heading": "heading heading <Objective response rate> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \"",
      "start_page": 292,
      "end_page": 292
    },
    {
      "heading": "heading heading <Objective response rate> (column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 292,
      "end_page": 292
    },
    {
      "heading": "heading heading <Objective response rate> (column 3)",
      "text": "Row 1: Row 2: Importance Row 3: Row 4:",
      "start_page": 292,
      "end_page": 292
    },
    {
      "heading": "heading heading <Objective response rate> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 293,
      "end_page": 293
    },
    {
      "heading": "heading heading <Objective response rate> (column column 1)",
      "text": "Row 1: ... .. . . . ... . ..\" . . .\" . .",
      "start_page": 293,
      "end_page": 293
    },
    {
      "heading": "heading heading <Objective response rate> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row Row 7: Row 8:",
      "start_page": 293,
      "end_page": 293
    },
    {
      "heading": "heading heading <Objective response rate> (column column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 293,
      "end_page": 293
    },
    {
      "heading": "heading heading <Objective response rate> (column column 3)",
      "text": "Row 1: \"Row 2: No of patients\" \"Certain Row\" 3: \"Raw\" 4: osimertinibThe chemotherapy \"Relative\" (95% CI) \"Absolute\" (95%CI) \"Rown\" 5: \"Rop\" 6: 197/279 (70.6%) \"44/140 (31.4%) \"25 25 (2. 2.90) \"100 100 (60 60 more) \" Row 7: \" Row 8: \"Row\" 9: 228\" \"113\" - \"less less (2. 2.17) \" row 10: \"row 11\": \"Now 12: 239\" \"97\"- \"scorpes scorpes (3. 3.6) \" Row 13: \" Now 14: \"Wow 15: 228.\"113-\" \"36 36 lower\" (2. 2.53) \" Row 16: \"Shore 17: \"",
      "start_page": 293,
      "end_page": 293
    },
    {
      "heading": "heading heading <Objective response rate> (column column 4)",
      "text": "Row 1: \"Row 2: \"Important Row 3: \" Row 4: \"CRITIC Row 5: \" Row 6: \" \" Row 7: \" CRITIC Row 8: \" ' Row 9: \" Row 10: \" CRITIC Row 11: \" row 12: \" - \" Row 13: \" Criticic Row 14: \" Now 15: \"",
      "start_page": 293,
      "end_page": 293
    },
    {
      "heading": "heading heading <Thrombocytopenia grade <= 3>",
      "text": "== Demographic evolution ====References==",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "heading heading <Thrombocytopenia grade <= 3> (column 1)",
      "text": "Row 1: \"Row\" 1: \"Certainty assessment\" = \"Raw\" 3: \" Row 4: \" Row 5: No of studies\" = study study \"Distortion risk\" = 'Non-important risk' = 'Row 8: life life - Fatigue symptom' (assessed with: QLQ-LC13; Scale from: 0 to 100) \" Row 9: \"Rw 10: 1 2\" randomized studies \"Serio a,b\" not important \"Sereio c\" = non-important row 11: \"Diarrhea grade\" = 3\" Row 12: \" Row 13: 1\" Randomised studies \"serio\" = ,b \"non-important\" = C) = \"Great\" = .\"",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "heading heading <Thrombocytopenia grade <= 3> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row Row 7: Row 8:",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "heading heading <Thrombocytopenia grade <= 3> (column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "heading heading <Thrombocytopenia grade <= 3> (column 3)",
      "text": "Row 1: \"Row\": patients patients \"Raw\" (95% CI) \"Absolute\" (95%CI) \"Rw 5: \"Rop\" 6: 228\"-\"Row\"\"113-\"MD 7.09\" lower (33 33 lower) \" Row 7: \"Row\" 8: \"ROW 9: 239\" (14. 14.34) \"100 100 (10 10 more) \" row 13: \" Row\" 14: \" Row\" 12: 3/279 (1.1%) \"R\" 1 / 140 (0.7%) \"51 51 (14. 14.34).",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "heading heading <Thrombocytopenia grade <= 3> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \"",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "heading heading <Thrombocytopenia grade <= 3> (column 5)",
      "text": "Row 1: Row 2: Importance",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "heading heading <References>",
      "text": "Row 1: • Row 2: Certainty assessment •patients patients •Effect •Certain •Important Row 3: •Row 4: studies studies •study study •Distort risk •results results • generalisation generalisation •More considerations •_MEDTERM0___The chemotherapy •Relational (95% CI) • Absolute (95% CI), • row 5: •row 6 • Grade neutropenia •3 (0. 0.25) •100 100 (than than --) − • BASSA • None •1/279 (0.4%) •15/140 (10.7%) •RR • • 0. 0.25) ■100 100 (than than ----)",
      "start_page": 295,
      "end_page": 295
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS>",
      "text": "==References===External links==*Official website* Official website* http://www.interpol.int/en/notice/search/search_en/index_en.htm",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS>",
      "text": "Row 1: \"Row 2: a a priority?\" Row 3: \"Raw 4: JUDICES\" ADDITIONAL ADDITIONAL TESTS\" CONSIDERATIONS \"RW 5: \"No\" - \" Probably no\" - X X \"Yes\"mechanism. mechanism. (Feb Feb 16;376(7):629-640).",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Relative Row 2: effect Row 3: (95% CI)",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: participants Row 3: (studies)",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (GRADE)",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: (42 to 65)b",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 2)",
      "text": "Row 1: Row 2: Evergreen Row 3: Everlasting Row 4:",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 3)",
      "text": "Row 1: Row 2: rable Row 3: Row Row 4:",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: Desirable Those Expected? \" Row 4: \"",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 4)",
      "text": "==See also==*Row==References===External links==",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 5)",
      "text": "Row 1: \"Row\" 2: \"Certainty the eviden\" (GRADE) \"Certainty Row 3: pants\" Row Row 4: e.g. \"GRADE\")",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 6)",
      "text": "Row 1: \"Row 2: of\"C Row 3: \"Nce\" Row 4: \"",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 7)",
      "text": "Row 1: Row 2: Commen Row 3:",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 8)",
      "text": "Row 1: Row 2: nts",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: life life - assessed assessed with: QLQ-LC13 Scale from: 0 to 100",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: of life - Cough Row 3: Row Row 4: Scores",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (Row Row 4: Row Row 5: lower)",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: of life - Appetite Row 3: Row Row 4: 0 scores",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (Row Row 4: 6 6 lower)",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: of life - Row Row 3: Row Row 4: Scores",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (Row Row 4: 2.53 lower)",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: of life - Dyspnea Row 3: Row Row 4: Scores",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (Row Row 4: Row Row 5: lower)",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: of life - Fatigue Row 3: Row Row 4: Scores",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (Row Row 4: Row Row 5: lower)",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 1)",
      "text": "Row 1: life life - assessed assessed with: QLQ-LC13 Scale from: 0 to 100",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: \"100 100 <3 (0 to 6) 415 415 (assessed assessed with: 4.32) (1 RCT) grade grade <=415 415 (assembled with: (to to (1 RTC) 0. 0.38) (0 To 4) 415 415 (01 to (1RCT) LOWC,e;b assigned with: of of events",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Diarrhea Grade <=3 assessed with: NCI-CTCAE",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: (0 to 6)",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: (0 to 3)",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Relative Row 2: effect Row 3: (95% CI)",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: participants Row 3: (studies)",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (GRADE)",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: (42 to 65)b",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: (8 to 20)",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 2)",
      "text": "Row 1: \"Row 2: ndesiderables\" \"Raw 3: be be evocative? \"Rown 4: \"",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 2)",
      "text": "==References===External links==* Official website",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 3)",
      "text": "Row 1: \"Row\" 2: \"the the evidence\" (GRADE) \"C Row 3: pants\" \"Rop 4: es) \" Row 5: \"MODERATEc,\" \"D,\" \"E\" Row 6: \"e, e,\" \"f\" Row 7: \"LOWc,\" and \"Raw 8: \"LoWc, d,e\"",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 4)",
      "text": "Row 1: Row 2: Comments",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: life life - assended assended with: QLQ-LC13 Scale from: 0 to 100",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: of life - Cough Row 3: Row Row 4: Scores",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (Row Row 4: Row Row 5: lower)",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: of life - Appetite Row 3: Row Row 4: 0 scores",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (Row Row 4: 6 6 lower)",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: of life - Row Row 3: Row Row 4: Scores",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (Row Row 4: 2.53 lower)",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: of life - Dyspnea Row 3: Row Row 4: Scores",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (Row Row 4: Row Row 5: lower)",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: of life - Fatigue Row 3: Row Row 4: Scores",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (Row Row 4: Row Row 5: lower)",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 1)",
      "text": "Row 1: life life - assessed assessed with: QLQ-LC13 Scale from: 0 to 100",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: \"100 100 <3 (0 to 6) 415 415 (assessed assessed with: 4.32) (1 RCT) grade grade <=415 415 (assembled with: (to to (1 RTC) 0. 0.38) N CI-CTCALVI (0to 3) of of events",
      "start_page": 302,
      "end_page": 302
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "== Demographic evolution ====References==",
      "start_page": 302,
      "end_page": 302
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: (0 to 6)",
      "start_page": 302,
      "end_page": 302
    },
    {
      "heading": "heading heading <Valori>",
      "text": "Row 1: \"of of events\" Row 2: \"Row 3: \"the the tests\" Row 4: \"safety safety tests?\" Row 5: \"Raw 6: \"JUDICI\" THE THE EVIDENCES\" ADDITIONAL CONSIDERATIONS \"RW 7: \" low, low,\" \"low,\" \"moderate,\" \"high,\" \"no study included\"b b ias\" Row 8: \"row 9: \"values\" Row 10: \"C\" main main outcomes? \" Row 11: \"or or variation\" variability. variability.",
      "start_page": 303,
      "end_page": 303
    },
    {
      "heading": "heading heading <Valori> (column 1)",
      "text": "Row 1: \"Row\" 2: \"Raw\" 3: \"the the tests\" = Row 4: \"safety safety tests?\" = Row 5: \" Row 6: \"JUDIZI\" = row 7: \"Very low\" = \"Moderate\" = high\" = Row Row 8: \"Rough\" = 9: \"Valori\" = Row 10: \"C\" main main outcomes?",
      "start_page": 303,
      "end_page": 303
    },
    {
      "heading": "heading heading <Valori> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 303,
      "end_page": 303
    },
    {
      "heading": "heading heading <Valori> (column 10)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 303,
      "end_page": 303
    },
    {
      "heading": "heading heading <Equity>",
      "text": "Row 1: 'Row' 2: 'Raw': 'Right' 3: 'or or comparison?': 'Row 4: 'Rop 5': JUDICES': \"ADDING TESTS'\": 'Wait for comparison' comparison comparison 'confrontation confrontation 'He'intervention intervention 'X' He'intervention intervention 'Varia' doesn'fact, fact, '_MEDTERM0_' profile. profile.'Row 7: 'Now 8: 'Equities' = 9: 'of of equity?",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "heading heading <Equity> (column 1)",
      "text": "Row 1: \"Row\" 2: \"Budget of effects\" = \"Raw 3: \"undesirable undesirable effects\" * Row 4: \" Row 5: JUDIZI\" = 6: \"He'of of comparison\" = 7: \"Right 8: \"Equity\" = 9: \"of of equity?\" = 10: \" Row 11: \"Judizi\" = 12: \"Reduce equity\" = 1 - improves improves equity",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "heading heading <Equity> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "heading heading <Equity> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "heading heading <Equity> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "heading heading <Equity> (column 4)",
      "text": "Row 1: Row 2: Row 3: Onto? Row 4:",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "heading heading <Equity> (column 12)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "heading heading <Fatsibility>",
      "text": "Row 1: \"Row 2: main main stakeholders?",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading <Fatsibility>",
      "text": "Row 1: \"JUDIZI\" Row 2: \"N\" or \"Si\"Probably not \"Probabilment\" and \"Sii\" Si\" = \"Varia\" Row Row 3: \"PROBLEM\" RW 4: \"Row\" 5: \"Irrelevant\" Rw 7: \"Small\" Moderators \"Grand i\" (Varia) \"Don'Row Row 6: DESIDERABLE EFFECTS\" ROWN 7:",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: Row 2: Row Row 3:",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: Row 2: Row Row 3:",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: Row 2: PROBLEM Row 3: Row 4: Row 5: Row Row 6:",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: main stakeholders? Row 4:",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: intervention? \" Row 4: \"",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading <Fatsibility> (column 8)",
      "text": "Row 1: Row 2: JUD Row 3:",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading <Fatsibility> (column 9)",
      "text": "Row 1: Row 2: TIZI Row 3:",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading <Fatsibility> (column 11)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" row 8: \" \" Row 9: \"",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading <Fatsibility> (column 12)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9:",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading <Fatsibility> (column 13)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading <Fatsibility> (column 14)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Don't know\" Row 5: \"Do not know\"",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading <LINEE GUIDE>",
      "text": "==References===External links==* Official website",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "heading heading <LINEE GUIDE> (column 1)",
      "text": "Row 1: Row 2: FACTS Row 3:RowBIL Row 4: I Row 5: Row 6: Row 7: Row 8: Row Row 9: Row 10: Row 11: Row 12: Row 13: VALUES Row 14: Row 15: Row 16: Row 17: Row Row 18: SIDES Row 19: Row 20: Row 21: EQUITA Row 22: Row 23: Row 24: ACCEPTABILITY Row 25: Row 26: Row 27: FACTIVITY Row 28:",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "heading heading <LINEE GUIDE> (column 2)",
      "text": "Row 1: \"Row 2: \"Great Row 3: \" Row 4: \" Row 5: \"Row Row 6: \" Row 7: \"",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "heading heading <LINEE GUIDE> (column 3)",
      "text": "Row 1: \"Row 2: JUDIZI\" Row 3: \"Rop 4: \"Small\" Row 5: \"Raw 6: \" Row 7: \"Moderata\" Row 8: \"Row 9: \"The Row 10: \"or or variability\"",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "heading heading <LINEE GUIDE> (column 3)",
      "text": "Row 1: equity equity (i.e., on on equity) Row 2: Probably no (ii) Row 3: Probably not (iii) Probably",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "heading heading <LINEE GUID> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" ' Row 8: \" row 9: \" \" Row 10: \"\" Row 11: \" Now 12: \"",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "heading heading <LINEE GUID> (column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6:",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "heading heading <LINEE GUIDE> (column 5)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Do Not So\" Row 5: \"or or \" Row 6: \" Row 7: \" \" Row 8: \" - Row 9: \" row 10: \" ' Row 11: \"Do not So\" row 12: \"Varia\" So So \" Row 13: \" Varia\" Don'Row Row 14: \" Row 15: \"\" Row 16: \"Maria\" Non so \" Row 17: \"Raw 18: \"",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: intervention intervention -++ operation operation -+-+ intervention intervention --++intervention intervention X",
      "start_page": 307,
      "end_page": 307
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: • Row 2: • Recommendation • row 3: •",
      "start_page": 307,
      "end_page": 307
    },
    {
      "heading": "heading heading <QUESITO 18>",
      "text": "000 000 (Fifth Century)",
      "start_page": 308,
      "end_page": 308
    },
    {
      "heading": "heading heading <QUESITO 18> (column 1)",
      "text": "== Demographic evolution ====References==",
      "start_page": 308,
      "end_page": 308
    },
    {
      "heading": "heading heading <QUESITO 18> (column 2)",
      "text": "Row 1: \"Row 2: \"Importance Row 3: \" Row 4: \" Row 5: \" Row 6: \" CRITIC Row 7: \" Row 8: \"",
      "start_page": 308,
      "end_page": 308
    },
    {
      "heading": "heading heading <References>",
      "text": "== Demographic evolution ====References==",
      "start_page": 309,
      "end_page": 309
    },
    {
      "heading": "heading heading <Problem>",
      "text": "== References ==== External links ==* European European Union: http://europa.eu.int/comm/index_en.htm",
      "start_page": 310,
      "end_page": 310
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: \"Row\" 2: \"Problem\" Row 3: \"a a priority?\" Row 4: \"Rop 5: \"JUDICIAL EVIDENCE TESTS\" \"CONSIDERATIONS\" Additional Row 6: \"No\" \"Probably no \"Probably yes\" ● \"Yes,\" \"Varies,\" \"Don't know\"",
      "start_page": 310,
      "end_page": 310
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: or or meta-...Row 2: __medTERM2__. __medTERM2__...\"Row 3: \"Row 4: \"POPULATION:\" Row 5: \"Now 6: \"Raw 7: \"INTERVENTION: \" Row 8: \" Row 9: \"COMPARISON: \"\" Row 10: \"NOW 11: \"MAIN OUTCOMES: \"ROW 12: \" -\" Row 13: \"SETTING: \"Row 14: \"'Row 15: \"PERSPECIVES: \" Now 16: \" 'Row 17: \"BACKGROUND: \"",
      "start_page": 310,
      "end_page": 310
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: \"Row 2: \"Problem\" Row 3: \"a a priority? \" Row 4: \" Row 5: \"JUDICIAL EVIDENCE TESTS\" Row 6: \"No,\" \"Probably no \"Probably yes\" ● \"Yes,\" \"Varies,\" \"Don't know\"",
      "start_page": 310,
      "end_page": 310
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Astatic with ... ..Row 2: • Row 3: •",
      "start_page": 310,
      "end_page": 310
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 310,
      "end_page": 310
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Comments Comments anticipated* (95% CI) participants participants (95% (studies) (GRADE) Risk CI) 697 697 • follows follows up: (a a (3 RCT) 0. 0.46) 100 100 (37 to 50)",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: \"Row\" 2: \"Exit\" effect effect (95% CI) = participants participants (studies) = 6: \"Rischio\" = 7: \"with\" with\" row 8: \"_MEDTERM0\" = \"_medTERM1___\" Row 9: \" Row 10: PFS follow up: months months \"37 37 (0. 0.46) \"697\" (3 RCT) 3 3 \" c, c,d\"Row Row 11: \"Population in studio\" = Row 12: \"Now 13:",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row 2: Relative Row 3: (95% Row 4: CI)",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: participants (studies)",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Certainty Row 2: of Row 3: (GRADE)",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \"Desirabl Row 3: \"Row Row 4: \"",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: Row Row 3: Row Row 4:",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: ects Row 3: Row Row 4:",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: Row 3: ble anticipated effects? Row 4:",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: \"Row 2\": \"Raw 2\" effect effect (95% CI) \"participants participants (studies) \"tests tests (GRADE) \"Commentary\": Row 3: \"Anticipated\": (95% CI), \"Rown\" 4: \"Rough\" 5: \"Row 6: \" Rischio\" = 7: \"with\" with\" row 8: \"_MEDTERM0____\"_alectinib\" Row 9: \" Row 10: __MEDTERM2_ follow up: months months \"HR 0.37\" (0. 0.46) \"697 (3 RCT) 1,2 \" Row Row 11: \"Population in study\"",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row 2:",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading <Problem> (column column 7)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "follow follow up: (to to (2 RCT) 0. 0.79) survival. survival. (13 to 23) followed followed up: (to to (3 RCT), 1. 1.23) increase the __1⁄100 100 (81 to 94) 303 303 → progressive progressive - (to to (1 TCT) al. al., 0. 0.27) MEDTERM8__-positive MEDTERM8__-positive non-Lung Lung Cancer; T. T., R. R., M. M., Rosell, R.",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: follow follow up: months months •56 56 (0. 0.79) •Row 510 (2 RCT) 3 3 • e e •that that •Row Row 2: • Row 8: • Row 9: ♪ MEDTERM5__ followed up: months months - •15 15 (1. 1.23) •663 (3 RCT), • • row 13: −476 • Very much Row: â â .",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (0 to 4)",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "follow follow up: (to to (2 RCT) 0. 0.79) survival. survival. (13 to 23) followed followed up: (to to (3 RCT), 1. 1.23) increase the __1⁄100 100 (81 to 94) 303 303 → progressive progressive - (to to (1 TCT) al. al., 0. 0.27) MEDTERM8__-positive MEDTERM8__-positive non-Lung Lung Cancer; T. T., R. R., M. M., Rosell, R.",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "heading heading <OS>",
      "text": "et et al; et et al",
      "start_page": 313,
      "end_page": 313
    },
    {
      "heading": "heading heading <OS> (column 1)",
      "text": "===Row 1:, Ruf, T., Noé, J., Peters, S.. ALK__-positive ALK__-positive non-small- Ann Ann Oncol; et et al",
      "start_page": 313,
      "end_page": 313
    },
    {
      "heading": "heading heading <ORR>",
      "text": "found. found.",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "heading heading <ORR> (column 1)",
      "text": "Row 1: \"Row 2: \"Undesira Row 3: \"Row Row 4: \"",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "heading heading <ORR> (column 2)",
      "text": "Row 1: Row 2: Row Row 3: Row Row 4:",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "heading heading <ORR> (column 3)",
      "text": "Row 1: \"_MEDTERM0__\" Row 2: \"Row 3: \"S\" Row 4: \"irable anticipated effects\"?",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "heading heading <ORR> (column 3)",
      "text": "with with •phase. phase.",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "heading heading <ORR> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "heading heading <ORR> (from previous page)",
      "text": "Row 1: Certainties Certainties Comments* (95% CI) Participants Participants (95% (Studies) (GRADE) Aminotrasferase Aminotrasferase (to to (3 RCT) increase increase 3- aminotrasphere aminotrasphere (to to (2 RCT), increase increase - grade 3- 0. 0.91) 4 4 (2 to 7)",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading <ORR> (from previous page)",
      "text": "Row 1; Row 3; Row 2; Esiti 5; Effetto essolutivo (95% CI) participants participants (studies) Row 4;Row 5; Row 6; Rw 10: Alanine anotrasferase increase- 23 23 (0. 0.45) Row 8; Raw 4; RW 9: • Row 10: 23 23 (0. 0.44) Row 11: grade grade 3- 4. Row 11: -Population in study",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading <ORR> (from previous page)",
      "text": "Row 1: Row 2: Relative Row 3: (95% Row 4: CI)",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading <ORR> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: participants (studies)",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading <ORR> (from previous page)",
      "text": "Row 1: Certainty Row 2: of Row 3: (GRADE)",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading <ORR> (from previous page)",
      "text": "Row 1: Row Row 2: (1 to 6)",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading <ORR> (from previous page)",
      "text": "Row 1: Row Row 2: (2 to 7)",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading <ORR> (from previous page)",
      "text": "Row 1: Row Row 2: (0 to 2)",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading <ORR> (from previous page)",
      "text": "Row 1: Row Row 2: (1 to 5)",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading <ORR_> (column column 1)",
      "text": "==See also==*Row==References===External links==",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading <ORR_> (column column 2)",
      "text": "Row 1: \"Row\" 2: \"the the tests\" (GRADE) \"Comments\" Row 3: \"Nti\" Row 4: \"Rop\" 5: \"VERY BASSAa,\" \"b,\" \"c,\" \"D\" Row 6: \"Very BASSaa,\" \"B,\" \"C\"d\" Row 7: \"MUCH BASSAA, \"b\"c, \"d\" \"RW\" 8: \"Many Bassaa, \"B\"c\"",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading <ORR_> (column column 3)",
      "text": "Row 1: Row 2:",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading <ORR> (from previous page)",
      "text": "Kow 1: kinase-positive kinase-positive non- small-cell cancer (ALESIA): Respir Respir Med; K. K., Hida, T., Nokihara, H., Kumagai, M., A., Watanabe, S., Goto, K ., Satouchi, m., Kozuki, t., stuyama, R., Mitsudomi, T",
      "start_page": 316,
      "end_page": 316
    },
    {
      "heading": "heading heading <ORR_> (column column 1)",
      "text": "Kow 1: kinase-positive kinase-positive non- small-cell cancer (ALESIA): Respir Respir Med; K. K., Hida, T., Nokihara, H., Kumagai, M., A., Watanabe, S., Goto, K ., Satouchi, m., Kozuki, t., stuyama, R., Mitsudomi, T",
      "start_page": 316,
      "end_page": 316
    },
    {
      "heading": "heading heading <ORR> (from previous page)",
      "text": "Row 1: • ALT 3+ Nausea 3+ Toxic death •",
      "start_page": 317,
      "end_page": 317
    },
    {
      "heading": "heading heading <Values>",
      "text": "Row 1: \"Row\" 2: \"Certainty of evidence\" is equal to: \"of of effects? \" Row\" 4: \"Rown\" 5: \"JUDICIAL EVIDENCE TRIALS\" = \"CONSIDERATIONS ADDENTY\" = 6: ● \"Very low \"Low\" = Modern \"High \" No included studies\" = 9: \"main main outcome?\" = 7: \"Raw 8: \"Values\" = 10: \"I don't know\" = 11: \"It'main main factors?\"",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "heading heading <Values> (column 1)",
      "text": "Row 1: 'Row 2: 'Certainty of evidence' Row 3: 'of of effects? ' Row 4: 'Raw 5: 'JUDIZI' Row 6: 'Very low 'Low' Moderate 'High 'No included studies'.' Row 7: 'Rop 8: 'Values' Row 9: 'value value ' Row 10: ' Row 11: JUDIZIO Row 12: 'variable variable 'variability variability '",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "heading heading <Values> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "heading heading <Values> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "heading heading <Values> (column 3)",
      "text": "Row 1: Row 2: Row 3: mes? Row 4:",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "heading heading <Values> (column 10)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "heading heading <Acceptability>",
      "text": "death. death.",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading <Acceptability> (column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading <Acceptability> (column 1)",
      "text": "Row 1: \"Row 2: \"Equity Row 3: \"Row Row 4: \"",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading <Acceptability> (column 1)",
      "text": "Row 1: \"Row 2: \"Acceptability Row 3: \"Row Row 4: \"",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: health equity? \" Row 4: \"",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: to key stakeholders? \" Row 4: \"",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading <Acceptability> (column 3)",
      "text": "Row 1: Row 2: Row 3: n? Row 4:",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading <Acceptability> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading <Acceptability> (column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading <Acceptability> (from previous page)",
      "text": "Row 1: ● Yes • Varies • Don't know • Row 2: • Right 3: • Feasibility • row 4: • implement implement ? •row 5: •Row 6: COURTS • TESTS TESTS •ADDATIVE CONSIDERATIONS • NOW 7: ♪ No • Probably no •Probably yes ● Yes • Various • don't knows •found found • No evidence found",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading <Acceptability> (from previous page)",
      "text": "Row 1: \"Row 2: \"JUDIZI\" Row 3: \"Raw 4: \"No\"Probably no\" \"Probabilly yes\" \"Yes\" and \"Don't know\" Row 5: \"PROBLEM\" Row 6: \"Rw\" 7: \"Trivial\" Small\" \"Moderate\" Large and \"Don't Know\" Row 8: \"DESIRABLE\" Row 9: \"EFFECTS\" Row 10: \"White\" Row 11: \"Large\" Moderate\" Small (Small) Trivials and \"Smale\" = \"Done't known\" Row 12: \"UNDESIRABLE\" Row 13: \"EFFECTS\" Row 14: \"Donot know\"",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading <Acceptability> (column column 1)",
      "text": "Row 1: \"Row 2: \"Feasibilit Row 3: \"Row Row 4: \"",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading <Acceptability> (column column 1)",
      "text": "Row 1: Row 2: Row 3: PROBLEM Row 4: Row 5: Row 6: Row 7: DESIGNABLE Row 8: EFFECTS Row 9: Row 10: Row 11: UNDESIRABLE Row 12: EFFEECTS Row 13:",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading <Acceptability> (column column 2)",
      "text": "Row 1: Row 2: ty Row 3:Row Row 4:",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading <Acceptability> (column column 2)",
      "text": "Row 1: Row 2: Row 3: M Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13:",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading <Acceptability> (column column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: ble to implementation? \" Row 4: \"",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading <Acceptability> (column column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" row 7: \" Row 8: \" ' Row 9: \" \" Row 10: \" - Row 11: \" Now 12: \" Route 13: \"\" Row 14: \"",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading <Acceptability> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading <Acceptability> (column column 4)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading <Acceptability> (column column 8)",
      "text": "Row 1: Row 2: G Row 3:",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading <Acceptability> (column column 9)",
      "text": "Row 1: Row 2: JUDGES Row 3:",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading <Acceptability> (column column 10)",
      "text": "Row 1: Row 2: IZI Row 3:",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading <Acceptability> (column column 12)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12:",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading <Acceptability> (column column 13)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading <Acceptability> (column column 14)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Don't Know\" Row 5: \"Raw 6: \"Way 7: \"Do't know\" Row 8: \"Now 9: \"Row 10: \"Varie\" and \"Done't Well\" Row 11: \" Row 12: \"",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading <Acceptability> (from previous page)",
      "text": "== References ==== External links ==* Official website",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading <Acceptability> (column column 1)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: Row 5: VALUES Row 6: Row 7: Row 8: Row Row 9: Row 10: Row 11: Row Row 12: Row 13: Row 14: EQUITY Row 15: Row 16: Row 17: Row Row 18: Row 19: Row 20: FEASIBILITY Row 21:",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading <Acceptability> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: S Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row 22: Row 23: Row 24: Row 25: Row 26: Row 27: Row 28: I Row 29: Row 30: Row 31: Row 32: Row 33: Row 34: Row 35:",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading <Acceptability> (column column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \" Right 12: \"",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading <Acceptability> (column column 3)",
      "text": "Row 1: Row 2:",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading <Acceptability> (column column 4)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading <Acceptability> (column column 5)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Low Row 5: \"Row Row 6: \"Row Row 7: \"Row Row 8: \" Row Row 9: \" Row Row 10: \"",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading <Acceptability> (column column 6)",
      "text": "Row 1: Row 2: GI Row 3:",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading <Acceptability> (column column 7)",
      "text": "Row 1: Row 2: IUDIZI Row 3:",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading <Acceptability> (column column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" row 8: \" \" Row 9: \"",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading <Acceptability> (column column 8)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6:",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading <Acceptability> (column column 9)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9:",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading <Acceptability> (column column 11)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"studies studies \" Row 5: \" Row 6: \" row 7: \" Row 8: \" ' Row 9: \" \" Row 10: \" Do n'or or w\" Row 11: \"Do n' o o w\" \" Row 12: \"Don't know \" Row 13: \" Don't Know \" Row 14: \" don't knowing\"",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: the the intervention",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: • Row 2: • Recommendation • row 3: •",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "heading heading <Recommendation> (column 1)",
      "text": "Row 1: \"Row 2: \"Recommendation Row 3: \"",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "heading heading <Recommendation> (column 2)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "heading heading <Recommendation> (column 3)",
      "text": "Row 1: Row 2: Row Row 3: Row Row 4: Row 5: ● Row 6:",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "heading heading <Recommendation> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \"",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "heading heading <QUESITO 19>",
      "text": "== Demographic evolution ====References==",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "heading heading <QUESITO 19> (column 1)",
      "text": "Row 1: ^Row 2: Certainty assessment ^ Row 3: ■ Row 4: • Row 5: studies studies ■study study ■Distortion risk ■results results ■ generalization generalization ■Immediacy Row 6: • row 7: survival survival (follow up: 9 9 months) a •row 8: ♪ Row 9: 1 • Randomized studies • c c •non important •e e •Row Row 10: Overall survival (pollow up: 9 9 mesi)a • rows 11: {Row 12: 1 = randomised studios • 9 9 • Row Row 13: ORR (followup: median24.9 mei)a Row 14: ‐Row 15: 1 - 9 9 - midday • midday .",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "heading heading <QUESITO 19> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row Row 7: Row 8: Row 9: Row 10:",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "heading heading <QUESITO 19> (column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "heading heading <QUESITO 19> (column 3)",
      "text": "Row 1: \"Row\" 1: \"No\": \"No of patients\" \"Effect\" \"Certainly\" \"Importion Row 3: \"Rown\" 4: \"_MEDTERM0\"_ \"_ MEDTERM1\" _ \"Relational\" (95% CI) \"Absolute\" (95%CI) \" Row 5: \"Rout\" 6: \"Row\" 7: \"Now\" 8: \"63/137\" (46.0%) \"87/138 (63.0%) \"49 49 (0. 0.68) \"100 100 (14 14 less) \"BASSA\" = CRITIC Row 9: \"Wow\" 10: \"ROW\" 11: \"3/137 (24.1%), \"Raw 13: \"10\" (26.8%) \"R\" 0.92 \"R.\"",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "heading heading <bearing bearing inGHS/QoL>",
      "text": "==References===External links==* Official website",
      "start_page": 324,
      "end_page": 324
    },
    {
      "heading": "heading heading <bearing bearing inGHS/QoL> (column 1)",
      "text": "== Demographic evolution ====References==",
      "start_page": 324,
      "end_page": 324
    },
    {
      "heading": "heading heading <bearing bearing inGHS/QoL> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row Row 7: Row 8:",
      "start_page": 324,
      "end_page": 324
    },
    {
      "heading": "heading heading <bearing bearing inGHS/QoL> (column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 324,
      "end_page": 324
    },
    {
      "heading": "heading heading <bearing bearing inGHS/QoL> (column 2)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 324,
      "end_page": 324
    },
    {
      "heading": "heading heading <bearing bearing inGHS/QoL> (column 3)",
      "text": "Row 1: minus 1; minus 1 - 10: less 1 - 13 - _ _ - 10 - 0 0 - - 3 3 - minus minus 2: No of patients' 'Effected' -Certo Row 3: \" Out Row 4: _ _ - - - _ - MEDTERM1___ MEDTERM1___ [Relativo (95% CI) - Absolute (95% CI (CI) - - Total Row 5: • Row 6: 31/47 (66.0%) - [66.0%) -8 (16.3%) - 9 (16.3%) - 04 04 (7. 7.87) - 50 / 47 (66.8%) - + 100 (100 100 + to 100 (to to 100) - 12 (to to 25) - Row: Row 11:",
      "start_page": 324,
      "end_page": 324
    },
    {
      "heading": "heading heading <bearing bearing inGHS/QoL> (column 4)",
      "text": "Row 1: \"Row 2: \"Importation Row 3: \" Row 4: \"CRITIC Row 5: \" Row 6: \" \" Row 7: \" CRITIC Row 8: \" row 9: \" ' Row 10: \" CRITIC Row 11: \" Row 12: \" - \" Row 13: \" Crititic Row 14: \" \" Row 15: \" Right 16: \"Critical Row 17: \" Now 18: \" Route 19: \"",
      "start_page": 324,
      "end_page": 324
    },
    {
      "heading": "heading heading <References>",
      "text": "Row 1: \"Row 2: Certainty assessment\" Patient's No (s) of patients \"Effect\" (sure) \"Important Row 3: \"Raw\" 4: studies studies \"the the study\" \"Distortion risk\" (ies) \"Absolute\" (95% CI) \"Rout\" 5: \"Rown\" 6: 1 \"Studies randomized\" (164 164 plus) \"G\" series \"None\"17/136 (12.5%) \"12/137 (8.8%) \"43 43 (2. 2.87) \"000 000 (164 164 more) \"MUCH BASSA\" (ii) \"CRITIC",
      "start_page": 325,
      "end_page": 325
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: advanced advanced stage",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: \"Row 2: a a priority? \" Row 3: \" Row 4: \" JUDICES\" \"EVIDENCE EVIDENCE TESTS\" \"CONSIDERATIONS\" Row 5: \"No\" \"Probably not \"Yes\" ● \"Varia\" \"I don'out. out.\"",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: with with NSLC/Row 2: • Row 3: POPULATION: • Row 4: • row 5: INTERVENTION: â ¢ Row 6: Â Row 7: COMPARISON: ■ Row 8: − Row 9: MAIN EXITS: ¶",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: \"Row 2: SETTING: \" Row 3: \" Row 4: PROSPECTIVE: \" row 5: \" Row 6: \" BACKGROUND: \"row 7: \"RW 8: CONFLICTS OF \" Row 9: INTEREST \" Row 10: \"",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: Row 2: a a priority? Row 3: Row 4: JUDICES Row 5:",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Row Row 2:",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading <Problem> (column 3)",
      "text": "Row 1: Row Row 2:",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading <Problem> (column 4)",
      "text": "Row 1: Row 2:",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading <Problem> (column 4)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row 2: Relative Row 3: (95% Row 4: CI)",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: participants (studies)",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Certainty Row 2: of Row 3: (GRADE)",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: 100 Row 3: (29 to 49)",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: Esider Row 3: Row Row 4:",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Siderable Expected? Row 4:",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row Row 2: study study (ALTA-1) age age > Early Early comments* (95% CI) trials trials (95% MEDTERMOPERM0_ vintage &amp; day. day.",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading <Problem> (column column 7)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "follow follow up: 4.04 (1 RCT.) of of (62 to 87) response. response.",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/en_en/index_en.htm",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: 100 Row 3: (62 to 87)",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: 100 Row 3: (17 to 45)",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: 100 Row 3: (34 to 100)",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: 1,000",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: 1,000",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: • Row 2: • row 3: •row 4: •MEDTERM0_ follow up: months months •20 20 (1. 1.41) Row 5: • study population •Row 6: ♪ Row 7: ■ Row 8: @100 100 •100 100 (62 to 87) • Row 9: ¶ Row 10: Intracranial •_MEDTERM1_ follow-up: months months ‐25 25 (0. 0.45) Row 11: ^â â ¢ Row 12: Row Row 13: − Row 14: â¬ Row 14; â€100 100 (17 to 45) Row Row 15: · Row 16: ¢â â .",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row Row 2: Row Row 3: Row Row 4: row row 5: not not having",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References==",
      "start_page": 329,
      "end_page": 329
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: \"life. life.\" Row 2: \"312 to 534) \" Row 3: \"Row 4: improvements improvements inGHS/follow follow up: 9 9 months\"26 26 (0. 0.56) \"119 (1 RCT) \"1 \" d, d,e\" \"__medTERM1_ __medTERM1_ Q- C30 Row 5: \"Population in study\"",
      "start_page": 329,
      "end_page": 329
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: (Row Row 2: 534)",
      "start_page": 329,
      "end_page": 329
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: 1,000",
      "start_page": 329,
      "end_page": 329
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (49 to 210)",
      "start_page": 329,
      "end_page": 329
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row\" 2: \"312 to 534) \" Row 3: \" Row 4: improvements improvements inGHS/follow follow up: months months \"26 26 (0. 0.56) \"119 (1 RCT) \"1 Row 5: \"Population in study\" \"Rw 6: \"Raw 7: \" Row 8: \"344\" 000 000 \"104\" 000 000 (49 to 210) \" Row 9: \"",
      "start_page": 329,
      "end_page": 329
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row Row 2: MEDTERM1__ MEDTERM1__ Q-C30",
      "start_page": 329,
      "end_page": 329
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: ndesid Row 3: Row Row 4:",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: Derabi Row 3: Row Row 4:",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: ii Row 3: Row Row 4:",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: \"__medTERM2__ __medTERM2__ + cancer cancer (ALTA-1L). Lung Cancer; that that 27% indirectity indirectity (inappropriate inappropriate follow-up). default default (an an interim-analysis). bias bias (open label study). e. 3: d. d.",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row Row 2: study study (ALTA-1) patients patients > treatment treatment arms: BID. BID.",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading <Problem> (column column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: (GRADE) Risk CI) grade grade < 273 273 • 19 19 (1 RCT)follow follow up: 100 100 (9 9 (61 to 86) 1,40) RR73 RR73 •_MEDTERM1,c follow-up: 0.91 (1 RTC) 100 100 (100 100 (97 to 100) 10.01) AST AST (< G3 Study population",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row 2: Relative Row 3: (95% Row 4: CI)",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: participants (studies)",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Certainty Row 2: of Row 3: (GRADE)",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (61 to 86)",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: 100",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (97 to 100)",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: 1,000",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (12 to 107)",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row: partecip partecip (studies) Row Row 3: \"anticipated\" (95% CI) -partecip Row 4: \"Studies\" Row 5: \" \"Row 6: \"Rischio\" Raw Raw 7: \"con\" Row 7:",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: \"Row\" 2: \"Certe delle p\" (GRA) \"Certe Row 3: panti\" Row Row 4: \"GRA\"",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: ADE) Row 5:",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: • Row 2: • Comments Row 3: • row 4: •row 5: •Row Row 6: ♪Row Row 7: ■the the •ST ST < 3. Row 8: −",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "much much (13 to 99) RR RR <3 - follow follow up: (to to (1 RCT)grade grade <=RR RR 273",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: ALT grade <3 follow-up: 9 9 months/36 36 (0. 0.97)",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: 1,000",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (13 to 99)",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: 1,000",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (62 to 251)",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: ALT grade <=3 follow-up: 36 36 (0. 0.97)",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row Row 2: discontinuity. discontinuity.",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "heading heading <Valori>",
      "text": "bias bias (open label study). data data (sponsor bias). imprecision imprecision (an an interim-analysis).",
      "start_page": 333,
      "end_page": 333
    },
    {
      "heading": "heading heading <Valori> (column 1)",
      "text": "Row 1: \"Row 2: \" Row 3: \"the the tests\" [Row 4: \"safety safety tests?\"] Row 5: \"Raw 6: \"JUDIZI\" Row 7: \"Very low\" - \"Low\" - moderated - \"High\" - included included - \"Rw 8\": \" Row 9: \"Valori\" - Row 10: \"C\" main main outcomes? \" Row 11: \"Wow\" 12: \"GIUDIZI\"\" Row 13: \"or or variable\" - variation variation ● or or variability",
      "start_page": 333,
      "end_page": 333
    },
    {
      "heading": "heading heading <Valori> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 333,
      "end_page": 333
    },
    {
      "heading": "heading heading <Equity>",
      "text": "==References===External links==* Official website",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "heading heading <Equity> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "heading heading <Equity> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "heading heading <Equity> (column 2)",
      "text": "Row 1: Row 2: Row 3: or or comparison? Row 4:",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "heading heading <Equity> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: uità? \" Row 4: \"",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "heading heading <Equity> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "heading heading <Equity> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "heading heading <Fatsibility>",
      "text": "Row 1: \"Row\" 2: \"Acceptibility\" \"Rop 3: \"main main stakeholders?\" \"Raw 4: \"Roo 5: \"JUDICI\" \"EVIDENCE EVIDENCE TESTS\" \"ADDENTIONS\" \"ROW 6: \"No\" \"Probably no\" \"You\" ● \"Yes,\" \"Vary,\" \"I don't know,\" \"found. found. \"filled. filled.\" \"Ruh 7: \"Roh 8: \"Fatsibility\" \"Row 9: \"the the intervention\" \"Now 10: \"Needle\" \"Not known.\"",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Acceptability Row 3: •Row Row 4: •",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •Now 4:",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: Main Row 4:",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: ell'interve Row 4:",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading <Fatsibility> (column 4)",
      "text": "Row 1: Row 2: Row 3: stakeholders? Row 4:",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading <Fatsibility> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: ento\"? \"Raw 4: \"",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading <Fatsibility> (column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading <Fatsibility> (column 12)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading <Fatsibility> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading <Fatsibility> (column column 1)",
      "text": "Row 1: Row 2: PROBLEM Row 3: Row 4: Row 5: Row Row 6: Row 7: Row 8: Row Row 9: Row 10: Row 11: Row Row 12: Row 13: Row 14: VALUES Row 15: Row 16: Row 17: Row Row 18:",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading <Fatsibility> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: ERABILI Row 9: Row 10: Row 11: Row 12: Row 13: IBERABLE Row 14: Row 15: Row 16: Row 17: ELLE Row 18: Row 19: Row 20: Row 21: Row 22: Row 23: Row 24: Row 25: Row 26: Row 27: OR Row 28: Row 29: Row 30: Row 31:",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading <Fatsibility> (column column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \" Now 12: \" Roll 13: \" Route 14: \" Right 15: \" [ Row 16: \"] Row 17: \" # Row 18: \"\" Row 19: \") Row 20: \" * Row 21: \" Rule 22: \"",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading <Fatsibility> (column column 3)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading <Fatsibility> (column column 7)",
      "text": "Row 1: Row 2: JUDICES Row 3:",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading <Fatsibility> (column column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\" Row 17: \" Raw 18: \"",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading <Fatsibility> (column column 9)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18:",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading <Fatsibility> (column column 11)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Don't know\" Row 5: \"Don't knowing\" Row 6: \"Do't known\" Row 7: \"No included studies\" Row 8: \"Raw 9: \" Row 10: \" row 11: \" Row 12: \"N\" 13: \"don't knows\"",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading <Fatsibility> (from previous page)",
      "text": "Row 1: \"Row 2: \"JUDIZI\" Row 3: \"Raw 4: \"Reduce d\"reduce reduce d\" Probably no impact\" by by \"Increased by \"Varies\" or \"n\" or or \"w\" Row 5: \" EQUITA\" Row 6: \"N\" Row 7: \"No\" no no \"yes yes \"Yes\"",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "heading heading <Fatsibility> (column column 1)",
      "text": "Row 1: Row 2: EQUITA: Row 3: Row 4: Row 5: Row Row 6: Row 7: Row 8: FACTIVITY Row 9:",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "heading heading <Fatsibility> (column column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" ' Row 8: \" row 9: \" \" Row 10: \"\" Row 11: \" Now 12: \"",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "heading heading <Fatsibility> (column column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "heading heading <Fatsibility> (column column 3)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "heading heading <Fatsibility> (column column 7)",
      "text": "Row 1: Row 2: JU Row 3:",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "heading heading <Fatsibility> (column column 8)",
      "text": "Row 1: Row 2: UDIZI Row 3:",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "heading heading <Fatsibility> (column column 9)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6:",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "heading heading <Fatsibility> (column column 13)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"D o n' o o w\" \" Row 5: \"D or \"n' t \" n o \" \" Row 6: \" n n \" or or \" w\"",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: against against intervention",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: • Row 2: • Recommendation • row 3: •",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "heading heading <QUESITO 20>",
      "text": "== Demographic evolution ====References==",
      "start_page": 339,
      "end_page": 339
    },
    {
      "heading": "heading heading <QUESITO 20> (column 1)",
      "text": "Row 1: Certainty assessment: Row 2: ... Row 3:...\"Study\" Row 4: ..Row 8: Progression free survival\" Row 9: 2...\"randomised trials\" b. b..\"\"serious c\"not seriousus d\"not seriousness\" Row 10: \"Overall survival\" row 11: 2\"randomized trials\" b, b,e\"not graveus\"not silky d\"serious f ... Row 12: rate rate \"Row 13: 2'randomisised trials\" B, B,g\"unsericious unsericious d\"serious h\") Row 14: \"Nausea responde rate\" Row 13: ...",
      "start_page": 339,
      "end_page": 339
    },
    {
      "heading": "heading heading <QUESITO 20> (column 2)",
      "text": "Row 1: Row 2: Row 3: subscription Row 4: Row 5:",
      "start_page": 339,
      "end_page": 339
    },
    {
      "heading": "heading heading <QUESITO 20> (column 3)",
      "text": "Row 1, \"No of patients\" = \"Importance Row,\" \"No\" =\"\"ceritinib or\"_Relative\" = [Absolute] = \"Certainty\" =\"Important Row 3: \"ns\"_MEDTERM1_ _ or\"chemotherapy\" (95% CI) ] = \"Row 4: \"_MEDTHERM2___\" Row 5: \"\"Row 6: \"Moderate Row 7: \"111/187\" (59.4%) \"110/151 (72.8%) \"45 45 (0. 0.59) \"100 100 (37 37 feet) \" MODERATE\" = CRITICAL Row 8: \"RW 9:",
      "start_page": 339,
      "end_page": 339
    },
    {
      "heading": "heading heading <QUESITO 20> (from previous page)",
      "text": "Row 1: GGT increased - ceritinib",
      "start_page": 340,
      "end_page": 340
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS>",
      "text": "Row 9: - 10: SETTING: \"Row Row 11: \"Row 12: • 28: 2nd diet: 2; 2nd metastatic: 2D_Mow: 1; Row Row 3:",
      "start_page": 341,
      "end_page": 341
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS>",
      "text": "Row 1: • Row 2: a a priority? •row 3: • row 4: JUDICES •TESTS TESTS •Row 5: • no • probably no ♪ X X • Yes",
      "start_page": 341,
      "end_page": 341
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "desirable desirable effects?Row 5: \"Row 6: \"JUDICIS\" Row 7: \"Comments Comments CI) evidence evidence (95% CI) (studies) (GRAD) chemotherapy chemotherapy (Comments Comments CI) evidence evidence 95% CI (studies) (GRADE) chemotherapy chemotherapy (_168TERM _168TERM 1__] 59 59 (36) 338 338 ? Survival (to to (2 RCTs) 9 9 (36).",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Relative Row 2: effect Row 3: (95% CI)",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: participants Row 3: (studies)",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: evidence Row 3: (GRADE)",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (from previous page)",
      "text": "Row 1: Row Row 2: chemotherapy",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 2)",
      "text": "Row 1: Row 2: Evergreen Row 3: Everlasting Row 4:",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 3)",
      "text": "Row 1: Row 2: rable Row 3: Row Row 4:",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: Desirable Those Expected? \" Row 4: \"",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 4)",
      "text": "Row 1: \"Row 2: Outcomes\" \"Outcomes\"",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 5)",
      "text": "Row 1: ... \"Row 5: ..Row Row 11: ..\"Row 12: . ..Row 13: .\"Row Row 14: .\"\"Row 15: . ... row row 23: .",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 6)",
      "text": "Row 1: \"Row with Row\" 2: d absolute effects* (9th Row 3: \"Raw\" 4: \"Rop\" 5: \"Rown\" 6: \"Row Row 7: \"Apy\" (Q9): \"Ceritini Row 8: \"_MEDTERM0__\" Row 9: \"Wow\" 10: \" Row 11: \"ation\" Row 12: \"Now\" 13: \"Dow\" 14: \"4\" for \"100 Row 15: \"8th Row\" to \"54) Row 16: \"How\" 17: \"How\" 18: \"athion\" Row 19: \"Sow\" 20: \"Row\" 21: \"7\" Row Row 22: \"28 to \"49\" Row 23: \"He\" Row 24: \"Fow\" 25: \"Jow\" Row 26: \"New\" 27: \"The Row\" 28: \"Row Row 29: \"20 to \"79\" Row 30: \"Imrow\" 31: \"10 \"Rlow\" 38: \"Eight\": \"3: ation Row\" Row: \"Bow\" 33: \"",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 7)",
      "text": "Row 1: ... .. . . . ... . ...\" . ..\" ..\"",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 8)",
      "text": "Row 1: \"Row\" 2: \"Certainty\" or evidence (GRADE) \"Certainty\" and \"Raw\" 3: pants\" \"evidence Row 4: \"s\" (GRADE)",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 9)",
      "text": "Row 1: Row 2: Row Row 3: Row 4:",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 10)",
      "text": "Row 1: \"Row 2: Commen\"",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 11)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS> (column column 11)",
      "text": "Row 1: Row 2: nts",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading <I2=89%>",
      "text": "==References===External links==* Official website",
      "start_page": 343,
      "end_page": 343
    },
    {
      "heading": "heading heading <I2=89%>",
      "text": "Row 1: GGT increased - ceritinib",
      "start_page": 343,
      "end_page": 343
    },
    {
      "heading": "heading heading <I2=89%>",
      "text": "Row 1: Row Row 2: (0 to 0)",
      "start_page": 343,
      "end_page": 343
    },
    {
      "heading": "heading heading <I2=89%> (column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 343,
      "end_page": 343
    },
    {
      "heading": "heading heading <I2=89%> (from previous page)",
      "text": "Row 1: \"Row 2: \"Indesirable effects\" [Row 3]: \"effects effects expected?\" (Row 4: \"Wow 5: \"ADDITIVE ADDITIVE TESTS\" (Raw 6): \"Great\" (Now 6: \") \"Moderate X\" (Studies) \" (GRADE) \" Chemotherapy Chemotherapy (Q9) \"338 338 \"Survival\" (to to (2 RCTs) 59 59 (36 to 54) \"HR HR .",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (from previous page)",
      "text": "Row 1: Relative Row 2: effect Row 3: (95% CI)",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (from previous page)",
      "text": "Row 1: Row Row 2: participants Row 3: (studies)",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (from previous page)",
      "text": "Row 1: Row Row 2: evidence Row 3: (GRADE)",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (from previous page)",
      "text": "Row 1: Row Row 2: chemotherapy",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (column column 2)",
      "text": "Row 1: Row 2: ndesid Row 3: Row Row 4:",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (column column 3)",
      "text": "Row 1: Row 2: derabi Row 3: Row Row 4:",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (column column 4)",
      "text": "Row 1: Row 2: ii Row 3: Unwanted Tits Expected? Row 4:",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (column column 4)",
      "text": "Row: Row 4: Row 5: Row 6: - \"Row 6: \"Raw 5: \" Row 7: \"Row Row 11: \" Row Row 12: \"\" Row 13: \"Chemothera Row 8: \" \" RW 9: Row Row 10: \" row row 11:",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (column column 5)",
      "text": "Row 1: \"Row with Row\" 2: d absolute effects* (9th Row 3: \"Raw\" 4: \"Rop\" 5: \"Rown\" 6: \"Row Row 7: \"Apy\" (Q9): \"Ceritini Row 8: \"_MEDTERM0__\" Row 9: \"Wow\" 10: \" Row\" 11: \"ation\" Row 12: \"Now\" 13: \"Dow\" 14: \"4\" for \"100 Row 15: \"28 to \"54) Row 16: \"How\" 17: \"Row\" 18: \"Otion\" [Row] 19: \"==Row 20: \"Sow\" 21: \"7\" Row Row 22: \"20 to \"79\" Row 23: \" Row\" 24: \"5\" Row 25: \"Action\" Row 26: \"Fow\" 33: \"10\" Row 28: \"Row Row 29: \"+20 to 79\" Row 30: \"- Row\" Row 31: \"ROW\": \"3: \"50: \"35\" Row\" - 35: \"Bight to \" Row.\"",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (column column 6)",
      "text": "==References===External links==* Official website",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (column column 7)",
      "text": "Row 1: \"Row\" 2: \"Certainty\" or evidence (GRADE) \"Certainty\" and \"Raw\" 3: pants\" \"evidence Row 4: \"s\" (GRADE)",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (column column 8)",
      "text": "Row 1: Row 2: Row Row 3: Row 4:",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (column column 9)",
      "text": "Row 1: \"Row 2: Commen\"",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (column column 10)",
      "text": "Row 1: Row 2: nts",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (column column 12)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading <I2=89%> (from previous page)",
      "text": "Rowter 1: • 291 291 • treatment (3 to 15) (to to (2 RCTs) 1. 1.94) I2=31% patients patients was: 26% and and 33% MEDTERM7_ MEDTERM7_ 0/1 (91.7% vs 85.7% metastasis metastasis (34.7% vs 25.7%).",
      "start_page": 345,
      "end_page": 345
    },
    {
      "heading": "heading heading <I2=89%> (from previous page)",
      "text": "Row 1: 85 85 (1. 1.94)",
      "start_page": 345,
      "end_page": 345
    },
    {
      "heading": "heading heading <I2=89%> (from previous page)",
      "text": "Row 1: Row Row 2: (3 to 15)",
      "start_page": 345,
      "end_page": 345
    },
    {
      "heading": "heading heading <I2=89%> (column column 1)",
      "text": "Rowter 1: • 291 291 • treatment (3 to 15) (to to (2 RCTs) 1. 1.94) I2=31% patients patients was: 26% and and 33% MEDTERM7_ MEDTERM7_ 0/1 (91.7% vs 85.7% metastasis metastasis (34.7% vs 25.7%).",
      "start_page": 345,
      "end_page": 345
    },
    {
      "heading": "heading heading <Valori>",
      "text": "Row 1: \"Row\" 2: \"the the tests\" • Row 3: \"safety safety tests?\" • row 4: •row 5: \"JUDIZI\" ♪tests tests •now 6: • X X • moderated • high • included included • •biases biases • estimates estimates • Now 7: − Row 8: \"Valori\" ¶ Row 9: \"C\" main main outcomes? • Row 10: \"Raw 11: JUDITIONS •EVENTS EVENTS • NOW 12: \"variability variability • variation variation • or or variability\"",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "heading heading <Valori> (column 1)",
      "text": "Row 1: \"Row\" 2: \"the the tests\" = \"Raw 3: \"safety safety tests?\" = \" Row 4: \" Row 5: \"JUDIZI\" = row 6: \"X X \"Moderated low\" = high 7: \" Row 8: \"Valori\" = Row 9: \"C\" main main outcomes\" = . Row 10: \"Rown 11: \"Giudizi\" = rows 12: \"or or variation\" = whatsoever. whatsoever.",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "heading heading <Valori> (column 2)",
      "text": "Row 1: Row 2: Row 3: ? Row 4:",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "heading heading <Valori> (column 2)",
      "text": "Row 1: Row 2: Row 3: wings? Row 4:",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "heading heading <Valori> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "heading heading <Valori> (column 12)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "heading heading <Acceptability>",
      "text": "or or comparison?",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "heading heading <Acceptability> (column 1)",
      "text": "Row 1: \"Row\" 2: \"Budget of effects\" = \"Raw 3: \"undesirable undesirable effects\" favour favour , \"Varia\" = , row row 7: \"Right 8: \"Equity\" = 9: \"of of equity?\" = 10: \"Wait\" = 11: \"Judizi\" = 12: \"Reduce equity\" = 15: \"stakeh stakeh = 10\" - \"Improve equity\" - 5: \"Vay\" - 1: \"Don't know\" - 13: \"Now\" - 14: \"Acceptability\" -15: \"Possibly no impact\" - equity equity -- \"Improved equity\"",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: Row 2: Row 3: Keepers? Row 4:",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "heading heading <Acceptability> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "heading heading <Acceptability> (column 4)",
      "text": "Row 1: Row 2: Row 3: Front? Row 4:",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "heading heading <Acceptability> (column 12)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "heading heading <BILI>",
      "text": "Row 1: \"Varia\" doesn'Row Row 2: \"Row\" 3: the the intervention? \"Rop\" 4: \"Rw\" 5: \"JUDICI\" = \"ADDITIONAL ADDITIONAL TESTS\" = row 6: \"No\" no no \"Probably yes\" x \"Varia\" known. known.",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "heading heading <BILI>",
      "text": "Row 1: 'Row 2: 'JUDIZI' Row 3: 'Rop 4: 'No'Probabilm ente no'Probilm entre si' \"Si\": 'Varia' not so 'Raw 5': 'PROBLEM' Row 6: 'Rout' 7: 'Relevances' 'Small' 'Moderates' 'Various' 'Do not so' Row 8: DESIDERABLE SIDES' Row 9: 'Row 10: 'Great' 'Moderati' 'Piccoli' (Smells) 'Models'\" 'Vary 'Not so 'Wow 11: Sides' Row 12: 'Now 13: BILIS' Row 14: 'row 15: 'bas bas sa'Bassa'Moderated 'Alta'or or 'Right 16: QUITA Row 17: 'DELLE Row 18: WATCHES' Row 19: '",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "heading heading <BILI> (column 1)",
      "text": "Row 1: Row 2: Row Row 3:",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "heading heading <BILI> (column 1)",
      "text": "Row 1: Row 2: Row 3: PROBLEM Row 4: Row 5: Row 6: Row 7: Row 8: Row Row 9: Row 10: Row 11: Row 12: SIDES Row 13:RIGHT Row 14: BIBILI Row 15: Row 16: Row 17: QUALITY Row 18: DELLE Row 19: TESTS Row 20:",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "table under heading<bile> (column 2)",
      "text": "Row 1: Row 2: Row 3: the the surgery? Row 4:",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "table under heading<bile> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \" Now 12: \" Roll 13: \" Route 14: \"\" Row 15: \" Right 16: \") Row 17: \" [ \" Row 18: \"] Row 19: \"",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "heading heading <BILI> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "heading heading <BILI> (column 3)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "heading heading <BILI> (column 7)",
      "text": "Row 1: Row 2: G Row 3:",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "table under heading> (column 8)",
      "text": "Row 1: Row 2: JUDIZ Row 3:",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "table under heading> (column 9)",
      "text": "Row 1: Row 2: ZI Row 3:",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "table under heading> (column 11)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" row 7: \" Row 8: \" ' Row 9: \" \" Row 10: \" - Row 11: \" Now 12: \" Route 13: \"\" Row 14: \" Right 15: \"",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "table under heading> (column 12)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15:",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "table under heading> (column 13)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "table under heading> (column 14)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Don'Row Row 5: \"Row Row 6: \"D\" Row 7: \"o o \" Row 8: \" Row 9: \"",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "heading heading <JUDIZI>",
      "text": "Row 1: ... \"Row 7\": \"or or variability\" variation. variation...\"or or variable\" comparison. comparison..\"\"or or variability\" = \"Raw 8\" is important: \"Row 9\": ...\"Row 10: \"of of comparison\" and and \"interven to\" isn'comparison, comparison, \"comparison, comparison,\" \"Probabably reduces equity\" (on on equity) \"Probiably increase equity\" to to \"Ru\" 12: \"RWow 13: \"Reduces equity\")...",
      "start_page": 349,
      "end_page": 349
    },
    {
      "heading": "heading heading <JUDIZI> (column 1)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: EQUITA Row 12: Row 13: Row 14: ACCEPTABILITY Row 15: Row 16: Row 17: FACTIVITY Row 18:",
      "start_page": 349,
      "end_page": 349
    },
    {
      "heading": "heading heading <JUDIZI> (column 2)",
      "text": "Row 1: \"Row\" 2: \"JUDIZI\" Row 3: \"Raw\" 4: \" Row\" 5: \" Row 6: \"Rop\" 7: \"or or variability\" = \"or or variation\" - \"or or variability\" - ...\"Row 8: \"Row\" 9: \"- Row 10: \"of of comparison\" -\"\"comparison comparison - \"intervention intervention - \"intervention intervention \"nto\" Row 11: \"Now\" 12: \"Wow\" 13: \"Reduce equity\" - equity equity - \"on on equity\"",
      "start_page": 349,
      "end_page": 349
    },
    {
      "heading": "heading heading <JUDIZI> (column 2)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 349,
      "end_page": 349
    },
    {
      "heading": "heading heading <JUDIZI> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" row 8: \" \" Row 9: \"",
      "start_page": 349,
      "end_page": 349
    },
    {
      "heading": "heading heading <JUDIZI> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6:",
      "start_page": 349,
      "end_page": 349
    },
    {
      "heading": "heading heading <JUDIZI> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Nor so\" Row 5: \"Raw 6: \" Row 7: \" Row 8: \" row 9: \" \" Row 10: \"Don't know\" Row 11: \"Varia\" know know \" Row 12: \"Miscellaneous\" Row 13: \"Row 14: \"Way\" 15: \"Save\" Row 16: \"Now 17: \"I don't care\"",
      "start_page": 349,
      "end_page": 349
    },
    {
      "heading": "heading heading <Strong recommendation>",
      "text": "Row 1: intervention intervention -++ operation operation -+-+ intervention intervention --++intervention intervention X",
      "start_page": 350,
      "end_page": 350
    },
    {
      "heading": "heading heading <Strong recommendation>",
      "text": "Row 1: • Row 2: • Recommendation • row 3: •",
      "start_page": 350,
      "end_page": 350
    },
    {
      "heading": "heading heading <Strong recommendation> (column 1)",
      "text": "Row 1: intervention intervention • • operation operation •",
      "start_page": 350,
      "end_page": 350
    },
    {
      "heading": "heading heading <Strong recommendation> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Recommendation",
      "start_page": 350,
      "end_page": 350
    },
    {
      "heading": "heading heading <Strong recommendation> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \"",
      "start_page": 350,
      "end_page": 350
    },
    {
      "heading": "heading heading <QUESITO 21>",
      "text": "==References===External links==* Official website",
      "start_page": 351,
      "end_page": 351
    },
    {
      "heading": "heading heading <Ipertridemia grade 3-4>",
      "text": "Row 1: \"Row\": \"Raw\": 5 hours \"Rown 3: \"Right\": studies studies \"Rough\": 15 years \"Different\": 4 years \"Worthful\": 3 years \"Few months\": 10 years \"Serious\": 2 years \"Very serious\": very serious (very serious) = \"Current\": 7 years \"Harthly\": 6 years \"Great\": 1 years \"Garly\"; 5 years \"Life\": 9 years \"al. al. 10/baseline. baseline.\" 47/patients. patients.",
      "start_page": 352,
      "end_page": 352
    },
    {
      "heading": "heading heading < Hypertridemia grade 3-4> (column 1)",
      "text": "Row 1: \"Distorting risk\": Certainty assessment: \"Row\" 3: \"Raw 4: \" Row\" 5: \"No studies\": \"the the study\": very serious: \"Very serious\": c\" very serious; \"Rw\" 8: \"grade grade 3-4\" Row 9: \"Row 10: 2 1,2\" observational studies: very seriously: \"very serious\" = \"Verily serious\"; \"C\": Very serious: C\": Highly serious: high: \"High\": Low: low: 2 1.2\" observationally studied: very Serious: very severe: very bad: low to high: high to low: high level: high-grade: low-level: low 16: 2,2\" serious. serious.",
      "start_page": 352,
      "end_page": 352
    },
    {
      "heading": "heading heading < Hypertridemia grade 3-4> (column 2)",
      "text": "Row 1: Few-to-five-century patients: al. al. 10/al al 1/patient patient (Row).",
      "start_page": 352,
      "end_page": 352
    },
    {
      "heading": "heading heading < Hypertridemia grade 3-4> (column 3)",
      "text": "Row 1: Row 2: Importance",
      "start_page": 352,
      "end_page": 352
    },
    {
      "heading": "heading heading < Hypertridemia grade 3-4> (column 3)",
      "text": "Row 1: Row 2:",
      "start_page": 352,
      "end_page": 352
    },
    {
      "heading": "heading heading <References>",
      "text": "Row 1: • Row 2: Certainty assessment •row 3: • row 4: design design •distortion distortion • results results •now 8: 1 • observational studies •not important • very serious • no one •study study •15/4. 4. • molto bassa •",
      "start_page": 353,
      "end_page": 353
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: or or __DETERM2__",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: \"Row 2: a a priority? \" Row 3: \" Row 4: \" JUDICES\" \"EVIDENCE EVIDENCE TESTS\" \"CONSIDERATIONS\" Row 5: \"No\" \"Probably not \"Yes\" ● \"Varia\" \"I don'out. out.\"",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: Should Row 2: Row Row 3: Row 4: POPULATION: Row 5: Row 6: INTERVENTION: Row 7: Row 8: COMPARISON: Row 9: Row 10: MAIN EXITS: Row 11: Row 12: Row 13: SETTING: Row 14: Row 15: PROSPECTIVE: Row 16: Row 17: BACKGROUND: Row 18: Row 19: Row Row 20:",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: Row 2: Row Row 3: priority:",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: re-arrangem re-arrangem + Row 2: or or __medTERM2___",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" row 7: \" Row 8: \" E \" Row 9: \"",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Row 2: Row 3: Tà? Row 4:",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Row Row 2: completed. completed.",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading <Problem> (column 3)",
      "text": "Row 1: Row Row 2:",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading <Problem> (column 3)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "====Effects Effects (Row 3: \"desirable desirable effects?==:::;;;::.:: .::]:: Row:: , , 5: CONSIDERATIONS CONSIDERATIONS , Row 6: • Irrelevant , Little ● Varian Varian , _ _ &amp; had had before; treated, treated, and",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: \"Row\" 2: \"Impact\": \"No\" of the \"the the Rows\" 3: \"Participants\" \"Tests\" \"Raw 4: \"Studies\" \"GRADE) \" Row 5: \"follow follow up\": months months \"(1 observational study\") 1 \" MANY BASSAA, \"b\" \" Row 7: \"months months (95%1-30. 1-30.3). \" Row 8: \"Row 9: Response duration\" = 12: \"_MEDTERM0__ rearranged\" months months \"Rown 13: \"95%IC 6.8-NR\"). \"Rop 14: \"Now\" with with \"Right 12: •ranged. ranged.\"",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: months (95%1-30. 1-30.3).",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: Esider Row 3: Row Row 4:",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Siderable Expected? Row 4:",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "between between 10- 35 35 - of of −the the follow_MERALM1_=Festes Festes (GR duration) of of , one one line- 1 line; iron, iron, and",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading <Problem> (column column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row. , Fl. Fl., months months (95%4-7. 4-7.4). al. al. 10/32 patients (disease. disease.",
      "start_page": 356,
      "end_page": 356
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 356,
      "end_page": 356
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "et et al'TKI. TKI. 1/patient. patient.",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: 'Row 2: Outcomes'\"Impact\"the the \"Certainness\" \"Row 3: \"Participants\" of the tests\" \"Row 4: \"Studies\" \"GRADE) \" Row 5: \"Raw 6: \"3-4 3-4 \"(2 observational studies) 1,2 \" MANY BASSAA, b\" Row 7: \"54 54 \" Row 8: \"Total patients\" Row Row 9: \"3 3 \" Row 10: \"al. al.\" 1/295 \" Row 11: \"Persons\" Row Row 12: \"AST\" Row Row 13: \"Grade 4 \" Row 14: \"",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: ndesid Row 3: Row Row 4:",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: Derabi Row 3: Row Row 4:",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: ii Row 3: Row Row 4:",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: \"TKI. TKI.",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row Row 2: al. al.'et et al'by by −of of − MEDTERM2_ patient.",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading <Problem> (column column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: al. al. 2/54 (on on observationals) b b (verbal verbal expression), al al . of 54 (developed developed observationals).patients patients (have have observed).",
      "start_page": 358,
      "end_page": 358
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "== Demographic evolution ====References==",
      "start_page": 358,
      "end_page": 358
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: al. al. 15/295 Row 2: Row Row 3: gain. gain.",
      "start_page": 358,
      "end_page": 358
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "== Demographic evolution ====References==*density density ==External links==",
      "start_page": 358,
      "end_page": 358
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/en_en/index_en.htm",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: Row Row 3: Row 4:",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: ve Row 3: of Row 4:",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: \"J. S., Chen, J., F. F., Abbattista, A., J. J.. Lorlatinib in non-__medTERM2__ __medTERM2__ rearrangement: single-arm single-arm first-Lancet Lancet Oncol; or or several?",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row Row 2: following following reasons: - distortion distortion (uncontrolled observational studies) - non-consistency non-consistency - indirectness indirectness - inaccuracy. inaccuracy.",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading <Problem> (column column 7)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading <Effect balance>",
      "text": "==References===External links==* gain. gain.",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "heading heading <Budget of effects> (column 1)",
      "text": "gain. gain.",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "heading heading <Budget of effects> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "heading heading <Budget of effects> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "heading heading <Fatsibility>",
      "text": "Row 1: \"Row\": \"Raw\" 2: \"Right\" = \"Rown\" 3: \"of of equity? \"Rop\" 4: \"Rough\" 5: \"JUDIZI\" 5 - \"EVIDENCE EVIDENCE TESTS\" ): \"Reduces equity\" equity equity ● \"No impact\" equity equity \"Improves equity,\" \"Vary\" 10: \"found. found.\" \"filled. filled.\" \"Rw 7: \"Row 8: \"Acceptibility\"",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Acceptability Row 3: •Row Row 4: •",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •The Row 4:",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: Uità? Row 4:",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: stakeholders? \" Row 4: \"",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: ento\"? \"Raw 4: \"",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading <Fatsibility> (column 9)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading <Fatsibility> (from previous page)",
      "text": "Row 1: • Vary • Not known",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading <Fatsibility> (from previous page)",
      "text": "== Demographic evolution ====References==",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading <Fatsibility> (column column 1)",
      "text": "Row 1: Row 2: PROBLEM Row 3: Row 4: Row 5: Row Row 6: Row 7: Row 8: Row Row 9: Row 10: Row 11: Row Row 12: Row 13: Row 14: VALUES Row 15: Row 16: Row 17: Row Row 18: Row 19: Row 20: EQUITA Row 21:",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading <Fatsibility> (column column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \" I Row 12: \" Now 13: \" Route 14: \" Right 15: \"",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading <Fatsibility> (column column 2)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading <Fatsibility> (column column 3)",
      "text": "Row 1: Row 2: JUDICES Row 3:",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading <Fatsibility> (column column 3)",
      "text": "Row 1: Probably no\"Row Row 2: Small\"Moderate Row 3: Moderat e\"Small Row 4: Low\"Moderat e \"Row 5: or or variable\"\"Row Row 6: on on \"Row Row 7: ProBably reduced [Probabilly no impact]",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading <Fatsibility> (column column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\" Row 17: \" Raw 18: \"",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading <Fatsibility> (column column 6)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Don't know\" Row 5: \"Dun't knows\" Row 6: \"Do't known\" Row 7: \"No included studies\" Row 8: \"Raw 9: \"Row 10: \" Row 11: \" Row 12: \"Now 13: \" Don't Know\" Row 14: \"don't really know\"",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: \"Row 2: \"JUDIZI\" Row 3: \"Rown 4: \"No\"Probably no\" \"Probabilly yes\" \"Yes\" \"Varies D\"on'Row Row 5: ACCEPTABLE TY\" Row 6: \"Raw 7: \"No\"\"Probably no \"Probably yes \"Yes\" \"Warries\" Don'Row Row 8: FACTABILITY\" Row 9: \"",
      "start_page": 363,
      "end_page": 363
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: against against intervention",
      "start_page": 363,
      "end_page": 363
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: Row 2: recommendation Row 3:",
      "start_page": 363,
      "end_page": 363
    },
    {
      "heading": "heading heading <Recommendation> (column 1)",
      "text": "Row 1: \"Row 2: \"JUDIZI\" Row 3: \"Rown 4: \"No\"Probably no\" \"Probabilly yes\" \"Yes\" Row 5: ACCEPTABLE \"TY\" Row 6: \"Now 7: \"No\"\"Probable no\"Probably yes \"Yes\") Row 8: FACTIVITY \"Raw 9: \"",
      "start_page": 363,
      "end_page": 363
    },
    {
      "heading": "heading heading <Recommendation> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" On'Row Row 5: \"Don't know",
      "start_page": 363,
      "end_page": 363
    },
    {
      "heading": "heading heading <Recommendation> (column 2)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 363,
      "end_page": 363
    },
    {
      "heading": "heading heading <QUESITO 22>",
      "text": "== Demographic evolution ====References==",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading <QUESITO 22> (column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading <QUESITO 22> (column 2)",
      "text": "Row 1: \"Row Row 2: \"Row Row 3: \"Row Row 4: \"ions\" with Row 5: \"_MEDTERM0__ Row 6: \"Row 7: \"",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading <QUESITO 22> (column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading <QUESITO 22> (column 3)",
      "text": "Row 1: tients... Row 2: st...\"chemothera Row 3: apy\" Row 4: \"Row 5: b\" Row 6: \"Raw 7: \"",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading <QUESITO 22> (column 4)",
      "text": "Row 1: \"Effect\" Row 2: \"Row\" 3: \"Certainty\"Importance Row 4: \"Relational\" Row 5: \"Apy\" Row 6: \"95% CI\") \"Rop 7: \"Raw 8: \"Row\" 9: \"Now\" 10: \"Wow\" 11: \"-\" Row 11:",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading <QUESITO 22> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 365,
      "end_page": 365
    },
    {
      "heading": "heading heading <QUESITO 22> (column column 1)",
      "text": "==Filmography===References==",
      "start_page": 365,
      "end_page": 365
    },
    {
      "heading": "heading heading <QUESITO 22> (column column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 365,
      "end_page": 365
    },
    {
      "heading": "heading heading <QUESITO 22> (column column 4)",
      "text": "Row 1: -...",
      "start_page": 365,
      "end_page": 365
    },
    {
      "heading": "heading heading <QUESITO 22> (column column 5)",
      "text": "Row 1: \"Row\" 2: \"Rop\" 3: \"Critical\" Row 4: \"Rown\" Row 5: \"Raw\" 6: \"Critical\" Row 7: \"Row\" 8: \"Now\" 9: \"CRITAL\" Row 10: \"Wow\" Row 11: \"How\" 12: \"Gritical\" Row 13: \"Heavy\" Row 14: \"Short\" Row 15: \"Clitical\" row 16: \"The Row\" 17: \"Weapon\" 18: \"Free\" Row 19: \"Down\" 20: \"No\" Row 21: \"Christical\" row 22: \"News\" 23: \"Il\" Row 24: \"Charcoal\" Row 25: \"Oh, no.\"",
      "start_page": 365,
      "end_page": 365
    },
    {
      "heading": "heading heading <Explanations>",
      "text": "== Demographic evolution ====References==",
      "start_page": 366,
      "end_page": 366
    },
    {
      "heading": "heading heading <CONFLICTS OF INTEREST>",
      "text": "Row_Low_Med_Material_Impairment: __Mad_Matt_Maw_Mut_Map_Patient: __MEDTERS2_Row __MEDTERS2_Row 3: \"Row 4: \"INTERVENTION: \"Row Row 5: \"RW\" 6: \"CONFRONT: \"Chemotherapy Row 7: \" Row 8: Main outcomes: \"Global survival; objective response rate; quality of life; diarrhea/to to 3; to to three; Row Row 9: \"ROW\"",
      "start_page": 367,
      "end_page": 367
    },
    {
      "heading": "heading heading <X Si>",
      "text": "Row 1: \"Row 2: \"Problem\" = \"Raw 3: \"a a priority?\" = \" Row 5: \"JUDIZI\" = ADDITIVE ADDITIVE TESTS\" = 6: \"No,\" \" Probably no\" = 10, \"Wouldn't\" = 7: \"Right 8: \"Wishable effects\" = 9: \"desirable desirable effects?\" = 10: \"Now 11: \"absolute absolute effects\"==References===External links==",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si>",
      "text": "Row 1: \"Row\": \"Raw\" 2: \"Advanced absolute effects\"* \"Rolative effect (95% CI) \"participants participants (studies) \"evidence evidence (GRADE) \"Comments Row 3: \"95% CI\") \" Row 4: \"Rown 5: \"With chemotherapy\" \"clue clue 7: \"Q6a first\" Row 8: \"Li\" and \"therapy\" Row 9: \"with\" Row 10: \"Medterm0\"_ \"Rw\" 11: \"Now 12: survival survival - al al (METROS) \" Freenot estimated\" [26] (1 observational study) \"VERY LOWa,b\" Row 13: \"Study population\" [Row] 14: \" Row 15: \"",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si>",
      "text": "Row 1: Relative Row 2: effect Row 3: (95% Row 4: CI)",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si>",
      "text": "Row 1: Row Row 2: participants Row 3: (studies)",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si>",
      "text": "Row 1: Row Row 2: Row Row 3: (GRADE)",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si>",
      "text": "Row 1: Row Row 2: chemotherapy",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si> (column 1)",
      "text": "Row 1: • Row 2: • The Row 3: • Row Row 4: •",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si> (column 1)",
      "text": "Row 1: • Row 2: • Row Row 3: • Row Row 4: •",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si> (column 2)",
      "text": "Row 1: Row 2: Row 3: à? Row 4:",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si> (column 2)",
      "text": "Row 1: Row 2: rable Row 3: Row Row 4:",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: Desirable Those Expected? \" Row 4: \"",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si> (column 3)",
      "text": "Row 1: \"Row 2: Outcomes\" Anticipated Row 3: \"95% CI\" Row 4: \"Rop 5: \"Raw 6: \" Risk with chemotherapy\" Row Row 7: \"chemothera Row 8: \" Row 9: survival survival - al al (METROS) \" Row 10: \"Row Row 11: \"Row 12: \" row 13: \"0\" Row Row 14: \"How 15: Progressions-free survival - at at - not reported\" Row 16: \"-\"- Row 17: \"",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si> (column 4)",
      "text": "Row 1: \"Row 2: d absolute effects*\"Relat effect (95% CI) \"Relat Row 3: \"Effect Row 4: \"95% Row 5: \" \"Raw 6: \" Risk with\" \"CI\") \" Row 7: \"apy\" \"Q6)\" first Row 8: \"I\" and \"therapy\" Row 9: \"With\" Row 10: \"_MEDTERM0__\" Row 11: \" Row 12: \"Rop 13: \"Lation\" Row 14: \" Row 15: \"Now 16: \"0\" for \"1,000\" Row 17: \" (0 to \") \" Row 18: \"- Row 19: \"\" Row 20: \" - \" Row 21: \"",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si> (column 5)",
      "text": "Row 1: \"Row 2: tive\" participants participants (studies) \"evid evid (GRAD) \" Certain Row 3: t\"Row Row 4: % \"GRAD Row 5: \"Raw 6: \"26\" (1 observational study) \" Row 7: \"-\"",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si> (column 6)",
      "text": "Row 1: Row 2: Row Row 3: dence Row 4: DE)",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si> (column 7)",
      "text": "Row 1: \"Row 2: Commen\"",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si> (column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si> (column 8)",
      "text": "Row 1: Row 2: nts",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "===Progression-free survival - 30 30 \" estimated estimated (observational observational (to 0) study) Overall survival - 26 26 \" al (METROS) estimated (observational observational (0 to 0] study) Overall survival - not not 53",
      "start_page": 369,
      "end_page": 369
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "== Demographic evolution ====References==",
      "start_page": 369,
      "end_page": 369
    },
    {
      "heading": "heading heading <X Si> (column column 2)",
      "text": "Row 1: ... ..Row 6: .. Row 7: . . ..\"Row 8: ..\"Row Row 9: . \" Row 10: .\" Row 11: .",
      "start_page": 369,
      "end_page": 369
    },
    {
      "heading": "heading heading <X Si> (column column 3)",
      "text": "Row 5: 00-Row Row 6: .Row Row 7: .0 Row 8: .9 Row 9: .10: .00 Row 11: .000 Row 12: 00 -Row Row 13: .02 to 0) Row 14: .09 Row 15: .06 Row 16: .17: .18:",
      "start_page": 369,
      "end_page": 369
    },
    {
      "heading": "heading heading <X Si> (column column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: 00 \" Row 6: \" Row 7: \" Row 8: \" \" Row 9: \" ' Row 10: \" row 11: \" Right 12: \"",
      "start_page": 369,
      "end_page": 369
    },
    {
      "heading": "heading heading <X Si> (column column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" 00 \" Row 7: \" Row 8: \" \" Row 9: \" row 10: \"",
      "start_page": 369,
      "end_page": 369
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "== References ==== External links ==* Official website",
      "start_page": 370,
      "end_page": 370
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 370,
      "end_page": 370
    },
    {
      "heading": "heading heading <X Si> (column column 1)",
      "text": "== Demographic evolution ====References==",
      "start_page": 370,
      "end_page": 370
    },
    {
      "heading": "heading heading <X Si> (column column 2)",
      "text": "==References===External links==* Official website",
      "start_page": 370,
      "end_page": 370
    },
    {
      "heading": "heading heading <X Si> (column column 3)",
      "text": "Row 1: Row 2:",
      "start_page": 370,
      "end_page": 370
    },
    {
      "heading": "heading heading <X Si> (column column 3)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 370,
      "end_page": 370
    },
    {
      "heading": "heading heading <X Si> (column column 3)",
      "text": "Row 1: \"Row\" 2: \"Rop\" 3: \"Raw\" 4: \"Rown\" 5: \"Rw\" 6: \"00\" Row 7: \"Row\" 8: \"Wow\" 9: \"Now\" 10: \"The Row\" 11: \"Dow\" 12: \"Sow\" 13: \" 00\" Row 14: \"How\" 15: \"Using Row 16: \"Cow\" 17: \"Images Row 18: \"Weeping Row\" 19: \"Turning Row 20: \"No\" 21: \"Hearting Row 22: \"A\" Row 23: \"Employing Row 24: \"Young Row 25: \"It's Row 26: \"Double Row 27: 00\" row 28: \"One Row 29: \"===References==",
      "start_page": 370,
      "end_page": 370
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "Row 1: \"Toxicity grade <=3 - of of - (to to study) reduction. reduction.\" of of 8/from from 7/nature. nature.",
      "start_page": 371,
      "end_page": 371
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "Row 1: Toxicity grade <=3 - al al ... ((1 observational study) \" VERY LOWa,c\" Row 2: \"of. of...' Row 3: \"of of our\" Row 4: \"able able to\" Row 5: \"or or \"Row 6: \"5 toxicity.\" series, series, no\" Row 7: \"grade grade 4\" or \" Row 8: \"One One patient\" Row 9: \"3 3 \"row\" Row 10: \"Toxicity,\" Row Row 11: \"and and dose\" Row 12: \"Reduction\" 13: \"Toxity grade.\"",
      "start_page": 371,
      "end_page": 371
    },
    {
      "heading": "heading heading <X Si> (column column 1)",
      "text": "Row 1: Toxicity grade <=3 - al al ... ((1 observational study) \" Row Row 2: \"2Because 2Because of\" Row 3: \"of of our\" Row 4: \"able able to\" Row 5: \"or or \"Row 6: \"5 toxicity.\" series, series, no\" Row 7: \"4or 4or \" Row 8: \"One One patient\" Row 9: \"3 3 Liver\" Row 10: \"Toxity,\" Row Row 11: \"and and dose\" Row 12: \"Reduction.\"",
      "start_page": 371,
      "end_page": 371
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "Row 1: \"Row 2: \"Indesirable effects\" \"Raw 3: \"to to be? \" Row 4: \" Row 5: \"JUDIZI\" \"ADDITIVE ADDITIVE TESTS\" \"ROW 6: \"Great\" \"Moderate\" \"Small X Irrelevant\" \"Varianous\" \"Not known\" \"Absolute Absolute Effects\" \"Comments Comments (95% CI) evidence evidence \" (95% (study) \" (GRADE) with with CI\") chemotherapy \" (Q6)line line therapy\" survival survival (0, 0, \"tudy population\" not 26 \"al al (METROS) estimated (observational observational (to 0, stuvedy) on non-survival - not.",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "Row 1: Relative Row 2: effect Row 3: (95% Row 4: CI)",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "Row 1: Row Row 2: participants Row 3: (studies)",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: (GRADE)",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "Row 1: Row Row 2: chemotherapy",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading <X Si> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading <X Si> (column column 2)",
      "text": "Row 1: Row 2: ndesid Row 3: Row Row 4:",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading <X Si> (column column 3)",
      "text": "Row 1: Row 2: derabi Row 3: Row Row 4:",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading <X Si> (column column 4)",
      "text": "Row 1: Row 2: ii Row 3: Unwanted Tits Expected? Row 4:",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading <X Si> (column column 4)",
      "text": "Row 1: \"Row 1: \"Raw 5: \" Row 5: 'Row 6: \" chemothera. chemothera.' Row Row 7: \"chemothera row 8: \"\" Row 9: survival survival - al al (METROS) Row 10: \"row row 11: \" \" RW 12: \"-",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading <X Si> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading <X Si> (column column 5)",
      "text": "==References===External links==* Official website",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading <X Si> (column column 6)",
      "text": "Row 1: \"Row 2: tive\" participants participants (studies) \"evidence evidence (GRADE) Row 3: t\" Row 4: %\" Row 5: \"Rown 6: \"M\"26 (1 observational study) \"Row Row 7: \"VERY Lowa,\"b Row 8: \"10\" (1 observational study), \"VLY Lowa\"c Row 9: \"12\" (1 observed study) ...\"",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading <X Si> (column column 7)",
      "text": "Row 1: \"Row 2: Commen\"",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading <X Si> (column column 8)",
      "text": "Row 1: Row 2: nts",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading <X Si> (column column 10)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "Row 1, \"Overall survival - Mazières J. - - - et al. - Objective Objective - 2019 2019 (_MEDTERM0_) estimated (rated rated with: observational observational (0 to 0) study) rate rate - not not 30",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "Row 1: Overall survival - al. al. - not reported-",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading <X Si> (column column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading <X Si> (column column 2)",
      "text": "==References===External links==* Official website",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading <X Si> (column column 3)",
      "text": "Row 1: Row 2:",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading <X Si> (column column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: 0 \" Row 7: \" row 8: \" \" Row 9: \" ' Row 10: \" Row 11: \" Right 12: \" - Row 13: 00 \" Row 14: \" Route 15: \" Roll 16: \"\" Row 17: \") Row 18: \" # Row 19: \" Now 20: \" = \" Row 21: \" [ Row 22: \"] Row 23: \" * Row 24: \"",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading <X Si> (column column 3)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading <X Si> (column column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" 0 \" Row 7: \" Row 8: \" ' Row 9: \" row 10: \" \" Row 11: \" - Row 12: \" Now 13: \" Route 14: \" Right 15: \" [ Row 16: \"] Row 17: \"\" Row 18: \"",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "grade grade <3 - (0 to 0) not (1, , al. al. (METROS) b b study) Neutropenias grade <=3 - 53 53 , estimated estimated (0, 0, study).",
      "start_page": 374,
      "end_page": 374
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 374,
      "end_page": 374
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "Row 1: Row Row 2: (0 to 0)",
      "start_page": 374,
      "end_page": 374
    },
    {
      "heading": "heading heading <X Si> (column column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 374,
      "end_page": 374
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "Row 1: \"76% patients patients (89%) and and 42% sufferers sufferers (80.7% line line ... Row 2:",
      "start_page": 375,
      "end_page": 375
    },
    {
      "heading": "heading heading <X Si> (column column 1)",
      "text": "Row 1: \"Row 2\": \"Row Row 3: \"Row Row 4: \"Row Row 3\"",
      "start_page": 375,
      "end_page": 375
    },
    {
      "heading": "heading heading <X Si> (column column 2)",
      "text": "Row 1: \"76% patients patients (89%) and and 42% sufferers sufferers (80.7%) chemotherapy chemotherapy line\" Row 2: \"Row 3: rove",
      "start_page": 375,
      "end_page": 375
    },
    {
      "heading": "heading heading <X Si> (column column 2)",
      "text": "Row 1: Row Row 2: and and indirectness",
      "start_page": 375,
      "end_page": 375
    },
    {
      "heading": "heading heading <X Si> (column column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 375,
      "end_page": 375
    },
    {
      "heading": "heading heading <Effect balance>",
      "text": "Row 1: \"Row\" 2: \"Raw values\" 3: \"C\" main main outcomes? \" Row 4: \" Row 5\": \"Right\" 5: \"Wait\" 7: \"Row 8: \"Budget of effects\" Row 9: \"or or comparison?\" \"Rown 10: \"row 11: \"Judizios\" RICERCA OF TESTS\" X \"Ready\" 12: \"It'comparison, comparison,\" \"Probably it'comparison. comparison.\"",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "heading heading <Budget of effects> (column 1)",
      "text": "Row 1: \"Row 2: \"Valori\" Row 3: \"C\" main main outcomes? \"Rop 4: \"Raw 5: \"JUDIZI\" Row 6: \"variation, variation,\" \"volatility, volatility,\" \"major major variability\" or or variability\" Row 7: \"Rw 8: \"Budget of effects\"",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "heading heading <Budget of effects> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "heading heading <Budget of effects> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "heading heading <Budget of effects> (column 3)",
      "text": "Row 1: Row 2: Row 3: Front? Row 4:",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "heading heading <Budget of effects> (column 11)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "heading heading <Acceptability>",
      "text": "Row 1: \"Row\" 2: \"Equity\" = Row 3: \"of of equity?\" = \"Right\" = 5: \"Judizi\" = 7: \"Reduce equity\" = 6: \"Freeness\" = 9: \"Probably no impact\" = 10: \"Improve equity\" / \"Vary\" = 11: \"Raw\" = 8: \"Acceptability\" = row = 9, \"No intervention\" main main stakeholders?",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading <Acceptability> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •of of equity?",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading <Acceptability> (column 1)",
      "text": "Row 1: • Row 2: •Acceptability Row 3: •Row Row 4: •",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: Row 2: Row 3: ? Row 4:",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: keepers? \" Row 4: \"",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading <Acceptability> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading <Acceptability> (column 15)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading <DESIDABLE>",
      "text": "Row 1: \"Row 2: intervention intervention feasible? \" Row 3: \" Row 4: \"JUDIZI\" TESTS TESTS \"RW 5: \"No\" \"Probably no \"Yeah\" X \"Varia\"",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading <DESIDABLE>",
      "text": "Row 1: \"Row\" 2: \"JUDIZI\" Row 3: \"Rop\" 4: \"No\"Probably not \"Probabilmente no\" - \"Si\" - (\"Various\") - \"Non so\" Row 5: \"PROBLEM\" - row 6: \"Rw\" 7: \"Great\" - ...\"Moderate\" --\"Small\" -\"\"Smelling\" -\"Varities\" -- \"Do not know\" -‐ Row 8: DESIDERABLE EFFECTS -- Row 9: \"Very low --\"Row 10: \"Moderated --\"\"included included -- row 14: THE THE TESTS\" -'Row 15: \"Wow 16: \"or or variability\" - variable variable -- significant. significant.",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 1)",
      "text": "Row 1: Row 2: the the intervention? Row 3: Row 4: JUDICES Row 5:",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 1)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" PROBLEM \" Row 6: \" Row 7: \" Row 8: \" DESIDABLE EFFECTS \" Row 9: \" row 10: \" Route 11: \" SIDES \" Row 12: \" - Row 13: \" Roll 14: \" TESTS TESTS \" Row 15: \" Now 16: \" ' Row 17: \" \" Row 18: \"",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 2)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 4)",
      "text": "Row 1: Row 2: JUD Row 3:",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading <DESIDABLE> (column 5)",
      "text": "Row 1: Row 2: TIZI Row 3:",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 7)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\" Row 17: \" Raw 18: \"",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading <DESIDABLE> (column 9)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading <DESIDABLE> (column 9)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Non so\" Row 5: \"Non so\" row 6: \"Do not know\" Row 7: \"No study included\" Row 8: \" Row 9: \"Raw 10: \" Row 11: \"row 12: \"",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading <JUDIZI>",
      "text": "Row 1: \"Row 2: \"JUDIZI\" Row 3: \"Rop 4: \"of of comparison\" : \"Raw 5\": \"Budget\" Row 6: \"Face\" Row 7: \"Reduces equity\" 9: \"Freeness\" on on equity\" increased. increased.",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading <JUDIZI>",
      "text": "Row 1: intervention intervention -++ operation operation -+-+ intervention intervention --++intervention intervention X",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading <JUDIZI> (column 1)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"of of comparison\" Row 5: \"Budget\" Row 6: \"Raw 7\": \"Reflectivity\" Row 8: \"Row 9: \" Reduces equity\" Row 10: \" EQUITA\" Row 11: \"row 12: \"No Row 13: ACCEPTABILITY\" Row 14: \" Row 15: \"Now 16: FACTIVITY\" Row 17: \"",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading <JUDIZI> (column 2)",
      "text": "Row 1: Row 2: JUDICES Row 3:",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading <JUDIZI> (column 2)",
      "text": "Row 1: intervention. intervention.",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading <JUDIZI> (column 2)",
      "text": "Row 1: equity. equity.",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading <JUDIZI> (column 2)",
      "text": "Row 1: intervention intervention X",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading <JUDIZI> (column 3)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading <JUDIZI> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6:",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading <JUDIZI> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Don't know\" Row 5: \"Varia\" Doesn'Row Row 6: \"Miscellaneous\" Row 7: \"Raw 8: \"Next\" Row 9: \"White\" Row 10: \"I don't care\" Row 11: \"no. no.\"",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: • Row 2: • Recommendation • row 3: •",
      "start_page": 380,
      "end_page": 380
    },
    {
      "heading": "heading heading <Recommendation> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Recommendation",
      "start_page": 380,
      "end_page": 380
    },
    {
      "heading": "heading heading <Recommendation> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \"",
      "start_page": 380,
      "end_page": 380
    },
    {
      "heading": "heading heading <QUESITO 23>",
      "text": "==References===External links==* Official website",
      "start_page": 381,
      "end_page": 381
    },
    {
      "heading": "heading heading <References>",
      "text": "Row 1: • Row 2: Certainty assessment •row 3: • row 4: studies studies •study study • distortion distortion • results results • generalization generalization •immediation • additional considerations • impact • sure • rows 5: • low 6: 1 • observational studies ■ very serious • not important • a a • none • months months (IC95% 13.9-28.6) • VERY LOW • CRITIC",
      "start_page": 382,
      "end_page": 382
    },
    {
      "heading": "heading heading <References> (column 1)",
      "text": "Row 1: • Row 2: Certainty assessment •row 3: • row 4: No studies • study study • distortion risk • results results • generalization generalization •immediation • additional considerations • impact • sure row 5: • rows 6: 1 • observational studies ♪ very serious • not important • at at • no major • months months (IC95% 13.9-28.6) •",
      "start_page": 382,
      "end_page": 382
    },
    {
      "heading": "heading heading <References> (column 2)",
      "text": "Row 1: \"Row 2: \"Important Row 3: \" Row 4: \"CRITIC\"",
      "start_page": 382,
      "end_page": 382
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: of of __medTERM2__",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: \"Row 2: a a priority? \" Row 3: \" Row 4: \" JUDICES\" \"EVIDENCE EVIDENCE TESTS\" \"CONSIDERATIONS\" Row 5: \"No\" \"Probably not \"Yes\" ● \"Varia\" \"I don'out. out.\"",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: Row Row 2:",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: Row 2: a a priority? Row 3: Row 4: JUDICES Row 5:",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Row Row 2:",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading <Problem> (column 3)",
      "text": "Row 1: row row 2:",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading <Problem> (column 4)",
      "text": "Row 1: Row Row 2:",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading <Problem> (column 5)",
      "text": "Row 1: rangiam Row 2:",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading <Problem> (column 6)",
      "text": "Row 1: Row Row 2:",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading <Problem> (column 6)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "al. al. (202) al. al. (2021) __ __ [__MEDTERM2_ __MEDTERM2_ ====trials trials (l MEDTERM0__ < < trial trial (study of study) the the patient'trial trial (ested before) a a clinical; 48; met met , cerebral cerebral (1 cerebral/ cerebral (with cerebral) with Behatatal) since since , 15 15 - evaluation evaluation (see) a a medicalal) response response (a) least least (and and 2;;; two two months;; the the response;;",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: \"Row 2: Impact\" (Impact) the the \"the the Rows\" 3: \"Participants\" (observational study) \"VERY BASSAa,\" \"b\" Row 7: \"Obiective response\" obtained from 108/161 patients\" Row 8: \"Raw 9: follow follow up: 8 8 months\" (\"1 observational study\") \"AA, AA, \"B\" Row 10: \"of of __MEDTERM0_\" months months (11-21.1), 48/event. event. \"Rough 11: \"Now 12: cephalic cephalic disease: 8 8 months\" (1 observational trial) \"MOST metastases\" (Bassa, b) \"Rown\": \"Wow\" (non-targeted non-targeted patients): \"No\" (8 8 month\" (1st).",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: from from 108/161 Row 2: patients",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: months (11-21.1), 48/Row Row 3: event. event.",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: 52.5% Row Row 3: baseline baseline (Row Row 4: measurable and non-measurable).",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: Esider Row 3: Row Row 4:",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Siderable Expected? Row 4:",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row Row 2: al. al. (2021) patient patient observational) MEDTERM3__ MEDTERM3__ (1 study",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading <Problem> (column column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==response response (months months (IC95% 13.9-28.6) observational) VERY follow-up up: months months (1 study",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: follow-up follow-up response: months months ((1 observational study) • Row Row 2: • months months (IC95% 13.9-28.6) • Row 3: • follow follow up: months months • 1 observational trial) ♪ Row Row 5: • months months 81%, follow-ups. follow-ups. • row 6: −",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: months months (IC95% 13.9-28.6)",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: 81%, Row Row 3: during follow-up.",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: ndesid Row 3: Row Row 4:",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: Derabi Row 3: Row Row 4:",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: ii Row 3: Row Row 4:",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: \"response response (1 study - months months (IC95% 13.9-28.6) observational) VERY follow-up: months months (1 trial - follow up: median 81%, observational observational patients) arm. arm.",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row Row 2: al. al. (2021) __Entrectinib __Entrectinib < effects. effects.",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading <Problem> (column column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading <Valori>",
      "text": "Row 1: \"To be completed\": \"Row 3: \"safety safety tests?\" Row 4: \"Rop 5: \"Judizi\" •di di evidenza\" ■ADDATIVE CONSIDERATIONS • Row 6: ● Very low • Moderate • • High • imprecision. imprecision. • row 7: ♪ Row 8: \"Valori\" − Row 9: \"C\" main main outcomes? • Row 10:",
      "start_page": 386,
      "end_page": 386
    },
    {
      "heading": "heading heading <Valori> (column 1)",
      "text": "Row 1: \"Row\" 2: \"the the tests\" \"Raw 3: \"safety safety tests?\" \" Row 4: \" Row 5: \"JUDIZI\" Row 6: \"Very low\" \"Moderate Low\" \"High\" \"included included \"Rough\" 7: \"Rop 8: \"Valori\" Row 9: \"C\" main main outcomes? \"Rown 10: \" Row 11: \"JUSTICES\" Row 12: \"or or variation\" ● volatility volatility ● or or variability",
      "start_page": 386,
      "end_page": 386
    },
    {
      "heading": "heading heading <Valori> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 386,
      "end_page": 386
    },
    {
      "heading": "heading heading <Valori> (column 7)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 386,
      "end_page": 386
    },
    {
      "heading": "heading heading <Equity>",
      "text": "months months (IC95% 13.9-28.6).52. 52.5% baseline baseline (and and non-measurable).",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading <Equity> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading <Equity> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading <Equity> (column 2)",
      "text": "Row 1: Row 2: Row 3: or or comparison? Row 4:",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading <Equity> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: uità? \" Row 4: \"",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading <Equity> (column 3)",
      "text": "Row 1: Row 2: Row 3: ? Row 4:",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading <Equity> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading <Equity> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading <Fatsibility>",
      "text": "Row 1: \"Row\" 2: \"Acceptibility\" \"Raw 3: \"main main stakeholders?\" \"Rop 4: \"Rown 5: \"Judizi\"\" \"found. found.\"\"Row 7: \"Right 8: \"Fatsibility\" \"Now 9: \"the the intervention?\" \"Wait 10: \"Need 11: \"Don't know\" \"in. in.\" \"Rw 7:",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Acceptability Row 3: •Row Row 4: •",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •Now 4:",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: Main Row 4:",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: ell'interve Row 4:",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading <Fatsibility> (column 4)",
      "text": "Row 1: Row 2: Row 3: stakeholders? Row 4:",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading <Fatsibility> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: ento\"? \"Raw 4: \"",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading <Fatsibility> (column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading <Fatsibility> (column 12)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading <Fatsibility> (from previous page)",
      "text": "Row 1: \"Row\" = \"Don't kno\" = [Row] = \"Now\": \"Proba bly no\" = (Probab) * \"Small\" = (\"Very low\") = \"Moderate\" =\"\"Wow 5: \"PROBLEM\" = ,\"Row 6: \"Raw 7: \"Trivial\" = ...\"Moder ate\" (Smell) = \"ie ie s\" =\"Don 't kn \" w\" Row 8: DESIDERABLE SIDES\" + \"Rw 12: \" Row 13: \"Very very low\" / \"Moder ate\" - \"High\" No incl.",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <Fatsibility> (from previous page)",
      "text": "Row 1: RIGHT SIDES 2: WISHABLE",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <Fatsibility> (from previous page)",
      "text": "Row 1:Row 2 EFFECTS:BECAUSE",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <Fatsibility> (from previous page)",
      "text": "Row 1: QUALITY: Row 2: OF Row 3: TESTS",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <Fatsibility> (column column 1)",
      "text": "Row 1: Row 2: Row 3: PROBLEM Row 4: Row 5: Row 6: Row 7: Row 8: SIDES Row 9: DESIDERABLE Row 10: Row 11: Row 12: Row 13: Row 14: EFFECTS Row 15:Row Row 16: Row 17: Row 18: Row 19: Row 20: QUALITY Row 21: DELLE Row 22: TESTS Row 23: Row 24: Row 25: Row 26: Row 27: VALUES Row 28: Row 29:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <Fatsibility> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: BIBILI Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row 22: Row 23: Row 24: Row 25: Row 26: Row 27: Row 28: Row 29:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <Fatsibility> (column column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\" Row 17: \" Raw 18: \"",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <Fatsibility> (column column 4)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <Fatsibility> (column column 6)",
      "text": "Row 1: Row 2: JUDICES Row 3:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <Fatsibility> (column column 6)",
      "text": "Row 1: Row Row 2: Moderate Row 3: Small Row 4: Row Row 5: or or variability",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <Fatsibility> (column column 7)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\" Row 17: \" Raw 18: \"",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <Fatsibility> (column column 8)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <Fatsibility> (column column 11)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Don't kno w\" Row 5: \"Don't know w\" row 6: \" Don't Kno W\" Row 7: \"stud stud ies\" Row 8: \"Raw 9: \" Row 10: \" Row 11: \" Now 12: \"",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <JUDIZI>",
      "text": "Row 1: \"Row\" 1: \"JUDIZI\": \"Raw\" 3: \"Rop\" 4: \"compa compa rison\" •rison rison •rison rison . •Row 7: \"intervention intervention •ntion ntion •s. s. •Don 't kno • Row 8: SIDES SIDES • Row 9: \"Reduc ed ♪d d • impact impact •sed sed •Increas ed • e e s\"Don't know 11: EQUITA row 12: \"10\"",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading <JUDIZI> (column 1)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row Row 6: Row 7: Row 8: EQUITA Row 9: Row 10: Row 11: Row Row 12: Row 13: Row 14: Row Row 15:",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading <JUDIZI> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\" Row 17: \" Raw 18: \"",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading <JUDIZI> (column 2)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading <JUDIZI> (column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading <JUDIZI> (column 7)",
      "text": "Row 1: Row 2: JUDICES Row 3:",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading <JUDIZI> (column 9)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \"",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading <JUDIZI> (column 9)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6:",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading <JUDIZI> (column 12)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" Don 't kno w\" Row 8: \"Don 't know w\" row 9: \"Do 't Kno w\")",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: against against intervention",
      "start_page": 391,
      "end_page": 391
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: • Row 2: • Recommendation • row 3: •",
      "start_page": 391,
      "end_page": 391
    },
    {
      "heading": "heading heading <QUESITO 24>",
      "text": "000, 000,000;000, 000,000;this this year;Four Four (11%) 27 27 (75%, 95% CI 58/88) control. control. • Very low (CRITIC Row 12): life life - not measured • Row 13: - • • studies studies • not important • cases cases • none • 25 (69%) events events (8 [22%)), disease progression (14 [39%)), investigator decision (2 [6%) decision decision (1 [3%) nine nine (36%) one one (4%) two two (8%) nine nine (136%) one one (4%), follow. follow.",
      "start_page": 392,
      "end_page": 392
    },
    {
      "heading": "heading heading <References>",
      "text": "Row 1: \"Row 2: Certainty assessment\" = \"Impact\" = ...\"Certainty\" =\"Importion Row 3: \"Rop 4: No study design\": \"Distortion risk\" =\"\"study, study,\" \"episodes episodes (four [11%), aminotransferase aminotransferase (four [1%]), hypertension (four (11%)) and vomiting (three [8%). \" MOLTO BASSA\" = CRITIC Row 7: Treatment-related deaths (follow up: 9 9 months) \" Row 8: 1\" observational studies \"very serious\" = not important b\" = treatment treatment (follow up: 9 9 month) \"Raw 8:1\" studies studies \"not important\" = and and \"no death\" ===References===External links==",
      "start_page": 393,
      "end_page": 393
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: Row Row 18:88:Dr. Row 2: POPULATION: ...3 3 mutation: \"Row 4: INTERVENTION\": \"Row Row 5: \"Row 6: CONFRONTO: \"Row Row 7: \" Row 8: Main outcomes: \"Overall Survival; Progression free survival\"; Response rate; Quality of life; Any interruption; grade grade 3-4; Row Row 9: \" Row 10: \"Inpatients Row 11: \"Now 12: Prospectiva: \"Nove Row 13: \" - Row 14: BACKGROUND: \" Now 15: \" ROW 16: THE THE Votes: Dr.",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: \"Row\" 2: a a priority? • Row 3: • Row 4: JUDICES • TESTS TESTS •Row 5: • No • Probably no • X Yes • Varia • I don't know • cancer cancer (_MEDTERM4_) in in 4% with with non-cancers cancers (_medterm4_). 50% and and Mediterm_",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: \"Row 2: POPULATION: \" Row 3: \" Row 4: INTERVENTION: \" row 5: \" ' Row 6: COMPARISON: \" Row 7: \" - Row 8: MAIN EXITS: \" ROW 9: \" \" Row 10: SETTING: \"row 11: \" NOW 12: PROSPITIVE: \" Route 13: \" Now 14: \" BACKGROUND: \" Rome 15: \" . \" Row 16: CONFLICTS OF \" Row 17: INTEREST \" Row 18: \"",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "a a priority?",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "heading heading <Problem> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* dabrafenib dabrafenib (twice twice daily) __trametinib __trametinib (once once daily) patient. patient.",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: Esider Row 3: Row Row 4:",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: monotherapy monotherapy (2) Row8_MEDTERMI8_min. Row8_MEDTERMI8_min.",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row Row 2: central, central, PubMed/gov gov (www.clinicaltrials .gov). included included (1) oral oral (twice twice daily) oral oral (once once daily) patient. patient.",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading <Problem> (column column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "36 36 (67%) patients went (Survival Survival (PFS) or or observational) evaluated evaluated with: cause cause follow-up: 36 36 67%) gone gone (survival survival (_ _MEDTERMM1___) or or observational) measured measured with: b b ,months months (95% of of 7·0",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: 36 36 (67%) Row Row 2: Row Row 3: Row Row 4: Row Row 5: months months (95% CI Row 6: 7·0",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "==Filmography===References==",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: \"Row 2: \"No\" of Row 3: \"Partecipate Row 4: \"Studies\") Row 5: \"Rop 6: \"Now 7: \"",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: a Row 6: Row 7: Row 8: Row 9:",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\" Row 17: \"",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: \"Row\" 2: \"Cer Row\" 3: \"anti-the Row\" 4: \"GR Row 5: \"",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: difficulty Row 3: Row Row 4: RADE Row 5:",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: \"Row 2: y of\" Row 3: \"Nce\" Row 4: \"Raw 5: \"",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: • Any 25 (69%) discontinued treatment (1 study • events events (8 [22%], observational) 1 - MANY follow-up: progression progression (14 [39%)), decision decision (2 [6%)) decision decision (1 [3%) nine nine (36%) one one (4%) two two (8%) three three (12%) ten ten (40%) therapy. therapy.",
      "start_page": 397,
      "end_page": 397
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 397,
      "end_page": 397
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: treatment",
      "start_page": 397,
      "end_page": 397
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "==References===External links==*Official website* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 397,
      "end_page": 397
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" row 6: \" Row 7: \" \" Row 8: \" or \" Row 9: \" a \" Row 10: \" ' Row 11: \" - \" Row 12: \" Route 13: \" O \" Row 14: \" Right 15: \" * Row 16: \" Roll 17: \" Now 18: \"\" Row 19: \" [ \" Row 20: \"] Row 21: \" = \" Row 22: \" # Row 23: \" Rule 24: \" ] Row 25: \" .",
      "start_page": 397,
      "end_page": 397
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Lancet Lancet Oncol; are are expected? Row 5:",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: ndesid Row 3: Row Row 4:",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: Derabi Row 3: Row Row 4:",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: ii Row 3: Row Row 4:",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: \"BRAFV600E-mutant metastatic non-small-cell lung cancer: Lancet Lancet Oncol; It It 'for for imprecision: Row Row 2: \"Row 3: \" Row 4: desirable\"?",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row Row 2: central, central, PubMed/gov gov (www.clinicaltrials .gov). included included (1) oral oral (twice twice daily) oral oral (once once daily) patient. patient.",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading <Problem> (column column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "36 36 (67%) patients went (Survival Survival (PFS) or or observational) evaluated evaluated with: cause cause follow-up: 36 36 67%) gone gone (survival survival (_ _MEDTERMM1___) or or observational) measured measured with: b b ,months months (95% of of 7·0",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: 36 36 (67%) Row Row 2: Row Row 3: Row Row 4: Row Row 5: months months (95% CI Row 6: 7·0",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "==Filmography===References==",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: \"Row 2: \"No\" of Row 3: \"Partecipate Row 4: \"Studies\") Row 5: \"Rop 6: \"Now 7: \"",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: a Row 6: Row 7: Row 8: Row 9:",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\" Row 17: \"",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: \"Row\" 2: \"Cer Row\" 3: \"anti-the Row\" 4: \"GR Row 5: \"",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: difficulty Row 3: Row Row 4: RADE Row 5:",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: \"Row 2: y of\" Row 3: \"Nce\" Row 4: \"Raw 5: \"",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "25 25 (69%) discontinued treatment (1 study →events events (8 [22%], observational) follow follow up: progression progression (14 [39%)), decision decision (2 [6%)) decision decision (1 [3%) nine nine (12%) one one (4%) two two (8%) three three (12%) ten ten (40%) therapy. therapy.",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: treatment",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" row 6: \" Row 7: \" \" Row 8: \" or \" Row 9: \" a \" Row 10: \" ' Row 11: \" - \" Row 12: \" Route 13: \" O \" Row 14: \" Right 15: \" * Row 16: \" Roll 17: \" Now 18: \"\" Row 19: \" [ \" Row 20: \"] Row 21: \" = \" Row 22: \" # Row 23: \" Rule 24: \" ] Row 25: \" .",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL TESTS>",
      "text": "Row Row 2:",
      "start_page": 401,
      "end_page": 401
    },
    {
      "heading": "heading heading <Equity>",
      "text": "Row 1: \"Row 2: \"Budget of effects\" = \"Raw 3: \"or or comparison?\" = \"Row 4: \" Row 5: \"JUDICES\" = ADJUSTABLE TESTS + \"RW 6: \"He'comparison, comparison,\" \"comparison, comparison, \"He doesn'confrontation, confrontation,\" \"X\" intervention, intervention, \"favour, favour,\" \"Varia\" - \"I don't know\" - row 7: \"Right 8: \"Equity\" - Row 9: \"of of equity?\" - \"Ru 10: \"ROW 11: JUDIZI\" - THE THE EVENTS\" - Additional CONSIDERATIONS - \"Nequità\" - 12: \"Reduce equity\" - X X \"No impact\" - equity equity --improves equity.",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading <Equity> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading <Equity> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading <Equity> (column 2)",
      "text": "Row 1: Row 2: Row 3: siderabili Row 4:",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading <Equity> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: uità? \" Row 4: \"",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading <Equity> (column 3)",
      "text": "Row 1: Row 2: Row 3: favor Row 4:",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading <Equity> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading <Equity> (column 4)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading <Equity> (column 5)",
      "text": "Row 1: Row 2: Row 3: Onfront? Row 4:",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading <Equity> (column 6)",
      "text": "Row 1: Row 2: Row 3: ? Row 4:",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading <Equity> (column 13)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading <Fatsibility>",
      "text": "Row 1: \"Row\" 2: \"Acceptability\" \"Raw 3: \"main main stakeholders?\" \"Rop 4: \"Rw 5: \"JUDIZI\" \"ADDITIONAL ADDITIONAL TESTS\" \"ROW 6: \"No\" \"Probably no\" \" Probably no\" - \"Yes\" - X \"Varia\" \"No test found\" \"None found\" [Row 7: \"Roo 8: \"Fatsibility\" \"Row 9: \"intervention intervention \"Ru\" 10: \"So\" Row 11: \"Giudizi\" \"RICERCA\" TESTS TESTS \"RW\" 12: \" No\" \"Perhaps not\" \"It'X X \"Ye\" \"Vary\" \"Not so\"found. found.\"",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Acceptability Row 3: •Row Row 4: •",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •Now 4:",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: Main Row 4:",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: ell'interve Row 4:",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading <Fatsibility> (column 4)",
      "text": "Row 1: Row 2: Row 3: stakeholders? Row 4:",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading <Fatsibility> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: ento\"? \"Raw 4: \"",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading <Fatsibility> (column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading <Fatsibility> (column 13)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading <DESIDABLE>",
      "text": "==References===External links==* Official website",
      "start_page": 404,
      "end_page": 404
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 1)",
      "text": "Row 1: Row 2: PROBLEM Row 3: Row 4: Row 5: Row Row 6: Row 7: Row 8: Row Row 9: Row 10: Row 11: Row Row 12: Row 13: Row 14: VALUES Row 15: Row 16: Row 17: Row Row 18: Row 19: Row 20: EQUITA Row 21: Row 22: Row 23: ACCEPTABILITY Row 24:",
      "start_page": 404,
      "end_page": 404
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 2)",
      "text": "Row 1, \"Row 10,\" \"Raw 6\": \"Rw 7\": ...\"Row 4: \"No\"Probably no\" is \"Probabilmente no\" = \"Rown 5\": - \"Rop 6\" = *\"Row 7: \"Immportant\" = ...\"Row 11: \"Row 12: \"Very low\" =\"\"Row 9: \"Moderate\" =",
      "start_page": 404,
      "end_page": 404
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\" Row 17: \" Raw 18: \"",
      "start_page": 404,
      "end_page": 404
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 3)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 404,
      "end_page": 404
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Do Not So\" Row 5: \"Do not So\" row 6: \"Don't Know\" Row 7: \"No Study Included\" Row 8: \"Now 9: \"Raw 10: \" Row 11: \"Row 12: \"I don't So\" 13: \"Not So\"",
      "start_page": 404,
      "end_page": 404
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 4)",
      "text": "Row 1: \"Varia\" doesn'Row Row 2: \"Via\" Row Row 3: \"Row\" 4: \"Vay\"",
      "start_page": 404,
      "end_page": 404
    },
    {
      "heading": "heading heading <Strong recommendation>",
      "text": "Row 1: \"No\" - Probably not \"Probably \"Yes\" - \"Varia\" - I don'Row Row 2: FACTIBILITY\" - Row 3: \"",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading <Strong recommendation>",
      "text": "Row 1: against against intervention",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading <Strong recommendation>",
      "text": "Row 1: Row 2: recommendation Row 3:",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading <Strong recommendation> (column 1)",
      "text": "Row 1: \"No\"Row Row 2: FACTIVITY\" \"Row 3: \"No,\" \"No.\"",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading <Strong recommendation> (column 1)",
      "text": "Row 1: intervention intervention • • operation operation •",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading <Strong recommendation> (column 2)",
      "text": "Row 1: Yes... Row 2: ..Row 3: ..",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading <Strong recommendation> (column 2)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading <Strong recommendation> (column 3)",
      "text": "Row 1: \"Varia\" doesn'Row Row 2: \"Row\" 3: \"Mary\"",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading <QUESITO 30>",
      "text": "Row 1; row 1; = 5; = 2; = 3; = 4; = 6; = 8; = 7; = 10; = 9; = 11; = 12; = 13; = 15; = 14; = 17; = 16; = 20; = 30; = 25; = 45; = 40; = 50; = 100; = 35; = 38; = 22; = 21; = 29; = 23; = 28; = 18; = 24; = 36; = 37; = 44; = 41; = 43; = 42; = 34; = 52; = 39; = 33; = 49; = 56; = 54; = 57; = 61; = 60; = 55; = 48; = 58; = 59; = 51; = 53; = 95; = 66; = 105; = 65; = 97; = 0; = 106; = 75; = 85; = 103; = 74; = 96; = 90; = 80; = 102; = 101; = 107; = 68; = 104; = 98; = 47; = .",
      "start_page": 406,
      "end_page": 406
    },
    {
      "heading": "heading heading <QUESITO 30> (column 1)",
      "text": "Row 1: \"Row\" 1: \"Study design\" - Risk of bias\" - Inconsistency - Imprecision - Other considerations - Row Row 6: \"Raw 7: Overall survival\" (follow up: 2 2 months) - Row 8: \"Row 9: 1\"randomised trials\" - a, a,b\" not serious -not serious - Not serious -None 73/154 (47.4%) - Row 10: survival survival (follow up: 2 2 months)",
      "start_page": 406,
      "end_page": 406
    },
    {
      "heading": "heading heading <QUESITO 30> (column 2)",
      "text": "Row 1: \"Row\" 2: \"Effect\" = \"Certainty\" = Importance Row 3: \"Raw\" = : \"Rop\" = 5: pia\" = 95% CI) \"Absolute\" = (95% CI) = 6: \" Row\" = 7: \" Row\" = 8: \" row\" = 9: \"HR\" = 0.49 (0. 0.69) = 25 Fewer = 100 (13 13 feder) = 10: \"CRITAL Row \" = 11: \"row\" = 12: \"TR 0.50\" (0. 0.68) = 100 100 (13 13 fewer) = 15: \"ROW\" = 14: \"Row\" = 15, \"61 61 (2. 2.20) = per per 100",
      "start_page": 406,
      "end_page": 406
    },
    {
      "heading": "heading heading <QUESITO 30> (from previous page)",
      "text": "Row 1: \"33 33 more) \" Row 2: AEs AEs (follow up: 2 2 months) Row 3: \"Row\" 4: \"1\" randomised trials\" \"serious\" a, \"d\"not serious\" \"not serious,\" \"not silky\" \"none\" \"48/154\" (31.2%) \"80/150 (53.3%) \"58 58 (0. 0.77) \"100 100 (12 12 feet) \"MODERATE\" \"CRITICAL\" \"Raw 5: treatment treatment component\" Row 6: \"Rown 7: 1\"randomised trials\"\"s\"\"serius a,d\" not serious\" (\"not serious\") \"not seriously\" [80/154 (51.9%) and \"106/151 (70.2%) \"74 74 (0. 0.89) \"18 feder\" for 100 (femere) 2788 (femur) ]",
      "start_page": 407,
      "end_page": 407
    },
    {
      "heading": "heading heading <QUESITO 30> (column column 1)",
      "text": "Row 1: \"33 33 more) Row 2: AEs AEs (follow up: 2 2 months) Row 3: \"Row\" 4: \"1\" randomized trials\" \"serious\" a, \"d\"not serious\" \"not serious,\" \"not silky\" \"none\" \"48/154\" (31.2%) \"80/150\" (53.3%) \"58 58 (0. 0.77) \"100 100 (12 12 feet) Row 5: treatment treatment component\" Row 6: \"Raw 7: \"1\"\"randomised trials\" (\"serious\") \"a,\" \"D\" not serious\" (\"not serious\") \"not seriously\"\"80/154 (51.9%) and \"106/151\" (70.2%) f\"74 74 (0. 0.88) \"100 100 (to to 8wer)",
      "start_page": 407,
      "end_page": 407
    },
    {
      "heading": "heading heading <QUESITO 30> (column column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 407,
      "end_page": 407
    },
    {
      "heading": "heading heading <QUESITO 30> (column column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" CRITICAL\" Row 5: \" Row 6: \"Raw 7: \" CRITICAL\"",
      "start_page": 407,
      "end_page": 407
    },
    {
      "heading": "heading heading <CONFLICTS OF INTEREST>",
      "text": "Row: 000, 000,000; 000, 000,000; of of 1995; years years ago; years years old; year year olds; of of age; months months old; years years later; years years older; years years earlier; old. old.",
      "start_page": 408,
      "end_page": 408
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: \"Row\" 2: \"Problem\" • Row 3: \"a a priority?\" • row 4: •row 5: \"JUDIZI\" ♪Row 7: \"Raw 8: \"Wishful effects\" − Row 9: \"desirable desirable effects? • now 10: \"Now 11: \"Giudizi\" ■teste teste •\"a a (95% (GRADES) • as as \"absolute absolute effects\") • (95% CI) Commentary Commentary • Minor • Moderate X • Varian • Non-Solute Effects\" (FRADE)",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: \"Row 2: Outcomes\" * Anticipated absolute effects* (95% CI) - Relative effect (95% CI), \"participants participants (studies) \"evidence evidence (GRADE) \"Comments Row 3: \" Row 4: \" Row 5: \" Risk with chemotherapy\" \" with with pembrolizumab\" Row 6: \" Row 7: follow follow up: 2 2 months/49 49 (0. 0.69).",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: Row Row 2: participants Row 3: (studies)",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: • Row 2: • The Row 3: • Row Row 4: •",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: • Row 2: • Row Row 3: • Row Row 4: •",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Row 2: Row 3: ita? Row 4:",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Row 2: Rabili Row 3: Row Row 4:",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <Problem> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <Problem> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <Problem> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: Eratable Expected? \" Row 4: \"",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <Problem> (column 4)",
      "text": "Row 1: Row 2: Outcomes",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <Problem> (column 5)",
      "text": "Row 1: \"Row 2: \"Anticipated Row 3: \" Row 4: \" Row 5: \" Row Row 6: \"chemiotera Row 7: \" Row 8: \" \" Row 9: \" ' Row 10: \" Row Row 11: \" Row 12: \" row 13: \" - Row Row 14: \" Now 15: \" Route 16: \"\" Row 17: \"Row Row 18: \"",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <Problem> (column 6)",
      "text": "Row 1: \"Row 2: d absolute effects* (95% CI) = Related effect (95% CI), Row 3: \" Row 4: \" Row 5: apia\" with with pembrolizumab",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <Problem> (column 7)",
      "text": "Row 1: \"Row 2: ive\" \"participants participants (studies) \"Certaint evidence (Grade): \"Certaint Row 3: \"Evidence Row 4: \"GRADE Row 5: \"Raw 6: \" Row 7: \" - 305 (1 RCT) \" Row 8: \"",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <Problem> (column 8)",
      "text": "Row 1: Row 2: Row Row 3: and Row 4: E) Row 5:",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <Problem> (column 9)",
      "text": "Row 1: Row 2: Commen",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <Problem> (column 10)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <Problem> (column 10)",
      "text": "Row 1: Row 2: nts",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: •survival survival (49 to 71) 305 • (follow follow up: median (1 RCT) 0. 0.68) 305 305 ■ rate (to to (1 RTC) HICHA,c follow-up: 2. 2.20) 0. 0.77) (23 to 41) 305 305 › treatment treatment (1 1 RCT),0. 0.89) (43 to 62)",
      "start_page": 410,
      "end_page": 410
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 410,
      "end_page": 410
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: follow follow up: 2 2 months",
      "start_page": 410,
      "end_page": 410
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: \"50 50 (0. 0.68) = .305 (1 RCT) Row 2: \" Row 3: \" Row\" 4: \" Row 5: \" Row 6: \"R 1.61\" (2. 2.20) \"Row 7: \" row 8: \" \" Row 9: \" ' Row 10: \" - \" Row 11: \" Right 12: \" Row 13: \"58 58 (0. 0.77) \"304 (1 RTC) \" Row 14: \" [Row 15: \"] Row 16: \"",
      "start_page": 410,
      "end_page": 410
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: participants Row 3: (studies)",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: • Row 2: • Ind Row 3: • Row Row 4: •",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: Desired Row 3: Row Row 4:",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: erable Row 3: Row Row 4:",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Unwanted Tits Expected? Row 4:",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "==References===External links==* Official website",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "==References===External links==* Official website",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: Row 2: the the e)",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading <Problem> (column column 7)",
      "text": "Row 1: Row 2: Commen",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading <Problem> (column column 8)",
      "text": "Row 1: Row 2: nts",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading <Problem> (column column 10)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: \"Continuation Continuation reasons: treatment. treatment.",
      "start_page": 412,
      "end_page": 412
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2\": \"Row Row 3: \"Row Row 4: \"Row Row 3\"",
      "start_page": 412,
      "end_page": 412
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: \"bias. bias.",
      "start_page": 412,
      "end_page": 412
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row Row 2: detection detection bias",
      "start_page": 412,
      "end_page": 412
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 412,
      "end_page": 412
    },
    {
      "heading": "heading heading <Effect balance>",
      "text": "Row 1: \"Row\" 2: \"Raw value\" 3: \"C\" main main outcomes? \" Row 4: \" Row 5\": \"Right\" 5: \"Wait\" 8: \"Budget of effects\" Row 9: \"or or comparison?\" \"Rw 10: \"Row 11: \"Judizios\" RICERCA OF TESTS\" X \"Ready\" 12: \"It'comparison, comparison,\" \"Probably it'comparison. comparison.\"",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "heading heading <Budget of effects> (column 1)",
      "text": "Row 1: \"Row 2: \"Valori\" Row 3: \"C\" main main outcomes? \"Rop 4: \"Raw 5: \"JUDIZI\" Row 6: \"or or variation\"",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "heading heading <Budget of effects> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "heading heading <Budget of effects> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "heading heading <Budget of effects> (column 3)",
      "text": "Row 1: Row 2: Row 3: Front? Row 4:",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "heading heading <Budget of effects> (column 11)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "heading heading <Fatsibility>",
      "text": "Row 1: \"Row\" 2: \"Right\": \"Raw\" 3: \"of of equity? \"Rop\" 4: \"Rough\" 5: \"Judizi\" 5, \"Ricerca\" of \"ADDING\" TESTS\" Row 6: \"Reduces equity\" = \"equity equity X\" equity equity \"Improves equity,\" \"Improved equity,\" and \"Improving equity\" (not not known) Row 7: \"Row 8: \"Acceptibility\" ^ Row 9: \"No\" main main stakeholders?",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: \"Row 2: \"Equity Row 3: \"Row Row 4: \"",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Acceptability Row 3: •Row Row 4: •",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •The Row 4:",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: i of equity? Row 4:",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: ? Row 4:",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: keepers? \" Row 4: \"",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" or \" Row 4: \"",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading <Fatsibility> (column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading <Fatsibility> (column 16)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading <DESIDABLE>",
      "text": "Row 1: \"Probabilment and no\"Probability and si\": \"Si\" = \"Variety\" = 5: \"PROBLEM\" = 6: \"Row\" = 7: \"Irish nti\" = 10: \"Moderate\" = 9: \"White\" = 8: \"Great\" = 11: \"Bold\" = 12: \"Very low\" = 1: \"High\" = 0: \"Moded\" = 14: \"or or \"Raw\" = 15: \"Row\" = 16: \"Non-uncertainty\" or \"variable\" = 13: \"Popularity\" = 30: \"Alta\" = 25: \"in in favour\" = 20: \"Dowperfection\" = 17: \"Not known\" = 35: \"Further\" = 36: \"Earred\" = 4\" = 2: \"Ready\" = 3: \"Gold\"===References==External links==* Official website",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 1)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" PROBLEM\" Row 6: \" Row 7: \" Row 8: \"Desiderable Effects\" Row 9: \"Raw 10: \" row 11: \"Residency\" Row 12: \"Row 13: \"ROW 14: THE THE TESTS\" Row 15: \"Now 16: \"row 17: \"Times\" Row 18: \" Now 19: \" NOW 20: THE THE EFFECTS\" Row 21: \"",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 2)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 3)",
      "text": "Row 1: Row 2: JUD Row 3:",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 4)",
      "text": "Row 1: Row 2: TIZI Row 3:",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "heading heading <DESIDABLE> (column 6)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" row 7: \" Row 8: \"",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "heading heading <DESIDERABLE> (column 7)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Not so\" Row 5: \"Not so\" row 6: \"Do not know\" Row 7: \"inclus inclus o\" Row 8: \"Raw 9: \" Row 10: \"Row 11: \"Don't know\"",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: \"Row 2: \"JUDIZI\" Row 3: \"Raw 4: \"equity equity a\"equity equity \"equity equity \"equity equity \"Increases equity \"Varia\" = \"Row Row 5: EQUITA\" = row 6: \"Rop 7: \"No\" =",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: intervention intervention -++ operation operation -+-+ intervention intervention --++intervention intervention X",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: Row 2: recommendation Row 3:",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "heading heading <Recommendation> (column 1)",
      "text": "Row 1: \"Row\" 2: \"JUDIZI\" Row 3: \"Raw\" 4: \"the the entity\" \"Probabilm\" reduces equity\" \"equity equity \"Probabilm\" increases equity \"Rop\" 5: EQUITA\" Row 6: \"Rown\" 7: \"No\"Probably not \"Probbabilm,\" \"Si\" Row 8: ACCEPTABILITY\" Row 9: \"Now 10: \"Not\"Probedibly no\" \"Yes\" Row 11: FACTIBI LITY\" Row 12: \"Wow\"",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "heading heading <Recommendation> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Varia\" \"Don'Row Row 5: \"Via\" \"Row Row 6: \"Raw 7: \"Wow 8: \"Maria\" row row 9: \"Now 10: \"",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "heading heading <Recommendation> (column 2)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "heading heading <patients patients Effect>",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 417,
      "end_page": 417
    },
    {
      "heading": "heading heading <any any AEs>",
      "text": "== Demographic evolution ====References==",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "heading heading <any any AEs> (column 1)",
      "text": "Row 1: \"Row 2: Certainty assessment\" = Row 3: \" Row 4: \" Row 5: No of studies\" = \"Study design\" + \"Inconsistency\" = Inconsistentness = \"Inaccesi Row 6: \" Row 7: Progression free survival\" = row 8: \"Raw 9: 2\" / \"randomised trials\" = and and \"not serious\" = ,d \" Row 10: Objective response rate\" = [Row 11: \"] Row 12: \"2\" /\"randomized trials \"not seriously\" a,e \"not seriousness\" = d d ] Row 13: AEs AEs \" Row 14: \"",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "heading heading <any any AEs> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row Row 6: \" Row 7: \" Row 8: \" row 9: \"",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "heading heading <any any AEs> (column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "heading heading <any any AEs> (column 3)",
      "text": "Row 1: \" Row 2: \"No of patients\" Row 3: \" Row 4: \" Row 5: ons\" Row Row 6: \" Row 7: \"Row 8: \" Row 9: \"",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "heading heading <any any AEs> (column 4)",
      "text": "Row 1: \"Row\" 2: \"Effect\" = \"Certainty\" = Importance Row 3: \"Rop\" 4: \"Apia\" = 5: \"Rolative\" = (95% CI) \"Absolute\" = 6: \"Row\" = 7: \" Row\" = 8: \" Row\" = 9: \"HR \" 0.63\" (0. 0.80) \"16 fewer\" = 100 (7 7 feet) \" MODERATE\" = 10: \"CRITAL Row\" + 11: \"ROW\" = 12: \"RR 2.16\" (.2. 2.95) \"100 100 (41 41 more) \" MODERATE\" - CRITICAL Row 13: \"Now 14: \"",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "heading heading <any any AEs> (from previous page)",
      "text": "== Demographic evolution ====References==",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "heading heading <any any AEs> (column column 1)",
      "text": "Row 1: • Row 2: Certainty assessment • row 3: •row 4: •now 5: studies studies •study design •bias bias •inconsistentness •imprecise Row 6: •bow 7: 2 •randomised trials •f f •serious g •h h •Row 8: componentj componentj •low 9: ♪ row 10: 2",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "heading heading <any any AEs> (column column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row Row 6: \"",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "heading heading <any any AEs> (column column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "heading heading <any any AEs> (column column 3)",
      "text": "Row 1: 'Row 2: 'No of patients' Row 3: ' Row 4: ' Row 5': 'ons' Row Row 6: 'first line' Row 7: 'platin base' Row 8: 'Pemetrexed and 'row' Row 9: '_MEDTERM0', 'Rop 10: 'followed' Row 11: 'maintaining' Row 12: 'con' Row 13: 'pemetrexed' and 'raw' Row 14: 'Medterm0' _ 'Raw 15: 'of of 'row 16: 'turning' or 'row 17: 'stability of 'rows' Row 18: 'after 4' Row 19: 'wheel cycles' Row 20: 'treating Row 21: 'row 22: '- 295/464' (63.6%)",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "heading heading <any any AEs> (column column 4)",
      "text": "Row 1: \"Row\" 2: \"Effect\" = \"Certainty\" = Importance Row 3: \"Raw\" = : \"Rop 5\": apia\" = (95% CI) = \"Absolute\" = (CI) = 6: \" Row\" = 7: \"RR\" = 1.06 (1. 1.19) = 100 100 (11 11 more) = VERY LOW\" = CRITICAL Row 8: \" Row\" = 9: \"row\" = 10: \"ROW\" = 0. 0.88) = 16 Fewer = 100 (9 9 feet) = VERY LOW CRITICAL",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS>",
      "text": "Row 1: status status (0-1)?Row 2: • Row 3: •expression expression <50% mutation mutation l",
      "start_page": 421,
      "end_page": 421
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS>",
      "text": "Row 1: \"Row 2: a a priority? \" Row 3: \" Row 4: JUDGEMENT\" RESEARCH EVIDENCE\" Row Row 5: \"No,\" \"Probably no\" \"Probably yes\" \"1 1 (PD-1) metastatic metastatic non-cancer cancer (NSCLC) MEDTERM0_ MEDTERM0_ (Keytruda, Merck), __medTERM1_ (Opdivo, Bristol-Myers Squibb), and __AMTERM2_ (Tecentriq, Genentech) therapy. therapy.",
      "start_page": 421,
      "end_page": 421
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS> (from previous page)",
      "text": "Yes Yes - Varies - Don't know (Med Med 2018;378:2078-92.",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS> (from previous page)",
      "text": "Row 1: Relative Row 2: effect Row 3: (95% Row 4: CI)",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS> (from previous page)",
      "text": "Row 1: Row Row 2: participants Row 3: (studies)",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS> (from previous page)",
      "text": "Row 1: Row Row 2: evidence Row 3: (GRADE)",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS> (from previous page)",
      "text": "Row 1: Row Row 2: chemotherapy",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS> (column column 1)",
      "text": "Row 1: \"Row 2: \"Desirable Row 3: \"Row Row 4: \"",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS> (column column 2)",
      "text": "Row 1: Row 2: Row Row 3: Row Row 4:",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS> (column column 3)",
      "text": "Row 1: Row 2: cts Row 3: Row Row 4:",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS> (column column 4)",
      "text": "Row 1: \"Med Med 2018;378:2078-92.",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS> (column column 4)",
      "text": "==References===;;; - . - . . .;; _ - .; - , , .; , - . , 15 15 , 35 35 , 17 17 , 29 29 , 28 28 , 31 31 , 24 24 , 65 65 , 12 12 , 77 77 , 7 7 , by by maintenance: , 1 1 , 34 34 , at at , case case , Row 9: • after after 4",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS> (column column 5)",
      "text": "Row 1: Row 2: Comment Row 3:",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS> (column column 6)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" ADDITIONAL CONSIDERATIONS \" Row 6: \"",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS> (column column 6)",
      "text": "Row 1: Row 2: ts",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS> (from previous page)",
      "text": "Row one: 728 728 (to to (2 RCTs) 1. 1.19) i i (53 to 67) following following reasons: 189 189 study: following following reasons: 78 78 AEs; clinical clinical progression; Following Following reason: monitoring monitoring reasons: 21 21 AEs",
      "start_page": 423,
      "end_page": 423
    },
    {
      "heading": "heading heading <ADDITIONAL ADDITIONAL CONSIDERATIONS> (from previous page)",
      "text": "Row 1: 06 06 (1. 1.19) = 728 (2 RCTs) = h, h,i",
      "start_page": 423,
      "end_page": 423
    },
    {
      "heading": "heading heading <PFS:>",
      "text": "Row 1: \"Plot Plot OS: PFS: Objective response rate: ...",
      "start_page": 424,
      "end_page": 424
    },
    {
      "heading": "heading heading <PFS:> (from previous page)",
      "text": "Row 1: \"grade grade 3-5: Continuation rate: ...",
      "start_page": 425,
      "end_page": 425
    },
    {
      "heading": "heading heading <PFS:> (from previous page)",
      "text": "Row 1: \"Row 2: \"Undesirable effects\" Row 3: \"anticipated anticipated effects? \" Row 5: \"JUDGEMENT RESEARCH EVIDENCE\" \"ADDITIONAL CONSIDERATION\" * (95% CI) at at (95% (studies) (GRADE) and and CI) HR. HR.",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading <PFS:> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading <PFS:> (from previous page)",
      "text": "Row 1: Relative Row 2: effect Row 3: (95% Row 4: CI)",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading <PFS:> (from previous page)",
      "text": "Row 1: Row Row 2: participants Row 3: (studies)",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading <PFS:> (from previous page)",
      "text": "Row 1: Row Row 2: evidence Row 3: (GRADE)",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading <PFS:> (from previous page)",
      "text": "Row 1: Row Row 2: chemotherapy",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading <PFS:> (column column 1)",
      "text": "Row 1: \"Row 2: \"Undesira Row 3: \"Row Row 4: \"",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading <PFS:> (column column 2)",
      "text": "Row 1: Row 2: Row Row 3: Row Row 4:",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading <PFS:> (column column 3)",
      "text": "Row 1: Row 2: Row 3: the anticipated effects? Row 4:",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading <PFS:> (column column 3)",
      "text": "==References===External links==* Official website",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading <PFS:> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading <PFS:> (column column 4)",
      "text": "Row 1: Row 2: Comment Row 3:",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading <PFS:> (column column 5)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" ADDITIONAL CONSIDERATIONS \" Row 6: \"",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading <PFS:> (column column 5)",
      "text": "Row 1: Row 2: ts",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading <PFS:> (from previous page)",
      "text": "Row of 1: an...any any (to to (2 RCTs) 0. 0.88) (57 to 68) 189 189 study: following following reasons: clinical clinical progression; following following reasons: monitoring monitoring reasons: clinical clinical progression; proportion proportion score",
      "start_page": 427,
      "end_page": 427
    },
    {
      "heading": "heading heading <PFS:> (from previous page)",
      "text": "Row 1: 80 80 (0. 0.88) • 739 (2 RCTs) • • k k • Row 2: • Study population • row 3: •row 4: • rows 5: •100 100 •100 100 (57 to 68) ♪ Row 6: ♪",
      "start_page": 427,
      "end_page": 427
    },
    {
      "heading": "heading heading <PFS:> (from previous page)",
      "text": "Row 1: Row Row 2: (57 to 68)",
      "start_page": 427,
      "end_page": 427
    },
    {
      "heading": "heading heading <PFS:>",
      "text": "Row 1: \"Forest Plot OS: __ MEDTERM1__: Objective response rate:\"",
      "start_page": 428,
      "end_page": 428
    },
    {
      "heading": "heading heading <PFS:> (from previous page)",
      "text": "Row 1: \"grade grade 3-5: Continuation rate: ...",
      "start_page": 429,
      "end_page": 429
    },
    {
      "heading": "heading heading <Values>",
      "text": "Row 1: \"Row\": \"Certainty of evidence\" = \"Raw\" of of effects?",
      "start_page": 430,
      "end_page": 430
    },
    {
      "heading": "heading heading <Values> (column 1)",
      "text": "Row 1: 'Row 2: 'Certainty of evidence' Row 3: 'of of effects? ' Row 4: 'Raw 5: 'JUDGEMENT' Row 6: 'Very low 'Moderate Moderate 'High ' No included studies' Row 7: ' Row 8: 'Words' Row 9: 'main main outcomes?' Row 10: 'Rop 11: JUDGEment' Row 12: 'variable variable 'variability variability 'variable variable '",
      "start_page": 430,
      "end_page": 430
    },
    {
      "heading": "heading heading <Values> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 430,
      "end_page": 430
    },
    {
      "heading": "heading heading <Values> (column 7)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 430,
      "end_page": 430
    },
    {
      "heading": "heading heading <Acceptability>",
      "text": "==References===External links==* Official website",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading <Acceptability> (column 1)",
      "text": "Row 1: \"Row\" and \"undesira\" Row 4: \"Raw\" 5: \"JUDGEMENT\" Row 6: \"Favors the comparison\" comparison comparison \"appearance appearance \"participation participation \"Don't know\" Row 7: \"Right 8: \"Equity\" Row 9: \"health health equity\" Row 10: \"Row 11: \" JUDGEment\" Row 12: \"Reduced \"Probabally reduced\" x \"Probbable\" no impact \"ProBably increased\"",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: Row 2: Row 3: s? Row 4:",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading <Acceptability> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading <Acceptability> (column 4)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading <Acceptability> (column 5)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading <Acceptability> (column 6)",
      "text": "Row 1: Row 2: Row 3: mparison? Row 4:",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading <Acceptability> (column 13)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading <Feasibility>",
      "text": "Row 1: x Yes ... Varieties Don't know...\" Row 2: \"Row 3: to to implementation?\" Row 4: \"Raw 5: \"JUDGEMENT\"RESEARCH EVIDENCE\" \"ADDITIONAL CONSIDERATIONS\" Row 6: \"No\" \"Probably no \"Probably yes\" x \"Yes\" Varies \"Don't Know\"No evidence found\"",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading <Feasibility>",
      "text": "Row 1: \"Row\" 2: \"JUDGEMENT\" Row 3: \"Rop\" 4: \"No\"Probab ly no\" \"Probabl y yes\" \"Yes\" \"Varies\" \"Don't know\" Row 5: \"PROBLEM\" Row 6: \"Rw\" 7: \"Trivial\" \"Small\" \"Modera te\" \"Large\" \"Very Small\" \"Don't Know\" Row 8: \"DESIRABLE EFFECTS\" Row 9: \"Row 10: \"Large\"Moder ate\" \"Little\" \"Trivial\" \"Vories\" Don't known\" Row 11: \"UNDESIRABLE EFFECTS\" Row 12: \"Now\"",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading <Feasibility> (column 1)",
      "text": "Row 1: Row 2: Row Row 3:",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading <Feasibility> (column 1)",
      "text": "Row 1: Row 2: PROBLEM Row 3: Row 4: Row 5: Row Row 6: Row 7: Row 8: Row Row 9:",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading <Feasibility> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: and to implement? \" Row 4: \"",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading <Feasibility> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" row 7: \" Row 8: \" ' Row 9: \" \" Row 10: \" - Row 11: \" Now 12: \" Route 13: \"\" Row 14: \"",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading <Feasibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading <Feasibility> (column 3)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading <Feasibility> (column 6)",
      "text": "Row 1: Row 2: JUDG Row 3:",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading <Feasibility> (column 7)",
      "text": "Row 1: Row 2: GEMENT Row 3:",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading <Feasibility> (column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" ' Row 8: \" row 9: \" \" Row 10: \"\" Row 11: \" Now 12: \"",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading <Feasibility> (column 9)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12:",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading <Feasibility> (column 11)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading <Feasibility> (column 11)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Don't know\" Row 5: \"Don't knows\" Row 6: \"Do't Know\"",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading <Feasibility> (from previous page)",
      "text": "Row 1: \"Row\" 2: \"JUDGEMENT\" Row 3: \"Raw\" 4: \"Very low\" \"Low\" \"Moderate\" \"High\" \"No included studies\" \"Rown\" 5: \"CERTAINTY OF\" Row 6: \"IVIDENCE\" Row 7: \"Right\" 8: \"variabil variabil ity\" \"ity ity \"variable variable \"ty\" \"o o variablety\" Row 9: VALUES \"RW\" 10: \"Row\" 11: \"compare compare ison\" \"ison ison \"N\" \"ison. ison.\"",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading <Feasibility> (from previous page)",
      "text": "Row 1: BALANCE Row 2: OF Row 3: EFFECTS",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading <Feasibility> (column column 1)",
      "text": "Row 1: Row 2: Row Row 3: EVIDENCE Row 4: Row 5: Row 6: Row 7: VALUES Row 8: Row 9: Row 10: Row 11: Row 12: BALANCE Row 13: OF Row 14: EFFECTS Row 15: Row 16: Row 17: Row 18: Row 19: EQUITY Row 20: Row 21:",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading <Feasibility> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21:",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading <Feasibility> (column column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" row 7: \" Row 8: \" ' Row 9: \" \" Row 10: \" - Row 11: \"row 12: \" Now 13: \" Route 14: \" Roll 15: \"\" Row 16: \"",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading <Feasibility> (column column 3)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading <Feasibility> (column column 7)",
      "text": "Row 1: Row 2: JUDG Row 3:",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading <Feasibility> (column column 8)",
      "text": "Row 1: Row 2: GEMENT Row 3:",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading <Feasibility> (column column 9)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" row 8: \" \" Row 9: \"",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading <Feasibility> (column column 10)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9:",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading <Feasibility> (column column 12)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"studies studies \" Row 5: \" Row 6: \" Row 7: \" row 8: \" \" Row 9: \" ' Row 10: \" D or n' o o w\" Row 11: \"n n \" t \" or or w\" \"",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading <Feasibility> (from previous page)",
      "text": "Row 1: \"Row\" 2: \"JUDGEMENT\" Row 3: \"Rop\" 4: \"No\"Probab ly no\" \"Probabl y yes\" \"Yes\" \"Va rie s\" \"D\" or \"n\" \"W\" Row 5: \"ACCEPTAB ILITY\" Row 6: \"Raw 7: \"No\"\"no no \"yes yes \"Yes\") \"Vaa río s\" or n' or or \"w\" Row 8: FEASIBILIT Y\" Row 9: \"",
      "start_page": 434,
      "end_page": 434
    },
    {
      "heading": "heading heading <Feasibility> (from previous page)",
      "text": "Row 1: the the intervention",
      "start_page": 434,
      "end_page": 434
    },
    {
      "heading": "heading heading <Feasibility> (column column 1)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" ACCEPTAB ILITY \" Row 6: \" Row 7: \" Row 8: \" FEASIBILITY Y \" Row 9: \"",
      "start_page": 434,
      "end_page": 434
    },
    {
      "heading": "heading heading <Feasibility> (column column 2)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 434,
      "end_page": 434
    },
    {
      "heading": "heading heading <Feasibility> (column column 3)",
      "text": "Row 1: Row 2: JUDG Row 3:",
      "start_page": 434,
      "end_page": 434
    },
    {
      "heading": "heading heading <Feasibility> (column column 3)",
      "text": "Row 1: Row Row 2: Probabl y yes",
      "start_page": 434,
      "end_page": 434
    },
    {
      "heading": "heading heading <Feasibility> (column column 4)",
      "text": "Row 1: \"Row 2: GEMENT\" Row 3: \"Rop 4: \"Rown 5: \"Raw 6: \" Row 7: \" Row 8: \"Row 9: \"",
      "start_page": 434,
      "end_page": 434
    },
    {
      "heading": "heading heading <Feasibility> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9:",
      "start_page": 434,
      "end_page": 434
    },
    {
      "heading": "heading heading <Feasibility> (column column 6)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"D o n' o o w\" \" Row 5: \"D or \"n\" \"k\" or \"w\"",
      "start_page": 434,
      "end_page": 434
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: • Row 2: • Recommendation • row 3: •",
      "start_page": 435,
      "end_page": 435
    },
    {
      "heading": "heading heading < Progression free survival>",
      "text": "==References===External links==* Official website",
      "start_page": 436,
      "end_page": 436
    },
    {
      "heading": "heading heading < Progression free survival> (column 1)",
      "text": "Row 1: •Row 2: patients patients • Row 3: • Row 4; • Low 5: studies studies • Distortation risk • results results • generalization generalization • Imperfection • Other considerations • CBCCA + Paclitaxel or Nab- Paclitaxel • Non-important sage • None • 181/338 (53.6%) •row 10: survival survival • row 11: ♪ Row 12: Studs Studs • Randomized stories • Serious stove • Not important •stoop stoop •None •240/338 (71.0%) • Fast rate (answers answers + partial answers) • Low 12: 1 1 • High quality • schoke schoke •non significant •Non-important •no 240/338 (8.0%)",
      "start_page": 436,
      "end_page": 436
    },
    {
      "heading": "heading heading < Progression free survival> (column 2)",
      "text": "Row 1: \"Row 2: Sure Row 3: \" Row 4: \" Row 5\": Relative (95% CI) \"Absolute (95% CI): \" Row 6\": \" Row 7\": ♪ Row 8: \"Raw 9\": 72 72 (0. 0.88) \"100 100 (5 5 less) \" Row 10: \" row 11: \" Row 12: \"57 57 (0. 0.68) \"100 100 (13 13 less) ' Row 13: \" Now 14: \"row 15: 66 66 (1. 1.96) \"100 100 (35 35 more) \" [Row 16: \"] Row 17: \" -\" Row 18: \"greater greater (7 7 greater) ] \" Row 19: \"- Row 20: \"",
      "start_page": 436,
      "end_page": 436
    },
    {
      "heading": "heading heading < Progression free survival> (column 3)",
      "text": "Row 1: Row 2: Importance Row 3: Row 4: Row 5: CRITIC Row 6: Row 7: Row 8: IMPORTANT Row 9: Row 10: Row 11: CRITICAL Row 12: Row 13: Row 14: CRISTIC Row 15: Row 16:",
      "start_page": 436,
      "end_page": 436
    },
    {
      "heading": "heading heading <Immunotherapy-related adverse events>",
      "text": "==References===External links==* Official website",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading <Immunotherapy-related adverse events> (column 1)",
      "text": "Row 1: •Row 2: Certainty assessment • Row 3: •row 4: • row 5: studies studies •study study •Distortion risk •results results • generalization generalization •Immediacy • Right 6: • Row 7: 1 •Studies randomized •Very serious •No important •important important ■Row 8: Any discontinuation • Raw 9: ♪ Row 10: 2 •2 •studies randomised •Unimportant •Warly •Not important ‐Serium •Know 11: Toxic death (treatment-related deaths) • Rot 12: − Row 13: 3 3 •studi randomised •non important â€important important ¢Row 17: â â .",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading <Immunotherapy-related adverse events> (column 2)",
      "text": "Row 1: • Row 2: •patients patients •Effect •Certo Row 3: •Row 4: • row 5: Additional considerations •CBDCA + Paclitaxel or • Nab-Paclitaxel + •MEDTERM0__ •chemotherapy •Relation (95% CI) • Absolute (95% CI), •row 6: • Row 7: ♪191 •162 • •greater greater (5 5 greater) −",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading <Immunotherapy-related adverse events> (column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading <Immunotherapy-related adverse events> (column 2)",
      "text": "Row 1: 188/338 (55.6%) = 251/344 (73.0%) = 0.76 (0. 0.85) = 100 100 (11 11 less)",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading <Immunotherapy-related adverse events> (column 2)",
      "text": "Row 1: 32/337 (9.5%) • 21/342 (6.1%) • 1,55 (2. 2.64) • 100 100 (10 10 plus)",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading <Immunotherapy-related adverse events> (column 2)",
      "text": "Row 1: 51/337 (15.1%) = 67/342 (19.6%) = 77 77 (1. 1.07) = 100 100 (1 1 plus)",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading <Immunotherapy-related adverse events> (column 2)",
      "text": "Row 1: 66/337 (19.6%) •70/342 (20.5%) •95 95 (1. 1.27) •100 100 (6 6 more)",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading <Immunotherapy-related adverse events> (column 2)",
      "text": "Row 1: 25/337 (7.4%) • 21/342 (6.1%) • 1.20 (2. 2.11) •100 100 (7 7 plus)",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading <Immunotherapy-related adverse events> (column 3)",
      "text": "Row 1: \"Row 2: \"Important Row 3: \" Row 4: \"CRITIC Row 5: \" Row 6: \" \" Row 7: \" IMMPORTANT Row 8: \" Row 9: \" CRITIC Row 11: \" row 12: \" ' Row 13: \"Critic Row 14: \" - \" Row 15: \"",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading <References>",
      "text": "Row 1: \"Row 2: Certainty assessment\" Patient's No (s): \"Effect\" (s) \"Important Row 3: \"Raw 4: \" Row 5\": \"No\" Study Design\" (Study Drawing) \"Distortion Risk\" (Middles) \"Made-of-Globalization Lack\" (i.e. \"CBDCA\" + \"Paclitaxel\" or \"Nab- Paclitaxel\") + \"_MEDTERM0\"_\"Relational (% CI) \"Absolute (95% CI) 'Row 6: \"Rough 7: 2 2,3\" Randomized studies\" (ii) \"non-important\" (iii) \"serious\" and \"none\" (32.9%) \"32/342 (9.4%) \"07 07 (5. 5.96) \"100 100 (5 plus 46+) \"BASSA BASE\"",
      "start_page": 438,
      "end_page": 438
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: Should CBDCA + nab-paclitaxel nab-paclitaxel + status status (0-1)",
      "start_page": 439,
      "end_page": 439
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: \"Row 2: a a priority? \" Row 3: \" Row 4: JUDICIAL EVIDENCE TESTS\" \"Row Row 5: \"no no \"Probably yes \" Yes ● Varies \"Don't know \"",
      "start_page": 439,
      "end_page": 439
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: Row Row 2: Row Row 3: Row 4: POPULATION: Row 5: Row 6: INTERVENTION: Row 7: Row 8: COMPARISON: Row 9: Row 10: MAIN OUTCOMES: Row 11: Row 12: Row 13: SETTING: Row 14: Row 15: PERSPECTIVE: Row 16: Row 17: BACKGROUND: Row 18: Row 19: CONFLICT OF INTERESTS: Row 20:",
      "start_page": 439,
      "end_page": 439
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: Row 2: a a priority? Row 3:",
      "start_page": 439,
      "end_page": 439
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Verified by: CBDCA + nab-paclitaxel nab-paclitaxel + status status (0-1) Row 2:",
      "start_page": 439,
      "end_page": 439
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: \"Row\" 2: \"Rop\" 3: \"Raw\" 4: \"REARING EVIDENCE TESTS\"",
      "start_page": 439,
      "end_page": 439
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "status status (0-1), banks. banks.",
      "start_page": 440,
      "end_page": 440
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \"Desirabl Row 3: \"Row Row 4: \"",
      "start_page": 440,
      "end_page": 440
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: Row Row 3: Row Row 4:",
      "start_page": 440,
      "end_page": 440
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: ects Row 3: Row Row 4:",
      "start_page": 440,
      "end_page": 440
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: Row 3: the anticipated effects? Row 4:",
      "start_page": 440,
      "end_page": 440
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 440,
      "end_page": 440
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 440,
      "end_page": 440
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: (GRADE) Absolute early effect* (95% CI CI Comments) relative participants (95% (studies) with with CI) (GRADE) chemotherapy CBDCA + Nab-Paclitaxel Nab-Paclitaxel + HR HR 682",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row 2: Relative Row 3: (95% Row 4: CI)",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: participants (studies)",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: (GRADE)",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Chemotherapy",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (43 to 57)",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (56 to 70)",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (52 to 72)",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1, 2009-2011: 10, 2011-2015: 11, 2012-2016: 20, 2015-2010: 10 and 2010-2014: 12, 2012: 15, 2013-2015 (Row 16, 2015: 10) - 10, 2014: 10 (Raw 13, 2011: 10): 10, 2010-2018: 14 (Rw 25, 2016: 0, 2012) - 11, 2010: 23, 2012; 10, 2012 - 10: 10: \" 2015 2015 - 5, 2011 - 2011 2011 , 2006: 2007 2007 , 2005 2005 , 2001 2001 , 2015 2015 , 2017 2017 , 1995 1995 , 1998 1998 , 1996 , 1994 , 2012",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: • Row 2: •tests tests (GRAD) • Certezz Row 3: Anti-Row 4: •Row 5: •GRAD",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: ...Row 2: za...\"Comments Row 3: \" Row 4: \" Row 5: DE) \" Row 6: \"CBDCA CBDCA + Paclitaxel or Nab- Paclitaxel + Row Row 7: \"CBDCA CBDCA + Paclitaxel or Nab- Paclitaxel + Row Row 8: \"CBDCa CBDCa + Pacrotaxel or nab- Paclivastatin + response. response.",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 442,
      "end_page": 442
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: life life (EORTC QLQ-C30) assessed with: Life Life Questionnaire- Core 30 (global health status/life life score) Scale from: 100 100 follow-up: 9 weeks",
      "start_page": 442,
      "end_page": 442
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Average Row 2: Row Row 3: Life was 0",
      "start_page": 442,
      "end_page": 442
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (Row Row 3: 7.7 greater)",
      "start_page": 442,
      "end_page": 442
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Average Row 2: Row Row 3: Life was 0",
      "start_page": 442,
      "end_page": 442
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (Row Row 3: 7.5 greater)",
      "start_page": 442,
      "end_page": 442
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: life life (EORTC QLQ-C30) evaluated with: Life Life Questionnaire- Core 30 (global health status/life life score) Scale from: 100 100 follow-up: 9 weeks",
      "start_page": 442,
      "end_page": 442
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: \"VERY LOW\"Row Row 2: \"Very LOW,\"c",
      "start_page": 442,
      "end_page": 442
    },
    {
      "heading": "heading heading <OS>",
      "text": "==References===External links==* data. data. OS_",
      "start_page": 443,
      "end_page": 443
    },
    {
      "heading": "heading heading <OS> (column 1)",
      "text": "==References===External links==* efficacy efficacy data). OS",
      "start_page": 443,
      "end_page": 443
    },
    {
      "heading": "heading heading <PFS>",
      "text": "Row 1: ...rate rate ... Row 2: ..Row 3: ..with with .. . . . and . ..and . . with with . .",
      "start_page": 444,
      "end_page": 444
    },
    {
      "heading": "heading heading <PFS> (column 1)",
      "text": "Row 1: \"Row 2: \"Undesira Row 3: \"Row Row 4: \"",
      "start_page": 444,
      "end_page": 444
    },
    {
      "heading": "heading heading <PFS> (column 2)",
      "text": "Row 1: Row 2: Row Row 3: Row Row 4:",
      "start_page": 444,
      "end_page": 444
    },
    {
      "heading": "heading heading <PFS> (column 3)",
      "text": "Row 1: \"Row 2: s\" Row 3: rable anticipated effects?",
      "start_page": 444,
      "end_page": 444
    },
    {
      "heading": "heading heading <PFS> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 444,
      "end_page": 444
    },
    {
      "heading": "heading heading <PFS> (from previous page)",
      "text": "Row 1: (GRADE) Absolute early effect* Comments Comments (95% CI) relative participants (95% (studies) with with CI) (GRADE) chemotherapy CBDCA + nab-paclitaxel nab-paclitaxel + RR RR 682",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading <PFS> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading <PFS> (from previous page)",
      "text": "Row 1: Row 2: Relative Row 3: (95% Row 4: CI)",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading <PFS> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: participants (studies)",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading <PFS> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: (GRADE)",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading <PFS> (from previous page)",
      "text": "Row 1: Row Row 2: Chemotherapy",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading <PFS> (from previous page)",
      "text": "Row 1: Row Row 2: (50 to 62)",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading <PFS> (from previous page)",
      "text": "Row 1: Row Row 2: (6 to 16)",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading <PFS> (from previous page)",
      "text": "Row 1: Row Row 2: (11 to 21)",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading <PFS_> (column column 1)",
      "text": "Row 1: (0fm) = 100 m3 = 10 m3 + 10 m2 = 20 m3 / 10 m4 = 10 cm3 = m5 m5 = m7 m7 = 2 m3 - 3 m3",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading <PFS_> (column column 2)",
      "text": "Row 1: \"Row\" 2: \"the the tests\" (GRADE) = \"Creative Row 3: \"Nti\" Row Row 4: \"Tree Row 5\": \"GRADE\"",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading <PFS_> (column column 3)",
      "text": "Row 1: \"Row 2\": a \"Comments Row 3: \" Row 4: \" Row 5: E\" \" Row 6\": \"CBDCA\" + \"Paclitaxel\" or \"Nab- Paclitaxel\") + \"_MEDTERM0\" Row Row 7: \"CBDCA CBDCA + \"Paclitaxel\" and \"Nab- Paciltaxel\" + Row Row 8: \"CBCCA\"+ \"Paclitaxel,\" or \"Nabi- Pacrotaxel\" in in determining",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading <PFS> (from previous page)",
      "text": "Row 1: .95 (2 RCT) or or Nab- 100 100 (Paclitaxel Paclitaxel + (14 to 26) 1.27) 679 679 • CBDCA + Grade 3-4: 1.20 (2 RTC) 100 100 (Paciltaxel Paciltaxel + (4 to 13) 2.11) 679 679 - 07 07 (2 Rct) 100 100 (deed deed + the the CBA+Padc)",
      "start_page": 446,
      "end_page": 446
    },
    {
      "heading": "heading heading <PFS> (from previous page)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 446,
      "end_page": 446
    },
    {
      "heading": "heading heading <PFS> (from previous page)",
      "text": "Row 1: Row Row 2: (14 to 26)",
      "start_page": 446,
      "end_page": 446
    },
    {
      "heading": "heading heading <PFS> (from previous page)",
      "text": "Row 1: Row Row 2: (4 to 13)",
      "start_page": 446,
      "end_page": 446
    },
    {
      "heading": "heading heading <PFS> (from previous page)",
      "text": "Row 1: Row Row 2: (15 to 56)",
      "start_page": 446,
      "end_page": 446
    },
    {
      "heading": "heading heading <PFS_> (column column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" People Row 6: \" Row 7: \" \" Row 8: \" 20 for \" 100 Row 9: \" row 10: \" ' Row 11: \" Popularity Row 12: \" Route 13: \" Row 14: \" 6 for \"100 Row 15: \" - \" Row 16: \"\" Row 17: \"Population Row 18: \" Now 19: \" Roll 20: \" 9 for \"10 Row 21: \"",
      "start_page": 446,
      "end_page": 446
    },
    {
      "heading": "heading heading <PFS_> (column column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: ne in studio\" \" Row 6: \" Row 7: \" Row 8: \"0\" 100 100 (14 to 26) \"Row Row 9: \"14 to 26\" Row 10: \"Raw 11: \" row 12: \"studio studio \" Row 13: \"row 14: \" Route 15: \"100 100 (4 to 13) \"Row Row 16: \"4 to 13\" Row 17: \" Now 18: \" Roll 19: \"Ne in studio\"\" Row 20: \" Right 21: \" - \" Row 22: \" 100 100 (15 to 56) \"row row 23: \"15 to 56\" Row 24: \"",
      "start_page": 446,
      "end_page": 446
    },
    {
      "heading": "heading heading <PFS> (column column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" 95 95 (1. 1.27) \" Row 5: \" Row 6: \" Row 7: \" row 8: \" ' Row 9: \" \" Row 10: \" - Row 11: \" 20 20 (2. 2.11) \" Row 12: \" Roll 13: \" Route 14: \"\" Row 15: \" Now 16: \" Right 17: \" . Row 18: \"07 07 (5. 5.96) Row 19: \" Rule 20: \"",
      "start_page": 446,
      "end_page": 446
    },
    {
      "heading": "heading heading <PFS_> (column column 7)",
      "text": "Row 1: Grade 3- 4. Row 2: CBDCA + Paclitaxel or Nab- Paclitaxel + Row Row 3: CBDC A + Paclitaxel or Nab- Paclitaxel + Row Row 4: CBDCAs CBDCAs + Pacrotaxel or nab- Pacilitaxel+ adverse adverse events",
      "start_page": 446,
      "end_page": 446
    },
    {
      "heading": "heading heading <PFS> (from previous page)",
      "text": "Row 1: -- J. J., M. M., Borghaei, H., A. A., F. F., D. D., population population (Langer Langer 2016: or or IV; RTC RTC KEYNOTE-407: stage stage IV). for for imprecision: confidence. confidence.",
      "start_page": 447,
      "end_page": 447
    },
    {
      "heading": "heading heading <PFS> (from previous page)",
      "text": "Row 1: Row Row 2: • Row 3: •",
      "start_page": 447,
      "end_page": 447
    },
    {
      "heading": "heading heading <PFS_> (column column 1)",
      "text": "Row 1: -- J. J., M. M., Borghaei, H., A. A., F. F., D. D., population population (Langer Langer 2016: or or IV; RTC RTC KEYNOTE-407: stage stage IV). for for imprecision: confidence. confidence.",
      "start_page": 447,
      "end_page": 447
    },
    {
      "heading": "heading heading <PFS> (from previous page)",
      "text": "Row 1: \"D\" for for inaccuracy: heterogeneity heterogeneity (I2= 55%) death death Anaemia",
      "start_page": 448,
      "end_page": 448
    },
    {
      "heading": "heading heading <PFS> (from previous page)",
      "text": "Row 1: ...to to imunotherapy",
      "start_page": 449,
      "end_page": 449
    },
    {
      "heading": "heading heading <Values>",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search_en/index_en.htm",
      "start_page": 450,
      "end_page": 450
    },
    {
      "heading": "heading heading <Values> (column 1)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/en_en/index_en.htm",
      "start_page": 450,
      "end_page": 450
    },
    {
      "heading": "heading heading <Values> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 450,
      "end_page": 450
    },
    {
      "heading": "heading heading <Equity>",
      "text": "Row 1500: ... .. . . . ... . ..\" . . .\" . .\" . . \" . .\"; . .' . .; . .",
      "start_page": 451,
      "end_page": 451
    },
    {
      "heading": "heading heading <Equity> (column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 451,
      "end_page": 451
    },
    {
      "heading": "heading heading <Equity> (column 1)",
      "text": "Row 1: \"Row 2: \"Equity Row 3: \"Row Row 4: \"",
      "start_page": 451,
      "end_page": 451
    },
    {
      "heading": "heading heading <Equity> (column 2)",
      "text": "Row 1: Row 2: Row 3: the the comparison? Row 4:",
      "start_page": 451,
      "end_page": 451
    },
    {
      "heading": "heading heading <Equity> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: ealth equity? \" Row 4: \"",
      "start_page": 451,
      "end_page": 451
    },
    {
      "heading": "heading heading <Equity> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 451,
      "end_page": 451
    },
    {
      "heading": "heading heading <Equity> (column 5)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 451,
      "end_page": 451
    },
    {
      "heading": "heading heading <Feasibility>",
      "text": "Row 1: \" Row 2: \"Acceptability\" Row 3: \"key key stakeholders? \" Row 4: \"Row 5: \"Judizi\" \"di di evidenza\" \"found. found.\"Row 6: \"No probability\" no \"Probably yes ● \"Yes,\" \"Varies,\" \"Don't know\"Row Row 7: \"Raw 8: \"Feasibility\" Row 9: \"to to implementation\" Row 10: \"Row 11: \"JUSTICES\" EVIDENCE EVIDENCE TESTS\" ADDITIONAL CONSIDERATIONS \"RWay 12: \" No,\" \"Probably no,\" \" probably yes,\" \"Yes\" \"Various\" Don'whatsoever. whatsoever.",
      "start_page": 452,
      "end_page": 452
    },
    {
      "heading": "heading heading <Feasibility> (column 1)",
      "text": "Row 1: \"Row 2: \"Acceptability Row 3: \"Row Row 4: \"",
      "start_page": 452,
      "end_page": 452
    },
    {
      "heading": "heading heading <Feasibility> (column 1)",
      "text": "Row 1: \"Row 2: \"Feasibility Row 3: \"Row Row 4: \"",
      "start_page": 452,
      "end_page": 452
    },
    {
      "heading": "heading heading <Feasibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: key key stakeholders? Row 4:",
      "start_page": 452,
      "end_page": 452
    },
    {
      "heading": "heading heading <Feasibility> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: sible to implementation? \" Row 4: \"",
      "start_page": 452,
      "end_page": 452
    },
    {
      "heading": "heading heading <Feasibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 452,
      "end_page": 452
    },
    {
      "heading": "heading heading <Feasibility> (column 12)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 452,
      "end_page": 452
    },
    {
      "heading": "heading heading <Feasibility> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 453,
      "end_page": 453
    },
    {
      "heading": "heading heading <Feasibility> (column column 1)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" PROBLEM\" Row 6: \" Row 7: \" Row 8: \" DESIRABLE EFFECTS\" Row 9: \"Raw 10: \"ROW 11: \"UNDESIRABLE EffECTS\") Row 12: \"Row 13: \"Rule 14: \"CERTAINTY OF EVIDENCE\" Row 15: \" NOW 16: \"QUETY\" Row 17: \"VALUES\" Row 18: \"WOW 19: \"BALANCE OF EFFECTS\" Row 21: \"",
      "start_page": 453,
      "end_page": 453
    },
    {
      "heading": "heading heading <Feasibility> (column column 2)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 453,
      "end_page": 453
    },
    {
      "heading": "heading heading <Feasibility> (column column 3)",
      "text": "Row 1: Row 2: JUDICES Row 3:",
      "start_page": 453,
      "end_page": 453
    },
    {
      "heading": "heading heading <Feasibility> (column column 3)",
      "text": "Row 1: Probably no ...yes. yes...Row 2: \" Row\" 3: \"Row\" 4: \"Small\": \"Modera te\" & \"Larg\" 5: \"Raw\" 6: \"Row\" 7: \" Moderate\" = \"Small\" / \"Trivi al\" * Row 8: \"Wow\" 9: \"How\" 10: \"Low\" / ...\"Modera te \"High\" Row 11: \" Row 12: \"- Row 13: \"or or variable\" /\"\"or or variableity\" /\"or or variableness\" /\") Row 14: \"row 15: \"Now 16: on. on.\"",
      "start_page": 453,
      "end_page": 453
    },
    {
      "heading": "heading heading <Feasibility> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6:",
      "start_page": 453,
      "end_page": 453
    },
    {
      "heading": "heading heading <Feasibility> (column column 5)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Don't know\" Row 5: \"Dun't knows\" Row 6: \"Do't Know\" Row 7: \"No included studies\" Row 8: \"Raw 9: \" Row 10: \"Now 11: \"Row 12: \"Wow 13: \" Don't known\" Row 14: \"don't knowing\" Row 15: \" don't really know\"",
      "start_page": 453,
      "end_page": 453
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: \"Row 2: \"JUDIZI\" Row 3: \"Rown 4: \"No\"Probably no\"Probably yes\" Yes\" = \"Vari es\" Don 'Row Row 5: FEASIBILITY\" Row 6: \"Don't know\"",
      "start_page": 454,
      "end_page": 454
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: the the intervention",
      "start_page": 454,
      "end_page": 454
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: Row 2: Recommendation Row 3:",
      "start_page": 454,
      "end_page": 454
    },
    {
      "heading": "heading heading <QUESITO 37>",
      "text": "==References===External links==* Official website",
      "start_page": 455,
      "end_page": 455
    },
    {
      "heading": "heading heading <QUESITO 37> (column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 455,
      "end_page": 455
    },
    {
      "heading": "heading heading <QUESITO 37> (column 2)",
      "text": "Row 1: \"Row\" 2: \"Effect\" Row 3: \"Quality\" \"Importance Row 4: \"Rop\" 5: \"y\"Rolative\" Row 6: \"Picture\" , \"Absolute\" Row 7: \"95%\" Row 8: \"Raw\" 9: \"-Row 10: \"140/180\" (77.8%) \"78 78 (0. 0.96) \"2 \"9 Fewer\" per 100 (16 16 feder) \"HIGH\" \"CRITAL3 Row 11: \") \"Rout 12: \"62/180 (34.4%) \"62 62 (0. 0.79) \"6 \"per per 100\" (16 16 fewer) \"High\" \"IMPORTANT3 Row 13: ST 1.07) \" Row 14: \"1/156 (0.64%) \"44 44 (34. 34.36) \"TO TO 2188LIGHT",
      "start_page": 455,
      "end_page": 455
    },
    {
      "heading": "heading heading <transfusion (5 5 months)>",
      "text": "I'm sorry. == Demographic evolution ====References==",
      "start_page": 456,
      "end_page": 456
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: advanced advanced NSCLC",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: \"Row 2: a a priority? \" Row 3: \" Row 4: \" JUDICES\" \"EVIDENCE EVIDENCE TESTS\" \"CONSIDERATIONS\" Row 5: \"No\" \"Probably not \"Yes\" ● \"Varia\" known. known.",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: used used (Row Row 2:) Row 3: POPULATION (ii) Row 4: (iii) Row 5: INTERVENTION (iv) Row 6: (v) Row 7: COMPARISON (vv) row 8: (vi) Row 9: MAIN EXITS (v/v)",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: \"Row 2: SETTING: \" Row 3: \" Row 4: PROSPECTIVE: \" row 5: \" Row 6: \" BACKGROUND: \"row 7: \"RW 8: CONFLICTS OF \" Row 9: INTEREST \" Row 10: \"",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: Row 2: a a priority? Row 3: Row 4: JUDICES Row 5:",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Row Row 2:",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading <Problem> (column 3)",
      "text": "Row 1: Row Row 2:",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading <Problem> (column 4)",
      "text": "Row 1: Row 2:",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading <Problem> (column 5)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "two two phases: phase phase (in induction phase) time. time.",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: \"Row 2\": \"Raw 3\" effect effect (95% CI) \"participants participants (studies) \"tests tests (GRADE) \"Comments Row 3: \"Rop 4\" row row 5: \" Row 6\" placebo placebo \"Risk with \"Ru 7\" zero. zero.",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row 2: Relative Row 3: (95% Row 4: CI)",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: participants (studies)",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Certainty Row 2: of Row 3: (GRADE)",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Risk Row 2: with Row 3: placebo",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: 100",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (62 to 76)",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: Esider Row 3: Row Row 4:",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Siderable Expected? Row 4:",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "phase phase (stage IIIB/IV). two two phases: phase phase (induction phase) with with cisplatin/pemetrexed (cisplatin 75 mg/500 500 mg/ mq e",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading <Problem> (column column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: \"100 100 (19 to 28) (PFS) rated with: 539 539 \"masked to treat\" (a a (1 RCT) ALTA 0.79) follow follow up: 472 472 \"4. 4.44\" (1 RTC) ALTAC (___MEDTERM1_) 100 100 (valued valued with: 100 (0 to 22) 34.36) rate rate (partial partial response) followed followed up: 04 04 - average average (1 Rct) BASSAd,e (_medTERM2_) quality (evaluated evaluated with: of life - 5D 5D greater",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: survival survival (__MEDTERM0_) evaluated with: follow follow up: 62 62 (0. 0.79)",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: 100",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (19 to 28)",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: 100",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (0 to 22)",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: The Row 2: Average Row 3: Quality Row 4: of life - Row 5: EQ-5D Row 6: Was 0",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Lower Row 3: (Row Row 4: Row Row 5: greater)",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: survival survival (__MEDTERM0_) evaluated with: follow follow up: median 5 monthsa",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: \"Row\" 2: \"Rw\" 2: 100 100 (19 to 28) \"23\" Row Row 3: \" 19 to 28\" Row 4: \" Row 5: \" Row 6: action in studio\" \"Raw 7: \" Row 8: \"Rown 9: \"3 per 100\" (0 to 22) \"3\" for \"100 Row 10: \"0\" to 22\") Row 11: \"Now 12: \"Wow 13: \"less less (34 34 greater) \"Row Row 14: \"Bottom Row 15: y\"(Row Row 16: - \"Row Row 17: D\" major) Row 18: \"Row 19: \"",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: 62 62 (0. 0.79) Row 2: Row Row 3:",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08>",
      "text": "==References===External links==* http://available available 88% and and 95% sources sources 95%;",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08>",
      "text": "Row 1: life life -VAS (QOL) assessed by: VAS - Cycle 6",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08>",
      "text": "Row 1: Row Row 2: Lower Row 3: (Row Row 4: Row Row 5: greater)",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (column 2)",
      "text": "Row 1: Row 2: ndesid Row 3: Row Row 4:",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (column 3)",
      "text": "Row 1: Row 2: Derabi Row 3: Row Row 4:",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (column 4)",
      "text": "Row 1: Row 2: ii Row 3: Row Row 4:",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (column 5)",
      "text": "Row 1: life life -VAS (QOL) assessed by: VAS - Cycle 6",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (column 5)",
      "text": "Row 1: \"Row 2: \" Row 3: Wishful Expected? \" Row 4: \"",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (column 6)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (column 7)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: • Large • Moderate • Irrelevant • Variant • Not so • on on PubMed/databases databases (Cochrane Library) with with cysplatin/pemetrexed (cisplatin 75 mg/v. v.; phase phase (induction phase) phase phase (maintenance phase) with Cisplatin/pethotrexed (diseased).",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: \"Row 2\": \"Exits\" Exhibits\" = \"Related effect\" (95% CI) \"participants participants (studies) \"tests tests (GRADE) \"Comments Row 3: \"Anticipated\" * (95% CI): \"Raw 5: \"Ruy 6: \"Corruption with placebo\" \"Risk\" with \"Rw 7: \"Maintenance\" \" Row 8: \"Therapy with \" Row 9: \"pemetrexed\" \"row 10: \" Row 11: Severe Toxicity (Non-Laboratory) \" (ST) rated by: \"N° follow follow up: months months \"RR 2.51\" (5. 5.91) \"539 (1 RCT) \" ALTA\" \"ROW 12: \"Popportation in study\" - Row 13: \"Row 14: \"Short 15: \"Power\" for 100",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: Row 2: Relative Row 3: (95% Row 4: CI)",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: participants (studies)",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: Certainty Row 2: of Row 3: (GRADE)",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: Risk Row 2: with Row 3: placebo",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: Row Row 2: 100",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: Row Row 2: (4 to 20)",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (column column 5)",
      "text": "Row 1: \"Row 2\": \"Raw 3\": Absolute effect\" = \"Rop 4\" = (CI) = \"participants participants (studies) = (GRADE) = ...\"Right with placebo\" = [Row 7]: \"Maintenance\" = (\"Row 8\") = \"Therapy\" =\" Row 9: \"pemetrexed\" = row 10: \" Row 11: Severe Toxicity (Non-Laboratory) (ST) = rated by: N° follow follow up: months months \"51 51 (5. 5.91) \"539 (1 RCT) \" ALTA\" =",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (column column 6)",
      "text": "Row 1: Row 2: i",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: •100 100 (1 to 20) RR rated with: 539 539 • Grade 3-4 (to to (1 RCT) ALTaa follow-up: 18.25) m m • transfusion • 539 539 - follow up: 2.67 (1 Rct) • 100 100 (100 100 (7 to 27) 5.33) • G-CSF • rr rr 539",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: evaluated evaluated with: Grade 3-4 follow-up: m m esi",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: Row Row 2: 100",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: Row Row 2: (1 to 20)",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: Row Row 2: 100",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: Row Row 2: (7 to 27)",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: Row Row 2: 100",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: Row Row 2: (1 to 41)",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: Row Row 2: 100",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: Row Row 2: (1 to 47)",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: Row Row 2: 100",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (from previous page)",
      "text": "Row 1: Row Row 2: (1 to 45)",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (column column 1)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading <difference difference (MID= 0.08> (column column 2)",
      "text": "Row 1: •26 26 (18. 18.25) Row 2: • Row 3: •row 4: • row 5: • • 67 67 (5. 5.33) Row 6: ♪ row 7: â row 8: ■ row 9: @ Row 10: Â • right 11: ¶ row 12: ‐03 03 (74. 74.13) Row 13: − row 14: TM Row 15: □ Row 16: ^ Row 17: Ø Row 18: ř Row 19: {53 53 (84. 84.71) Row 20: ► Row 21:",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading <Valori>",
      "text": "Row 1: \"Wide Wide 95% for for inaccuracision\" Row 2: \"Row 3: \"Certainness of evidence\" Row 4: \"safety safety tests?\" Row 5: \"Raw 6: \"JUDICIES\" EVIDENCE EVIDENCE TESTS\" Row Row 7: \"Very low\" ● Low",
      "start_page": 464,
      "end_page": 464
    },
    {
      "heading": "heading heading <Valori>",
      "text": "Row 1: 5 5 months",
      "start_page": 464,
      "end_page": 464
    },
    {
      "heading": "heading heading <Valori> (column 1)",
      "text": "Row 1: \"Row 2: \" Row 3: \"the the tests\" [Row 4: \"safety safety tests?\"] Row 5: \"Raw 6: \"JUDIZI\" Row 7: \"Very low\" ● \"Low,\" \"Moderated,\" \"High,\" \"included, included, \"Rop 8\": \"Row 9: \"Valori\" Row 10: \"C\" main main outcomes?\" Row 11: \" Row 12: JUDICI\" Row 13: \"or or variation\" - volatility volatility ● or or variability",
      "start_page": 464,
      "end_page": 464
    },
    {
      "heading": "heading heading <Valori> (column 1)",
      "text": "Row 1: 5 5 months",
      "start_page": 464,
      "end_page": 464
    },
    {
      "heading": "heading heading <Valori> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 464,
      "end_page": 464
    },
    {
      "heading": "heading heading <Valori> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 464,
      "end_page": 464
    },
    {
      "heading": "heading heading <Equity>",
      "text": "Row 1: \"Row\" 2: \"Budget of effects\" = \"Rop\" 3: \"or or comparison?\" = \"Row\" 4: \"Raw\" 5: \"JUDICES\" ● intervention intervention \"Wait\" operation operation \"Warring\" 7: \"Wearing\" 8: \"Right\" 9: \"of of equity? \"Rown\" 10: \"Now\" 11: \"Don't know\" Row 7:",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading <Equity> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading <Equity> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading <Equity> (column 2)",
      "text": "Row 1: Row 2: Row 3: siderabili Row 4:",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading <Equity> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: uità? \" Row 4: \"",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading <Equity> (column 3)",
      "text": "Row 1: Row 2: Row 3: favor Row 4:",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading <Equity> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading <Equity> (column 4)",
      "text": "Row 1: Row 2: Row 3: or or comparison? Row 4:",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading <Equity> (column 5)",
      "text": "Row 1: Row 2: Row 3: ? Row 4:",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading <Equity> (column 12)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading <Fatsibility>",
      "text": "Row 1: \"Row\" 2: \"Acceptibility\" \"Rop 3: \"main main stakeholders?\" \"Raw 4: \"Rown 5: \"JUDICI\" \"EVIDENCE EVIDENCE TESTS\" \"ADDENTIONS\" \"Now 6: \"No\" \"Probably no\" ● \"Yes\" \"Varia\" \"I don't know\" \"found. found.\" \"Rw 7: \"Roh 8: \"Fatsibility\" \"row 9: \"intervention intervention \"Right\" 10: \"Way\" 11: \"Don't I know\" found. found.",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Acceptability Row 3: •Row Row 4: •",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •Now 4:",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: Main Row 4:",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: ell'interve Row 4:",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading <Fatsibility> (column 4)",
      "text": "Row 1: Row 2: Row 3: stakeholders? Row 4:",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading <Fatsibility> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: ento\"? \"Raw 4: \"",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading <Fatsibility> (column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading <Fatsibility> (column 12)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading <Fatsibility> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading <Fatsibility> (from previous page)",
      "text": "Row 1: QUALITY: Row 2: TESTS",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading <Fatsibility> (from previous page)",
      "text": "Row 1: BILANCI Row 2: OR Row 3: EFFECTS",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading <Fatsibility> (column column 1)",
      "text": "Row 1: Row 2: Row 3: PROBLEM Row 4: Row 5: Row 6: Row 7: SIDES Row 8: DESIDERABLE Row 9: Row 10: Row 11: EFFECTS Row 12:ROWNBIL Row 13: Row 14: Row 15: Row 16: QUALITY Row 17: TESTS Row 18: Row 19: Row 20: Row 21: Row 22: VALUES Row 23: Row 24: Row 25: Row 26: Row 27: BILANCI Row 28: Row Row 29: EFFECTS row 30: Row 31:",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading <Fatsibility> (column column 2)",
      "text": "Row 1: Row 2: Row 3: A Row 4: Row 5: Row 6: Row 7: Row 8: I Row 9: Row 10: Row 11: Row 12: LI Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row 22: Row 23: Row 24: Row 25: Row 26: Row 27: Row 28: Row 29: Row 30: Row 31:",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading <Fatsibility> (column column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" No\" Row 5: \"Irril eva nti\" Row 6: \"Gra ndi\" Row 7: \"bass bass a\" Row 8: or or variability\" Row 9: \"of of comparison\"",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading <Fatsibility> (column column 4)",
      "text": "Row 1: Row 2: JUDICES Row 3:",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading <Fatsibility> (column column 4)",
      "text": "Row 1: Row Row 2: Row Row 3: Piccoli Row 4: Row Row 5: Row Row 6: to to intervention",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading <Fatsibility> (column column 5)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\" Row 17: \" Raw 18: \"",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading <Fatsibility> (column column 7)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Don't know\" Row 5: \"Do not know\" row 6: \"Not so\" Row 7: \"use use \" Row 8: \"Raw 9: \" Row 10: \"Row 11: \" Row 12: \"I don't care\" Row 13: \"DON'T know\"",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: \"Ridu ce l'eq uità\" reduce reduce equity: \"on on equity\" to to \"Aument a l'equity\" is fair.",
      "start_page": 468,
      "end_page": 468
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: against against intervention",
      "start_page": 468,
      "end_page": 468
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: • Row 2: •Row 3: •Recommendation",
      "start_page": 468,
      "end_page": 468
    },
    {
      "heading": "heading heading <Discontinuation rate>",
      "text": "== Demographic evolution ====References==",
      "start_page": 469,
      "end_page": 469
    },
    {
      "heading": "heading heading <Discontinuation rate> (column 1)",
      "text": "the the study: \"Distortion risk\" = \"Driving risk\" + \"Drive risk\" - \"Drink risk\" / \"Drained risk\" · \"Disaster risk\" * - \"Currency loss\" -\"\"Immediacy loss\" − \"Improvement\" ‐ \"Row 6: \"Raw 7: Overall Survival\" Row 8: \"Row 9: 5,\" 2, 2, 4\" Randomized studies\" -- \"non-important\" --\" not important\" -\" Not important - \"Not important\" ► Row 13: \"Overall response rate\" ^ Row 14: \"Now 15: 5\" randomized studios \"Serium\" b b ¢non-important non-important - \"No important\" row 16: Treatment-related AE (or or 4) Row 17: \"More important\"",
      "start_page": 469,
      "end_page": 469
    },
    {
      "heading": "heading heading <Discontinuation rate> (column 2)",
      "text": "== Demographic evolution ====References==",
      "start_page": 469,
      "end_page": 469
    },
    {
      "heading": "heading heading <Discontinuation rate> (column 3)",
      "text": "Row 1: Row 2: Importance Row 3: Row 4:",
      "start_page": 469,
      "end_page": 469
    },
    {
      "heading": "heading heading <Discontinuation rate> (column 3)",
      "text": "Row 1: Row 2:",
      "start_page": 469,
      "end_page": 469
    },
    {
      "heading": "heading heading <References>",
      "text": "Row 1: 7 7 minus)",
      "start_page": 470,
      "end_page": 470
    },
    {
      "heading": "heading heading <X Si>",
      "text": "Row 1: • Private: Row Row 3:",
      "start_page": 471,
      "end_page": 471
    },
    {
      "heading": "heading heading <X Si>",
      "text": "Row 1: • Row 2: a a priority? •row 3: • row 4: JUDICES •TESTS TESTS •Row 5: • no • probably no ♪ X X • Yes",
      "start_page": 471,
      "end_page": 471
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "desirable desirable effects?Row 5: \"Row 6: \" JUDICIS\" Row 3: \"Warfarable effects\"Row 4: \"effects effects expected?\"Row 4: \" be be expected? Row 5: - \" Row 6: 'JUDIS'RW 3: \"ADDANTIVE TESTS\" CONDITIONS) Row Row 7: \"Irrelevant . \" Small \"Big Big \" Large \" Varian \" Absolute Absolute Effects* (95% CI) with with Q10: (95% (studies) (GRADE) with with CI) ___MEDTERM0.00_===__medTERM3 0;3024 3024 3024",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "Row 1: Relative Row 2: effect Row 3: (95% Row 4: CI)",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "Row 1: Row Row 2: participants Row 3: (studies)",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "Row 1: Row Row 2: evidence Row 3: (GRADE)",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading <X Si> (from previous page)",
      "text": "Row 1: Row Row 2: chemotherapy",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading <X Si> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading <X Si> (column column 2)",
      "text": "Row 1: Row 2: Evergreen Row 3: Everlasting Row 4:",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading <X Si> (column column 3)",
      "text": "Row 1: Row 2: rable Row 3: Row Row 4:",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading <X Si> (column column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: Desirable Those Expected? \" Row 4: \"",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading <X Si> (column column 4)",
      "text": "==References===External links==* Official website",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading <X Si> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading <X Si> (column column 5)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: E)",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading <X Si> (column column 6)",
      "text": "Row 1: \"Row 2: Commen\"",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading <X Si> (column column 7)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading <X Si> (column column 7)",
      "text": "Row 1: Row 2: nts",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading <I2=61%>",
      "text": "Row 1: \"3014 3014 • (6 to 10) (rate rate (5 RCTs) 0. 0.59) studies studies (POPLAR POPLAR studies) label label I2=61% found found (I2=82%), survival. survival.",
      "start_page": 473,
      "end_page": 473
    },
    {
      "heading": "heading heading <I2=61%>",
      "text": "Row 1: Continuation rate (47 47 (0. 0.59) = 3014 (5 RCTs) = MODERATEA, b = Row 2: = 100 100 (R) = 100 (6 to 10) = row 3:",
      "start_page": 473,
      "end_page": 473
    },
    {
      "heading": "heading heading <I2=61%>",
      "text": "Row 1: Row Row 2: (6 to 10)",
      "start_page": 473,
      "end_page": 473
    },
    {
      "heading": "heading heading <I2=61%> (from previous page)",
      "text": "Row 1: \"related related AEs\"",
      "start_page": 474,
      "end_page": 474
    },
    {
      "heading": "heading heading <I2=61%> (from previous page)",
      "text": "Row 1: ... \"Discontinuation rate\"",
      "start_page": 475,
      "end_page": 475
    },
    {
      "heading": "heading heading <I2=61%> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading <I2=61%> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading <I2=61%> (from previous page)",
      "text": "Row 1: Relative Row 2: effect Row 3: (95% Row 4: CI)",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading <I2=61%> (from previous page)",
      "text": "Row 1: Row Row 2: participants Row 3: (studies)",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading <I2=61%> (from previous page)",
      "text": "Row 1: Row Row 2: evidence Row 3: (GRADE)",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading <I2=61%> (from previous page)",
      "text": "Row 1: Row Row 2: chemotherapy",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading <I2=61%> (column column 1)",
      "text": "Row 1: • Row 2: • Ind Row 3: • Row Row 4: •",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading <I2=61%> (column column 2)",
      "text": "Row 1: Row 2: Desired Row 3: Row Row 4:",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading <I2=61%> (column column 3)",
      "text": "Row 1: Row 2: erable Row 3: Row Row 4:",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading <I2=61%> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Unwanted Tits Expected? Row 4:",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading <I2=61%> (column column 4)",
      "text": "==References===External links==* Official website",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading <I2=61%> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading <I2=61%> (column column 5)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: E)",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading <I2=61%> (column column 6)",
      "text": "Row 1: \"Row 2: Commen\"",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading <I2=61%> (column column 7)",
      "text": "Row 1: Row 2: nts",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading <I2=61%> (column column 9)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading <I2=61%>",
      "text": "Row 1: \"studies studies (OPLAR OPLAR studies) label label I2=61% found found (I2=82%), free free survival\"",
      "start_page": 477,
      "end_page": 477
    },
    {
      "heading": "heading heading <I2=61%> (from previous page)",
      "text": "Row 1: \"related related AEs\"",
      "start_page": 478,
      "end_page": 478
    },
    {
      "heading": "heading heading <I2=61%> (from previous page)",
      "text": "Row 1: \"Discontinuation rate\" Row 2: \"Row 3: \"the the tests\" Row 4: \"safety safety tests?\" Row 5: \"Rw 6: \"JUDICI\" THE THE TESTS\" ADDITIONAL CONSIDRATIONS \"Raw 7: \"Very low\" Low X \"Moderated\" High \"No study included\"detection detection bias\"",
      "start_page": 479,
      "end_page": 479
    },
    {
      "heading": "heading heading <I2=61%> (column column 1)",
      "text": "Row 1: \"Row 2\": \"Row Row 3: \"Row Row 4: \"Row Row 3\"",
      "start_page": 479,
      "end_page": 479
    },
    {
      "heading": "heading heading <I2=61%> (column column 2)",
      "text": "Row 1: \"Row 2: Rove\" Row 3: safety safety tests?",
      "start_page": 479,
      "end_page": 479
    },
    {
      "heading": "heading heading <I2=61%> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 479,
      "end_page": 479
    },
    {
      "heading": "heading heading <I2=61%> (column column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 479,
      "end_page": 479
    },
    {
      "heading": "heading heading <Effect balance>",
      "text": "Row 1: \"Row 2\": \"Raw 3: \"C\" main main outcomes? \" Row 4: \" Row 5\": 'Row 5': \"Warnings\" = \"ADDATIVE CONSIDERATION\" = 6: \"or or variation\" = variability variability * \"or or variables\" = 7: \" Row 8: \"Budget of effects\" = 9: \"or or comparison\" = 10: \"row\" = 11: \"ROW 11: JUDITIONS\" = 8: ...\"ADDANTIVE CONSIDERATIONS = 12: \"comparison comparison \"Probably\" confrontation. confrontation.\"",
      "start_page": 480,
      "end_page": 480
    },
    {
      "heading": "heading heading <Budget of effects> (column 1)",
      "text": "Row 1: \"Row 2: \"Valori\" Row 3: \"C\" main main outcomes? \"Rop 4: \"Raw 5: \"JUDIZI\" Row 6: \"or or variation\"",
      "start_page": 480,
      "end_page": 480
    },
    {
      "heading": "heading heading <Budget of effects> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 480,
      "end_page": 480
    },
    {
      "heading": "heading heading <Budget of effects> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 480,
      "end_page": 480
    },
    {
      "heading": "heading heading <Budget of effects> (column 3)",
      "text": "Row 1: Row 2: Row 3: Onto? Row 4:",
      "start_page": 480,
      "end_page": 480
    },
    {
      "heading": "heading heading <Budget of effects> (column 11)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 480,
      "end_page": 480
    },
    {
      "heading": "heading heading <Acceptability>",
      "text": "Row 1: \"Row\" 2: \"Equity\" = Row 3: \"of of equity?\" = \"Right\" = 5: \"Judizi\" = 7: \"Reduce equity\" = 6: \"Freeness\" = 9: \"Probably no impact\" = 10: \"Improve equity\" / \"Vary\" = 11: \"Raw\" = 8: \"Acceptability\" = row = 9, \"No intervention\" main main stakeholders?",
      "start_page": 481,
      "end_page": 481
    },
    {
      "heading": "heading heading <Acceptability> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •of of equity?",
      "start_page": 481,
      "end_page": 481
    },
    {
      "heading": "heading heading <Acceptability> (column 1)",
      "text": "Row 1: • Row 2: •Acceptability Row 3: •Row Row 4: •",
      "start_page": 481,
      "end_page": 481
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: Row 2: Row 3: ? Row 4:",
      "start_page": 481,
      "end_page": 481
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: keepers? \" Row 4: \"",
      "start_page": 481,
      "end_page": 481
    },
    {
      "heading": "heading heading <Acceptability> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 481,
      "end_page": 481
    },
    {
      "heading": "heading heading <Acceptability> (column 15)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 481,
      "end_page": 481
    },
    {
      "heading": "heading heading <Fatsibility>",
      "text": "Row 1: \"Row 2: intervention intervention feasible? \" Row 3: \" Row 4: \"JUDIZI\" TESTS TESTS \"RW 5: \"No\" \"Probably no \"Yeah\" X \"Varia\"",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading <Fatsibility>",
      "text": "Row 1: \"Row 2: \"JUDIZI\" Row 3: \"Rop 4: \"No\"Probably not \"Probabilme nte si\" \"Si\" \"Varia\" \"Non so\" Row 5: \"PROBLEM\" Row 6: \"Rw 7: \"Irrilev anti\" \"Little\" \"Moderates\" \"Grands\" \"Great\" \"Very Large\" \"Don't know\" Row 8: \"Now\" [Row] 9: \"DESIDERABLES\" Row 10: \"Row 11: \"Grand i\" \"Moderati\" (Moderated) \"Small\" or \"Iron\" \"Raw\" 16: \"Qualita dele proprima\" Row 17: \"Wow\"",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading <Fatsibility>",
      "text": "Row 1: Row Row 2: TESTS",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: Row 2: Row Row 3:",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" PROBLEM\" Row 6: \" Row 7: \" Row 8: \"Shifts\" Row 9: \"Desiderabile\" Row 10: \"Raw 11: \"Whoo\" 12: \"Faces\" row 13: \"Buildables\") Row 14: \"Row 15: \"Now 16: QUALITY OF TESTS\" Row 17: \"Downloaded\"",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: the the surgery? Row 4:",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading <Fatsibility> (column 7)",
      "text": "Row 1: Row 2: JU Row 3:",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading <Fatsibility> (column 8)",
      "text": "Row 1: Row 2: UDIZI Row 3:",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading <Fatsibility> (column 10)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" row 7: \" Row 8: \" ' Row 9: \" \" Row 10: \" - Row 11: \" Now 12: \" Route 13: \"\" Row 14: \" Right 15: \"",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading <Fatsibility> (column 11)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15:",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading <Fatsibility> (column 13)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading <Fatsibility> (column 13)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Don't know\" Row 5: \"Dn't so\" Row 6: \"Do not know\" row 7: \"stud stud io\" Row 8: \"Raw 9: \"",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading <JUDIZI>",
      "text": "Row 1: - Row 2: - GIUDIZI-Row 3: - \"Row 4: - \"incl. use\" - Row 5: - \" Row 6: \" Row 7: \"or or variability\" - \"or or variation\" - variable variable - \"or or variability\") - Row 8: \"Raw 9: \"Row 10: \"confr confr onto\" -\"\"of of comparison\" - or or \"interversv interversv ento\"",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading <JUDIZI> (column 1)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: EQUITA Row 12: Row 13: Row 14: Row Row 15: Row 16: Row 17: NOW NOW 18:",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading <JUDIZI> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \" Right 12: \" Now 13: \" Route 14: \" [ Row 15: \"] Row 16: \" # Row 17: \"\" Row 18: \" Rule 19: \") Row 20: \" * Row 21: \" = Row 22: \" Roll 23: \"",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading <JUDIZI> (column 2)",
      "text": "Row 1: LI Row 2:",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading <JUDIZI> (column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading <JUDIZI> (column 3)",
      "text": "Row 1: Row 2: G Row 3: Row 4: Row 5: Row Row 6: of of comparison",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading <JUDIZI> (column 3)",
      "text": "Row 1: Row Row 2: Row Row 3: Probably not",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading <JUDIZI> (column 4)",
      "text": "Row 1: Row 2: JUDICES Row 3:",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading <JUDIZI> (column 5)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" row 8: \" ' Row 9: \" \" Row 10: \" the the wind\"",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading <JUDIZI> (column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6:",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading <JUDIZI> (column 6)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Incl. use \" Row 5: \" Row 6: \" \" Row 7: \" ' Row 8: \" row 9: \" Row 10: \"\" Not so \" Row 11: \"Varia\" \"know know \" Row 12: \" Varia\" Do not \" Row 13: \" Now 14: \") Row 15: \"Miscellaneous\" \"Non \" Row 16: \" Right 17: \"",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: intervention intervention -++ operation operation -+-+ intervention intervention --++intervention intervention X",
      "start_page": 484,
      "end_page": 484
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: • Row 2: • Recommendation • row 3: •",
      "start_page": 484,
      "end_page": 484
    },
    {
      "heading": "heading heading <Recommendation> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Recommendation",
      "start_page": 484,
      "end_page": 484
    },
    {
      "heading": "heading heading <Recommendation> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \"",
      "start_page": 484,
      "end_page": 484
    },
    {
      "heading": "heading heading <QUESITO 42>",
      "text": "== Demographic evolution ====References==",
      "start_page": 485,
      "end_page": 485
    },
    {
      "heading": "heading heading <QUESITO 42> (from previous page)",
      "text": "Row 1: \"Row\" 1: \"Certainty assessment\" patients patients \"Effect\" = \"Corporate effect\" = *Important Row 3: \"Rown 4: \" Row 5: studies studies \"study study \"Distortion risk\" = results results \"generalization generalization \"Immediacy \" Other considerations \"cycles cycles \"QL\" QL-QL-Initially, 175 (87%) arm arm (and and ethoposide) and 179 (89%) arm arm (36 36 - no arm - QL). arm arm (mostly <10 points) 21. 21.",
      "start_page": 486,
      "end_page": 486
    },
    {
      "heading": "heading heading <QUESITO 42> (column column 1)",
      "text": "Row 1: \"Row 2: Certainty assessment\" Row 3: \" Row 4: \" Row 5: the the studies\" study study \"Risk of distortion\" results results \"Row Row 6: \"Raw 7: 1 1,2\" randomized studies \"Serium a non-important\" Row 8: \"Any discontinuation\" Row 9: 1 1\" randomised studies \"No important\" Row 10: Any interruption (of of treatment) \" Row 11: 2, 2,\" \"studies randomised\" \"No significant\" Row 14: Toxic death (treatment related deaths) Row 15: 1-1\" randomised study \"No major\"",
      "start_page": 486,
      "end_page": 486
    },
    {
      "heading": "heading heading <QUESITO 42> (column column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Imprecision Row 6: \" Row 7: \"Row Row 8: \" row 9: \" Row Row 10: \" Row 11: \" Row Row 12: \" maintenance \" Row 13: \" d d \" Row 14: \" \" Row 15: \"",
      "start_page": 486,
      "end_page": 486
    },
    {
      "heading": "heading heading <QUESITO 42> (column column 3)",
      "text": "Row 1: • Row 2: •patients patients •Effect •Certo Row 3: •Row 4: •row 5: Further considerations •and and •with with • treatment treatment •chemotherapy •Relative (95% CI) • Absolute (95% CI), • row 6: • Initially, 175 (87%) arm arm (and and ethoposide) and 179 (89%) arm arm (and and etoposide) 176 176 (88%) patients in week-assessments assessments • week-upper week-upper week-patients patients (48).",
      "start_page": 486,
      "end_page": 486
    },
    {
      "heading": "heading heading <QUESITO 42> (column column 3)",
      "text": "Row 1: 124/201 (61.7%) = 142/202 (70.3%) = 88 88 (1. 1.01) = 100 100 (1 1 more)",
      "start_page": 486,
      "end_page": 486
    },
    {
      "heading": "heading heading <QUESITO 42> (column column 3)",
      "text": "Row 1: 21/155 (13.5%) willows5/163 (3.1%) 42 42 (11. 11.42) + 100 (32 32 plus)",
      "start_page": 486,
      "end_page": 486
    },
    {
      "heading": "heading heading <QUESITO 42> (column column 3)",
      "text": "Row 1: 8/155 (5.2%) .22/163 (1.2%) •21 21 (19. 19.50) •100 100 (23 23 more)",
      "start_page": 486,
      "end_page": 486
    },
    {
      "heading": "heading heading <QUESITO 42> (column column 3)",
      "text": "Row 1: 3/198 (1.5%) ?3/196 (1.5%) •99 99 (4. 4.84) •100 100 (6 6 plus)",
      "start_page": 486,
      "end_page": 486
    },
    {
      "heading": "heading heading <QUESITO 42> (column column 4)",
      "text": "Row 1: \"Row 2: \"Importance Row 3: \"CRITIC Row 4: \" Row 5: \"IMPORTANT Row 6: \" Row 7: \"Immportant Row 8: \" Row 9: \" IMPORTANT Row 10: \" - Row 11: \" CRITIC \"",
      "start_page": 486,
      "end_page": 486
    },
    {
      "heading": "heading heading <Explanations>",
      "text": "== Demographic evolution ====References==",
      "start_page": 487,
      "end_page": 487
    },
    {
      "heading": "heading heading <Explanations> (column 1)",
      "text": "45. 45.",
      "start_page": 487,
      "end_page": 487
    },
    {
      "heading": "heading heading <Explanations> (column 2)",
      "text": "Row 1: Row 2: nza Row 3:",
      "start_page": 487,
      "end_page": 487
    },
    {
      "heading": "heading heading <BACKGROUND:>",
      "text": "== Demographic evolution ====References==",
      "start_page": 489,
      "end_page": 489
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: \"Row 2: \"Problem\" = Row 3: \"a a priority?\" = Row 4: \"Raw 5: \"JUDIZI\" = ADDING ADDING TESTS\" = row 6: \"No\" = probably not \" Probably no\" = X \"Varia\" = \"Non so\" = * Row 7: \"Now 8: \"Desirable effects\" = # Row 9: \"effects effects expected?",
      "start_page": 490,
      "end_page": 490
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: \"Row 2: \"The Row 3: \" a a priority? Row 4: \"",
      "start_page": 490,
      "end_page": 490
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: • Row 2: • Row Row 3: • Row Row 4: •",
      "start_page": 490,
      "end_page": 490
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 490,
      "end_page": 490
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Row 2: i Row 3: Row Row 4:",
      "start_page": 490,
      "end_page": 490
    },
    {
      "heading": "heading heading <Problem> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: desirable \" Row 4: \"",
      "start_page": 490,
      "end_page": 490
    },
    {
      "heading": "heading heading <Problem> (column 4)",
      "text": "Row 1: Row 2: Row 3: the expected? Row 4:",
      "start_page": 490,
      "end_page": 490
    },
    {
      "heading": "heading heading <Problem> (column 17)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 490,
      "end_page": 490
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: ...Absolute Absolute Effect* Comments Comments (95% CI) Participants Participants (95% (Studies) (GRADE) CI) 403 403 - follow-up: 0.70 (1 RCT)100 100 (month month (44 a 63) 0.91) 403 403 + 77 77 (1 RTC) 100 100 (a a (82 a 93) 0.96) Study Population",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "== Demographic evolution ====References==",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row 2: Relative Row 3: (95% Row 4: CI)",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: participants (studies)",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Certainty Row 2: of Row 3: (GRADE)",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Chemotherapy",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: Exits\"",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "==See also==*Row==References===External links==",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: \"Row\" 2: \"pros pros (GRADE) \"Creative Row 3: \"Nti\" Row Row 4: \"GRADE\"",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: \"Row\" 2: a \"C Row\" 3: where \"Raw\" 4: \") \"",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row 2: Comme Row 3:",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: Row 2: entities",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: •100 100 (format from (51 to 70) 403 403 • (answers answers (1 RCT) 1. 1.09) and partial responses) 175 175 (87%) patients - (1 RTC) 1.2 • (_MEDTERM2_) (QoL) evaluated evaluated with: (179 179 (89%) arm arm (and and ethoposide) Core 30 (QLQ- C30 C30 visits) 176 176 (88%) and 168 (83%), cancer. cancer.",
      "start_page": 492,
      "end_page": 492
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 492,
      "end_page": 492
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (51 to 70)",
      "start_page": 492,
      "end_page": 492
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "==See also==*Row==References===External links==",
      "start_page": 492,
      "end_page": 492
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: \"arm arm (mostly <10 points) 403 403 - \"discontinuation\" (a a (1 RCT) 1. 1.01) 100 100 (53 a 71) 318 318 - \"Discontinuion\" (1 Rct) VERY VERY (11. 11.42) to to (5 a 35) treatment discontinuation) 318 318 - discontinuation (a a (1 RTT) MOLTO MOLTO (19. 19.50) to to (1 a 24) treatment suspension) - Study Study population",
      "start_page": 493,
      "end_page": 493
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 493,
      "end_page": 493
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (5 to 35)",
      "start_page": 493,
      "end_page": 493
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (1 to 24)",
      "start_page": 493,
      "end_page": 493
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: \"Row\" 2: \"the the \"Raw\" 3: \"control control arm\" \"Rop\" 4: \"Mostly <10 points\" \" Row 5: \"the the \"row\" 6: \"Week 21.\"\" Row 7: \"Rw 8: \"88 88 (1. 1.01) Row 9: \"Study population\" \"Row 10: \"Now 11: \"Wow 12: \"70\" for 100\" Row 13: \"53 to 71) \" Row 14: \"===Row 15: \"ROW\" 4.42 (11. 11.42) Row 16: \"population population \"Rown 17: \"How to study\" Row 18: \" Row 19: \"3\" for \"100\"100 100 (five to 35) Row 20: \" Row 21: \" ROW\" (19. 19.50) Row 22: \"Stand population\" [Row 19: 3 for \"R.\"",
      "start_page": 493,
      "end_page": 493
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: (Toxic death) 394 394 - (a a (1 RCT) 1, 1,32) 100 100 (16 a 32) 15 15 394",
      "start_page": 494,
      "end_page": 494
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Toxic death (treatment-related deaths) 99 99 -0.20 - 4,84 - 1 RCT - b. b.",
      "start_page": 494,
      "end_page": 494
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (0 to 7)",
      "start_page": 494,
      "end_page": 494
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (9 to 22)",
      "start_page": 494,
      "end_page": 494
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (17 to 42)",
      "start_page": 494,
      "end_page": 494
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: Toxic death (treatment-related deaths) Row 2:",
      "start_page": 494,
      "end_page": 494
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: •99 99 (4. 4.84) Row 2: • Row 3: • row 4: •Row 5: • • 93 93 (1. 1.42) Row 6: ♪ Row 7: Row Row 8: Â â \" Row 9: ■ Row 10: @ Row 11: ¶ Row 12: ‐15 15 (1. 1.92) Row 13: · Row 14: − Row 15: ¢ Row 16: ^ Row 17: Ã Â\" Row 18: ¬ Row 19: ?84 84 (1. 1.33) Row 20: \\ Row 21: } Row 22: □ Row 23: · Row 24: ► Row 25: {Row 26: *80 80 (2. 2.83) Row 27:",
      "start_page": 494,
      "end_page": 494
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 495,
      "end_page": 495
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 495,
      "end_page": 495
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: ndesid Row 3: Row Row 4:",
      "start_page": 495,
      "end_page": 495
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: Derabi Row 3: Row Row 4:",
      "start_page": 495,
      "end_page": 495
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: ii Row 3: Row Row 4:",
      "start_page": 495,
      "end_page": 495
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "==References===External links==* Official website",
      "start_page": 495,
      "end_page": 495
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 495,
      "end_page": 495
    },
    {
      "heading": "heading heading <Problem> (column column 7)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 495,
      "end_page": 495
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: • Large • Small Small • Irrelevant • Variant • Not so •early early effect* Comments Comments (95% CI) Participants Participants (95% (Studies) (GRADE) CI) and and •403 403 • Follow-up: 0.70 (1 RCT)9 9 (0. 0.91) (44 to 63) 403 403 - 77 77 (1 RTC) 1 MODERATAa (0. 0.96) (82 to 93)",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==See also==*Row==References===External links==",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row 2: Relative Row 3: (95% Row 4: CI)",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: participants (studies)",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Certainty Row 2: of Row 3: (GRADE)",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Chemotherapy",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "==See also==*Row==References===External links==",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: \"Row\" 2: \"the the tests\" (GRADE) \"Creative Row 3: Trials Row 4: \"GRADE\"",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading <Problem> (column column 7)",
      "text": "Row 1: \"Row 2: \"Comm\" Comm Row 3: and \"Raw 4: \"",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading <Problem> (column column 8)",
      "text": "Row 1: Row 2: Minds",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: •403 403 • (to to (1 RCT) 1. 1.09) Partial Partial Responses) (51 to 70) 175 175 (87%) patients - (1 RTC) 1.2 (_MEDTERM2_) (QoL) evaluated evaluated with: (and and Etoposide) and 179 (89%) arm arm (and and ethoposide) Core 30 (QLQ- C30 C30 visits) 176 176 (88%) and 168 (83%), cancer. cancer.",
      "start_page": 497,
      "end_page": 497
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 497,
      "end_page": 497
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "==See also==*Row==References===Further reading==External links==",
      "start_page": 497,
      "end_page": 497
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: arm arm (mostly <10 points) 403 403 - discontinuation (a a (1 RCT) 1. 1.01) 100 100 (53 a 71) 318 318 - breakdown (a a (1RCT) VERY VERY (11. 11.42) to to (5 a 35) discontinuation of treatment) 318 318 - discontinuance (a a (1 RTT) MUCH MUCH (19. 19.50) to to (1 a 24) interruption of treatment). - Study Study population",
      "start_page": 498,
      "end_page": 498
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==See also==*Row==References===External links==",
      "start_page": 498,
      "end_page": 498
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (5 to 35)",
      "start_page": 498,
      "end_page": 498
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (1 to 24)",
      "start_page": 498,
      "end_page": 498
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: \"Row 5\": \"control control arm\" = \"Raw 6\" (mostly <10 points) \" Row 7: \"row row 8: \"Week 21. \" Row 9: \"Rw 10: \"88 88 \" (1. 1.01) \" Row 11: \"Study population\" = [Row 12: \" Row 13: \"] Row 14: \" 100 100 \"RW 15: \"[53 to 71] \" Row 16: \"==Row 17: \"ROW 2\" (11. 11.42) Row 18: \"Population in study\" =",
      "start_page": 498,
      "end_page": 498
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: (Toxic death) 394 394 - (a a (1 RCT) 1, 1,32) 100 100 (16 a 32) 15 15 394",
      "start_page": 499,
      "end_page": 499
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Toxic death (treatment-related deaths) 99 99 -0.20 - 4,84 - 1 RCT - b. b.",
      "start_page": 499,
      "end_page": 499
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (0 to 7)",
      "start_page": 499,
      "end_page": 499
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (9 to 22)",
      "start_page": 499,
      "end_page": 499
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (17 to 42)",
      "start_page": 499,
      "end_page": 499
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: Toxic death (treatment-related deaths) Row 2:",
      "start_page": 499,
      "end_page": 499
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: •99 99 (4. 4.84) Row 2: • Row 3: • row 4: •Row 5: • • 93 93 (1. 1.42) Row 6: ♪ Row 7: Row Row 8: Â â \" Row 9: ■ Row 10: @ Row 11: ¶ Row 12: ‐15 15 (1. 1.92) Row 13: · Row 14: − Row 15: ¢ Row 16: ^ Row 17: Ã Â\" Row 18: ¬ Row 19: ?84 84 (1. 1.33) Row 20: \\ Row 21: } Row 22: □ Row 23: · Row 24: ► Row 25: {Row 26: *80 80 (2. 2.83) Row 27:",
      "start_page": 499,
      "end_page": 499
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 500,
      "end_page": 500
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2\": \"Row Row 3: \"Row Row 4: \"Row Row 3\"",
      "start_page": 500,
      "end_page": 500
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 500,
      "end_page": 500
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: and Row 3: Row Row 4:",
      "start_page": 500,
      "end_page": 500
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "==References===External links==* Official website",
      "start_page": 500,
      "end_page": 500
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 500,
      "end_page": 500
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 500,
      "end_page": 500
    },
    {
      "heading": "heading heading <Effect balance>",
      "text": "Row 1: \"Very low\" X \"Moderate\" X • High • included included • imprecision imprecision • Row 2: \"Row 3: \"Warnings\" • row 4: \"C\" main main outcomes? • Row 5: ♪ Row 6: \"JUDIZI\" ♪Row 3 ♪ Additional Considerations ♪ row 7: \"variation variation Â\" Â. Â.\" Row Row 8: Â Row 9: â€Row Row 10: ¢or or comparison?",
      "start_page": 501,
      "end_page": 501
    },
    {
      "heading": "heading heading <Budget of effects> (column 1)",
      "text": "Row 1: \"Row\" 2: \"Raw values\" 3: \"C\" Row Row 4: \"C.\"",
      "start_page": 501,
      "end_page": 501
    },
    {
      "heading": "heading heading <Budget of effects> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •",
      "start_page": 501,
      "end_page": 501
    },
    {
      "heading": "heading heading <Budget of effects> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: main main outcomes? \" Row 4: \"",
      "start_page": 501,
      "end_page": 501
    },
    {
      "heading": "heading heading <Budget of effects> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: or or comparison? \" Row 4: \"",
      "start_page": 501,
      "end_page": 501
    },
    {
      "heading": "heading heading <Budget of effects> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 501,
      "end_page": 501
    },
    {
      "heading": "heading heading <Budget of effects> (column 3)",
      "text": "Row 1: Row 2: Row 3: ? Row 4:",
      "start_page": 501,
      "end_page": 501
    },
    {
      "heading": "heading heading <Budget of effects> (column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 501,
      "end_page": 501
    },
    {
      "heading": "heading heading <Acceptability>",
      "text": "==References===External links==*Official website* Official website* http://www.interpol.int/en/notice/search/en_en/index_en.htm",
      "start_page": 502,
      "end_page": 502
    },
    {
      "heading": "heading heading <Acceptability> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •",
      "start_page": 502,
      "end_page": 502
    },
    {
      "heading": "heading heading <Acceptability> (column 1)",
      "text": "Row 1: • Row 2: •Acceptability Row 3: •Row Row 4: •",
      "start_page": 502,
      "end_page": 502
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: uità? \" Row 4: \"",
      "start_page": 502,
      "end_page": 502
    },
    {
      "heading": "heading heading <Acceptability> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: stakeholders? \" Row 4: \"",
      "start_page": 502,
      "end_page": 502
    },
    {
      "heading": "heading heading <Acceptability> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 502,
      "end_page": 502
    },
    {
      "heading": "heading heading <Acceptability> (column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 502,
      "end_page": 502
    },
    {
      "heading": "heading heading <Fatsibility>",
      "text": "Row 1: X Si • Varia • Non so • Row 2: • row 3: •necessity •Row 4: •the the intervention? •row 5: ♪ Row 6: JUDICES •TESTS TESTS •Now 7: •No • Probably no •X X •Vary •I don't know • found found •",
      "start_page": 503,
      "end_page": 503
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •Now 4:",
      "start_page": 503,
      "end_page": 503
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 503,
      "end_page": 503
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: ell'interve Row 4:",
      "start_page": 503,
      "end_page": 503
    },
    {
      "heading": "heading heading <Fatsibility> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: ento\"? \"Raw 4: \"",
      "start_page": 503,
      "end_page": 503
    },
    {
      "heading": "heading heading <Fatsibility> (column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 503,
      "end_page": 503
    },
    {
      "heading": "heading heading <Fatsibility> (column 15)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 503,
      "end_page": 503
    },
    {
      "heading": "heading heading <JUDIZI>",
      "text": "==References===External links==* Official website",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "heading heading <JUDIZI> (column 1)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" PROBLEM\" Row 6: \" Row 7: \" Row 8: \"Desiderable Effects\" Row 9: \"Rop 10: \"Row 11: \"Residency\" Row 12: \"Wow 13: \" row 14: \"Quality of Evidence\" Row 15: \"Now 16: \"Dow 17: \"Hearts\" Row 18: \"row 19: \" Now 20: \"Side Side Effects\" row 21: \"Short 22: \"ROW 23: EQUITA\" Row 24: \"New 25: \"The Right 26: ACCEPTABILITY\" Row 27: \"- Row 28: \" NOW 29: FACTIBILITY\" Row 30: \"",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "heading heading <JUDIZI> (column 2)",
      "text": "Row 1: \"Row 2: JUDICES\" Row 3: \"Rop 4: \"Probably no\" Featured: \"Si Row 5\": \"Little\" Moderators \"Moderates\" Row 6: \"Mode\" = \"Small\" = row 7: \"Low\" = moderate \"High Row 8: \"or or variability\" = variation variation \"Row Row 9: \"of of comparison\" = intervention intervention \"Row Row 10: \"probably reduces equity\" = equity equity \"Row Row 11: \"Perhaps not\"",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "heading heading <JUDIZI> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18:",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "heading heading <JUDIZI> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6:",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "heading heading <JUDIZI> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\" Row 17: \" Raw 18: \"",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "heading heading <JUDIZI> (column 5)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "heading heading <JUDIZI> (column 5)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \"",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "heading heading <JUDIZI> (column 6)",
      "text": "Row 1: \"Row 2: \" Row 3: \"",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: intervention intervention -++ operation operation -+-+ intervention intervention --++intervention intervention X",
      "start_page": 505,
      "end_page": 505
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: • Row 2: • Recommendation • row 3: •",
      "start_page": 505,
      "end_page": 505
    },
    {
      "heading": "heading heading <QUESITO 43>",
      "text": "== Demographic evolution ====References==",
      "start_page": 506,
      "end_page": 506
    },
    {
      "heading": "heading heading <QUESITO 43> (column 1)",
      "text": "== Demographic evolution ====References==",
      "start_page": 506,
      "end_page": 506
    },
    {
      "heading": "heading heading <QUESITO 43> (column 2)",
      "text": "Row 1: \"Row 2: \"Importation Row 3: \" Row 4: \" Row 5: \" Row 6: \" CRITIC Row 7: \" Row 8: \" \" Row 9: \"CRITIC Row 10: \" row 11: \" ' Row 12: \" CRITIC Row 13: \" Route 14: \" - \" Row 15: \" Criticic Row 16: \"\" Row 17: \"",
      "start_page": 506,
      "end_page": 506
    },
    {
      "heading": "heading heading <References>",
      "text": "Row 1: ...Row 5: studies studies ...study study .... ...Distortion risk ... ..... ...generalization generalization ... ... ...Important ... ...More considerations ... ..._Durvalumab + ethoposide ethoposide ... ...non-important ....?..",
      "start_page": 507,
      "end_page": 507
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: Should durvalumab + platinum- disease disease • Row 2: ♪ Row 3: POPULATION: ♪ from from ♪illness illness • row 4: ♪ row 5: INTERVENTION: •medTERM1_ • + Row Row 6: @medterm4_; AE any grade; AE grade <3; to to discontinuation; Row 10: □ Row 11: SETTING: Inpatients Row 12:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: \"Row 2: a a priority? \" Row 3: \" Row 4: \" JUDICES\" \"EVIDENCE EVIDENCE TESTS\" \"CONSIDERATIONS\" Row 5: \"No\" \"Probably not \"Yes\" ● \"Varia\" \"I don'out. out.\"",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: Row Row 2: Row Row 3: Row 4: POPULATION: Row 5: Row 6: INTERVENTION: Row 7: Row 8: COMPARISON: Row 9: Row 10: MAIN EXITS: Row 11: Row 12: WEEK: Row 13: Row 14: PROSPECT: Row 15: Row 16: BACKGROUND: Row 17: Row 18: Row Row 19:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: Row 2: Row Row 3: priority:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: durvalumab + Row Row 2: extended extended disease",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Row 2: Row 3: Tà? Row 4:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading <Problem> (column 3)",
      "text": "Row 1: Row Otherapes 2: Row 3:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading <Problem> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading <Problem> (column 4)",
      "text": "Row 1: Row Row 2: Row 3:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading <Problem> (column 5)",
      "text": "Row 1: Platinum Row 2: Row 3:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading <Problem> (column 6)",
      "text": "Row 1: Row Row 2: Row 3:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading <Problem> (column 7)",
      "text": "Row 1: Row Row 2: Row 3:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading <Problem> (column 8)",
      "text": "Row 1: Row Row 2:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading <Problem> (column 8)",
      "text": "Row 1: Row 2: Row 3:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: \"Row 2\": \"Exits\" Precipitated absolute effect* \"Related effect (95% CI) \"participants participants (studies) \"tests tests (GRADE) \"Comments Row 3: \"95% CI\" \"Rown 4: \"Raw 5: \"Ruy 6\" \"the the \"Rw 7\" \": \"Sola\" \"_MEDTERM0__ + \"Roh 8\" \"Chemotherapy\" \"chemotherapy \"RW 9: \"with platinum\" and \"Motium\" \"Now 10: \"Etoposide\" \"Ethoposide\" \"Row 11: \"Overall survival\" follow up: months months \"75 75 (0. 0.91) \"537\" (1 RCT) \" ALTA\" \"__MEDTERMM0_ _ + Row Row 13: \"Population in study\"",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row 2: Relative Row 3: (95% Row 4: CI)",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: participants (studies)",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Certainty Row 2: of Row 3: (GRADE)",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (70 to 83)",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: Esider Row 3: Row Row 4:",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: Row 3: desirable effects expected? Row 4:",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 510,
      "end_page": 510
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: survival survival follow-up: 1 1 months",
      "start_page": 510,
      "end_page": 510
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (79 to 89)",
      "start_page": 510,
      "end_page": 510
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (60 to 77)",
      "start_page": 510,
      "end_page": 510
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: survival survival follow-up: months months •80 80 (0. 0.96) •537 (1 RCT) 1 • MODERATAa Row 2: • Studio population • Row 3: • row 4: •row 5: • 100 100 •100 100 (79 to 89) • rows 6: ♪ Row 7: ORR follow up: median",
      "start_page": 510,
      "end_page": 510
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==See also==*America==References===Further reading==out. out. ==External links==",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: \"Row 2: Exits\" Precipitated absolute effect* \"Related effect (95% CI) \"participants participants (studies) \"tests tests (GRADE) \"Commentaries Row 3: \"95% CI\" \"Raw 4: \" Row 5\": \"Ruy 6\" \"chemotherapy chemotherapy alone\" \"Row 7\" \": \"_MEDTERM0___\" Row 8: \"+\" Row 9: \"chemotherapy\" \"ROW 10: \"Platinous and Ethoposide\" \"Now 11: \"Etoposite\" \"row 12: \"4\" Row 13: \"followed followed up: months months \"RR 11.01\" (1. 1.04) \"531\" (1 RCT) \"MODERATAa\" \"__MEDTERMM0__ + Row Row 14: \"Population in study\" (Row 15) \"1 \"Right\" for 18: \"10 \"5\" -8 \"Rown: 16\" -15 \"Rlow: \" -8 -8\" - 16 \" - 10 - 10 \" - 8 - 8\" - 100,000 - 10-10 - 10",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row 2: Relative Row 3: (95% Row 4: CI)",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: participants (studies)",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Certainty Row 2: of Row 3: (GRADE)",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row Row 5: etoposide",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (95 to 100)",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: ndesid Row 3: Row Row 4:",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: Derabi Row 3: Row Row 4:",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: ii Row 3: expected undesirable effects? Row 4:",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Rowter 1: \"grade grade <=follow follow up: 0.99 (1 RCT) 1 + 100 100 (months months (57 to 73) 1,12) 531 531 → 08 08 (1 RTC) 1+ MODERATAa follow-up: 100 100 (1 1 (6 to 17) 1,82) probably probably don'W. W., Dvorkin, M., N. N., K., Trukhin, D., Statsenko, G., Hochmair, M",
      "start_page": 512,
      "end_page": 512
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: \"any degree.\" Row 2: \"Row\" 3: \"Raw 4: AE grade\" <3 follow-up: months months \"99 99 (1. 1.12) \"531\" (1 RCT) 1\" \"MODERATAa\" = \"MEDTERM0__ + and and ethoposis\" Row Row 5: \"Study population\" =",
      "start_page": 512,
      "end_page": 512
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (57 to 73)",
      "start_page": 512,
      "end_page": 512
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (6 to 17)",
      "start_page": 512,
      "end_page": 512
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: AE grade <3 follow-up: months months \"99 99 (1. 1.12) \" Row Row 5: \" Study population \" Row 6: \" Row 7: \" row 8: \" ' Row 8: '100 100 \" 100 100 (57 to 73) \" Row 9: \"",
      "start_page": 512,
      "end_page": 512
    },
    {
      "heading": "heading heading <Valori>",
      "text": "Row 1: \"Lancet Lancet Oncol; ow ow 2:",
      "start_page": 513,
      "end_page": 513
    },
    {
      "heading": "heading heading <Valori> (column 1)",
      "text": "Row 1: \"Row 2: \" Row 3: \"the the tests\" [Row 4: \"safety safety tests?\"] Row 5: \"Raw 6: \"JUDIZI\" Row 7: \"Very low\" ● \"Made-up\" - \"High\" - in in \"Rw 8\": \" Row 9: \"Valori\" Row 10: \"C\" main main outcomes? \" Row 11: \"Row 12: JUDICES\" Row 13: \"or or variable\" - variation variation ● or or variability",
      "start_page": 513,
      "end_page": 513
    },
    {
      "heading": "heading heading <Valori> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 513,
      "end_page": 513
    },
    {
      "heading": "heading heading <Valori> (column 5)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 513,
      "end_page": 513
    },
    {
      "heading": "heading heading <Equity>",
      "text": "or or comparison?",
      "start_page": 514,
      "end_page": 514
    },
    {
      "heading": "heading heading <Equity> (column 1)",
      "text": "Row 1: \"Row\" 2: \"Budget of effects\" = \"Raw 3: \"undesirable undesirable effects\" * Row 4: \" Row 5: JUDIZI\" = 6: \"He'of of comparison\" = 7: \"Right 8: \"Equity\" = 9: \"of of equity?\" = 10: \"Row 11: \"Judizi\" = 12: \"Reduce equity\" = 8: ...\"Equities\" = 5: \"on on equity?",
      "start_page": 514,
      "end_page": 514
    },
    {
      "heading": "heading heading <Equity> (column 2)",
      "text": "Row 1: Row 2: Row 3: or or comparison? Row 4:",
      "start_page": 514,
      "end_page": 514
    },
    {
      "heading": "heading heading <Equity> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 514,
      "end_page": 514
    },
    {
      "heading": "heading heading <Equity> (column 8)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 514,
      "end_page": 514
    },
    {
      "heading": "heading heading <Fatsibility>",
      "text": "Row 1: \"Row\" 2: \"Acceptibility\" \"Rop 3: \"main main stakeholders?\" \"Raw 4: \"Roo 5: \"JUDICI\" \"EVIDENCE EVIDENCE TESTS\" \"ADDENTIONS\" \"ROW 6: \"No\" \"Probably no\" \"You\" ● \"Yes,\" \"Vary,\" \"I don't know,\" \"found. found. \"filled. filled.\" \"Ruh 7: \"Roh 8: \"Fatsibility\" \"Row 9: \"the the intervention\" \"Now 10: \"Needle\" \"Not known.\"",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Acceptability Row 3: •Row Row 4: •",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •Now 4:",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \"Ell\" intervention? \" Row 4: \"",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading <Fatsibility> (column 4)",
      "text": "Row 1: Row 2: Row 3: ders? Row 4:",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading <Fatsibility> (column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading <Fatsibility> (column 13)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading <Fatsibility> (from previous page)",
      "text": "== Demographic evolution ====References==",
      "start_page": 516,
      "end_page": 516
    },
    {
      "heading": "heading heading <Fatsibility> (column column 1)",
      "text": "Row 1: Row 2: PROBLEM Row 3: Row 4: Row 5: Row Row 6: Row 7: Row 8: Row Row 9: Row 10: Row 11: Row Row 12: Row 13: Row 14: VALUES Row 15: Row 16: Row 17: Row Row 18: Row 19: Row 20: EQUITA Row 21: Row 22: Row 23: ACCEPTABILITY Row 24: Row 25: Row 26: FACTIVITY Row 27:",
      "start_page": 516,
      "end_page": 516
    },
    {
      "heading": "heading heading <Fatsibility> (column column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \"row 12: \" Route 13: \" Now 14: \" Right 15: \" [ Row 16: \"] Row 17: \" # Row 18: \"\" Row 19: \" Rule 20: \") Row 21: \" * Row 22: \"",
      "start_page": 516,
      "end_page": 516
    },
    {
      "heading": "heading heading <Fatsibility> (column column 2)",
      "text": "Row 1: Row 2:",
      "start_page": 516,
      "end_page": 516
    },
    {
      "heading": "heading heading <Fatsibility> (column column 3)",
      "text": "Row 1: Row 2: JUDICES Row 3:",
      "start_page": 516,
      "end_page": 516
    },
    {
      "heading": "heading heading <Fatsibility> (column column 3)",
      "text": "Row 1: Probably no\"Row Row 2: Small\"Moderate Row 3: Moderate\"Small Row 4: Low\"Miderate Row 5: or or variableity\"Row Row 6: the the comparison\"Row Row 7: PROBABLY REDUCED",
      "start_page": 516,
      "end_page": 516
    },
    {
      "heading": "heading heading <Fatsibility> (column column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" Row 7: \" \" Row 8: \" ' Row 9: \" row 10: \" - Row 11: \"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\" Row 17: \" Raw 18: \"",
      "start_page": 516,
      "end_page": 516
    },
    {
      "heading": "heading heading <Fatsibility> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6:",
      "start_page": 516,
      "end_page": 516
    },
    {
      "heading": "heading heading <Fatsibility> (column column 6)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"Don't know\" Row 5: \"Done't known\" Row 6: \"Do't knows\" Row 7: \"No included studies\" Row 8: \"Raw 9: \"Now\" 10: \"Row 11: \" Row 12: \"Wow\" 13: \" Don't Know\" Row 14: \"don't really know\" row 15: \" don't knowing\" Row 16: \"Soon't knowledge\"",
      "start_page": 516,
      "end_page": 516
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: intervention intervention • • operation operation • surgery surgery • Row 2: • Row Row 3: • Row Row 4: • row 5: ● Row 6: •",
      "start_page": 517,
      "end_page": 517
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: • Row 2: • Recommendation • row 3: •",
      "start_page": 517,
      "end_page": 517
    },
    {
      "heading": "heading heading <Quality of life>",
      "text": "==References===External links==* Official website",
      "start_page": 518,
      "end_page": 518
    },
    {
      "heading": "heading heading <Explanations>",
      "text": "Row 1: \"Row\" 2: \"Rop\" 3: \"Impered Cognitive Function\" (neurological damage) - AEs AEs - not reported \"Raw\" 7: \"Rw\" 8: \"-\"-\"‐\"-\"\"-\"-\"-\"-\"-\"\"\"-\"\"CRITICAL Row 9: \"Fatigue and Lethargy\" (any grade) \" Row 10: \"\" Row 11: \"\"\"observational studies \"l\" not serious\" \"not serious\" (from 52 more) \"serious\" \"m\"none\"52/386 (1.5%) \"16/570\" (2.8%) \"92 92 (8. 8.44) \"000 000 (209 209 more)",
      "start_page": 519,
      "end_page": 519
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: • Row 2: POPULATION: • row 3: •row 4: INTERVENTION: ♪ brain brain (PCI) Row 5: â ¢ Row 6: CONFRONT: Â\"Row 7: ■ Row 8: Main outcomes: − progression-free survival; overall survival; brain progression- free survival; quality of life; neurocognitive impairment (neurological damage); to to 3; Row Row 9: · Row 10: SETTING: ‐Ambulatorial Row 11: · Row 12: PROSPECTIVA: ¶ Row 13: ^ Row 14: BACKGROUND: ♫encephalus encephalus (PCI) treatment. treatment.",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading <Problem>",
      "text": "Row 1: • Row 2: a a priority? •row 3: • row 4: JUDICES • TESTS TESTS •Row 5: • no • Probably no ♪ X X • Vary • I don't know •",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: Row 2: POPULATION: Row 3: Row 4: INTERVENTION: Row 5: Row 6: COMPARISON: Row 7: Row 8: MAIN EXITS: Row 9: Row 10: Row 11: SETTING: Row 12: Row 13: PROSPECTIVE: Row 14: Row 15: BACKGROUND: Row 16: Row 17: Row 18: Row Row 19:",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading <Problem> (column 1)",
      "text": "Row 1: Row 2: Row Row 3: priority:",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \" row 7: \" Row 8: \"",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" Row 6: \"",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \"",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading <Problem> (column 2)",
      "text": "Row 1: Row 2: Row 3: à? Row 4:",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading <Problem> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading <Problem> (column 4)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" ADDITIONAL CONSIDERATIONS \" Row 6: \"",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: • Row 2: • Desirable effects • row 3: • desirable desirable effects? • Low 4: • Raw 5: JUDICES • TESTS TESTS •Row 6: • Irrelevant • Small • Large Large • Variano • Not known •Outcomes • Anticipated absolute effects* • (95% CI) • irradiation irradiation (95% (studies) brain brain • CI) (GRADE) (PCI) Brain metastases - - -- - free survival - survival survival • 7395 7395 • (to to (0. 0.66)) observational • (7 to 8) studies)a, b.",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Relative Row 2: effect Row 3: (95% Row 4: CI)",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: participants Row 3: (studies)",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Certainty Row 2: Row Row 3: evidence Row 4: (GRADE)",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: irradiation",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (7 to 8) b",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2:",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "Row 1: \"Row 2: \"Row Row 3: \"Row Row 4: \"",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading <Problem> (column column 2)",
      "text": "Row 1: Row 2: Everish Row 3: Everlasting Row 4:",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading <Problem> (column column 3)",
      "text": "Row 1: Row 2: Skillful Row 3: Row Row 4:",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "Row 1: Row 2: Row 3: desirable tti expected? Row 4:",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading <Problem> (column column 4)",
      "text": "==References===External links==* Official website",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading <Problem> (column column 5)",
      "text": "Row 1: \"Row\" 2: \"the the evidence\" (GRADE) Row 3: \"ts\" Row 4: \"Rown\" 5: \"Raw\" 6: \"VERY LOWc,\" \"d,\" \"f Row\" 7: \"Very Lowc, \"h,\" \"i Row 8: \"Highk Row\" 9: \"-",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading <Problem> (column column 6)",
      "text": "Row 1: Row 2: Commen Row 3:",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading <Problem> (column column 7)",
      "text": "Row 1: Row 2: nts",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading <Problem> (column column 9)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 522,
      "end_page": 522
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Function (neurological damage) - not reported",
      "start_page": 522,
      "end_page": 522
    },
    {
      "heading": "heading heading <Problem> (from previous page)",
      "text": "Row 1: Row Row 2: (80 to 237)",
      "start_page": 522,
      "end_page": 522
    },
    {
      "heading": "heading heading <Problem> (column column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 522,
      "end_page": 522
    },
    {
      "heading": "heading heading <PFS:>",
      "text": "Row 1: \"Forest plot: OS: __PFS:\"",
      "start_page": 523,
      "end_page": 523
    },
    {
      "heading": "heading heading <PFS:> (from previous page)",
      "text": "Row 1: \"Fatigue or lethargy\": \"Row 2: \"Rown 3: \"Undesirable effects\" = \"Raw 4: \"effects effects expected? \" Row 5: \"Judici\" 6: \"Created evidence\" * \"ADDATIVE CONSIDERATIONS\" * (95% CI) irradiation irradiation (95% (studies) Encephalus Encephalus CI) (GRADE) (PCI) metastases metastases - - - free survival - 7395 7395 (to to (100 100 066)",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading <PFS:> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading <PFS:> (from previous page)",
      "text": "Row 1: Relative Row 2: effect Row 3: (95% Row 4: CI)",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading <PFS:> (from previous page)",
      "text": "Row 1: Row Row 2: participants Row 3: (studies)",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading <PFS:> (from previous page)",
      "text": "Row 1: Certainty Row 2: Row Row 3: evidence Row 4: (GRADE)",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading <PFS:> (from previous page)",
      "text": "Row 1: Row Row 2: irradiation",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading <PFS:> (from previous page)",
      "text": "Row 1: Row Row 2: (7 to 8) b",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading <PFS:> (column column 1)",
      "text": "Row 1: • Row 2: • Ind Row 3: • Row Row 4: •",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading <PFS:> (column column 2)",
      "text": "Row 1: \"Row 2: Desirable\" Row 3: effects effects expected?",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading <PFS:> (column column 2)",
      "text": "Row 1: \"Row 2: Outcomes\" - Row Row 3: \" Row 4: \" Row 5: \" no no radiation\" - Row Row 6: \"Raw 7: \"Row 8: survival survival - not reported \" Row 9: \"-\"- Row 10: \"Wow 11: \"Overall survival\" - Row 12: \"Row Row 13: \" Row 14: \" Row 15: \"12 per 100b\" - \"Row Row 16: \" row 17: Progression free survival\"",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading <PFS:> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading <PFS:> (column column 3)",
      "text": "Row 1: 'Row 2: solute effects* (95% CI) Row 3: ' Row 4: ' Row 5': one 'Right with l'radiation Row 6': 'Row Row 7': - 'PCI' Row 8: 'Raw 9': • 'Rop 10': 11: 'Row 12: 'Now 13: n' Row 14: ' Row 15: 'Wow 16: '100 100 (7 to 8) 'b'Row Row 17: '[7 to 8] b Row 18: 'Dow 19: 'n' Row 20: n\" Row 21: 'row 22: ' Now 23: 'Row Row 24: 'NAN to NaN) Row 25: '",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading <PFS:> (column column 4)",
      "text": "Row 1: \"Row\" 2: \"Rolative effect (95% CI) \"participant participant (studies) \"Row Row 3: \"Participant Row 4: \"Raw\" 5: \"ne\" (\"Studies\") Row 6: \"halo\" Row 7: \"Rw\" 8: \"Wow\" 9: \"-\" Row 10: \"Row\" 11: \" Row 12: \"HR\" 0.62 (0. 0.66) \" Row 13: \" row 14: \" Row\" 15: \"row\" 16: \"How\" 17: \"The Row 18: \"Rule\" 19: \"TR\" 0.76 (0. 0.89) \" Row 20: \" Now 21: \"Alow\" 22: \"Row Row 23: \"Cow\" 24: \"==References===External links==",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading <PFS:> (column column 5)",
      "text": "Row 1: \"Row 2: \"evidence evidence (GRADE) Row 3: \"ts\" Row 4: \"Rop 5: \"- Row 6: \"Row Row 7: \"",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading <PFS:> (column column 6)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading <PFS:> (column column 6)",
      "text": "Row 1: Row 2: Comments",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading <(80 to 237) studies)l VERY>",
      "text": "Row 1: \"that that \"with with - (1 RCT)j = the quality-93. 93.7% 46. 46.3% groups groups (P = 0.10)\" Impered - - -- - - Cognitive Function (neurologically damage) - 3-5 3-5 - -",
      "start_page": 525,
      "end_page": 525
    },
    {
      "heading": "heading heading <(80 to 237) studies)l VERY>",
      "text": "==References===External links==* Official website",
      "start_page": 525,
      "end_page": 525
    },
    {
      "heading": "heading heading <(80 to 237) studies)l VERY>",
      "text": "Row 1: Row Row 2: (80 to 237)",
      "start_page": 525,
      "end_page": 525
    },
    {
      "heading": "heading heading <(80 to 237) studies)l VERY> (column 1)",
      "text": "Row 1: \"that that \"with with - (1 RCT)j = the quality-93. 93.7% 46. 46.3% groups groups (P = 0.10)\" Impered - - -- - - Cognitive Function (neurologically damage) - 3-5 3-5 - -",
      "start_page": 525,
      "end_page": 525
    },
    {
      "heading": "heading heading <(80 to 237) studies)l VERY> (from previous page)",
      "text": "Row 1: \"the the Newcastle- h. h. I2=64% RCT RCT &amp; Forest Forest plot: OS:",
      "start_page": 526,
      "end_page": 526
    },
    {
      "heading": "heading heading <PFS:>",
      "text": "Row 1: •_MEDTERM0__: Fatigue or lethargy: • Row 2: •Row 3: •tests tests • row 4: •safety safety tests? • Row 5: ♪ Row 6: JUDICES •TESTS TESTS • NOW 7: X • Very low • Moderate • High • included included • indirectness indirectness • •No study included",
      "start_page": 527,
      "end_page": 527
    },
    {
      "heading": "heading heading <PFS:> (column 1)",
      "text": "Row 1: \"Row 2\": \"Row Row 3: \"Row Row 4: \"Row Row 3\"",
      "start_page": 527,
      "end_page": 527
    },
    {
      "heading": "heading heading <PFS:> (column 2)",
      "text": "Row 1: \"Row 2: Rove\" Row 3: safety safety tests?",
      "start_page": 527,
      "end_page": 527
    },
    {
      "heading": "heading heading <PFS:> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 527,
      "end_page": 527
    },
    {
      "heading": "heading heading <PFS:> (column 5)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 527,
      "end_page": 527
    },
    {
      "heading": "heading heading <Effect balance>",
      "text": "Row 1: \"Row\" 2: \"Raw\" = \"Right\" 3: \"C\" main main outcomes? \" Row 4: \" Row 5: JUDIZI\" \"RW 7: \"Rw 8: \"Budget of effects\" \"Row 9: \"or or comparison\" \"Now 10: \"ROW 11: JUDICES\" \"RECERCA OF TESTS\" intervention intervention \"Varia\" \"Doesn'toxicity toxicity \"the the year\" comparison comparison \"X X \"Probably\" favour. favour.\"",
      "start_page": 528,
      "end_page": 528
    },
    {
      "heading": "heading heading <Budget of effects> (column 1)",
      "text": "Row 1: \"Row 2: \"Valori\" Row 3: \"C\" main main outcomes? \"Rop 4: \"Raw 5: \"JUDIZI\" Row 6: \"variable variable X\" major major variability",
      "start_page": 528,
      "end_page": 528
    },
    {
      "heading": "heading heading <Budget of effects> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 528,
      "end_page": 528
    },
    {
      "heading": "heading heading <Budget of effects> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 528,
      "end_page": 528
    },
    {
      "heading": "heading heading <Budget of effects> (column 3)",
      "text": "Row 1: Row 2: Row 3: Onto? Row 4:",
      "start_page": 528,
      "end_page": 528
    },
    {
      "heading": "heading heading <Budget of effects> (column 11)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \" Row 5: \" ADDITIONAL CONSIDERATIONS \" Row 6: \" Row 7: \" Row 8: \" \" Row 9: \" ' Row 10: \" row 11: \" Additional CONSIDERATION \" Row 12: \"toxicity. toxicity.",
      "start_page": 528,
      "end_page": 528
    },
    {
      "heading": "heading heading <Fatsibility>",
      "text": "Row 1: \"Row\" 2: \"Right\": \"Raw\" 3: \"of of equity? \"Rop\" 4: \"Rough\" 5: \"Judizi\" 5, \"Ricerca\" of \"ADDING\" TESTS\" Row 6: \"Reduces equity\" = \"equity equity X\" equity equity \"Improves equity,\" \"Improved equity,\" and \"Improving equity\" (not not known) Row 7: \"Row 8: \"Acceptibility\" ^ Row 9: \"No\" main main stakeholders?",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: \"Row 2: \"Equity Row 3: \"Row Row 4: \"",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Acceptability Row 3: •Row Row 4: •",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading <Fatsibility> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Row Row 4: •The Row 4:",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: i of equity? Row 4:",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4:",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading <Fatsibility> (column 2)",
      "text": "Row 1: Row 2: Row 3: narration? Row 4:",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: Row 2: Row 3: ? Row 4:",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: keepers? \" Row 4: \"",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading <Fatsibility> (column 3)",
      "text": "Row 1: \"Row 2: \" Row 3: \" or \" Row 4: \"",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading <Fatsibility> (column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4:",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading <Fatsibility> (column 16)",
      "text": "Row 1: \"Row 2: \" Row 3: \" Row 4: \"",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading <Fatsibility> (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 530,
      "end_page": 530
    },
    {
      "heading": "heading heading <Fatsibility> (column column 1)",
      "text": "Row 1: \"Row 2: PROBLEM\" Row 3: \"Raw 4: \"Rop 5\": DESIDABLE EFFECTS\" Row 6: \" Row 7: \"Wow 8: SIDE EFFECTS\" Row 9: \"Row 10: \"Now 11: QUALITY OF TESTS\" Row 12: \"row 13: \"Heavy 14: \"Shee 15: \"Cow 16: \"How 17: BUDGET OF EFFECTS\" row 18: \"New 19: \"The Row 20: EQUITA\" Row 21: \"Rule 22: \"Wee 23: ACCEPTABILITY\" Row 24: \"Immediate Row 25: \"It's Row 26: FACTIVITY\" Row 27: \"",
      "start_page": 530,
      "end_page": 530
    },
    {
      "heading": "heading heading <Fatsibility> (column column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \"",
      "start_page": 530,
      "end_page": 530
    },
    {
      "heading": "heading heading <Fatsibility> (column column 3)",
      "text": "Row 1: Row 2: JUDICES Row 3:",
      "start_page": 530,
      "end_page": 530
    },
    {
      "heading": "heading heading <Fatsibility> (column column 3)",
      "text": "Row 1: Probably no ...Row Row 2: Small \"Moderate\" Row 3: Moderate \"Small \"Row\" 4: Low \"Made\" Row 5: variability. variability.",
      "start_page": 530,
      "end_page": 530
    },
    {
      "heading": "heading heading <Fatsibility> (column column 4)",
      "text": "Row 1: \"Row\" 2: \"Raw\" 3: \"Rop\" 4: \"Varia\" Row Row 5: \"Rw\" 6: \"Wow\" 7: \"Via\" doesn'Row Row 8: \"Row\" 9: \"Voyage\" 10: \"Do not know\" Row 11: \"Row Row 13: \"No study included\" Row 14: \"How\" 15: \"Heavy\" 16: \"Weapon\" 17: \"Not so\" Row 18: \"Snow\" 19: \"of of intervention\" \"Whoa\" 20: \"Don't really know\" row 25: \"Two Row 26: \"I don't do it\"",
      "start_page": 530,
      "end_page": 530
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: against against intervention",
      "start_page": 531,
      "end_page": 531
    },
    {
      "heading": "heading heading <Recommendation>",
      "text": "Row 1: • Row 2: • Recommendation • row 3: •",
      "start_page": 531,
      "end_page": 531
    },
    {
      "heading": "heading heading <Recommendation> (column 1)",
      "text": "Row 1: • Row 2: •Row 3: •Recommendation",
      "start_page": 531,
      "end_page": 531
    },
    {
      "heading": "heading heading <Recommendation> (column 2)",
      "text": "Row 1: \"Row 2: \" Row 3: \"",
      "start_page": 531,
      "end_page": 531
    },
    {
      "heading": "heading heading <Records: 107>",
      "text": "==References===External links==* Official website",
      "start_page": 535,
      "end_page": 535
    },
    {
      "heading": "heading heading <Records: 238>",
      "text": "Rowter 1: ((((?((!(([((0]((·(( \"Carcinoma, Non-Small-Cell Lung/drug therapy\"[Mesh] OR \"Carcinoma, Not-Smal-Cello Row 2: Lung /pathology\"[Mesh]) OR ((\"lung cancer\"[Title/Abstract] OR\"lung Row 4: neoplasms\"[Thitle/Ambs] Or \"long tumor\"[Title/Apstract].Or \"Non-small-cell] lung Row 5: cancer\" ([Tytle/abstract) OR \"lung lung cancer\" [Title or Abstract] OR (\"Non-normal-cell-cell) lung Row: cancer_[Tittle/App]",
      "start_page": 536,
      "end_page": 536
    },
    {
      "heading": "heading heading <Records: 238>",
      "text": "==References===External links==* Official website",
      "start_page": 536,
      "end_page": 536
    },
    {
      "heading": "heading heading <Records: 238> (column 2)",
      "text": "Row 1: ((((?((!(([((·((0] \"Carcinoma, Non-Small-Cell Lung/drug therapy\"[Mesh] OR \"Carcino Row 2: Lung /pathology\"[Mesh]) OR ((\"lung cancer\"[Title/Abstract] Or \"lung Row 4: neoplasms\"[Title/Ambs] OR\"long tumor\"[Triple/Aps] or \"Non-Row Row 5: cancer\" [Title/abstract].",
      "start_page": 536,
      "end_page": 536
    },
    {
      "heading": "heading heading <Records: 238> (column 2)",
      "text": "==References===External links==* Official website",
      "start_page": 536,
      "end_page": 536
    },
    {
      "heading": "heading heading <Records: 238> (column 3)",
      "text": "Row 1: ((((Lung Row 2: ract]) Row Row 3: ung Row 4: C*[Title/Abstract]) Row 5: itle/abstract) OR Row 6:)) AND \"radical Row 7: cal Trial\" [Publica",
      "start_page": 536,
      "end_page": 536
    },
    {
      "heading": "heading heading <Records: 238> (column 3)",
      "text": "Row 1: OR Row 2: sh]) AND",
      "start_page": 536,
      "end_page": 536
    },
    {
      "heading": "heading heading <Records: 171>",
      "text": "ORow 1: ((\"neoadjuvant therapy\"[MeSH Terms] OR (\"neoadiuvant\"[All Fields] AND \"therapy\"[All Fields]] OR Row 2: \"neoadajuvent therapy\"\"[All field] OR \"neoeadjuvant\"[Fills]",
      "start_page": 537,
      "end_page": 537
    },
    {
      "heading": "heading heading <Records: 171>",
      "text": "[Majr:noexp]) OR ((((?((·((\"Carcinoma, Non-Small-Cell Lung/radiotherapy\") OR lung tumor*[Title/Abstract]) Or lung tumour*[Title/Approach] Row Row 4: Cancer*[Tritle/Attract] long long cancer*[thitle/abstract} OR __MEDTERM0_*[Tetle/An abstract]",
      "start_page": 537,
      "end_page": 537
    },
    {
      "heading": "heading heading <Selected 6 records>",
      "text": "Row 1: ((((?((!((\"Carcinoma, Non-Small-Cell Lung/radiotherapy\"[Majr:noexp]) OR ((·((¡((lung Row 2: cancer*[Title/Abstract]) Or lung tumor*[Title/Approach]) tumor tumor *[Tittle/abstract]] Row Row 4: Cancer*[Tritle/Attract]), long long cancer* [Titler/Actusto])",
      "start_page": 538,
      "end_page": 538
    },
    {
      "heading": "heading heading <Selected 6 records>",
      "text": "Row 1: ((((?((!((\" \"Carcinoma, Non-Small-Cell Lung/drug therapy\"[Mesh] OR \"Carcinoma, non-Smmall- Cell Row 2: Lung /pathology\"[Mesh]) OR ((\"lung cancer\"[Title/Abstract] Or \"lung neoplasms\"[Title/Ambs] Row 4: OR \"long tumor\"[Tritle/abstract]. OR \"Non-small-cell lung cancer\" [Titles/Apply] OR\"Row Row 5: Cancer\"[Totle/Abbs] OR",
      "start_page": 538,
      "end_page": 538
    },
    {
      "heading": "heading heading <Selected 6 records> (column 2)",
      "text": "Row 1: ((((?((!((\"Carcinoma, Non-Small-Cell Lung/radiotherapy\"[Majr:noexp]) OR ((·((¡((lung Row 2: cancer*[Title/Abstract]) Or lung tumor*[Title/Approach]) tumor tumor *[Tittle/abstract]] Row Row 4: cancer* [Titlet/Attract]), long long cancer*[1Titler/Actusto])",
      "start_page": 538,
      "end_page": 538
    },
    {
      "heading": "heading heading <Selected 6 records> (column 2)",
      "text": "Row 1: ((((?((·((!((\" \"Carcinoma, Non-Small-Cell Lung/drug therapy\"[Mesh] OR \"Carcinoma, Not-Smal- Row 2: Lung /pathology\"[Mesh]) OR (\"Lung Neoplasms/drug theory\"[ Mesh] OR (\"L Row 3: Neoplasmms/pathology\") [Mesh ]) OR (\"Non-small-cell lung cancer\"[Title/Abstract] Or \"Don'Row Row 5: cancer\" [Titler/A abstract] OR\"Non-small -cell long cancer\"[1Titletle/abstract].",
      "start_page": 538,
      "end_page": 538
    },
    {
      "heading": "heading heading <Selected 6 records> (column 3)",
      "text": "Row 1: -Cell Row 2: Lung Row 3: ract] Row 4: long Row 5: long Row 6: ntary",
      "start_page": 538,
      "end_page": 538
    },
    {
      "heading": "heading heading <Selected 4 record>",
      "text": "Row 1: ((((?((!((\" \"Carcinoma, Non-Small-Cell Lung/drug therapy\"[Mesh] OR \"Carcinoma, non-Smmall- Cell Row 2: Lung /pathology\"[Mesh]) OR ((\"lung cancer\"[Title/Abstract] OR\"lung neoplasms\"[Thitle/Ambs] Row 4: OR \"long tumor\"[Title/Approach] Or \"Non-small-cell lung cancer\" [Title/abstract]. OR \"Row Row 5: cancer\"[1Title_abs] OR",
      "start_page": 539,
      "end_page": 539
    },
    {
      "heading": "heading heading <Selected 1 record>",
      "text": "Row 1: review ascarcinoma\"[Title/Abstract) OR __MEDTERM2_[Title/A abstract] ())) () ('))) AND ((((?((\"grade III\" OR \"stage Row 2: III\" OR OR \"advanced disease\"))) (1))) ] OR (metastas*[Tittle/abstract])) and (( (...) ((!(\"Row Row 4: Topic\"[Mesh] OR \"Meta-Analysis\"[Publication Type]) OR \"meta-analysis[Tithle] Row Row 5: review\"[Toly] OR",
      "start_page": 540,
      "end_page": 540
    },
    {
      "heading": "heading heading <Selected 1 record>",
      "text": "==References===External links==* Official website",
      "start_page": 541,
      "end_page": 541
    },
    {
      "heading": "heading heading <Selected 1 record>",
      "text": "(((([(( [((?((!(( -(( \"Carcinoma, Non-Small-Cell Lung/drug therapy\"[Mesh] OR \"Carcinoma, Not-Smal-Ccell Row 2: Lung /pathology\"[Mesh]) OR ( \"Lung Neoplasms/drug therapy\"[ Mesh] OR (\"Lung neoplasms /drug therapy\"\"[Mesh]) ] OR ((\"lung cancer\"[Title/Abstract] OR or \"lung neoplasmas\"[Text] Row 4: OR \"lung tumor\"[Title/A abstract] OR OR \"Non-small-cell-cell long cancer\" ([Title/absabs] [Titler/abst] ] OR \"lung lung cancer\" [Tiple/abstr] OR [Tutle/ Abstract] ] Or \"Row Row 5: cancer\"[1Tille] OR non-cancer cancer cancer\"\"[[T) [Tadell-length long cancer]]] [[cancer cancer ([[tle]]]. [[[[;]]",
      "start_page": 541,
      "end_page": 541
    },
    {
      "heading": "heading heading <Records: 117>",
      "text": "Row 1: [Supplementary Concept]) OR (osimertinib[Title/Abstract])) AND ((((áz((⁄((\"Row Row 2: Topic\"[Mesh]) Or \"Meta -Analysis\"[Publication Type]) or \"meta-analysis[Title] Row Row 3: review\"[Title] OR \"meta analysis*\"[Tittle] Or \"metaanalysity*\"[1Titles] OR\" Meta-Analysis\"[Trial] OR Row 4: (\"systemic literature review\" [Titler])",
      "start_page": 542,
      "end_page": 542
    },
    {
      "heading": "heading heading <Records: 117>",
      "text": "Row 1: \"Meta-Analysis\"[Publication Type] OR \"meta-analysis[Title] OR: systematic review\"[Title] OR 'meta analysis'*\"[Title] OR (Meta-Analysis\" [Tittle]) OR: \"Systemic literature review\" [Title]) or ([Tittle] Or ((Randomized Row 5: Controlled Trial) OR (Publication type) OR \"as as Topic\"[Mesh] OR (\"Clinical Row 6: Trial\" [Publication Standard])",
      "start_page": 542,
      "end_page": 542
    },
    {
      "heading": "heading heading <Records: 40>",
      "text": "Row 1: Analysis\"[Publication Type]) OR \"meta-analysis[Title] OR systemic review\"[Title] OR \"meta Row 2: analysis\"*\"[Title] OR (\"Meta-Analysis\"[Tritle]) Or (\"Row Row 3: review\" [Tittle])) OR ((((\"Row Row 4: Trial\"[Pubblication Type]] OR \"as as Topic\"[Mesh]) or (\"Clinical Trial' Row 5: [Publication type])",
      "start_page": 543,
      "end_page": 543
    },
    {
      "heading": "heading heading <Records: 28>",
      "text": "==References===External links==* Official website",
      "start_page": 544,
      "end_page": 544
    },
    {
      "heading": "heading heading <Records: 28> (column 2)",
      "text": "==References===External links==* Official website",
      "start_page": 544,
      "end_page": 544
    },
    {
      "heading": "heading heading <Records: 9>",
      "text": "Row 1: Analysis as Topic\"[Mesh]) OR \"Meta-Analysis\"[Publication Type]) or \"meta-analysis[Title] OR: systemic review\"[Title] OR \"meta analysis*\"[Title] OR\"metaanalysity*\" [Tittle] OR (Meta‐Analysis\"[Triple]) Or: (\"systemic literature review\" [Title]) O ((((\"Randomized Row 4: Controlled Trial\"[Pubblication Type]] OR \"as as Topic'[Mesh])",
      "start_page": 545,
      "end_page": 545
    },
    {
      "heading": "heading heading <Selected 1 record>",
      "text": "Row 1: OR \"Meta-Analysis\"[Publication Type] OR \"meta-analysis[Title] OR systematic review\"[Title] OR Row 2: \"meta analysis\"[Title] OR 'metaanalysity*\"[Tritle] Or \"Mete-Analysis\" [Tittle]) OR (\"Row Row 3: review\" [Title]) or (\"systemic review\" ([Title/Abstract])) OR ((((\"Row Row 4: Trial\"[Pubblication Type]] OR \"as as Topic\"[Mesh]) Or (\"Clinical Trial' Row 5: [PublicationType])",
      "start_page": 546,
      "end_page": 546
    },
    {
      "heading": "heading heading <Records: 17>",
      "text": "Row 1: \"Meta-Analysis\"[Publication Type] OR \"meta-analysis[Title] Row Row 3: review\"[Title] OR (\"meta analysis\"*\"[Title] OR\"metaanalysity*\" [Tittle] or \"Mete-Analysis\"[1Tittle]) OR (((Randomized Row 5: Controlled Trial\") OR (Publication type) OR \"as as Topic\"[Mesh] OR (Clinical Row 6: Trial) OR",
      "start_page": 547,
      "end_page": 547
    },
    {
      "heading": "heading heading <Selected 5 records>",
      "text": "==References===External links==* Official website",
      "start_page": 549,
      "end_page": 549
    },
    {
      "heading": "heading heading <Records: 98>",
      "text": "OR (((( \"Drug Therapy/therapeutic use\"[Mesh] OR \"Drug Row 2: Therapy/therapy\"[Mesh] OR ([Mash] ] OR ('Drug Therapies'[Methle/Abstract] OR Chemotherapy[Title] OR Row 3: Chemotherapies[Tittle/abstract]]) OR \"meta-analysis[Title] OR systematic review\"[Tithle] or \"meta Row 5: analysity\"*\"[Tritle] Or \"Meta-analysis[Tytle]",
      "start_page": 550,
      "end_page": 550
    },
    {
      "heading": "heading heading <Records: 98> (column 2)",
      "text": "Row 1: 3475[Title/Abstract])) OR (((\"Drug Therapy/therapeutic use\"[Mesh] OR \"Drug Row 2: Therapy/therapy\"[Mesh]) OR (\"Drug Therapies/therapeutic use\" [Title/Approach] OR Chemotherapy[Titler/Apply]) ] AND ((!(((Ze] rait] OR Systematic review\"[Title] OR 'meta Row 5: analy*\"[Totle] Or \"meta-analysis[Tittle] OR",
      "start_page": 550,
      "end_page": 550
    },
    {
      "heading": "heading heading <Records: 98> (column 3)",
      "text": "Row 1: Stract] OR Row 2: a-",
      "start_page": 550,
      "end_page": 550
    },
    {
      "heading": "heading heading <Records: 220>",
      "text": "Row 1: ((((⁄((0]((?((!((.((·(([(( [((\"\"Lung Neoplasms\"[Mesh]) OR \"Carcinoma, Non-Small-Cell Lung\"[Mesh]) Row 2: OR (\"long cancer\"[Title/Abstract] OR \"lung neoplasms\"\"[Title/Aptract] Or \"lung tumor\"[Title/Attract] Row 3: OR \"Non-small-cell long cancer\" [Title/abstract]. OR \"long long cancer'[Title /abs])",
      "start_page": 551,
      "end_page": 551
    },
    {
      "heading": "heading heading <Selected 1 record>",
      "text": "())) AND (( ((\"non-squamous\"[Title/Abstract] OR \"no Row 2: squamous'[Title/Abrass] [Title/abs] OR 'non Row 2: Squamous\"\"[Title/A abstract] OR nonsquamoous[Titole/Astr.])) ] AND Row 3: (((([((?(( (!(( -(( [((· (( _ _MEDTERM0____\"[Supple/ Abstract] OR (___MEDTERMM1__[Tittle/absu] ] ] Raw Raw 4: Keytruda[Tile/At extract] OR MKMM-3475[Titule/Anstal/Austab]) ]) AND (1) AND ([]]] ORpemetrexed\"[Mesh]) OR Row 5: (",
      "start_page": 552,
      "end_page": 552
    },
    {
      "heading": "heading heading <Selected 2 records>",
      "text": "ORwain_milt: 1ORwaltif: 1 ORwaltik: 2 ORwalstif: 4 'lung lung cancer' OR 'the the lung' OR'epidermoid carcinoma' Row 3: OR 'lung squamous cells' OR (#1 OR #2) AND (#3 OR #4) Row 6: 6 ('cisplatin'/exp/mj OR 'carboplatin'./exp/mJ OR 'paclitaxel'/Exp/Mj) OR OR 'cis-Row 7: diAMentidichloroplatinum(ii)' OR \"Platinum diaminodichloride' or 'opdifloride' minedi-mj.",
      "start_page": 553,
      "end_page": 553
    },
    {
      "heading": "heading heading <Records:21>",
      "text": "==References===External links==* Official website",
      "start_page": 554,
      "end_page": 554
    },
    {
      "heading": "heading heading <Records: 27>",
      "text": "ORwain_milt: 1ORwaltif: 1 ORwaltik: 2 ORwalstif: 4 'lung lung cancer' OR 'the the lung' OR'epidermoid carcinoma' Row 3: OR 'lung squamous cells' OR (#1 OR #2) AND (#3 OR #4) Row 6: 6 ('cisplatin'/exp/mj OR 'carboplatin'./exp/mJ OR 'paclitaxel'/Exp/Mj) OR OR 'cis-Row 7: diAMentidichloroplatinum(ii)' OR \"Platinum diaminodichloride' or 'opdifloride' minedi-mj.",
      "start_page": 556,
      "end_page": 556
    },
    {
      "heading": "heading heading <Selected 4 records>",
      "text": "OR ((((\"Carcinoma, Non-Small-Cell Lung\"[Mesh])) OR (\"Non-small-cell long cancer\"[Title/Abstract] OR Row 2: \"lung lung cancer\" [Title/abstract]] OR NSCLC[Title/Approach]) ())) ]) AND Row 3: ((\"Chemoradiotherapy/therapeutic use\"[Mesh]) OR \"Chemoe radiotherapy\"[Titte/Apply] OR (\"meta-analysis\")",
      "start_page": 557,
      "end_page": 557
    },
    {
      "heading": "heading heading <Selected 4 records>",
      "text": "Row 1: (((() \"Lung Lung Carcinoma\"[Mesh]) OR (",
      "start_page": 557,
      "end_page": 557
    },
    {
      "heading": "heading heading <Records: 86>",
      "text": "Row 1: \"as as Topic\"[Mesh] OR (\"Clinical Trial\" [Publication Type]) OR Row 2: (randomized[Title/Abstract] OR randomized[Title/A abstract] OR Randomly[Title / Abstract]))",
      "start_page": 558,
      "end_page": 558
    },
    {
      "heading": "heading heading <Records: 86>",
      "text": "== Demographic evolution ====References==",
      "start_page": 558,
      "end_page": 558
    },
    {
      "heading": "heading heading <Records: 86> (column 2)",
      "text": "==References===External links==* Official website",
      "start_page": 558,
      "end_page": 558
    },
    {
      "heading": "heading heading <Records: 88>",
      "text": "Row 1: Proxel[Title/Abstract] OR Onxol[Title/Ambs] OR vinorelbina[Titte/Abbs] Or ((\"Drug Therapy\"[Mesh]) OR Row 3: ('Drug Therapies'[Tits/Aps] or Chemotherapy[Tytle/Apps]) ] AND Row 5: (( (( \"Etoposide\"[Mesh])",
      "start_page": 559,
      "end_page": 559
    },
    {
      "heading": "heading heading <Records: 88>",
      "text": "Row 1: OR ...Vépéside-Sandoz/[Title/Abstract] OR",
      "start_page": 559,
      "end_page": 559
    },
    {
      "heading": "heading heading <Records: 88>",
      "text": "Row 1: #1 'long long cancer'/exp/mj Row 2: #2 'lung lung cancer' OR 'lung lung Cancer' OR \"of of theung' OR'carcinoma, Row 3: lung lung cancer\" OR 'of of lung':Row Row 4: #4 'metastasis'/exp/mJ OR 'recurrent disease'/xp/mmj Row 5: #3 #1 OR #2 Row 6: #5 'neoplasm metastasis'/esp/my/my-rrent disease' /exp/ml/of of ling': row row 8: #6 #4 OR #5 Row 9: #7 'ethopide' or 'stage iv' OR OR recurence* ORRow 7: relapse*:ti",
      "start_page": 559,
      "end_page": 559
    },
    {
      "heading": "heading heading <Records: 88>",
      "text": "Row 1: Etoposide isomer' OR 'etoposido ferrer farma' OR OR 'nsc-141540' OR \"Row Row 2: OR 'nsce141540\" OR OR 'ethoposide teva' OR OR 'Row Row 3: 213' OR'vp16 213' or 'v p-16' OR evp 16' OR - vp16' OR (Vépéside-sandoz) OR 'vépésider sandoz' Row Row 4: OR OR 'ethoposide, (5a alpha)-Sor 'Row Row 5: fabre' OR OR 'anti-pdl1' OR anti-pd-l1'Or 'Etopospeside-endo' #46 OR 'Etoposide' r780 OR 'impq-3280 OR:",
      "start_page": 559,
      "end_page": 559
    },
    {
      "heading": "heading heading <Records: 88>",
      "text": "Row 1: 'docetaxel'/exp/mj OR 'paclitaxel' /exp/mJ OR 'vinorelbine tartrate' /exp/my Row 2: #OR OR 'cis-diaminedichloroplatinum(ii) ' OR 'platinum diaminodichloride' OR Row 3: 'diaminodichlorinated, platinum' OR 'cis-platelum' OR \"cis Platinum' Row Row 4: 'OR OR 'cys diaminedi chloroplattinum' or 'cis - row 5: dichlorodiaminamineplatynum(i) 'OR 'nsc-119875' Row Row 6: Or Or 'cis-\"cyclobutanedicarboxylate)platinume ii' cbd OR paraplatin",
      "start_page": 559,
      "end_page": 559
    },
    {
      "heading": "heading heading <Records: 83>",
      "text": "Row 1: Row Row 2: ercar OR 'jm-8' OR 'Jm 8' OR OR 'nsc-241240' OR \"nsc 241240' OR nsc241240 OR",
      "start_page": 560,
      "end_page": 560
    },
    {
      "heading": "heading heading <Records: 83>",
      "text": "Row 1: pharmacology:Row Row 2: #12 #10 OR #11 Row 3: #13 #3 AND #6 AND #9 AND #12",
      "start_page": 560,
      "end_page": 560
    },
    {
      "heading": "heading heading <Records: 83>",
      "text": "Row 1: ((((!((\"\"Lung Lung Carcinoma\"[Mesh]) OR ('Long Long Cancer'[Title/Abstract] OR ...\"Row Row 2: Lung Cancer\"[Title/Ambs] OR .. Lung Lung ...Row Row 3: \"Lung\"[Title/Application] OR \"Etoposide\"[All Fields]) AND ((\"platinum\"[MeSH Terms] Or \"Platinum\" ([All fields]))) AND Row 5: \"_MEDTERM0_\" [Supplementary Concept]",
      "start_page": 560,
      "end_page": 560
    },
    {
      "heading": "heading heading <Records: 83>",
      "text": "Row 1: #1 'lung lung cancer'/exp/mj Row 2: #2 'long long cancer' OR 'lung lung Cancer' OR \"of of theung' OR'carcinoma, Row 3: small cell lung' of of lung':ti,ab",
      "start_page": 560,
      "end_page": 560
    },
    {
      "heading": "heading heading <Records: 83>",
      "text": "Row 1: ((((!((\"\"Lung Lung Carcinoma\"[Mesh]) OR (*Cancer Cancer ... [Title/Abstract] OR --Row Row 2: Lung Cancer ...[Title/Ambs] OR *Lung Lung ... ... ] AND (( ((\"Etoposide\"[MeSH Row 4: Terms] OR \"Etoposide\"[All Fields] ] AND (\"[\"Platinum\"[ MeSH Terms]] OR\"Platinum\" [All Field's]",
      "start_page": 560,
      "end_page": 560
    },
    {
      "heading": "heading heading <Records: 89>",
      "text": "Row 1: ((((\"Lung Lung Carcinoma\"[Mesh]) OR (",
      "start_page": 561,
      "end_page": 561
    },
    {
      "heading": "heading heading <Records: 89>",
      "text": "Row 1: ((((!((\"Lung Lung Carcinoma\"[Mesh]) OR ('Long Long Cancer'[Title/Abstract] OR",
      "start_page": 561,
      "end_page": 561
    },
    {
      "heading": "heading heading <Records: 89> (column 2)",
      "text": "Row 1: ((((\"Lung Lung Carcinoma\"[Mesh]) OR (\"Long Long Cancer\" [Title/Abstract] OR \"Row Row 2: Lung Cancer\"[Title/Ambs] OR",
      "start_page": 561,
      "end_page": 561
    },
    {
      "heading": "heading heading <Records: 89> (column 2)",
      "text": "Row 1: ((((!((\"Lung Lung Carcinoma\"[Mesh]) OR ('Long Long Cancer'[Title/Abstract] OR ...\"Row Row 2: Lung Cancer\"[Title/Approach] OR ..'The The Lung', \"Carcinoma,\" \"Row Row 3: \"Lung\"[Title/Attract] or \"of of Lung\" [Title/abstract].))) AND (( ((\"topotecan\" Row 4: [Supplementary Concept]) Or topotecan[Title /abs]))",
      "start_page": 561,
      "end_page": 561
    },
    {
      "heading": "heading heading <C. METHODOLOGY> (from previous page)",
      "text": "Row 1: \"Clinical\" Row 4: of of \"Corporate\" Row 5: favour favour (selection criteria) * therapeutic therapeutic option* to to \"yyye\" alternatives alternatives (over over damages) Row 6: with with (selective criteria) to to yyyi\"l \"intervention under consideration; benefit benefit (s) of \"Personalised\" or \"Cerposited\" considered. considered.",
      "start_page": 611,
      "end_page": 611
    },
    {
      "heading": "heading heading <C. METHODOLOGY> (from previous page)",
      "text": "Row 1: Situation (s) of evidence (s): (i) (ii) (iii) (iv) (v) (vi) (e) (f) (j) (h) (i); (iv), (vi). (vib) (vii) (viii) (c) (d) (a) (m) (y) (l) (w) (ix) insecure insecure (uncertain uncertain benefit) intervention intervention (less less harmful/costy comparison) Row 5: the the other",
      "start_page": 613,
      "end_page": 613
    },
    {
      "heading": "heading heading <INTERNATIONAL INTERNATIONAL GUIDES>",
      "text": "Row 1: Row Row 2: January January 2018",
      "start_page": 615,
      "end_page": 615
    },
    {
      "heading": "heading heading <INTERNATIONAL INTERNATIONAL GUIDES> (from previous page)",
      "text": "I'm sorry. ==References===External links==*Official website* Official website",
      "start_page": 616,
      "end_page": 616
    },
    {
      "heading": "heading heading <INTERNATIONAL INTERNATIONAL GUIDES> (column column 2)",
      "text": "==References===External links==* Official website",
      "start_page": 616,
      "end_page": 616
    },
    {
      "heading": "heading heading <INTERNATIONAL INTERNATIONAL GUIDES> (column column 3)",
      "text": "Row 1: Comments Row 2: Row 3: Row Row 4: Row 5: Target Population: Oncologist (different different figures) Row 6: Row Row 7: Row Row 8: Target population: oncologue (figures figures exist) Row 9: Row Row 10: Row 11: Row 12: question question (PICO); appropriate appropriate engines; bibliographical bibliographical items; methodological quality assessment; evidence evidence (display table) Row Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row Row 19: Row 20: Row 21: questions questions (GRADE GRADE questions) Row 22: Row 23: Row Row project",
      "start_page": 616,
      "end_page": 616
    },
    {
      "heading": "heading heading <4. BIBLIOGRAPHY>",
      "text": "== Demographic evolution ===References===External links==* Official website",
      "start_page": 617,
      "end_page": 617
    },
    {
      "heading": "heading heading <4. BIBLIOGRAPHY> (column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 617,
      "end_page": 617
    },
    {
      "heading": "heading heading <4. BIBLIOGRAPHY> (column 2)",
      "text": "Row 1: ESMO-ASCO-NCCN Row 2: √\"NRow Row 3: Â\"NOR Row 4: NR'NR Row 5: Ã\" NROWN Row 6: NR\"N Row 7: NRâNR Row 8: NR·NROWN Row 9: NR′NRW 10: NO'NOR Row 11: È\"Nr Row 12: √À\"NAR Row 13: ̈\"NRA Row 14: NRÂ\"NORow 15: Ø\"NER Row 16: ¬\"Row 17: ą\"NA Row 18: Č\"NROW Row 19: NR \"NRown Row 20: ̨NRaw 21: NR\\Row Row 22: č\"NRN Row 23: NR.",
      "start_page": 617,
      "end_page": 617
    },
    {
      "heading": "heading heading <opinion. opinion.>",
      "text": "Row 1: 1\" individual individual RCTs\" Row 2: 1 ++\"risk. risk.\" Row 3: 1 +\"bias. bias.\" Row 4: 1 -\"risk risk -> Row Row 5: 2\"of of case/or or \"Row 6\": Single case/Raw Raw 7: 2+\"effect. effect.",
      "start_page": 621,
      "end_page": 621
    },
    {
      "heading": "heading heading < a a critic>",
      "text": "Row 1: assessed assessed 1++ Row Row 2:",
      "start_page": 622,
      "end_page": 622
    },
    {
      "heading": "heading heading < a a critic>",
      "text": "Row 1: rated rated 1++ Row Row 2: target target population; or",
      "start_page": 622,
      "end_page": 622
    },
    {
      "heading": "heading heading < a a critic>",
      "text": "Row 1: includes includes 2++ Row Row 2: size. size.",
      "start_page": 622,
      "end_page": 622
    },
    {
      "heading": "heading heading < a a critic>",
      "text": "Row 1: includes includes 2+ Row Row 2: size. size.",
      "start_page": 622,
      "end_page": 622
    },
    {
      "heading": "heading heading <Meaning Meaning Consequences>",
      "text": "Row 1: • Row 2: Level certainty • Meaning \"Consequences Row 3: results results • Row Row 4: Moderate •performance performance •Row Row 5: Low • credible credible • is is limited: estimated estimated • row 6: Very low • unreliable unreliable • effect effect • estimated estimated effect",
      "start_page": 624,
      "end_page": 624
    },
    {
      "heading": "heading heading <clinical clinical recommendations>",
      "text": "Row 1: \"Clinical\" Row 4: Strong at Favor: with with (selection criteria) option option (on on damage) Row 5: Conditional at Favour: with with (screening criteria) alternatives alternatives (on on damage), 6 6 treatment: Sfavore Sfavore (selecting criteria).",
      "start_page": 626,
      "end_page": 626
    },
    {
      "heading": "heading heading <Certain test>",
      "text": "Row 1: evidence evidence SIGN/Row Row 2: effects. effects.",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "heading heading <Certain test>",
      "text": "Row 1: Row 2: Highlight Row 3: SIGN",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "heading heading <Certain test>",
      "text": "Row 1: Row Row 2: recommendation Row 3: clinic",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "heading heading <Certain test>",
      "text": "Row 1: evidence evidence (or or IV) inhibitor inhibitor + melanoma. melanoma.",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "heading heading <Certain test>",
      "text": "Row 1: Row 2: overall Row 3: evidence",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "heading heading <Certain test>",
      "text": "Row 1: Row Row 2: recommendation Row 3: clinic",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "heading heading <Certain test>",
      "text": "Row 1: \"Quesito xx: .........\" Row 2: RECOMMENDATION: ...Row 3: the the recommendation: ... Row 4: Motivations/sheet sheet Benefits/Wait: been been identified: the the benefit/damage balance: ....Row 5: future future research: ...\" Row 6: judged judged ..... following following reasons: \"Row 7: of of evidence: ..... ... Row 8: COI: ...",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "heading heading <5. CRITICAL APPRAISAL> (from previous page)",
      "text": "==References===External links==*Official website* European European Union: http://europa.eu.int/comm/Row Row 26: Row Row 27: \"Excuse me\" Row Row 28: \"Row Row 29: \"so. so.\" Row 30: without without meta-analysis\" Row 31: \"Certain studies\": properly properly assessed? Row 32: \"Row Row 34: \"picture picture (or tables) Row Row 33: \"Row Row 37: \"Specifically,\" studies. studies.",
      "start_page": 629,
      "end_page": 629
    },
    {
      "heading": "heading heading <5. CRITICAL APPRAISAL> (from previous page)",
      "text": "Row 1: Row Row 2: was was generated? Row 3: Row Row 4: was was hidden? Row 5: balanced balanced groups?",
      "start_page": 629,
      "end_page": 629
    },
    {
      "heading": "heading heading <5. CRITICAL APPRAISAL> (from previous page)",
      "text": "Row 1: Row Row 2: (first two) Row 3: Row 4: baseline baseline table: results. results.",
      "start_page": 629,
      "end_page": 629
    },
    {
      "heading": "heading heading <5. CRITICAL APPRAISAL> (from previous page)",
      "text": "Row 1: Row Row 2: CONSORT. CONSORT.",
      "start_page": 629,
      "end_page": 629
    },
    {
      "heading": "heading heading <5. CRITICAL APPRAISAL> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: pcs.",
      "start_page": 629,
      "end_page": 629
    },
    {
      "heading": "heading heading <5. CRITICAL APPRAISAL> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: picture picture (or tables) Row 4: Row Row 5: Discussion.",
      "start_page": 629,
      "end_page": 629
    },
    {
      "heading": "heading heading < ASSOCIATION>",
      "text": "Row 1: \"heterogenity\" analysis, analysis, meta-... Row 2: \"explored. explored.\"",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "heading heading < ASSOCIATION>",
      "text": "as as eligible: 000 000 million: 000, 000,000; 25,000,000m; 15,000,000; population population (the the \"Row\" is referred; 5,000,000: the the \"Row\" the the \"ROW\": only difference = under under study; 10,000: the the \" Row\": accepted accepted / invited; the the \"Fow\" and \"Rown\" factors: factor factor (Row 13: • Row 14: Row 15: MEASURING Row 16: ^detection detection factor: 000, 000,000===References==External links=* Official website",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "heading heading < ASSOCIATION>",
      "text": "Row 1: populations populations (single difference = Row 2: risk factor studied)",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "heading heading < ASSOCIATION>",
      "text": "Row 1: subjects subjects / Row 2: invited subjects",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "heading heading < ASSOCIATION>",
      "text": "Row 1: Row Row 2: Row Row 3: (exposure exposure factor)",
      "start_page": 630,
      "end_page": 630
    }
  ]
}